DrugA,DrugB,Interaction,Mechanism,risk_level
Cinolazepam,Gepirone,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Gepirone.,increase,risk
Cinolazepam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Cinolazepam.,increase,risk
Cinolazepam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cinolazepam.,increase,risk
Cinolazepam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cinolazepam.,increase,risk
Cinolazepam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cinolazepam.,increase,risk
Cinolazepam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Cinolazepam.,increase,risk
Cinolazepam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cinolazepam.,increase,risk
Cinolazepam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cinolazepam.,increase,risk
Cinolazepam,Hydrocodone,Cinolazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cinolazepam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Cinolazepam.,increase,risk
Cinolazepam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cinolazepam.,increase,no risk
Cinolazepam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Cinolazepam.,increase,risk
Cinolazepam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Cinolazepam.,increase,risk
Cinolazepam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cinolazepam.,increase,risk
Cinolazepam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cinolazepam is combined with Oliceridine.",increase,risk
Cinolazepam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Cinolazepam.,increase,risk
Cinolazepam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Cinolazepam.,increase,risk
Cinolazepam,Orphenadrine,Cinolazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cinolazepam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Cinolazepam.,increase,risk
Cinolazepam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Cinolazepam.,increase,risk
Cinolazepam,Oxitriptan,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Oxitriptan.,increase,risk
Cinolazepam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Cinolazepam.,increase,risk
Cinolazepam,Oxtriphylline,The therapeutic efficacy of Cinolazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Cinolazepam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Cinolazepam.,increase,risk
Cinolazepam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Cinolazepam.,increase,risk
Cinolazepam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Cinolazepam.,increase,risk
Cinolazepam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Cinolazepam.,increase,risk
Cinolazepam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Cinolazepam.,increase,risk
Cinolazepam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Cinolazepam.,increase,risk
Cinolazepam,Quinupramine,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Quinupramine.,increase,risk
Cinolazepam,Urethane,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Urethane.,increase,risk
Cinolazepam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Cinolazepam.,increase,risk
Cinolazepam,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Cinolazepam.,increase,risk
Cinolazepam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Cinolazepam.,increase,risk
Cinolazepam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Cinolazepam.,increase,risk
Cinolazepam,Vilazodone,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Vilazodone.,increase,risk
Cinolazepam,Viloxazine,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Viloxazine.,increase,risk
Cinolazepam,Voriconazole,The serum concentration of Cinolazepam can be increased when it is combined with Voriconazole.,increase,no risk
Cinolazepam,Vortioxetine,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Vortioxetine.,increase,risk
Cinolazepam,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Cinolazepam.,increase,risk
Cinolazepam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Cinolazepam.,increase,risk
Cinolazepam,Ziconotide,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Ziconotide.,increase,risk
Cinolazepam,Zimelidine,The risk or severity of adverse effects can be increased when Cinolazepam is combined with Zimelidine.,increase,risk
Cinolazepam,Ziprasidone,The risk or severity of adverse effects can be increased when Cinolazepam is combined with Ziprasidone.,increase,risk
Cinolazepam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Cinolazepam.,increase,risk
Cinolazepam,Zolpidem,Cinolazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cinolazepam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Cinolazepam.,increase,risk
Cinolazepam,Zopiclone,The risk or severity of adverse effects can be increased when Cinolazepam is combined with Zopiclone.,increase,risk
Cinolazepam,Zotepine,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Zotepine.,increase,risk
Cinolazepam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Cinolazepam is combined with Zuclopenthixol.,increase,risk
Cinolazepam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cinolazepam.,increase,risk
Nitrazepam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Nitrazepam.,increase,risk
Nitrazepam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Gabapentin enacarbil.,increase,risk
Nitrazepam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Nitrazepam.,increase,risk
Nitrazepam,Gamolenic acid,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Nitrazepam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Nitrazepam is combined with Ganaxolone.",increase,risk
Nitrazepam,Ganciclovir,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Ganciclovir.,decrease,no risk
Nitrazepam,Gepirone,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Gepirone.,increase,risk
Nitrazepam,Gestrinone,The metabolism of Gestrinone can be increased when combined with Nitrazepam.,increase,no risk
Nitrazepam,Glofitamab,The serum concentration of Nitrazepam can be increased when it is combined with Glofitamab.,increase,no risk
Nitrazepam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Nitrazepam.,increase,risk
Nitrazepam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Nitrazepam.,increase,risk
Nitrazepam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Nitrazepam.,increase,risk
Nitrazepam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Nitrazepam.,increase,risk
Nitrazepam,Halofantrine,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Halofantrine.,decrease,no risk
Nitrazepam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Nitrazepam.,increase,risk
Nitrazepam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Nitrazepam.,increase,risk
Nitrazepam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Nitrazepam.,increase,risk
Nitrazepam,Hydrocodone,Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Nitrazepam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Nitrazepam.,increase,risk
Nitrazepam,Hydroxychloroquine,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Nitrazepam,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Nitrazepam.,increase,no risk
Nitrazepam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nitrazepam.,increase,no risk
Nitrazepam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Nitrazepam.,increase,risk
Nitrazepam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Nitrazepam.,increase,risk
Nitrazepam,Ketoconazole,The metabolism of Nitrazepam can be decreased when combined with Ketoconazole.,decrease,no risk
Nitrazepam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Nitrazepam.,increase,risk
Nitrazepam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Nitrazepam is combined with Oliceridine.",increase,risk
Nitrazepam,Omaveloxolone,The serum concentration of Nitrazepam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nitrazepam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nitrazepam.,increase,risk
Nitrazepam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Nitrazepam.,increase,risk
Nitrazepam,Orlistat,Orlistat can cause a decrease in the absorption of Nitrazepam resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nitrazepam,Orphenadrine,Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Nitrazepam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nitrazepam.,increase,risk
Nitrazepam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Nitrazepam.,increase,risk
Nitrazepam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nitrazepam is combined with Oxetacaine.,increase,risk
Nitrazepam,Oxitriptan,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Oxitriptan.,increase,risk
Nitrazepam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Nitrazepam.,increase,risk
Nitrazepam,Oxtriphylline,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Nitrazepam,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nitrazepam is combined with Oxybuprocaine.,increase,risk
Nitrazepam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Nitrazepam.,increase,risk
Nitrazepam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Nitrazepam.,increase,risk
Nitrazepam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Nitrazepam.,increase,risk
Nitrazepam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Nitrazepam.,increase,risk
Nitrazepam,Quinidine,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Quinidine.,decrease,no risk
Nitrazepam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Nitrazepam.,increase,risk
Nitrazepam,Quinupramine,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Quinupramine.,increase,risk
Nitrazepam,Ulipristal,The metabolism of Ulipristal can be increased when combined with Nitrazepam.,increase,no risk
Nitrazepam,Urethane,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Urethane.,increase,risk
Nitrazepam,Vadadustat,The serum concentration of Nitrazepam can be increased when it is combined with Vadadustat.,increase,no risk
Nitrazepam,Valganciclovir,The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Valganciclovir.,decrease,no risk
Nitrazepam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Nitrazepam.,increase,risk
Nitrazepam,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nitrazepam.,increase,risk
Nitrazepam,Venetoclax,The metabolism of Nitrazepam can be decreased when combined with Venetoclax.,decrease,no risk
Nitrazepam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Nitrazepam.,increase,risk
Nitrazepam,Verapamil,The metabolism of Nitrazepam can be decreased when combined with Verapamil.,decrease,no risk
Nitrazepam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Nitrazepam.,increase,risk
Nitrazepam,Vilazodone,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Vilazodone.,increase,risk
Nitrazepam,Viloxazine,The metabolism of Nitrazepam can be decreased when combined with Viloxazine.,decrease,no risk
Nitrazepam,Voriconazole,The serum concentration of Nitrazepam can be increased when it is combined with Voriconazole.,increase,no risk
Nitrazepam,Vortioxetine,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Vortioxetine.,increase,risk
Nitrazepam,Yohimbine,The therapeutic efficacy of Nitrazepam can be increased when used in combination with Yohimbine.,increase,no risk
Nitrazepam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Nitrazepam.,increase,risk
Nitrazepam,Ziconotide,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Ziconotide.,increase,risk
Nitrazepam,Zimelidine,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Zimelidine.,increase,risk
Nitrazepam,Ziprasidone,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Ziprasidone.,increase,risk
Nitrazepam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Nitrazepam.,increase,risk
Nitrazepam,Zolpidem,Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Nitrazepam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nitrazepam.,increase,risk
Nitrazepam,Zopiclone,The risk or severity of adverse effects can be increased when Nitrazepam is combined with Zopiclone.,increase,risk
Nitrazepam,Zotepine,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Zotepine.,increase,risk
Nitrazepam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Nitrazepam is combined with Zuclopenthixol.,increase,risk
Nitrazepam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Nitrazepam.,increase,risk
Cilastatin,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Cilastatin.,increase,no risk
Cilastatin,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Bumetanide,The excretion of Bumetanide can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Quinapril,The excretion of Quinapril can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Cilastatin.,increase,no risk
Cilastatin,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Valproic acid,The excretion of Valproic acid can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Cilastatin.,decrease,no risk
Cilastatin,Zidovudine,The excretion of Zidovudine can be decreased when combined with Cilastatin.,decrease,no risk
Imipenem,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Imipenem.,decrease,no risk
Imipenem,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Oxetacaine.,increase,risk
Imipenem,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Imipenem is combined with Oxybuprocaine.,increase,risk
Imipenem,Quinupramine,Imipenem may increase the neurotoxic activities of Quinupramine.,increase,no risk
Imipenem,Valganciclovir,The risk or severity of generalized seizure can be increased when Valganciclovir is combined with Imipenem.,increase,risk
Imipenem,Valproate bismuth,Imipenem may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Imipenem,Valproic acid,The serum concentration of Valproic acid can be decreased when it is combined with Imipenem.,decrease,no risk
Imipenem,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Imipenem.,decrease,no risk
Imipenem,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Imipenem.,decrease,no risk
Imipenem,Vincristine,Vincristine may increase the neurotoxic activities of Imipenem.,increase,no risk
Imipenem,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Imipenem.,increase,no risk
Imipenem,Viomycin,Imipenem may increase the neurotoxic activities of Viomycin.,increase,no risk
Imipenem,Warfarin,The risk or severity of bleeding can be increased when Imipenem is combined with Warfarin.,increase,risk
Imipenem,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Imipenem.,decrease,no risk
Imipenem,Ziprasidone,Ziprasidone may increase the neurotoxic activities of Imipenem.,increase,no risk
Imipenem,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Imipenem.,decrease,no risk
Imipenem,Zotepine,Imipenem may increase the neurotoxic activities of Zotepine.,increase,no risk
Imipenem,Zuclopenthixol,Imipenem may increase the neurotoxic activities of Zuclopenthixol.,increase,no risk
Probucol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Probucol.,increase,risk
Probucol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Probucol.,increase,risk
Probucol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Probucol.,increase,risk
Probucol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Probucol.,increase,risk
Probucol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Probucol.,increase,risk
Probucol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Probucol is combined with Gilteritinib.,increase,risk
Probucol,Glasdegib,The risk or severity of QTc prolongation can be increased when Probucol is combined with Glasdegib.,increase,risk
Probucol,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Probucol.,increase,risk
Probucol,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Probucol.,increase,risk
Probucol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Probucol is combined with Grepafloxacin.,increase,risk
Probucol,Halofantrine,The risk or severity of QTc prolongation can be increased when Probucol is combined with Halofantrine.,increase,risk
Probucol,Haloperidol,The risk or severity of QTc prolongation can be increased when Probucol is combined with Haloperidol.,increase,risk
Probucol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Probucol.,increase,risk
Probucol,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Probucol.,increase,risk
Probucol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Probucol.,increase,risk
Probucol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Probucol is combined with Hydroxyzine.,increase,risk
Probucol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Probucol.,increase,risk
Probucol,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Probucol.,increase,risk
Probucol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Probucol.,increase,risk
Probucol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Probucol.,increase,risk
Probucol,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Probucol.,increase,risk
Probucol,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Probucol.,increase,risk
Probucol,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Probucol.,increase,risk
Probucol,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Probucol.,increase,risk
Probucol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Probucol.,increase,risk
Probucol,Oxatomide,The risk or severity of QTc prolongation can be increased when Probucol is combined with Oxatomide.,increase,risk
Probucol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Probucol.,increase,risk
Probucol,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Probucol.,increase,risk
Probucol,Quinidine,The risk or severity of QTc prolongation can be increased when Probucol is combined with Quinidine.,increase,risk
Probucol,Quinine,The risk or severity of QTc prolongation can be increased when Probucol is combined with Quinine.,increase,risk
Probucol,Quizartinib,The risk or severity of QTc prolongation can be increased when Probucol is combined with Quizartinib.,increase,risk
Probucol,Valproic acid,The risk or severity of QTc prolongation can be increased when Probucol is combined with Valproic acid.,increase,risk
Probucol,Vandetanib,The risk or severity of QTc prolongation can be increased when Probucol is combined with Vandetanib.,increase,risk
Probucol,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Probucol.,increase,risk
Probucol,Vemurafenib,The risk or severity of QTc prolongation can be increased when Probucol is combined with Vemurafenib.,increase,risk
Probucol,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Probucol.,increase,risk
Probucol,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Probucol.,increase,risk
Probucol,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Probucol.,increase,risk
Probucol,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Probucol.,increase,risk
Probucol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Probucol is combined with Ziprasidone.,increase,risk
Probucol,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Probucol.,increase,risk
Probucol,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Probucol is combined with Zuclopenthixol.,increase,risk
Tiaprofenic acid,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tiaprofenic acid.,decrease,no risk
Tiaprofenic acid,Bismuth subgallate,Tiaprofenic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tiaprofenic acid.,decrease,no risk
Tiaprofenic acid,Bisoprolol,Tiaprofenic acid may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Tiaprofenic acid,Bisoxatin,Tiaprofenic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Bivalirudin.,increase,risk
Tiaprofenic acid,Bleomycin,Tiaprofenic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Tiaprofenic acid.,decrease,no risk
Tiaprofenic acid,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Tiaprofenic acid.,decrease,no risk
Tiaprofenic acid,Brexpiprazole,The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Brexpiprazole.,increase,risk
Tiaprofenic acid,Brivaracetam,Tiaprofenic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Bromazepam,Tiaprofenic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Tiaprofenic acid.,increase,risk
Tiaprofenic acid,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Tiaprofenic acid.,increase,risk
Tiaprofenic acid,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Tiaprofenic acid.,increase,risk
Tiaprofenic acid,Bufexamac,The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Bufexamac.,increase,risk
Tiaprofenic acid,Bumadizone,The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Bumadizone.,increase,risk
Tiaprofenic acid,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Tiaprofenic acid.,decrease,no risk
Tiaprofenic acid,Bupropion,Tiaprofenic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Tiaprofenic acid.,increase,risk
Tiaprofenic acid,Butabarbital,Tiaprofenic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Tiaprofenic acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Tiaprofenic acid.,increase,risk
Lopinavir,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Lopinavir.,increase,risk
Lopinavir,Baclofen,Lopinavir may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Lopinavir,Balsalazide,The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Lopinavir.,increase,risk
Lopinavir,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Basiliximab,The serum concentration of Basiliximab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Beclomethasone dipropionate,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Belatacept,The serum concentration of Belatacept can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Belimumab,The serum concentration of Belimumab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Belumosudil,The serum concentration of Belumosudil can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bempedoic acid,The excretion of Bempedoic acid can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Benorilate,The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Benorilate.,increase,risk
Lopinavir,Benoxaprofen,The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Benoxaprofen.,increase,risk
Lopinavir,Benserazide,Lopinavir may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Lopinavir,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lopinavir.,increase,risk
Lopinavir,Benznidazole,Lopinavir may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Lopinavir,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Benzydamine,The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Benzydamine.,increase,risk
Lopinavir,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bepotastine,Lopinavir may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Lopinavir,Bepridil,The metabolism of Bepridil can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Bexarotene,The serum concentration of Bexarotene can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bicisate,Lopinavir may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lopinavir,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bilastine,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Bilastine.,increase,risk
Lopinavir,Bimekizumab,The serum concentration of Bimekizumab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bismuth subgallate,Lopinavir may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lopinavir,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lopinavir,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bisoxatin,Lopinavir may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lopinavir,Bleomycin,The serum concentration of Bleomycin can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Blinatumomab,The serum concentration of Blinatumomab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Boceprevir,The serum concentration of Lopinavir can be decreased when it is combined with Boceprevir.,decrease,no risk
Lopinavir,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bosentan,The serum concentration of Bosentan can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lopinavir.,increase,risk
Lopinavir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Brodalumab,The serum concentration of Brodalumab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bromazepam,Lopinavir may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Lopinavir,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Lopinavir.,increase,risk
Lopinavir,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Lopinavir.,increase,risk
Lopinavir,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Bumadizone,The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Bumadizone.,increase,risk
Lopinavir,Bumetanide,The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Lopinavir.,increase,risk
Lopinavir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Bupropion,The serum concentration of Bupropion can be decreased when it is combined with Lopinavir.,decrease,no risk
Lopinavir,Buserelin,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Buserelin.,increase,risk
Lopinavir,Buspirone,The metabolism of Buspirone can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Butabarbital,Lopinavir may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Lopinavir,Butriptyline,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Butriptyline.,increase,risk
Lopinavir,Gabapentin enacarbil,Lopinavir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Lopinavir,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Gadobenic acid.,increase,risk
Lopinavir,Gadodiamide,Lopinavir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Lopinavir,Gadofosveset trisodium,Lopinavir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lopinavir,Gadopentetic acid,Lopinavir may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Lopinavir,Gadoteric acid,Lopinavir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lopinavir,Gadoteridol,Lopinavir may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Lopinavir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Galantamine,The metabolism of Galantamine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Ganciclovir,Lopinavir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Lopinavir,Garlic,Garlic can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lopinavir,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lopinavir.,increase,risk
Lopinavir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Gemifloxacin.,increase,risk
Lopinavir,Gemtuzumab ozogamicin,The serum concentration of Gemtuzumab ozogamicin can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Gentamicin,Lopinavir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lopinavir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Lopinavir.,decrease,no risk
Lopinavir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Gimeracil,Lopinavir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lopinavir,Givosiran,The risk or severity of nephrotoxicity can be increased when Lopinavir is combined with Givosiran.,increase,risk
Lopinavir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Glatiramer,The serum concentration of Glatiramer can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Glofitamab,The serum concentration of Lopinavir can be increased when it is combined with Glofitamab.,increase,no risk
Lopinavir,Glyburide,The metabolism of Glyburide can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Glycerol phenylbutyrate,Lopinavir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Lopinavir,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Golimumab,The serum concentration of Golimumab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Golodirsen,Lopinavir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Lopinavir,Goserelin,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Goserelin.,increase,risk
Lopinavir,Granisetron,The metabolism of Granisetron can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Guanethidine,Lopinavir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Lopinavir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Guselkumab,The serum concentration of Guselkumab can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Halcinonide,The serum concentration of Halcinonide can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Haloperidol,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Haloperidol.,increase,risk
Lopinavir,Halothane,The metabolism of Halothane can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Histrelin,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Histrelin.,increase,risk
Lopinavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Lopinavir.,decrease,no risk
Lopinavir,Hydralazine,Lopinavir may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Lopinavir,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Lopinavir.,increase,risk
Lopinavir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydromorphone,Lopinavir may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Lopinavir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Lopinavir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lopinavir,Hydroxocobalamin,Lopinavir may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Lopinavir,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydroxyethyl Starch,Lopinavir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Lopinavir,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Lopinavir.,decrease,no risk
Lopinavir,Hydroxyurea,The serum concentration of Hydroxyurea can be increased when it is combined with Lopinavir.,increase,no risk
Lopinavir,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Hydroxyzine.,increase,risk
Lopinavir,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lopinavir.,increase,risk
Lopinavir,Kanamycin,Lopinavir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Lopinavir,Ketamine,The metabolism of Ketamine can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Lopinavir.,decrease,no risk
Lopinavir,Ketoconazole,The serum concentration of Lopinavir can be increased when it is combined with Ketoconazole.,increase,no risk
Lopinavir,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Lopinavir.,increase,risk
Lopinavir,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Lopinavir.,increase,risk
Deferasirox,Gemfibrozil,The metabolism of Deferasirox can be decreased when combined with Gemfibrozil.,decrease,no risk
Deferasirox,Gestrinone,The metabolism of Gestrinone can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Glecaprevir,The metabolism of Deferasirox can be decreased when combined with Glecaprevir.,decrease,no risk
Deferasirox,Glipizide,The metabolism of Glipizide can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Glycol salicylate,The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Glycol salicylate is combined with Deferasirox.,increase,risk
Deferasirox,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Guanabenz,The serum concentration of Guanabenz can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Heparin,The risk or severity of gastrointestinal bleeding can be increased when Heparin is combined with Deferasirox.,increase,risk
Deferasirox,Hydrocortisone,The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Hydrocortisone is combined with Deferasirox.,increase,risk
Deferasirox,Hydrocortisone acetate,The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Deferasirox.,increase,risk
Deferasirox,Hydrocortisone butyrate,The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Deferasirox.,increase,risk
Deferasirox,Hydrocortisone cypionate,The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Deferasirox.,increase,risk
Deferasirox,Hydrocortisone succinate,The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Deferasirox.,increase,risk
Deferasirox,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Kaolin,Kaolin can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Ketamine,The metabolism of Ketamine can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Ketoconazole,The metabolism of Deferasirox can be decreased when combined with Ketoconazole.,decrease,no risk
Deferasirox,Ketoprofen,The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Ketoprofen is combined with Deferasirox.,increase,risk
Deferasirox,Ketorolac,The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Ketorolac is combined with Deferasirox.,increase,risk
Deferasirox,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Olaparib,The metabolism of Olaparib can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Deferasirox.,decrease,no risk
Deferasirox,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Ombitasvir,The metabolism of Deferasirox can be decreased when combined with Ombitasvir.,decrease,no risk
Deferasirox,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Osimertinib,The metabolism of Osimertinib can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Oxaprozin,The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Oxaprozin is combined with Deferasirox.,increase,risk
Deferasirox,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Oxyphenbutazone is combined with Deferasirox.,increase,risk
Deferasirox,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Quinidine,The metabolism of Quinidine can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Quinine,The serum concentration of Quinine can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Quizartinib,The metabolism of Deferasirox can be decreased when combined with Quizartinib.,decrease,no risk
Deferasirox,Ulipristal,The metabolism of Ulipristal can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Urokinase,The risk or severity of gastrointestinal bleeding can be increased when Urokinase is combined with Deferasirox.,increase,risk
Deferasirox,Vadadustat,The metabolism of Vadadustat can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Valdecoxib,The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Valdecoxib is combined with Deferasirox.,increase,risk
Deferasirox,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Vamorolone,The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Vamorolone is combined with Deferasirox.,increase,risk
Deferasirox,Vandetanib,The metabolism of Vandetanib can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Venetoclax,The metabolism of Venetoclax can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Vericiguat,The metabolism of Vericiguat can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Vinblastine,The metabolism of Vinblastine can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Vincristine,The metabolism of Vincristine can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Vindesine,The metabolism of Vindesine can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Vinflunine,The metabolism of Vinflunine can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Vorapaxar,The risk or severity of gastrointestinal bleeding can be increased when Vorapaxar is combined with Deferasirox.,increase,risk
Deferasirox,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Warfarin,The risk or severity of gastrointestinal bleeding can be increased when Warfarin is combined with Deferasirox.,increase,risk
Deferasirox,Ximelagatran,The risk or severity of gastrointestinal bleeding can be increased when Ximelagatran is combined with Deferasirox.,increase,risk
Deferasirox,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Zidovudine,The metabolism of Deferasirox can be increased when combined with Zidovudine.,increase,no risk
Deferasirox,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Zinc,Zinc can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferasirox,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Deferasirox,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Zoledronic acid,The risk or severity of gastrointestinal bleeding and gastrointestinal ulceration can be increased when Zoledronic acid is combined with Deferasirox.,increase,risk
Deferasirox,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Zolpidem,The metabolism of Zolpidem can be increased when combined with Deferasirox.,increase,no risk
Deferasirox,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Deferasirox.,decrease,no risk
Deferasirox,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Deferasirox.,increase,no risk
Deferasirox,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Deferasirox.,increase,no risk
Valganciclovir,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Gabapentin enacarbil,Valganciclovir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gadodiamide,Gadodiamide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gadofosveset trisodium,Valganciclovir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gadoteric acid,Valganciclovir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gadoteridol,Gadoteridol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Ganciclovir,Ganciclovir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gemcitabine,Gemcitabine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gentamicin,Valganciclovir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Valganciclovir,Gimeracil,Valganciclovir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Valganciclovir,Givosiran,Givosiran may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Glipizide,Glipizide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Glycerol phenylbutyrate,Valganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Valganciclovir,Golodirsen,Valganciclovir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Valganciclovir,Goserelin,Goserelin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Guanethidine,Guanethidine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Guanfacine,Guanfacine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Haloperidol,Haloperidol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Hydralazine,Hydralazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valganciclovir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valganciclovir,Hydromorphone,Hydromorphone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Valganciclovir.,increase,risk
Valganciclovir,Hydroxyethyl Starch,Valganciclovir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Valganciclovir,Kanamycin,Valganciclovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Valganciclovir,Ketamine,Ketamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Ketazolam,Ketazolam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Ketoprofen,Ketoprofen may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Ketorolac,Ketorolac may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Octinoxate,Valganciclovir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Valganciclovir,Olsalazine,Olsalazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Opium,Valganciclovir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oseltamivir,Oseltamivir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oxacillin,Oxacillin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oxaprozin,Oxaprozin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oxazepam,Oxazepam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Oxybenzone,Oxybenzone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Oxyquinoline,Valganciclovir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Valganciclovir,Quetiapine,Quetiapine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Quinethazone,Quinethazone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valganciclovir,Quinidine,Valganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Valganciclovir,Vaborbactam,Valganciclovir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Valganciclovir,Valaciclovir,Valaciclovir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Valbenazine,Valganciclovir may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Valganciclovir,Valdecoxib,Valdecoxib may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Vancomycin,Valganciclovir may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Valganciclovir,Varenicline,Varenicline may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Venlafaxine,Venlafaxine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Verapamil,Verapamil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Vilanterol,Valganciclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Valganciclovir,Viloxazine,Valganciclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Valganciclovir,Vortioxetine,Valganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Valganciclovir,Warfarin,Valganciclovir may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Valganciclovir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Zalcitabine,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Zalcitabine.,increase,risk
Valganciclovir,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valganciclovir,Zanamivir,Zanamivir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Valganciclovir,Zidovudine,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Zidovudine.,increase,risk
Valganciclovir,Zonisamide,Zonisamide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydroxychloroquine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Benzocaine.,increase,risk
Hydroxychloroquine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Benzyl alcohol.,increase,risk
Hydroxychloroquine,Bepridil,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Bepridil.,increase,risk
Hydroxychloroquine,Berotralstat,The metabolism of Hydroxychloroquine can be decreased when combined with Berotralstat.,decrease,no risk
Hydroxychloroquine,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Betaxolol,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Betaxolol.,decrease,risk
Hydroxychloroquine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Bezafibrate,The metabolism of Hydroxychloroquine can be decreased when combined with Bezafibrate.,decrease,no risk
Hydroxychloroquine,Bilastine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Bilastine.,increase,risk
Hydroxychloroquine,Bimekizumab,The metabolism of Hydroxychloroquine can be increased when combined with Bimekizumab.,increase,no risk
Hydroxychloroquine,Biperiden,The metabolism of Hydroxychloroquine can be decreased when combined with Biperiden.,decrease,no risk
Hydroxychloroquine,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Hydroxychloroquine,Bisoprolol,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bisoprolol.,decrease,risk
Hydroxychloroquine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Blinatumomab,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Blinatumomab.,increase,risk
Hydroxychloroquine,Boceprevir,The metabolism of Hydroxychloroquine can be decreased when combined with Boceprevir.,decrease,no risk
Hydroxychloroquine,Borage oil,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Borage oil.,increase,risk
Hydroxychloroquine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Hydroxychloroquine.",decrease,no risk
Hydroxychloroquine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Bosutinib,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Bosutinib.,increase,risk
Hydroxychloroquine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brentuximab vedotin.,increase,risk
Hydroxychloroquine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Brodalumab,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brodalumab.,increase,risk
Hydroxychloroquine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Bupivacaine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Bupivacaine.,increase,risk
Hydroxychloroquine,Buprenorphine,The metabolism of Hydroxychloroquine can be decreased when combined with Buprenorphine.,decrease,no risk
Hydroxychloroquine,Bupropion,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Bupropion.,increase,risk
Hydroxychloroquine,Buserelin,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Buserelin.,increase,risk
Hydroxychloroquine,Buspirone,The metabolism of Buspirone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Butacaine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Butacaine.,increase,risk
Hydroxychloroquine,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Butamben,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Butamben.,increase,risk
Hydroxychloroquine,Butaperazine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Butaperazine.,increase,risk
Hydroxychloroquine,Butriptyline,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Butriptyline.,increase,risk
Hydroxychloroquine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Gadobenic acid.,increase,risk
Hydroxychloroquine,Galantamine,The metabolism of Galantamine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Gamolenic acid,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Gamolenic acid.,increase,risk
Hydroxychloroquine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Ganciclovir,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Ganciclovir.,increase,risk
Hydroxychloroquine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Gemfibrozil,The metabolism of Hydroxychloroquine can be decreased when combined with Gemfibrozil.,decrease,no risk
Hydroxychloroquine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Gemifloxacin.,increase,risk
Hydroxychloroquine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Gilteritinib.,increase,risk
Hydroxychloroquine,Givosiran,The serum concentration of Hydroxychloroquine can be increased when it is combined with Givosiran.,increase,no risk
Hydroxychloroquine,Glasdegib,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Glasdegib.,increase,risk
Hydroxychloroquine,Glatiramer,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Glatiramer.,increase,risk
Hydroxychloroquine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Glofitamab,The serum concentration of Hydroxychloroquine can be increased when it is combined with Glofitamab.,increase,no risk
Hydroxychloroquine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Glycerol phenylbutyrate,The metabolism of Hydroxychloroquine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Hydroxychloroquine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Golimumab,The metabolism of Hydroxychloroquine can be increased when combined with Golimumab.,increase,no risk
Hydroxychloroquine,Goserelin,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Goserelin.,increase,risk
Hydroxychloroquine,Granisetron,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Granisetron.,increase,risk
Hydroxychloroquine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Grepafloxacin.,increase,risk
Hydroxychloroquine,Guselkumab,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Guselkumab.,increase,risk
Hydroxychloroquine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Halofantrine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Halofantrine.,increase,risk
Hydroxychloroquine,Haloperidol,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Haloperidol.,increase,risk
Hydroxychloroquine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Histrelin,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Histrelin.,increase,risk
Hydroxychloroquine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Hydrocortisone,The metabolism of Hydroxychloroquine can be increased when combined with Hydrocortisone.,increase,no risk
Hydroxychloroquine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Hydrocortisone acetate.,increase,risk
Hydroxychloroquine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Hydrocortisone butyrate.,increase,risk
Hydroxychloroquine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Hydrocortisone succinate.,increase,risk
Hydroxychloroquine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Hydroxychloroquine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Hydroxyzine.,increase,risk
Hydroxychloroquine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Kaolin,Kaolin can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Hydroxychloroquine,Ketamine,The metabolism of Hydroxychloroquine can be decreased when combined with Ketamine.,decrease,no risk
Hydroxychloroquine,Ketoconazole,The metabolism of Hydroxychloroquine can be decreased when combined with Ketoconazole.,decrease,no risk
Hydroxychloroquine,Ketoprofen,The metabolism of Hydroxychloroquine can be decreased when combined with Ketoprofen.,decrease,no risk
Hydroxychloroquine,Ketorolac,The metabolism of Hydroxychloroquine can be decreased when combined with Ketorolac.,decrease,no risk
Hydroxychloroquine,Obinutuzumab,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Obinutuzumab.,increase,risk
Hydroxychloroquine,Ocrelizumab,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ocrelizumab.,increase,risk
Hydroxychloroquine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Ofatumumab,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ofatumumab.,increase,risk
Hydroxychloroquine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Ofloxacin.,increase,risk
Hydroxychloroquine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Olaparib,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Olaparib.,increase,risk
Hydroxychloroquine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Omaveloxolone,The serum concentration of Hydroxychloroquine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Hydroxychloroquine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Opium,The metabolism of Opium can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Oritavancin,The metabolism of Hydroxychloroquine can be decreased when combined with Oritavancin.,decrease,no risk
Hydroxychloroquine,Orphenadrine,The metabolism of Hydroxychloroquine can be decreased when combined with Orphenadrine.,decrease,no risk
Hydroxychloroquine,Osilodrostat,The metabolism of Hydroxychloroquine can be decreased when combined with Osilodrostat.,decrease,no risk
Hydroxychloroquine,Ospemifene,The metabolism of Hydroxychloroquine can be decreased when combined with Ospemifene.,decrease,no risk
Hydroxychloroquine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Oxamniquine,The metabolism of Hydroxychloroquine can be decreased when combined with Oxamniquine.,decrease,no risk
Hydroxychloroquine,Oxatomide,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Oxatomide.,increase,risk
Hydroxychloroquine,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Oxetacaine.,increase,risk
Hydroxychloroquine,Oxprenolol,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Oxprenolol.,decrease,risk
Hydroxychloroquine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Oxybuprocaine.,increase,risk
Hydroxychloroquine,Oxybutynin,The metabolism of Hydroxychloroquine can be decreased when combined with Oxybutynin.,decrease,no risk
Hydroxychloroquine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Hydroxychloroquine.,increase,risk
Hydroxychloroquine,Ozanimod,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ozanimod.,increase,risk
Hydroxychloroquine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Hydroxychloroquine,Quinidine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Quinidine.,increase,risk
Hydroxychloroquine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Hydroxychloroquine,Quinupramine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Quinupramine.,increase,risk
Hydroxychloroquine,Quizartinib,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Quizartinib.,increase,risk
Amyl Nitrite,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Obinutuzumab,The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Obinutuzumab.,increase,risk
Amyl Nitrite,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Opicapone,The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Opicapone.,increase,risk
Amyl Nitrite,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Amyl Nitrite.,increase,risk
Amyl Nitrite,Verapamil,Verapamil may increase the vasodilatory activities of Amyl Nitrite.,increase,no risk
Amyl Nitrite,Vericiguat,The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Vericiguat.,increase,risk
Amyl Nitrite,Zofenopril,Amyl Nitrite may increase the hypotensive activities of Zofenopril.,increase,no risk
Amyl Nitrite,Zonisamide,Zonisamide may increase the vasodilatory activities of Amyl Nitrite.,increase,no risk
Amyl Nitrite,Zopiclone,The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Amyl Nitrite.,increase,risk
Erythrityl tetranitrate,Bepridil,Bepridil may increase the vasodilatory activities of Erythrityl tetranitrate.,increase,no risk
Erythrityl tetranitrate,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Erythrityl tetranitrate.,increase,risk
Erythrityl tetranitrate,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Erythrityl tetranitrate.,increase,risk
Erythrityl tetranitrate,Verapamil,Verapamil may increase the vasodilatory activities of Erythrityl tetranitrate.,increase,no risk
Erythrityl tetranitrate,Zonisamide,Zonisamide may increase the vasodilatory activities of Erythrityl tetranitrate.,increase,no risk
Acepromazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Acepromazine.,increase,risk
Acepromazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Acepromazine is combined with Gabapentin enacarbil.,increase,risk
Acepromazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Acepromazine.,increase,risk
Acepromazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Acepromazine is combined with Ganaxolone.",increase,risk
Acepromazine,Gepirone,The risk or severity of CNS depression can be increased when Acepromazine is combined with Gepirone.,increase,risk
Acepromazine,Gilteritinib,The therapeutic efficacy of Acepromazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Acepromazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Acepromazine.,decrease,no risk
Acepromazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Acepromazine.,decrease,no risk
Acepromazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Acepromazine.,decrease,no risk
Acepromazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Acepromazine.,decrease,no risk
Acepromazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Acepromazine.,increase,risk
Acepromazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Acepromazine.,decrease,no risk
Acepromazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Acepromazine.,increase,risk
Acepromazine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Acepromazine.,decrease,no risk
Acepromazine,Guanadrel,Acepromazine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Acepromazine,Guanethidine,Acepromazine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Aceprometazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Aceprometazine.,increase,risk
Aceprometazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Aceprometazine is combined with Gabapentin enacarbil.,increase,risk
Aceprometazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Aceprometazine.,increase,risk
Aceprometazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Aceprometazine.,increase,risk
Aceprometazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Aceprometazine.,increase,risk
Aceprometazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Aceprometazine is combined with Ganaxolone.",increase,risk
Aceprometazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Aceprometazine.,increase,risk
Aceprometazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Aceprometazine.,increase,risk
Aceprometazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Aceprometazine.,increase,risk
Aceprometazine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Gilteritinib.,increase,risk
Aceprometazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Glasdegib.,increase,risk
Aceprometazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Aceprometazine.,increase,risk
Aceprometazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Aceprometazine.,increase,risk
Aceprometazine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Aceprometazine.,increase,risk
Aceprometazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Grepafloxacin.,increase,risk
Aceprometazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Aceprometazine.,increase,risk
Aceprometazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Aceprometazine.,increase,risk
Aceprometazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Aceprometazine.,increase,risk
Aceprometazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Haloperidol.,increase,risk
Aceprometazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Aceprometazine.,increase,risk
Aceprometazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Aceprometazine.,increase,risk
Aceprometazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Aceprometazine.,increase,risk
Aceprometazine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Aceprometazine.,increase,risk
Aceprometazine,Hydrocodone,Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Aceprometazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Aceprometazine is combined with Hydromorphone.,increase,risk
Aceprometazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aceprometazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Aceprometazine.,increase,risk
Aceprometazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Hydroxyzine.,increase,risk
Aceprometazine,Hyoscyamine,Aceprometazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Aceprometazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Aceprometazine.,increase,risk
Aceprometazine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Aceprometazine.,increase,risk
Aceprometazine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Aceprometazine.,increase,risk
Aceprometazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Aceprometazine.,increase,risk
Aceprometazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Aceprometazine.,increase,risk
Aceprometazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Aceprometazine.,increase,risk
Aceprometazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Aceprometazine is combined with Oliceridine.",increase,risk
Aceprometazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Aceprometazine.,increase,risk
Aceprometazine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Aceprometazine.,increase,risk
Aceprometazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Aceprometazine is combined with Opium.,increase,risk
Aceprometazine,Orphenadrine,Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Aceprometazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Aceprometazine.,increase,risk
Aceprometazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Oxatomide.,increase,risk
Aceprometazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Aceprometazine.,increase,risk
Aceprometazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Aceprometazine.,increase,risk
Aceprometazine,Oxitriptan,The risk or severity of CNS depression can be increased when Aceprometazine is combined with Oxitriptan.,increase,risk
Aceprometazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Aceprometazine.,increase,no risk
Aceprometazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Aceprometazine.,increase,risk
Aceprometazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Aceprometazine is combined with Oxycodone.,increase,risk
Aceprometazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Aceprometazine is combined with Oxymorphone.,increase,risk
Aceprometazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Aceprometazine.,increase,risk
Aceprometazine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Aceprometazine.,increase,risk
Aceprometazine,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Aceprometazine.,increase,risk
Aceprometazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Aceprometazine.,decrease,no risk
Aceprometazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Aceprometazine.,increase,risk
Aceprometazine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Aceprometazine.,increase,risk
Aceprometazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Aceprometazine.,increase,no risk
Aceprometazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Quizartinib.,increase,risk
Aceprometazine,Urethane,The risk or severity of CNS depression can be increased when Aceprometazine is combined with Urethane.,increase,risk
Aceprometazine,Valproate bismuth,Aceprometazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Aceprometazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Valproic acid.,increase,risk
Aceprometazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Vandetanib.,increase,risk
Aceprometazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Aceprometazine.,increase,risk
Aceprometazine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Aceprometazine.,increase,risk
Aceprometazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Vemurafenib.,increase,risk
Aceprometazine,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Aceprometazine.,increase,risk
Aceprometazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Aceprometazine.,increase,risk
Aceprometazine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Aceprometazine.,increase,risk
Aceprometazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Aceprometazine.,increase,risk
Aceprometazine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Aceprometazine.,increase,risk
Aceprometazine,Viloxazine,The risk or severity of CNS depression can be increased when Aceprometazine is combined with Viloxazine.,increase,risk
Aceprometazine,Vincristine,Vincristine may increase the neurotoxic activities of Aceprometazine.,increase,no risk
Aceprometazine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Aceprometazine.,increase,no risk
Aceprometazine,Viomycin,Aceprometazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Aceprometazine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Aceprometazine.,increase,risk
Aceprometazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Aceprometazine.,increase,risk
Aceprometazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Aceprometazine.,increase,risk
Aceprometazine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Aceprometazine.,increase,risk
Aceprometazine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Aceprometazine.,increase,risk
Aceprometazine,Ziconotide,The risk or severity of CNS depression can be increased when Aceprometazine is combined with Ziconotide.,increase,risk
Aceprometazine,Zimelidine,The risk or severity of adverse effects can be increased when Aceprometazine is combined with Zimelidine.,increase,risk
Aceprometazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Ziprasidone.,increase,risk
Aceprometazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Aceprometazine.,increase,risk
Aceprometazine,Zolpidem,Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Aceprometazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Aceprometazine.,increase,risk
Aceprometazine,Zopiclone,The risk or severity of adverse effects can be increased when Aceprometazine is combined with Zopiclone.,increase,risk
Aceprometazine,Zotepine,The risk or severity of CNS depression can be increased when Aceprometazine is combined with Zotepine.,increase,risk
Aceprometazine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Zuclopenthixol.,increase,risk
Aceprometazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Aceprometazine.,increase,risk
Alverine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Alverine.,increase,risk
Alverine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Alverine is combined with Gabapentin enacarbil.,increase,risk
Alverine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Alverine.,increase,risk
Alverine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Alverine is combined with Ganaxolone.",increase,risk
Alverine,Gepirone,The risk or severity of CNS depression can be increased when Alverine is combined with Gepirone.,increase,risk
Alverine,Gilteritinib,The therapeutic efficacy of Alverine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Alverine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Alverine.,increase,risk
Alverine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Alverine.,increase,risk
Alverine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Alverine.,increase,risk
Alverine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Alverine.,increase,risk
Alverine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Alverine.,increase,risk
Alverine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Alverine.,increase,risk
Alverine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Alverine.,increase,risk
Alverine,Hydrocodone,Alverine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Alverine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Alverine.,increase,risk
Alverine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alverine.,increase,no risk
Alverine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Alverine.,increase,risk
Alverine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Alverine.,increase,risk
Alverine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Alverine.,increase,risk
Alverine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Alverine is combined with Oliceridine.",increase,risk
Alverine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Alverine.,increase,risk
Alverine,Opium,The risk or severity of CNS depression can be increased when Alverine is combined with Opium.,increase,risk
Alverine,Orphenadrine,Alverine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Alverine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Alverine.,increase,risk
Alverine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Alverine.,increase,risk
Alverine,Oxitriptan,The risk or severity of CNS depression can be increased when Alverine is combined with Oxitriptan.,increase,risk
Alverine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Alverine.,increase,risk
Alverine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Alverine.,increase,risk
Alverine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Alverine.,increase,risk
Alverine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Alverine.,increase,risk
Alverine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Alverine.,increase,risk
Alverine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Alverine.,increase,risk
Alverine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Alverine.,increase,risk
Alverine,Quinupramine,The risk or severity of CNS depression can be increased when Alverine is combined with Quinupramine.,increase,risk
Alverine,Urethane,The risk or severity of CNS depression can be increased when Alverine is combined with Urethane.,increase,risk
Alverine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Alverine.,increase,risk
Alverine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Alverine.,increase,risk
Alverine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Alverine.,increase,risk
Alverine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Alverine.,increase,risk
Alverine,Vilazodone,The risk or severity of CNS depression can be increased when Alverine is combined with Vilazodone.,increase,risk
Alverine,Viloxazine,The risk or severity of CNS depression can be increased when Alverine is combined with Viloxazine.,increase,risk
Alverine,Vortioxetine,The risk or severity of CNS depression can be increased when Alverine is combined with Vortioxetine.,increase,risk
Alverine,Warfarin,The risk or severity of adverse effects can be increased when Alverine is combined with Warfarin.,increase,risk
Alverine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Alverine.,increase,risk
Alverine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Alverine.,increase,risk
Alverine,Ziconotide,The risk or severity of CNS depression can be increased when Alverine is combined with Ziconotide.,increase,risk
Alverine,Zimelidine,The risk or severity of adverse effects can be increased when Alverine is combined with Zimelidine.,increase,risk
Alverine,Ziprasidone,The risk or severity of adverse effects can be increased when Alverine is combined with Ziprasidone.,increase,risk
Alverine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Alverine.,increase,risk
Alverine,Zolpidem,Alverine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Alverine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Alverine.,increase,risk
Alverine,Zopiclone,The risk or severity of adverse effects can be increased when Alverine is combined with Zopiclone.,increase,risk
Alverine,Zotepine,The risk or severity of CNS depression can be increased when Alverine is combined with Zotepine.,increase,risk
Alverine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Alverine is combined with Zuclopenthixol.,increase,risk
Alverine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Alverine.,increase,risk
Molindone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Molindone.,increase,risk
Molindone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Molindone is combined with Gabapentin enacarbil.,increase,risk
Molindone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Molindone.,increase,risk
Molindone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Molindone is combined with Ganaxolone.",increase,risk
Molindone,Gepirone,The risk or severity of CNS depression can be increased when Molindone is combined with Gepirone.,increase,risk
Molindone,Gilteritinib,The therapeutic efficacy of Molindone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Molindone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Molindone.,increase,risk
Molindone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Molindone.,increase,risk
Molindone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Molindone.,increase,risk
Molindone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Molindone.,increase,risk
Molindone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Molindone.,increase,risk
Molindone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Molindone.,increase,risk
Molindone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Molindone.,increase,risk
Molindone,Hydrocodone,Molindone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Molindone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Molindone.,increase,risk
Molindone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Molindone.,increase,no risk
Molindone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Molindone.,increase,risk
Molindone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Molindone.,increase,risk
Molindone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Molindone.,increase,risk
Molindone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Molindone is combined with Oliceridine.",increase,risk
Molindone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Molindone.,increase,risk
Molindone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Molindone.,decrease,no risk
Molindone,Opium,The risk or severity of CNS depression can be increased when Molindone is combined with Opium.,increase,risk
Molindone,Orphenadrine,Molindone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Molindone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Molindone.,increase,risk
Molindone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Molindone.,increase,risk
Molindone,Oxitriptan,The risk or severity of CNS depression can be increased when Molindone is combined with Oxitriptan.,increase,risk
Molindone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Molindone.,increase,risk
Molindone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Molindone.,increase,risk
Molindone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Molindone.,increase,risk
Molindone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Molindone.,increase,risk
Molindone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Molindone.,increase,risk
Molindone,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Molindone.,increase,risk
Molindone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Molindone.,decrease,no risk
Molindone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Molindone.,increase,risk
Molindone,Quinupramine,The risk or severity of CNS depression can be increased when Molindone is combined with Quinupramine.,increase,risk
Molindone,Urethane,The risk or severity of CNS depression can be increased when Molindone is combined with Urethane.,increase,risk
Molindone,Valproate bismuth,Molindone may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Molindone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Molindone.,increase,risk
Molindone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Molindone.,increase,risk
Molindone,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Molindone.,increase,risk
Molindone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Molindone.,increase,risk
Molindone,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Molindone.,increase,risk
Molindone,Viloxazine,The risk or severity of CNS depression can be increased when Molindone is combined with Viloxazine.,increase,risk
Molindone,Vincristine,Vincristine may increase the neurotoxic activities of Molindone.,increase,no risk
Molindone,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Molindone.,increase,no risk
Molindone,Viomycin,Molindone may increase the neurotoxic activities of Viomycin.,increase,no risk
Molindone,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Molindone.,increase,risk
Molindone,Warfarin,The risk or severity of adverse effects can be increased when Molindone is combined with Warfarin.,increase,risk
Molindone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Molindone.,increase,risk
Molindone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Molindone.,increase,risk
Molindone,Ziconotide,The risk or severity of CNS depression can be increased when Molindone is combined with Ziconotide.,increase,risk
Molindone,Zimelidine,The risk or severity of adverse effects can be increased when Molindone is combined with Zimelidine.,increase,risk
Molindone,Ziprasidone,The risk or severity of adverse effects can be increased when Molindone is combined with Ziprasidone.,increase,risk
Molindone,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Molindone.,increase,risk
Molindone,Zolpidem,Molindone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Molindone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Molindone.,increase,risk
Molindone,Zopiclone,The risk or severity of adverse effects can be increased when Molindone is combined with Zopiclone.,increase,risk
Molindone,Zotepine,The risk or severity of CNS depression can be increased when Molindone is combined with Zotepine.,increase,risk
Molindone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Molindone is combined with Zuclopenthixol.,increase,risk
Molindone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Molindone.,increase,risk
Phenindamine,Benzphetamine,Benzphetamine may decrease the sedative activities of Phenindamine.,decrease,no risk
Phenindamine,Benzylpenicilloyl polylysine,Phenindamine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Phenindamine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Phenindamine.,decrease,no risk
Phenindamine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Phenindamine.,decrease,no risk
Phenindamine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Phenindamine.,decrease,no risk
Phenindamine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Phenindamine.,decrease,no risk
Phenindamine,Hyoscyamine,Phenindamine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Pheniramine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Gadobenic acid.,increase,risk
Pheniramine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Pheniramine.,increase,risk
Pheniramine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Pheniramine.,increase,risk
Pheniramine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Gemifloxacin.,increase,risk
Pheniramine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Pheniramine.,increase,risk
Pheniramine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Gilteritinib.,increase,risk
Pheniramine,Glasdegib,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Glasdegib.,increase,risk
Pheniramine,Goserelin,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Goserelin.,increase,risk
Pheniramine,Granisetron,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Granisetron.,increase,risk
Pheniramine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Grepafloxacin.,increase,risk
Pheniramine,Halofantrine,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Halofantrine.,increase,risk
Pheniramine,Haloperidol,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Haloperidol.,increase,risk
Pheniramine,Histrelin,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Histrelin.,increase,risk
Pheniramine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Pheniramine.,decrease,no risk
Pheniramine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Pheniramine.,decrease,no risk
Pheniramine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Pheniramine.,decrease,no risk
Pheniramine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Pheniramine.,increase,risk
Pheniramine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pheniramine.,increase,risk
Pheniramine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Hydroxyzine.,increase,risk
Pheniramine,Hyoscyamine,Pheniramine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Pheniramine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Pheniramine.,increase,risk
Pheniramine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Pheniramine.,increase,risk
Pheniramine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Ofloxacin.,increase,risk
Pheniramine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Pheniramine.,increase,risk
Pheniramine,Olodaterol,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Olodaterol.,increase,risk
Pheniramine,Ondansetron,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Ondansetron.,increase,risk
Pheniramine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Pheniramine.,increase,risk
Pheniramine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Pheniramine.,increase,risk
Pheniramine,Oxatomide,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Oxatomide.,increase,risk
Pheniramine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Pheniramine.,increase,risk
Pheniramine,Quetiapine,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Quetiapine.,increase,risk
Pheniramine,Quinidine,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Quinidine.,increase,risk
Pheniramine,Quinine,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Quinine.,increase,risk
Pheniramine,Quizartinib,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Quizartinib.,increase,risk
Pheniramine,Valproic acid,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Valproic acid.,increase,risk
Pheniramine,Vandetanib,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Vandetanib.,increase,risk
Pheniramine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Pheniramine.,increase,risk
Pheniramine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pheniramine.,increase,risk
Pheniramine,Vernakalant,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Vernakalant.,increase,risk
Pheniramine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Pheniramine.,increase,risk
Pheniramine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Pheniramine.,increase,risk
Pheniramine,Vorinostat,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Vorinostat.,increase,risk
Pheniramine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Ziprasidone.,increase,risk
Pheniramine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Pheniramine.,increase,risk
Pheniramine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Zuclopenthixol.,increase,risk
Pipotiazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pipotiazine.,increase,risk
Pipotiazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Gabapentin enacarbil.,increase,risk
Pipotiazine,Galantamine,The metabolism of Galantamine can be decreased when combined with Pipotiazine.,decrease,no risk
Pipotiazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Pipotiazine.,increase,risk
Pipotiazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pipotiazine is combined with Ganaxolone.",increase,risk
Pipotiazine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Pipotiazine.,decrease,no risk
Pipotiazine,Gepirone,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Gepirone.,increase,risk
Pipotiazine,Givosiran,The serum concentration of Pipotiazine can be increased when it is combined with Givosiran.,increase,no risk
Pipotiazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Glofitamab,The serum concentration of Pipotiazine can be increased when it is combined with Glofitamab.,increase,no risk
Pipotiazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Pipotiazine.,increase,risk
Pipotiazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Glycerol phenylbutyrate,The metabolism of Pipotiazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Pipotiazine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Golimumab,The metabolism of Pipotiazine can be increased when combined with Golimumab.,increase,no risk
Pipotiazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Pipotiazine.,increase,risk
Pipotiazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Pipotiazine.,increase,risk
Pipotiazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Pipotiazine.,increase,risk
Pipotiazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Pipotiazine.,increase,risk
Pipotiazine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pipotiazine.,increase,risk
Pipotiazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Pipotiazine.,increase,risk
Pipotiazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Pipotiazine.,increase,risk
Pipotiazine,Hydrocodone,Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pipotiazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Hydromorphone.,increase,risk
Pipotiazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Pipotiazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Pipotiazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pipotiazine.,increase,risk
Pipotiazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pipotiazine.,increase,no risk
Pipotiazine,Hyoscyamine,Pipotiazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Pipotiazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Pipotiazine.,increase,risk
Pipotiazine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Pipotiazine.,increase,risk
Pipotiazine,Ketoconazole,The metabolism of Pipotiazine can be decreased when combined with Ketoconazole.,decrease,no risk
Pipotiazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Pipotiazine.,increase,risk
Pipotiazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pipotiazine is combined with Oliceridine.",increase,risk
Pipotiazine,Omaveloxolone,The serum concentration of Pipotiazine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Pipotiazine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pipotiazine.,increase,risk
Pipotiazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Opium.,increase,risk
Pipotiazine,Oritavancin,The metabolism of Pipotiazine can be decreased when combined with Oritavancin.,decrease,no risk
Pipotiazine,Orphenadrine,Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pipotiazine,Osilodrostat,The metabolism of Pipotiazine can be decreased when combined with Osilodrostat.,decrease,no risk
Pipotiazine,Ospemifene,The metabolism of Pipotiazine can be decreased when combined with Ospemifene.,decrease,no risk
Pipotiazine,Oxamniquine,The metabolism of Pipotiazine can be decreased when combined with Oxamniquine.,decrease,no risk
Pipotiazine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pipotiazine.,increase,risk
Pipotiazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pipotiazine.,increase,risk
Pipotiazine,Oxitriptan,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Oxitriptan.,increase,risk
Pipotiazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Pipotiazine.,increase,no risk
Pipotiazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Pipotiazine.,increase,risk
Pipotiazine,Oxybutynin,The metabolism of Pipotiazine can be decreased when combined with Oxybutynin.,decrease,no risk
Pipotiazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Oxycodone.,increase,risk
Pipotiazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Pipotiazine is combined with Oxymorphone.,increase,risk
Pipotiazine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Pipotiazine.,increase,risk
Pipotiazine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Pipotiazine.,increase,risk
Pipotiazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Pipotiazine.,increase,risk
Pipotiazine,Quinine,The metabolism of Pipotiazine can be decreased when combined with Quinine.,decrease,no risk
Pipotiazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Pipotiazine.,increase,no risk
Pipotiazine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Pipotiazine.,decrease,no risk
Pipotiazine,Urethane,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Urethane.,increase,risk
Pipotiazine,Vadadustat,The serum concentration of Pipotiazine can be increased when it is combined with Vadadustat.,increase,no risk
Pipotiazine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Pipotiazine.,decrease,no risk
Pipotiazine,Valproate bismuth,Pipotiazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Pipotiazine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Pipotiazine.,increase,risk
Pipotiazine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Pipotiazine.,increase,risk
Pipotiazine,Vemurafenib,The metabolism of Pipotiazine can be decreased when combined with Vemurafenib.,decrease,no risk
Pipotiazine,Venetoclax,The metabolism of Pipotiazine can be decreased when combined with Venetoclax.,decrease,no risk
Pipotiazine,Venlafaxine,The metabolism of Pipotiazine can be decreased when combined with Venlafaxine.,decrease,no risk
Pipotiazine,Verapamil,The metabolism of Pipotiazine can be decreased when combined with Verapamil.,decrease,no risk
Pipotiazine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Pipotiazine.,decrease,no risk
Pipotiazine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Pipotiazine.,increase,risk
Pipotiazine,Vilazodone,The metabolism of Pipotiazine can be decreased when combined with Vilazodone.,decrease,no risk
Pipotiazine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Pipotiazine.,decrease,no risk
Pipotiazine,Viloxazine,The metabolism of Pipotiazine can be decreased when combined with Viloxazine.,decrease,no risk
Pipotiazine,Vinblastine,The metabolism of Pipotiazine can be decreased when combined with Vinblastine.,decrease,no risk
Pipotiazine,Vincristine,Vincristine may increase the neurotoxic activities of Pipotiazine.,increase,no risk
Pipotiazine,Vinorelbine,The metabolism of Pipotiazine can be decreased when combined with Vinorelbine.,decrease,no risk
Pipotiazine,Viomycin,Pipotiazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Pipotiazine,Voriconazole,The metabolism of Pipotiazine can be decreased when combined with Voriconazole.,decrease,no risk
Pipotiazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Pipotiazine.,increase,risk
Pipotiazine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Pipotiazine.,increase,risk
Pipotiazine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Pipotiazine.,increase,risk
Pipotiazine,Ziconotide,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Ziconotide.,increase,risk
Pipotiazine,Zimelidine,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Zimelidine.,increase,risk
Pipotiazine,Ziprasidone,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Ziprasidone.,increase,risk
Pipotiazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Pipotiazine.,increase,risk
Pipotiazine,Zolpidem,Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pipotiazine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Pipotiazine.,increase,risk
Pipotiazine,Zopiclone,The risk or severity of adverse effects can be increased when Pipotiazine is combined with Zopiclone.,increase,risk
Pipotiazine,Zotepine,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Zotepine.,increase,risk
Pipotiazine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Pipotiazine is combined with Zuclopenthixol.,increase,risk
Pipotiazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Pipotiazine.,increase,risk
Thioproperazine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Thioproperazine.,increase,risk
Thioproperazine,Butorphanol,The risk or severity of hypotension and CNS depression can be increased when Thioproperazine is combined with Butorphanol.,increase,risk
Thioproperazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Thioproperazine.,increase,no risk
Thioproperazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Thioproperazine.,increase,risk
Thioproperazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Thioproperazine is combined with Gabapentin enacarbil.,increase,risk
Thioproperazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Thioproperazine.,increase,risk
Thioproperazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Thioproperazine is combined with Ganaxolone.",increase,risk
Thioproperazine,Gepirone,The risk or severity of CNS depression can be increased when Thioproperazine is combined with Gepirone.,increase,risk
Thioproperazine,Gilteritinib,The therapeutic efficacy of Thioproperazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Thioproperazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Thioproperazine.,decrease,no risk
Thioproperazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Thioproperazine.,decrease,no risk
Thioproperazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Thioproperazine.,decrease,no risk
Thioproperazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Thioproperazine.,decrease,no risk
Thioproperazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Thioproperazine.,increase,risk
Thioproperazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Thioproperazine.,decrease,no risk
Thiothixene,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Thiothixene.,increase,risk
Thiothixene,Butaperazine,The risk or severity of CNS depression can be increased when Thiothixene is combined with Butaperazine.,increase,risk
Thiothixene,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Thiothixene.,increase,risk
Thiothixene,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Thiothixene.,increase,risk
Thiothixene,Butriptyline,The risk or severity of CNS depression can be increased when Thiothixene is combined with Butriptyline.,increase,risk
Thiothixene,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Thiothixene.,increase,risk
Thiothixene,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Thiothixene is combined with Gabapentin enacarbil.,increase,risk
Thiothixene,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Gadobenic acid.,increase,risk
Thiothixene,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Thiothixene.,increase,risk
Thiothixene,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Thiothixene.,increase,risk
Thiothixene,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Thiothixene is combined with Ganaxolone.",increase,risk
Thiothixene,Gatifloxacin,The metabolism of Thiothixene can be decreased when combined with Gatifloxacin.,decrease,no risk
Thiothixene,Gemfibrozil,The metabolism of Thiothixene can be decreased when combined with Gemfibrozil.,decrease,no risk
Thiothixene,Gemifloxacin,The metabolism of Thiothixene can be decreased when combined with Gemifloxacin.,decrease,no risk
Thiothixene,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Thiothixene.,increase,risk
Thiothixene,Gilteritinib,The therapeutic efficacy of Thiothixene can be decreased when used in combination with Gilteritinib.,decrease,no risk
Thiothixene,Givosiran,The serum concentration of Thiothixene can be increased when it is combined with Givosiran.,increase,no risk
Thiothixene,Glasdegib,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Glasdegib.,increase,risk
Thiothixene,Glofitamab,The serum concentration of Thiothixene can be increased when it is combined with Glofitamab.,increase,no risk
Thiothixene,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Thiothixene.,increase,risk
Thiothixene,Golimumab,The metabolism of Thiothixene can be increased when combined with Golimumab.,increase,no risk
Thiothixene,Goserelin,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Goserelin.,increase,risk
Thiothixene,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Thiothixene.,increase,risk
Thiothixene,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Grepafloxacin.,increase,risk
Thiothixene,Guanabenz,The metabolism of Thiothixene can be decreased when combined with Guanabenz.,decrease,no risk
Thiothixene,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Thiothixene.,increase,risk
Thiothixene,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Thiothixene.,increase,risk
Thiothixene,Halofantrine,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Halofantrine.,increase,risk
Thiothixene,Haloperidol,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Haloperidol.,increase,risk
Thiothixene,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Thiothixene.,increase,risk
Thiothixene,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Thiothixene.,increase,risk
Thiothixene,Histrelin,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Histrelin.,increase,risk
Thiothixene,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Thiothixene.,increase,risk
Thiothixene,Hydrocodone,Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Thiothixene,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Thiothixene.,increase,risk
Thiothixene,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Thiothixene.,increase,risk
Thiothixene,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Hydroxyzine.,increase,risk
Thiothixene,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Thiothixene.,increase,risk
Thiothixene,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Thiothixene.,increase,risk
Thiothixene,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Thiothixene.,increase,risk
Thiothixene,Ketoconazole,The metabolism of Thiothixene can be decreased when combined with Ketoconazole.,decrease,no risk
Thiothixene,Obeticholic acid,The metabolism of Thiothixene can be decreased when combined with Obeticholic acid.,decrease,no risk
Thiothixene,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Thiothixene.,increase,risk
Thiothixene,Ofloxacin,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ofloxacin.,increase,risk
Thiothixene,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Thiothixene.,increase,risk
Thiothixene,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Thiothixene is combined with Oliceridine.",increase,risk
Thiothixene,Olodaterol,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Olodaterol.,increase,risk
Thiothixene,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Thiothixene.,increase,risk
Thiothixene,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Thiothixene.,decrease,no risk
Thiothixene,Opium,The risk or severity of CNS depression can be increased when Thiothixene is combined with Opium.,increase,risk
Thiothixene,Orphenadrine,Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Thiothixene,Osilodrostat,The metabolism of Thiothixene can be decreased when combined with Osilodrostat.,decrease,no risk
Thiothixene,Osimertinib,The serum concentration of Thiothixene can be decreased when it is combined with Osimertinib.,decrease,no risk
Thiothixene,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Thiothixene.,increase,risk
Thiothixene,Oxatomide,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Oxatomide.,increase,risk
Thiothixene,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Thiothixene.,increase,risk
Thiothixene,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Thiothixene.,increase,risk
Thiothixene,Oxitriptan,The risk or severity of CNS depression can be increased when Thiothixene is combined with Oxitriptan.,increase,risk
Thiothixene,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Thiothixene.,increase,risk
Thiothixene,Oxtriphylline,The metabolism of Thiothixene can be decreased when combined with Oxtriphylline.,decrease,no risk
Thiothixene,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Thiothixene.,increase,risk
Thiothixene,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Thiothixene.,increase,risk
Thiothixene,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Thiothixene.,increase,risk
Thiothixene,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Thiothixene.,increase,risk
Thiothixene,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Thiothixene.,increase,risk
Thiothixene,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Thiothixene.,increase,risk
Thiothixene,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Thiothixene.,decrease,no risk
Thiothixene,Quinidine,The metabolism of Thiothixene can be decreased when combined with Quinidine.,decrease,no risk
Thiothixene,Quinine,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Quinine.,increase,risk
Thiothixene,Quinupramine,The risk or severity of CNS depression can be increased when Thiothixene is combined with Quinupramine.,increase,risk
Thiothixene,Quizartinib,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Quizartinib.,increase,risk
Thiothixene,Urethane,The risk or severity of CNS depression can be increased when Thiothixene is combined with Urethane.,increase,risk
Thiothixene,Valproate bismuth,Thiothixene may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Thiothixene,Valproic acid,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Valproic acid.,increase,risk
Thiothixene,Vandetanib,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vandetanib.,increase,risk
Thiothixene,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Thiothixene.,increase,risk
Thiothixene,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Thiothixene.,increase,risk
Thiothixene,Vemurafenib,The serum concentration of Thiothixene can be increased when it is combined with Vemurafenib.,increase,no risk
Thiothixene,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiothixene.,increase,risk
Thiothixene,Verapamil,The metabolism of Thiothixene can be decreased when combined with Verapamil.,decrease,no risk
Thiothixene,Vernakalant,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vernakalant.,increase,risk
Thiothixene,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Thiothixene.,increase,risk
Thiothixene,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Thiothixene.,increase,risk
Thiothixene,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Thiothixene.,increase,risk
Thiothixene,Viloxazine,The metabolism of Thiothixene can be decreased when combined with Viloxazine.,decrease,no risk
Thiothixene,Vincristine,Vincristine may increase the neurotoxic activities of Thiothixene.,increase,no risk
Thiothixene,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Thiothixene.,increase,no risk
Thiothixene,Viomycin,Thiothixene may increase the neurotoxic activities of Viomycin.,increase,no risk
Thiothixene,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Thiothixene.,increase,risk
Thiothixene,Vorinostat,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Vorinostat.,increase,risk
Thiothixene,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Thiothixene.,increase,risk
Thiothixene,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Thiothixene.,decrease,no risk
Thiothixene,Warfarin,The metabolism of Thiothixene can be decreased when combined with Warfarin.,decrease,no risk
Thiothixene,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Thiothixene.,increase,risk
Thiothixene,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Thiothixene.,increase,risk
Thiothixene,Ziconotide,The risk or severity of CNS depression can be increased when Thiothixene is combined with Ziconotide.,increase,risk
Thiothixene,Zileuton,The metabolism of Thiothixene can be decreased when combined with Zileuton.,decrease,no risk
Thiothixene,Zimelidine,The risk or severity of adverse effects can be increased when Thiothixene is combined with Zimelidine.,increase,risk
Thiothixene,Ziprasidone,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Ziprasidone.,increase,risk
Thiothixene,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiothixene.,increase,risk
Thiothixene,Zolpidem,Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Thiothixene,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Thiothixene.,increase,risk
Thiothixene,Zopiclone,The risk or severity of adverse effects can be increased when Thiothixene is combined with Zopiclone.,increase,risk
Thiothixene,Zotepine,The risk or severity of CNS depression can be increased when Thiothixene is combined with Zotepine.,increase,risk
Thiothixene,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Zuclopenthixol.,increase,risk
Thiothixene,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Thiothixene.,increase,risk
Zuclopenthixol,Benzyl alcohol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Benzyl alcohol.,increase,risk
Zuclopenthixol,Benzylpenicilloyl polylysine,Zuclopenthixol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Zuclopenthixol,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Berotralstat,The metabolism of Zuclopenthixol can be decreased when combined with Berotralstat.,decrease,no risk
Zuclopenthixol,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Betamethasone,The metabolism of Zuclopenthixol can be increased when combined with Betamethasone.,increase,no risk
Zuclopenthixol,Betamethasone phosphate,The metabolism of Zuclopenthixol can be increased when combined with Betamethasone phosphate.,increase,no risk
Zuclopenthixol,Betaxolol,Betaxolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Zuclopenthixol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Bexarotene,The metabolism of Zuclopenthixol can be increased when combined with Bexarotene.,increase,no risk
Zuclopenthixol,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Bifonazole,The metabolism of Zuclopenthixol can be decreased when combined with Bifonazole.,decrease,no risk
Zuclopenthixol,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Bimekizumab,The metabolism of Zuclopenthixol can be increased when combined with Bimekizumab.,increase,no risk
Zuclopenthixol,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Bismuth subcitrate potassium,Zuclopenthixol may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Zuclopenthixol,Bismuth subgallate,Zuclopenthixol may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Zuclopenthixol,Bismuth subnitrate,Zuclopenthixol may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Zuclopenthixol,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Zuclopenthixol,Boceprevir,The metabolism of Zuclopenthixol can be decreased when combined with Boceprevir.,decrease,no risk
Zuclopenthixol,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Bosentan,The metabolism of Zuclopenthixol can be increased when combined with Bosentan.,increase,no risk
Zuclopenthixol,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Brexanolone,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Brexanolone.,increase,risk
Zuclopenthixol,Brexpiprazole,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Zuclopenthixol,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Zuclopenthixol,Brivaracetam,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Brivaracetam.,increase,risk
Zuclopenthixol,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Bromperidol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Bromperidol.,increase,risk
Zuclopenthixol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Budesonide,The metabolism of Zuclopenthixol can be increased when combined with Budesonide.,increase,no risk
Zuclopenthixol,Bumadizone,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Bumadizone.,increase,risk
Zuclopenthixol,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Buprenorphine,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Zuclopenthixol,Bupropion,The metabolism of Zuclopenthixol can be decreased when combined with Bupropion.,decrease,no risk
Zuclopenthixol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Busulfan,The metabolism of Busulfan can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Butaperazine,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Butaperazine.,increase,risk
Zuclopenthixol,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Gabapentin enacarbil.,increase,risk
Zuclopenthixol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zuclopenthixol is combined with Ganaxolone.",increase,risk
Zuclopenthixol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Gefitinib,The metabolism of Zuclopenthixol can be decreased when combined with Gefitinib.,decrease,no risk
Zuclopenthixol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Gilteritinib,The therapeutic efficacy of Zuclopenthixol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Zuclopenthixol,Ginkgo biloba,The metabolism of Zuclopenthixol can be decreased when combined with Ginkgo biloba.,decrease,no risk
Zuclopenthixol,Givosiran,The serum concentration of Zuclopenthixol can be increased when it is combined with Givosiran.,increase,no risk
Zuclopenthixol,Glasdegib,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Glasdegib.,increase,risk
Zuclopenthixol,Glecaprevir,The metabolism of Zuclopenthixol can be decreased when combined with Glecaprevir.,decrease,no risk
Zuclopenthixol,Glofitamab,The serum concentration of Zuclopenthixol can be increased when it is combined with Glofitamab.,increase,no risk
Zuclopenthixol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Glyburide,The metabolism of Zuclopenthixol can be decreased when combined with Glyburide.,decrease,no risk
Zuclopenthixol,Glycerol phenylbutyrate,The metabolism of Zuclopenthixol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Zuclopenthixol,Golimumab,The metabolism of Zuclopenthixol can be increased when combined with Golimumab.,increase,no risk
Zuclopenthixol,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Grapefruit,The metabolism of Zuclopenthixol can be decreased when combined with Grapefruit.,decrease,no risk
Zuclopenthixol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Griseofulvin,The metabolism of Zuclopenthixol can be increased when combined with Griseofulvin.,increase,no risk
Zuclopenthixol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Guanadrel,Zuclopenthixol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Zuclopenthixol,Guanethidine,Zuclopenthixol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Zuclopenthixol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Guanoxan,Zuclopenthixol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Zuclopenthixol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Halofantrine,The metabolism of Zuclopenthixol can be decreased when combined with Halofantrine.,decrease,no risk
Zuclopenthixol,Haloperidol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Haloperidol.,increase,risk
Zuclopenthixol,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Hydralazine,The metabolism of Zuclopenthixol can be decreased when combined with Hydralazine.,decrease,no risk
Zuclopenthixol,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Hydrocodone,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zuclopenthixol,Hydrocortamate,The metabolism of Zuclopenthixol can be increased when combined with Hydrocortamate.,increase,no risk
Zuclopenthixol,Hydrocortisone,The metabolism of Zuclopenthixol can be increased when combined with Hydrocortisone.,increase,no risk
Zuclopenthixol,Hydrocortisone acetate,The metabolism of Zuclopenthixol can be increased when combined with Hydrocortisone acetate.,increase,no risk
Zuclopenthixol,Hydrocortisone butyrate,The metabolism of Zuclopenthixol can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Zuclopenthixol,Hydrocortisone succinate,The metabolism of Zuclopenthixol can be increased when combined with Hydrocortisone succinate.,increase,no risk
Zuclopenthixol,Hydroflumethiazide,Zuclopenthixol may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Zuclopenthixol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Hydroxyzine.,increase,risk
Zuclopenthixol,Hyoscyamine,Zuclopenthixol may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Zuclopenthixol,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Ketoconazole,The metabolism of Zuclopenthixol can be decreased when combined with Ketoconazole.,decrease,no risk
Zuclopenthixol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Zuclopenthixol,Olaparib,The metabolism of Olaparib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zuclopenthixol is combined with Oliceridine.",increase,risk
Zuclopenthixol,Olmesartan,Zuclopenthixol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Zuclopenthixol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Olutasidenib,The metabolism of Zuclopenthixol can be increased when combined with Olutasidenib.,increase,no risk
Zuclopenthixol,Omaveloxolone,The serum concentration of Zuclopenthixol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zuclopenthixol,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Opium,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Opium.,increase,risk
Zuclopenthixol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Oritavancin,The metabolism of Zuclopenthixol can be increased when combined with Oritavancin.,increase,no risk
Zuclopenthixol,Orphenadrine,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Zuclopenthixol,Osilodrostat,The metabolism of Zuclopenthixol can be decreased when combined with Osilodrostat.,decrease,no risk
Zuclopenthixol,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Ospemifene,The metabolism of Zuclopenthixol can be decreased when combined with Ospemifene.,decrease,no risk
Zuclopenthixol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxamniquine,The metabolism of Zuclopenthixol can be decreased when combined with Oxamniquine.,decrease,no risk
Zuclopenthixol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxitriptan,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Oxitriptan.,increase,risk
Zuclopenthixol,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Zuclopenthixol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxybutynin,The metabolism of Zuclopenthixol can be decreased when combined with Oxybutynin.,decrease,no risk
Zuclopenthixol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zuclopenthixol,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Zuclopenthixol.,increase,risk
Zuclopenthixol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Oxyphenbutazone.,increase,risk
Zuclopenthixol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Zuclopenthixol.,increase,risk
Isopropamide,Galantamine,The therapeutic efficacy of Isopropamide can be decreased when used in combination with Galantamine.,decrease,no risk
Isopropamide,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Isopropamide.,increase,risk
Isopropamide,Ginkgo biloba,The therapeutic efficacy of Isopropamide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Isopropamide,Glucagon,Isopropamide may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Isopropamide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Isopropamide.,decrease,no risk
Isopropamide,Glycopyrronium,The risk or severity of adverse effects can be increased when Isopropamide is combined with Glycopyrronium.,increase,risk
Isopropamide,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Isopropamide.,increase,risk
Isopropamide,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Isopropamide.,increase,risk
Isopropamide,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Isopropamide.,increase,risk
Isopropamide,Hexocyclium,The risk or severity of adverse effects can be increased when Isopropamide is combined with Hexocyclium.,increase,risk
Isopropamide,Homatropine,The risk or severity of adverse effects can be increased when Isopropamide is combined with Homatropine.,increase,risk
Isopropamide,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Isopropamide.,increase,risk
Isopropamide,Huperzine A,The therapeutic efficacy of Isopropamide can be decreased when used in combination with Huperzine A.,decrease,no risk
Isopropamide,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Isopropamide.,increase,no risk
Isopropamide,Hydrocodone,The risk or severity of adverse effects can be increased when Isopropamide is combined with Hydrocodone.,increase,risk
Isopropamide,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Isopropamide.,increase,no risk
Isopropamide,Hydromorphone,The risk or severity of adverse effects can be increased when Isopropamide is combined with Hydromorphone.,increase,risk
Isopropamide,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Isopropamide.,increase,risk
Isopropamide,Ketamine,The therapeutic efficacy of Isopropamide can be decreased when used in combination with Ketamine.,decrease,no risk
Isopropamide,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Isopropamide.,increase,risk
Isopropamide,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Isopropamide is combined with Oliceridine.",increase,risk
Isopropamide,Olodaterol,The risk or severity of Tachycardia can be increased when Isopropamide is combined with Olodaterol.,increase,risk
Isopropamide,Opium,The risk or severity of adverse effects can be increased when Isopropamide is combined with Opium.,increase,risk
Isopropamide,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Isopropamide.,increase,risk
Isopropamide,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Isopropamide.,increase,risk
Isopropamide,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Isopropamide.,increase,risk
Isopropamide,Oxycodone,The risk or severity of adverse effects can be increased when Isopropamide is combined with Oxycodone.,increase,risk
Isopropamide,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Isopropamide.,increase,risk
Isopropamide,Oxymorphone,The risk or severity of adverse effects can be increased when Isopropamide is combined with Oxymorphone.,increase,risk
Isopropamide,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Isopropamide.,increase,risk
Isopropamide,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Isopropamide.,decrease,no risk
Isopropamide,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Isopropamide.,increase,risk
Isopropamide,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Isopropamide.,increase,risk
Isopropamide,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Isopropamide.,increase,no risk
Isopropamide,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Isopropamide.,increase,risk
Isopropamide,Quinupramine,The risk or severity of adverse effects can be increased when Isopropamide is combined with Quinupramine.,increase,risk
Isopropamide,Umeclidinium,The risk or severity of adverse effects can be increased when Isopropamide is combined with Umeclidinium.,increase,risk
Isopropamide,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Isopropamide.,increase,risk
Isopropamide,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Isopropamide.,increase,risk
Isopropamide,Vilanterol,The risk or severity of Tachycardia can be increased when Isopropamide is combined with Vilanterol.,increase,risk
Isopropamide,Xamoterol,The risk or severity of Tachycardia can be increased when Isopropamide is combined with Xamoterol.,increase,risk
Isopropamide,Xylometazoline,The risk or severity of Tachycardia can be increased when Isopropamide is combined with Xylometazoline.,increase,risk
Isopropamide,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Isopropamide.,increase,risk
Pargyline,Brimonidine,Brimonidine may increase the antihypertensive activities of Pargyline.,increase,no risk
Pargyline,Brivaracetam,The risk or severity of CNS depression can be increased when Pargyline is combined with Brivaracetam.,increase,risk
Pargyline,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Pargyline.,increase,risk
Pargyline,Bromocriptine,Pargyline may increase the hypertensive activities of Bromocriptine.,increase,no risk
Pargyline,Bromperidol,The risk or severity of CNS depression can be increased when Pargyline is combined with Bromperidol.,increase,risk
Pargyline,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Pargyline.,increase,risk
Pargyline,Bumadizone,The therapeutic efficacy of Pargyline can be decreased when used in combination with Bumadizone.,decrease,no risk
Pargyline,Bumetanide,Pargyline may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Pargyline,Bupivacaine,Pargyline may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Pargyline,Buprenorphine,Pargyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Pargyline,Bupropion,The risk or severity of adverse effects can be increased when Pargyline is combined with Bupropion.,increase,risk
Pargyline,Buspirone,The risk or severity of hypertension can be increased when Pargyline is combined with Buspirone.,increase,risk
Pargyline,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Pargyline.,increase,risk
Pargyline,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Pargyline.,increase,risk
Pargyline,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Pargyline is combined with Butaperazine.,increase,risk
Pargyline,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Pargyline.,increase,risk
Pargyline,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Pargyline.,increase,risk
Pargyline,Butriptyline,Pargyline may increase the serotonergic activities of Butriptyline.,increase,no risk
Pargyline,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pargyline.,increase,risk
Pargyline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pargyline is combined with Gabapentin enacarbil.,increase,risk
Pargyline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Pargyline.,increase,risk
Pargyline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pargyline is combined with Ganaxolone.",increase,risk
Pargyline,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Pargyline.,increase,risk
Pargyline,Gliclazide,Pargyline may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Pargyline,Glimepiride,Pargyline may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Pargyline,Glipizide,Pargyline may increase the hypoglycemic activities of Glipizide.,increase,no risk
Pargyline,Gliquidone,Pargyline may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Pargyline,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Pargyline.,increase,risk
Pargyline,Glyburide,Pargyline may increase the hypoglycemic activities of Glyburide.,increase,no risk
Pargyline,Glycol salicylate,The therapeutic efficacy of Pargyline can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Pargyline,Glymidine,Pargyline may increase the hypoglycemic activities of Glymidine.,increase,no risk
Pargyline,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Pargyline.,increase,risk
Pargyline,Guanabenz,Pargyline may increase the hypotensive activities of Guanabenz.,increase,no risk
Pargyline,Guanadrel,Pargyline may increase the hypotensive activities of Guanadrel.,increase,no risk
Pargyline,Guanethidine,Pargyline may increase the hypotensive activities of Guanethidine.,increase,no risk
Pargyline,Guanfacine,Pargyline may increase the hypotensive activities of Guanfacine.,increase,no risk
Pargyline,Guanoxan,Pargyline may increase the hypotensive activities of Guanoxan.,increase,no risk
Pargyline,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Pargyline.,increase,risk
Pargyline,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pargyline.,increase,risk
Pargyline,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Pargyline.,increase,risk
Pargyline,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Heparin.,increase,risk
Pargyline,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Pargyline.,increase,risk
Pargyline,Hydralazine,Pargyline may increase the hypotensive activities of Hydralazine.,increase,no risk
Pargyline,Hydrochlorothiazide,The therapeutic efficacy of Pargyline can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Pargyline,Hydrocodone,Pargyline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pargyline,Hydroflumethiazide,The therapeutic efficacy of Pargyline can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Pargyline,Hydromorphone,Pargyline may increase the serotonergic activities of Hydromorphone.,increase,no risk
Pargyline,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Pargyline.,increase,risk
Pargyline,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pargyline.,increase,no risk
Pargyline,Hyoscyamine,Pargyline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Pargyline,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Pargyline.,increase,risk
Pargyline,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Pargyline.,increase,risk
Pargyline,Ketoprofen,The therapeutic efficacy of Pargyline can be decreased when used in combination with Ketoprofen.,decrease,no risk
Pargyline,Ketorolac,The therapeutic efficacy of Pargyline can be decreased when used in combination with Ketorolac.,decrease,no risk
Pargyline,Obinutuzumab,Pargyline may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Pargyline,Olanzapine,Pargyline may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Pargyline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pargyline is combined with Oliceridine.",increase,risk
Pargyline,Olmesartan,Pargyline may increase the hypotensive activities of Olmesartan.,increase,no risk
Pargyline,Olodaterol,Olodaterol may decrease the antihypertensive activities of Pargyline.,decrease,no risk
Pargyline,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pargyline.,increase,risk
Pargyline,Opicapone,Pargyline may increase the orthostatic hypotensive activities of Opicapone.,increase,no risk
Pargyline,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Pargyline.,increase,risk
Pargyline,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Pargyline.,decrease,no risk
Pargyline,Orphenadrine,Pargyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pargyline,Oxaprozin,The therapeutic efficacy of Pargyline can be decreased when used in combination with Oxaprozin.,decrease,no risk
Pargyline,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pargyline.,increase,risk
Pargyline,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pargyline.,increase,risk
Pargyline,Oxitriptan,The risk or severity of CNS depression can be increased when Pargyline is combined with Oxitriptan.,increase,risk
Pargyline,Oxprenolol,Pargyline may increase the hypotensive activities of Oxprenolol.,increase,no risk
Pargyline,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Pargyline.,increase,risk
Pargyline,Oxycodone,Pargyline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Pargyline,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Pargyline.,increase,no risk
Pargyline,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Pargyline.,increase,risk
Pargyline,Oxyphenbutazone,The therapeutic efficacy of Pargyline can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Pargyline,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Pargyline.,increase,risk
Pargyline,Quetiapine,Quetiapine may increase the hypotensive activities of Pargyline.,increase,no risk
Pargyline,Quinapril,Pargyline may increase the hypotensive activities of Quinapril.,increase,no risk
Pargyline,Quinidine,Quinidine may decrease the antihypertensive activities of Pargyline.,decrease,no risk
Pargyline,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Pargyline.,increase,risk
Pargyline,Quinupramine,Pargyline may increase the serotonergic activities of Quinupramine.,increase,no risk
Pargyline,Udenafil,Udenafil may increase the antihypertensive activities of Pargyline.,increase,no risk
Pargyline,Unoprostone,Pargyline may increase the hypotensive activities of Unoprostone.,increase,no risk
Pargyline,Urethane,The risk or severity of CNS depression can be increased when Pargyline is combined with Urethane.,increase,risk
Pargyline,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Urokinase.,increase,risk
Pargyline,Valbenazine,The risk or severity of adverse effects can be increased when Pargyline is combined with Valbenazine.,increase,risk
Pargyline,Valdecoxib,The therapeutic efficacy of Pargyline can be decreased when used in combination with Valdecoxib.,decrease,no risk
Pargyline,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Valproate bismuth.,increase,risk
Pargyline,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Pargyline.,increase,risk
Pargyline,Valsartan,Pargyline may increase the hypotensive activities of Valsartan.,increase,no risk
Pargyline,Vardenafil,Vardenafil may increase the antihypertensive activities of Pargyline.,increase,no risk
Pargyline,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Pargyline.,increase,risk
Pargyline,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Venlafaxine.,increase,risk
Pargyline,Verapamil,Pargyline may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Pargyline,Vericiguat,Pargyline may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Pargyline,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Pargyline.,increase,risk
Pargyline,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Pargyline is combined with Vilanterol.,increase,risk
Pargyline,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Pargyline.,decrease,no risk
Pargyline,Vildagliptin,Pargyline may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Pargyline,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Pargyline.,increase,risk
Pargyline,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Vorapaxar.,increase,risk
Pargyline,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Pargyline.,decrease,no risk
Pargyline,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Warfarin.,increase,risk
Pargyline,Xamoterol,Xamoterol may decrease the antihypertensive activities of Pargyline.,decrease,no risk
Pargyline,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Ximelagatran.,increase,risk
Pargyline,Xylometazoline,Pargyline may increase the hypertensive activities of Xylometazoline.,increase,no risk
Pargyline,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Pargyline.,increase,risk
Pargyline,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Pargyline.,increase,risk
Pargyline,Ziconotide,The risk or severity of CNS depression can be increased when Pargyline is combined with Ziconotide.,increase,risk
Pargyline,Zimelidine,Pargyline may increase the serotonergic activities of Zimelidine.,increase,no risk
Pargyline,Ziprasidone,The risk or severity of adverse effects can be increased when Pargyline is combined with Ziprasidone.,increase,risk
Pargyline,Zofenopril,Pargyline may increase the hypotensive activities of Zofenopril.,increase,no risk
Pargyline,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Zolmitriptan.,increase,risk
Pargyline,Zolpidem,Pargyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pargyline,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Pargyline.,increase,risk
Pargyline,Zopiclone,The risk or severity of adverse effects can be increased when Pargyline is combined with Zopiclone.,increase,risk
Pargyline,Zotepine,The risk or severity of CNS depression can be increased when Pargyline is combined with Zotepine.,increase,risk
Pargyline,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Pargyline.,increase,risk
Pargyline,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Pargyline.,increase,risk
Lincomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lincomycin is combined with Oxetacaine.,increase,risk
Lincomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lincomycin is combined with Oxybuprocaine.,increase,risk
Lincomycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Lincomycin.,increase,risk
Lincomycin,Quinidine,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Lincomycin.,increase,risk
Lincomycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Lincomycin.,increase,risk
Lincomycin,Quinupramine,Lincomycin may increase the neurotoxic activities of Quinupramine.,increase,no risk
Lincomycin,Valproate bismuth,Lincomycin may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Lincomycin,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Lincomycin.,increase,risk
Lincomycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Lincomycin.,increase,no risk
Lincomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Lincomycin.,decrease,no risk
Lincomycin,Vincristine,Vincristine may increase the neurotoxic activities of Lincomycin.,increase,no risk
Lincomycin,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Lincomycin.,increase,no risk
Lincomycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Lincomycin is combined with Viomycin.,increase,risk
Lincomycin,Warfarin,The risk or severity of bleeding can be increased when Lincomycin is combined with Warfarin.,increase,risk
Lincomycin,Zinc ascorbate,The therapeutic efficacy of Lincomycin can be decreased when used in combination with Zinc ascorbate.,decrease,no risk
Lincomycin,Ziprasidone,Ziprasidone may increase the neurotoxic activities of Lincomycin.,increase,no risk
Lincomycin,Zotepine,Lincomycin may increase the neurotoxic activities of Zotepine.,increase,no risk
Lincomycin,Zuclopenthixol,Zuclopenthixol may increase the neurotoxic activities of Lincomycin.,increase,no risk
Etoricoxib,Bacitracin,The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Etoricoxib.,increase,risk
Etoricoxib,Baclofen,Etoricoxib may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Etoricoxib,Balsalazide,The risk or severity of adverse effects can be increased when Balsalazide is combined with Etoricoxib.,increase,risk
Etoricoxib,Baricitinib,Etoricoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Etoricoxib,Beclomethasone dipropionate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Etoricoxib.,increase,risk
Etoricoxib,Belinostat,The metabolism of Etoricoxib can be increased when combined with Belinostat.,increase,no risk
Etoricoxib,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Bemiparin.,increase,risk
Etoricoxib,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etoricoxib is combined with Benazepril.",increase,risk
Etoricoxib,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Bendazac,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Bendazac.,increase,risk
Etoricoxib,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Benorilate,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Benorilate.,increase,risk
Etoricoxib,Benoxaprofen,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Benoxaprofen.,increase,risk
Etoricoxib,Benserazide,Etoricoxib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Etoricoxib,Benzatropine,Etoricoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Etoricoxib,Benznidazole,Etoricoxib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Etoricoxib,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Etoricoxib.,increase,risk
Etoricoxib,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Benzydamine,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Benzydamine.,increase,risk
Etoricoxib,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Bepotastine,Etoricoxib may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Etoricoxib,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Berotralstat,The metabolism of Etoricoxib can be decreased when combined with Berotralstat.,decrease,no risk
Etoricoxib,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Etoricoxib.,increase,risk
Etoricoxib,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Etoricoxib.,increase,risk
Etoricoxib,Betaxolol,Etoricoxib may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Etoricoxib,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Etoricoxib.,increase,risk
Etoricoxib,Betulinic Acid,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Betulinic Acid.,increase,risk
Etoricoxib,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Bicisate,Etoricoxib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Etoricoxib,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Bimekizumab,The metabolism of Etoricoxib can be increased when combined with Bimekizumab.,increase,no risk
Etoricoxib,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Bismuth subgallate,Etoricoxib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Etoricoxib,Bisoprolol,Etoricoxib may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Etoricoxib,Bisoxatin,Etoricoxib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Bivalirudin.,increase,risk
Etoricoxib,Bleomycin,Etoricoxib may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Boceprevir,The metabolism of Etoricoxib can be decreased when combined with Boceprevir.,decrease,no risk
Etoricoxib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Brexpiprazole,The risk or severity of hypertension can be increased when Etoricoxib is combined with Brexpiprazole.,increase,risk
Etoricoxib,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Bromazepam,The metabolism of Etoricoxib can be decreased when combined with Bromazepam.,decrease,no risk
Etoricoxib,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Etoricoxib.,increase,risk
Etoricoxib,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Etoricoxib.,increase,risk
Etoricoxib,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Etoricoxib.,increase,risk
Etoricoxib,Bufexamac,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Bufexamac.,increase,risk
Etoricoxib,Bumadizone,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Bumadizone.,increase,risk
Etoricoxib,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Bupropion,The metabolism of Bupropion can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Etoricoxib.,increase,risk
Etoricoxib,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Butabarbital,Etoricoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Etoricoxib,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Etoricoxib.,increase,risk
Etoricoxib,Gabapentin enacarbil,Etoricoxib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gadobenic acid,Etoricoxib may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gadodiamide,Etoricoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gadofosveset trisodium,Etoricoxib may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gadopentetic acid,Etoricoxib may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gadoteric acid,Etoricoxib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gadoteridol,Etoricoxib may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Etoricoxib,Galantamine,The metabolism of Galantamine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Ganciclovir,Etoricoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gatifloxacin,The metabolism of Etoricoxib can be decreased when combined with Gatifloxacin.,decrease,no risk
Etoricoxib,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Gemcitabine,Etoricoxib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gemfibrozil,The metabolism of Etoricoxib can be decreased when combined with Gemfibrozil.,decrease,no risk
Etoricoxib,Gemifloxacin,The metabolism of Etoricoxib can be decreased when combined with Gemifloxacin.,decrease,no risk
Etoricoxib,Gentamicin,Etoricoxib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Gimeracil,Etoricoxib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Etoricoxib,Ginkgo biloba,The metabolism of Etoricoxib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Etoricoxib,Givosiran,The serum concentration of Etoricoxib can be increased when it is combined with Givosiran.,increase,no risk
Etoricoxib,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Glipizide,The protein binding of Glipizide can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Glofitamab,The serum concentration of Etoricoxib can be increased when it is combined with Glofitamab.,increase,no risk
Etoricoxib,Glyburide,The protein binding of Glyburide can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Glycerol phenylbutyrate,Etoricoxib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Etoricoxib,Glycol salicylate,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Glycol salicylate.,increase,risk
Etoricoxib,Golimumab,The metabolism of Etoricoxib can be increased when combined with Golimumab.,increase,no risk
Etoricoxib,Golodirsen,Etoricoxib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Etoricoxib,Goserelin,Etoricoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Grepafloxacin,The metabolism of Etoricoxib can be decreased when combined with Grepafloxacin.,decrease,no risk
Etoricoxib,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Halothane,The metabolism of Halothane can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Heparin.,increase,risk
Etoricoxib,Hydralazine,Etoricoxib may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Etoricoxib,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Etoricoxib.,increase,risk
Etoricoxib,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Etoricoxib.,increase,risk
Etoricoxib,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Etoricoxib.,increase,risk
Etoricoxib,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Etoricoxib.,increase,risk
Etoricoxib,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Etoricoxib.,increase,risk
Etoricoxib,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Hydroxocobalamin,Etoricoxib may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Hydroxyethyl Starch,Etoricoxib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Etoricoxib,Kanamycin,Etoricoxib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Ketamine,The metabolism of Ketamine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Ketazolam,Etoricoxib may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Etoricoxib,Ketoconazole,The metabolism of Etoricoxib can be decreased when combined with Ketoconazole.,decrease,no risk
Etoricoxib,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etoricoxib.,increase,risk
Etoricoxib,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Etoricoxib.,increase,risk
Etoricoxib,Obeticholic acid,The metabolism of Etoricoxib can be decreased when combined with Obeticholic acid.,decrease,no risk
Etoricoxib,Octinoxate,Etoricoxib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Etoricoxib,Ofloxacin,Etoricoxib may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Etoricoxib,Olanzapine,The metabolism of Etoricoxib can be decreased when combined with Olanzapine.,decrease,no risk
Etoricoxib,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Etoricoxib.",increase,risk
Etoricoxib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Olsalazine,The risk or severity of nephrotoxicity can be increased when Etoricoxib is combined with Olsalazine.,increase,risk
Etoricoxib,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Etoricoxib is combined with Omacetaxine mepesuccinate.,increase,risk
Etoricoxib,Omaveloxolone,The serum concentration of Etoricoxib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Etoricoxib,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Ondansetron,The metabolism of Etoricoxib can be decreased when combined with Ondansetron.,decrease,no risk
Etoricoxib,Opium,Etoricoxib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Etoricoxib,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Etoricoxib.,increase,risk
Etoricoxib,Oritavancin,The metabolism of Etoricoxib can be decreased when combined with Oritavancin.,decrease,no risk
Etoricoxib,Orphenadrine,The metabolism of Etoricoxib can be decreased when combined with Orphenadrine.,decrease,no risk
Etoricoxib,Oseltamivir,Etoricoxib may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Etoricoxib,Osilodrostat,The metabolism of Etoricoxib can be decreased when combined with Osilodrostat.,decrease,no risk
Etoricoxib,Osimertinib,The serum concentration of Etoricoxib can be decreased when it is combined with Osimertinib.,decrease,no risk
Etoricoxib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Oxacillin,Etoricoxib may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Etoricoxib.,increase,risk
Etoricoxib,Oxandrolone,The metabolism of Etoricoxib can be decreased when combined with Oxandrolone.,decrease,no risk
Etoricoxib,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Etoricoxib.,increase,risk
Etoricoxib,Oxazepam,Etoricoxib may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Etoricoxib,Oxprenolol,Etoricoxib may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Etoricoxib,Oxtriphylline,The metabolism of Etoricoxib can be decreased when combined with Oxtriphylline.,decrease,no risk
Etoricoxib,Oxybenzone,Etoricoxib may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Etoricoxib,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Etoricoxib.,increase,risk
Etoricoxib,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Etoricoxib is combined with Oxyphenbutazone.,increase,risk
Etoricoxib,Oxyquinoline,Etoricoxib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Etoricoxib,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Etoricoxib.,increase,risk
Etoricoxib,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etoricoxib is combined with Quinapril.",increase,risk
Etoricoxib,Quinestrol,Etoricoxib may increase the thrombogenic activities of Quinestrol.,increase,no risk
Etoricoxib,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Quinine,The metabolism of Quinine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Etoricoxib.,increase,risk
Etoricoxib,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Etoricoxib.,decrease,no risk
Etoricoxib,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Urokinase.,increase,risk
Etoricoxib,Vaborbactam,Etoricoxib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Etoricoxib,Vadadustat,The serum concentration of Etoricoxib can be increased when it is combined with Vadadustat.,increase,no risk
Etoricoxib,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Etoricoxib.,increase,risk
Etoricoxib,Valbenazine,Etoricoxib may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Etoricoxib,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Etoricoxib.,increase,risk
Etoricoxib,Valganciclovir,Etoricoxib may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Etoricoxib,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Etoricoxib.",increase,risk
Etoricoxib,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Etoricoxib.,increase,risk
Etoricoxib,Vancomycin,Etoricoxib may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Etoricoxib,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Varenicline,Etoricoxib may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Etoricoxib,Vemurafenib,The serum concentration of Etoricoxib can be increased when it is combined with Vemurafenib.,increase,no risk
Etoricoxib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Venlafaxine,Etoricoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Etoricoxib,Verapamil,The metabolism of Etoricoxib can be decreased when combined with Verapamil.,decrease,no risk
Etoricoxib,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Vilanterol,The risk or severity of hypertension can be increased when Etoricoxib is combined with Vilanterol.,increase,risk
Etoricoxib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Viloxazine,The metabolism of Etoricoxib can be decreased when combined with Viloxazine.,decrease,no risk
Etoricoxib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Vorapaxar.,increase,risk
Etoricoxib,Voriconazole,The serum concentration of Etoricoxib can be increased when it is combined with Voriconazole.,increase,no risk
Etoricoxib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Xamoterol,The risk or severity of hypertension can be increased when Etoricoxib is combined with Xamoterol.,increase,risk
Etoricoxib,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Ximelagatran.,increase,risk
Etoricoxib,Xylometazoline,The risk or severity of hypertension can be increased when Etoricoxib is combined with Xylometazoline.,increase,risk
Etoricoxib,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Etoricoxib.,increase,risk
Etoricoxib,Zafirlukast,The metabolism of Etoricoxib can be decreased when combined with Zafirlukast.,decrease,no risk
Etoricoxib,Zaleplon,Etoricoxib may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Etoricoxib,Zanamivir,Etoricoxib may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Etoricoxib,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Etoricoxib.,increase,no risk
Etoricoxib,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Etoricoxib.,increase,risk
Etoricoxib,Zileuton,The metabolism of Etoricoxib can be decreased when combined with Zileuton.,decrease,no risk
Etoricoxib,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Etoricoxib.,increase,risk
Etoricoxib,Ziprasidone,The metabolism of Etoricoxib can be decreased when combined with Ziprasidone.,decrease,no risk
Etoricoxib,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etoricoxib is combined with Zofenopril.",increase,risk
Etoricoxib,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Etoricoxib is combined with Zoledronic acid.,increase,risk
Etoricoxib,Zolmitriptan,The metabolism of Etoricoxib can be decreased when combined with Zolmitriptan.,decrease,no risk
Etoricoxib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Etoricoxib.,decrease,no risk
Etoricoxib,Zotepine,The metabolism of Zotepine can be decreased when combined with Etoricoxib.,decrease,no risk
5-fluorouridine,Gemcitabine,The serum concentration of 5-fluorouridine can be increased when it is combined with Gemcitabine.,increase,no risk
5-fluorouridine,Gimeracil,The serum concentration of 5-fluorouridine can be increased when it is combined with Gimeracil.,increase,no risk
5-fluorouridine,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with 5-fluorouridine.,decrease,no risk
5-fluorouridine,Warfarin,The risk or severity of bleeding can be increased when 5-fluorouridine is combined with Warfarin.,increase,risk
Sorbitol,Gabapentin enacarbil,Sorbitol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Sorbitol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gadodiamide,Gadodiamide may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gadofosveset trisodium,Sorbitol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Sorbitol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gadoteric acid,Sorbitol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Sorbitol,Gadoteridol,Gadoteridol may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gallamine triethiodide,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Sorbitol,Ganciclovir,Ganciclovir may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gemcitabine,Gemcitabine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Gentamicin,Sorbitol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Sorbitol,Gimeracil,Sorbitol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Sorbitol,Givosiran,Givosiran may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Glipizide,Glipizide may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Glycerol phenylbutyrate,Sorbitol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Sorbitol,Glycopyrronium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Sorbitol,Golodirsen,Sorbitol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Sorbitol,Goserelin,Goserelin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Guanethidine,Guanethidine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Guanfacine,Guanfacine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Haloperidol,Haloperidol may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Hexafluronium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hexafluronium.,decrease,no risk
Sorbitol,Hexocyclium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hexocyclium.,decrease,no risk
Sorbitol,Homatropine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Homatropine.,decrease,no risk
Sorbitol,Homatropine methylbromide,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Sorbitol,Hydralazine,Hydralazine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Sorbitol.,increase,risk
Sorbitol,Hydrocodone,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hydrocodone.,decrease,no risk
Sorbitol,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Sorbitol.,increase,risk
Sorbitol,Hydromorphone,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hydromorphone.,decrease,no risk
Sorbitol,Hydrotalcite,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Sorbitol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Hydroxyethyl Starch,Sorbitol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Sorbitol,Hyoscyamine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Sorbitol,Kanamycin,Sorbitol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Sorbitol,Ketamine,Ketamine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Ketazolam,Ketazolam may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Ketoprofen,Ketoprofen may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Ketorolac,Ketorolac may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Octinoxate,Sorbitol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Sorbitol,Olanzapine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Olanzapine.,decrease,no risk
Sorbitol,Oliceridine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oliceridine.,decrease,no risk
Sorbitol,Olsalazine,Olsalazine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Opium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Opium.,decrease,no risk
Sorbitol,Orphenadrine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Orphenadrine.,decrease,no risk
Sorbitol,Oseltamivir,Oseltamivir may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Oxacillin,Oxacillin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Oxaprozin,Oxaprozin may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Oxazepam,Oxazepam may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Oxybenzone,Oxybenzone may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Oxybutynin,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oxybutynin.,decrease,no risk
Sorbitol,Oxycodone,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oxycodone.,decrease,no risk
Sorbitol,Oxymorphone,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oxymorphone.,decrease,no risk
Sorbitol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Oxyphencyclimine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Sorbitol,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Sorbitol is combined with Oxyphenisatin acetate.,increase,risk
Sorbitol,Oxyphenonium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Sorbitol,Oxyquinoline,Sorbitol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Sorbitol,Quetiapine,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Quetiapine.,decrease,no risk
Sorbitol,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Sorbitol.,increase,risk
Sorbitol,Quinidine,Sorbitol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Sorbitol,Umeclidinium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Umeclidinium.,decrease,no risk
Sorbitol,Vaborbactam,Sorbitol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Sorbitol,Valaciclovir,Valaciclovir may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Valbenazine,Sorbitol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Sorbitol,Valdecoxib,Valdecoxib may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Valganciclovir,Valganciclovir may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Vancomycin,Sorbitol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Sorbitol,Varenicline,Varenicline may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Vecuronium,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Vecuronium.,decrease,no risk
Sorbitol,Venlafaxine,Venlafaxine may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Verapamil,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Verapamil.,decrease,no risk
Sorbitol,Vilanterol,Sorbitol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Sorbitol,Viloxazine,Sorbitol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Sorbitol,Vortioxetine,Sorbitol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Sorbitol,Warfarin,Sorbitol may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Sorbitol,Xylometazoline,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Xylometazoline.,decrease,no risk
Sorbitol,Zaleplon,Zaleplon may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Zanamivir,Zanamivir may decrease the excretion rate of Sorbitol which could result in a higher serum level.,decrease,no risk
Sorbitol,Ziconotide,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Ziconotide.,decrease,no risk
Sorbitol,Ziprasidone,The therapeutic efficacy of Sorbitol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Sorbitol,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Sorbitol.,increase,risk
Genistein,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Genistein.,decrease,no risk
Genistein,Gatifloxacin,The metabolism of Genistein can be decreased when combined with Gatifloxacin.,decrease,no risk
Genistein,Gefitinib,Genistein may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Genistein,Gemfibrozil,The metabolism of Genistein can be decreased when combined with Gemfibrozil.,decrease,no risk
Genistein,Gemifloxacin,The metabolism of Genistein can be decreased when combined with Gemifloxacin.,decrease,no risk
Genistein,Gestrinone,The metabolism of Gestrinone can be increased when combined with Genistein.,increase,no risk
Genistein,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Genistein.,increase,no risk
Genistein,Givosiran,The serum concentration of Genistein can be increased when it is combined with Givosiran.,increase,no risk
Genistein,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Genistein.,decrease,no risk
Genistein,Glecaprevir,Genistein may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Genistein,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Genistein.,decrease,no risk
Genistein,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Genistein.,decrease,no risk
Genistein,Glipizide,The metabolism of Glipizide can be decreased when combined with Genistein.,decrease,no risk
Genistein,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Genistein.,decrease,no risk
Genistein,Glofitamab,The serum concentration of Genistein can be increased when it is combined with Glofitamab.,increase,no risk
Genistein,Glyburide,Genistein may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Genistein,Golimumab,The metabolism of Genistein can be increased when combined with Golimumab.,increase,no risk
Genistein,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Genistein.,decrease,no risk
Genistein,Grepafloxacin,The metabolism of Genistein can be decreased when combined with Grepafloxacin.,decrease,no risk
Genistein,Guanabenz,The metabolism of Genistein can be decreased when combined with Guanabenz.,decrease,no risk
Genistein,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Haloperidol,The metabolism of Genistein can be decreased when combined with Haloperidol.,decrease,no risk
Genistein,Halothane,The metabolism of Halothane can be decreased when combined with Genistein.,decrease,no risk
Genistein,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Genistein.,decrease,no risk
Genistein,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Genistein.,increase,no risk
Genistein,Ketamine,The metabolism of Ketamine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Ketoconazole,The metabolism of Genistein can be decreased when combined with Ketoconazole.,decrease,no risk
Genistein,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Genistein.,decrease,no risk
Genistein,Obeticholic acid,The metabolism of Genistein can be decreased when combined with Obeticholic acid.,decrease,no risk
Genistein,Olanzapine,The metabolism of Genistein can be decreased when combined with Olanzapine.,decrease,no risk
Genistein,Olaparib,The metabolism of Olaparib can be increased when combined with Genistein.,increase,no risk
Genistein,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Genistein.,decrease,no risk
Genistein,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Genistein.,decrease,no risk
Genistein,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Genistein.,decrease,no risk
Genistein,Ondansetron,The metabolism of Genistein can be decreased when combined with Ondansetron.,decrease,no risk
Genistein,Orphenadrine,The metabolism of Genistein can be decreased when combined with Orphenadrine.,decrease,no risk
Genistein,Osilodrostat,The metabolism of Genistein can be decreased when combined with Osilodrostat.,decrease,no risk
Genistein,Osimertinib,The serum concentration of Genistein can be decreased when it is combined with Osimertinib.,decrease,no risk
Genistein,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Genistein.,decrease,no risk
Genistein,Ouabain,The excretion of Ouabain can be decreased when combined with Genistein.,decrease,no risk
Genistein,Oxaliplatin,Genistein may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Genistein,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Genistein is combined with Oxetacaine.,increase,risk
Genistein,Oxtriphylline,The metabolism of Genistein can be decreased when combined with Oxtriphylline.,decrease,no risk
Genistein,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Genistein is combined with Oxybuprocaine.,increase,risk
Genistein,Ozanimod,Genistein may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Genistein,Quinidine,The metabolism of Quinidine can be increased when combined with Genistein.,increase,no risk
Genistein,Quinine,The metabolism of Quinine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Genistein.,decrease,no risk
Genistein,Ulipristal,The metabolism of Ulipristal can be increased when combined with Genistein.,increase,no risk
Genistein,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Genistein.,decrease,no risk
Genistein,Valproic acid,The metabolism of Genistein can be decreased when combined with Valproic acid.,decrease,no risk
Genistein,Valsartan,The metabolism of Valsartan can be decreased when combined with Genistein.,decrease,no risk
Genistein,Vandetanib,The metabolism of Vandetanib can be increased when combined with Genistein.,increase,no risk
Genistein,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Genistein.,decrease,no risk
Genistein,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Genistein.,decrease,no risk
Genistein,Vemurafenib,The serum concentration of Genistein can be increased when it is combined with Vemurafenib.,increase,no risk
Genistein,Venetoclax,The metabolism of Venetoclax can be increased when combined with Genistein.,increase,no risk
Genistein,Verapamil,The metabolism of Genistein can be decreased when combined with Verapamil.,decrease,no risk
Genistein,Viloxazine,The metabolism of Genistein can be decreased when combined with Viloxazine.,decrease,no risk
Genistein,Vinblastine,The metabolism of Vinblastine can be increased when combined with Genistein.,increase,no risk
Genistein,Vincristine,The metabolism of Vincristine can be increased when combined with Genistein.,increase,no risk
Genistein,Vindesine,The metabolism of Vindesine can be increased when combined with Genistein.,increase,no risk
Genistein,Vinflunine,The metabolism of Vinflunine can be increased when combined with Genistein.,increase,no risk
Genistein,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Genistein.,increase,no risk
Genistein,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Genistein.,increase,no risk
Genistein,Voriconazole,The serum concentration of Genistein can be increased when it is combined with Voriconazole.,increase,no risk
Genistein,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Genistein.,decrease,no risk
Genistein,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Genistein.,decrease,no risk
Genistein,Warfarin,The metabolism of Warfarin can be increased when combined with Genistein.,increase,no risk
Genistein,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Genistein.,decrease,no risk
Genistein,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Genistein.,decrease,no risk
Genistein,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Genistein.,increase,no risk
Genistein,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Zileuton,The metabolism of Genistein can be decreased when combined with Zileuton.,decrease,no risk
Genistein,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Genistein.,increase,no risk
Genistein,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Genistein.,decrease,no risk
Genistein,Zolpidem,The metabolism of Genistein can be decreased when combined with Zolpidem.,decrease,no risk
Genistein,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Genistein.,decrease,no risk
Genistein,Zotepine,The metabolism of Zotepine can be decreased when combined with Genistein.,decrease,no risk
Genistein,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Genistein.,increase,no risk
Genistein,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Genistein.,decrease,no risk
trans-2-hydroxycinnamic acid,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with trans-2-hydroxycinnamic acid.,increase,no risk
trans-2-hydroxycinnamic acid,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Bumetanide,The excretion of Bumetanide can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Quinapril,The excretion of Quinapril can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with trans-2-hydroxycinnamic acid.,increase,no risk
trans-2-hydroxycinnamic acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Valproic acid,The excretion of Valproic acid can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
trans-2-hydroxycinnamic acid,Zidovudine,The excretion of Zidovudine can be decreased when combined with trans-2-hydroxycinnamic acid.,decrease,no risk
Roflumilast,Benznidazole,Roflumilast may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Roflumilast,Benzocaine,The metabolism of Roflumilast can be decreased when combined with Benzocaine.,decrease,no risk
Roflumilast,Benzthiazide,Benzthiazide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Benzydamine,Benzydamine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Bepotastine,Roflumilast may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Roflumilast,Berotralstat,The metabolism of Roflumilast can be decreased when combined with Berotralstat.,decrease,no risk
Roflumilast,Betamethasone,Roflumilast may increase the immunosuppressive activities of Betamethasone.,increase,no risk
Roflumilast,Betamethasone phosphate,The metabolism of Roflumilast can be increased when combined with Betamethasone phosphate.,increase,no risk
Roflumilast,Betaxolol,The metabolism of Roflumilast can be decreased when combined with Betaxolol.,decrease,no risk
Roflumilast,Bexarotene,Roflumilast may increase the immunosuppressive activities of Bexarotene.,increase,no risk
Roflumilast,Bicalutamide,The serum concentration of Roflumilast can be increased when it is combined with Bicalutamide.,increase,no risk
Roflumilast,Bicisate,Roflumilast may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Roflumilast,Bifonazole,The serum concentration of Roflumilast can be increased when it is combined with Bifonazole.,increase,no risk
Roflumilast,Bimekizumab,Roflumilast may increase the immunosuppressive activities of Bimekizumab.,increase,no risk
Roflumilast,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Bismuth subgallate,Roflumilast may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Roflumilast,Bisoprolol,Bisoprolol may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Bisoxatin,Roflumilast may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Roflumilast,Bleomycin,Roflumilast may increase the immunosuppressive activities of Bleomycin.,increase,no risk
Roflumilast,Blinatumomab,Roflumilast may increase the immunosuppressive activities of Blinatumomab.,increase,no risk
Roflumilast,Boceprevir,The serum concentration of Roflumilast can be increased when it is combined with Boceprevir.,increase,no risk
Roflumilast,Bortezomib,Roflumilast may increase the immunosuppressive activities of Bortezomib.,increase,no risk
Roflumilast,Bosentan,The metabolism of Roflumilast can be increased when combined with Bosentan.,increase,no risk
Roflumilast,Bosutinib,The serum concentration of Roflumilast can be increased when it is combined with Bosutinib.,increase,no risk
Roflumilast,Brentuximab vedotin,The serum concentration of Roflumilast can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Roflumilast,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Brivaracetam,Roflumilast may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Roflumilast,Brodalumab,Roflumilast may increase the immunosuppressive activities of Brodalumab.,increase,no risk
Roflumilast,Bromazepam,The metabolism of Roflumilast can be decreased when combined with Bromazepam.,decrease,no risk
Roflumilast,Bromocriptine,The serum concentration of Roflumilast can be increased when it is combined with Bromocriptine.,increase,no risk
Roflumilast,Bromotheophylline,Bromotheophylline may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Budesonide,Roflumilast may increase the immunosuppressive activities of Budesonide.,increase,no risk
Roflumilast,Bumadizone,Bumadizone may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Bumetanide,Bumetanide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Buprenorphine,The serum concentration of Roflumilast can be increased when it is combined with Buprenorphine.,increase,no risk
Roflumilast,Bupropion,Bupropion may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Buspirone,Buspirone may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Busulfan,Roflumilast may increase the immunosuppressive activities of Busulfan.,increase,no risk
Roflumilast,Butabarbital,Butabarbital may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Butalbital,The metabolism of Roflumilast can be increased when combined with Butalbital.,increase,no risk
Roflumilast,Gabapentin enacarbil,Roflumilast may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Roflumilast,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Gadodiamide,Gadodiamide may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Gadofosveset trisodium,Roflumilast may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Roflumilast,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Gadoteric acid,Roflumilast may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Roflumilast,Gadoteridol,Gadoteridol may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Ganciclovir,Ganciclovir may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Gatifloxacin,The serum concentration of Roflumilast can be increased when it is combined with Gatifloxacin.,increase,no risk
Roflumilast,Gemcitabine,Roflumilast may increase the immunosuppressive activities of Gemcitabine.,increase,no risk
Roflumilast,Gemfibrozil,The serum concentration of Roflumilast can be increased when it is combined with Gemfibrozil.,increase,no risk
Roflumilast,Gemifloxacin,The serum concentration of Roflumilast can be increased when it is combined with Gemifloxacin.,increase,no risk
Roflumilast,Gemtuzumab ozogamicin,Roflumilast may increase the immunosuppressive activities of Gemtuzumab ozogamicin.,increase,no risk
Roflumilast,Gentamicin,Roflumilast may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Roflumilast,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Gimeracil,Roflumilast may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Roflumilast,Ginkgo biloba,The metabolism of Roflumilast can be decreased when combined with Ginkgo biloba.,decrease,no risk
Roflumilast,Givosiran,The serum concentration of Roflumilast can be increased when it is combined with Givosiran.,increase,no risk
Roflumilast,Glatiramer,Roflumilast may increase the immunosuppressive activities of Glatiramer.,increase,no risk
Roflumilast,Glecaprevir,The serum concentration of Roflumilast can be increased when it is combined with Glecaprevir.,increase,no risk
Roflumilast,Glipizide,Glipizide may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Glofitamab,The serum concentration of Roflumilast can be increased when it is combined with Glofitamab.,increase,no risk
Roflumilast,Glyburide,The serum concentration of Roflumilast can be increased when it is combined with Glyburide.,increase,no risk
Roflumilast,Glycerol phenylbutyrate,The metabolism of Roflumilast can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Roflumilast,Golimumab,Roflumilast may increase the immunosuppressive activities of Golimumab.,increase,no risk
Roflumilast,Golodirsen,Roflumilast may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Roflumilast,Goserelin,Goserelin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Grapefruit,The metabolism of Roflumilast can be decreased when combined with Grapefruit.,decrease,no risk
Roflumilast,Grepafloxacin,The serum concentration of Roflumilast can be increased when it is combined with Grepafloxacin.,increase,no risk
Roflumilast,Griseofulvin,The metabolism of Roflumilast can be increased when combined with Griseofulvin.,increase,no risk
Roflumilast,Guanabenz,The metabolism of Roflumilast can be decreased when combined with Guanabenz.,decrease,no risk
Roflumilast,Guanethidine,Guanethidine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Guanfacine,Guanfacine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Guselkumab,Roflumilast may increase the immunosuppressive activities of Guselkumab.,increase,no risk
Roflumilast,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Roflumilast.,increase,no risk
Roflumilast,Hydralazine,The serum concentration of Roflumilast can be increased when it is combined with Hydralazine.,increase,no risk
Roflumilast,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Hydrocortamate,The metabolism of Roflumilast can be increased when combined with Hydrocortamate.,increase,no risk
Roflumilast,Hydrocortisone,Roflumilast may increase the immunosuppressive activities of Hydrocortisone.,increase,no risk
Roflumilast,Hydrocortisone acetate,Roflumilast may increase the immunosuppressive activities of Hydrocortisone acetate.,increase,no risk
Roflumilast,Hydrocortisone butyrate,Roflumilast may increase the immunosuppressive activities of Hydrocortisone butyrate.,increase,no risk
Roflumilast,Hydrocortisone succinate,Roflumilast may increase the immunosuppressive activities of Hydrocortisone succinate.,increase,no risk
Roflumilast,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Hydromorphone,Hydromorphone may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Hydroxychloroquine,Roflumilast may increase the immunosuppressive activities of Hydroxychloroquine.,increase,no risk
Roflumilast,Hydroxyethyl Starch,Roflumilast may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Roflumilast,Hydroxyurea,Roflumilast may increase the immunosuppressive activities of Hydroxyurea.,increase,no risk
Roflumilast,Kanamycin,Roflumilast may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Roflumilast,Ketamine,Ketamine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Ketazolam,The serum concentration of Roflumilast can be increased when it is combined with Ketazolam.,increase,no risk
Roflumilast,Ketoconazole,The serum concentration of Roflumilast can be increased when it is combined with Ketoconazole.,increase,no risk
Roflumilast,Ketoprofen,Ketoprofen may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Ketorolac,Ketorolac may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Obeticholic acid,The serum concentration of Roflumilast can be increased when it is combined with Obeticholic acid.,increase,no risk
Roflumilast,Obinutuzumab,Roflumilast may increase the immunosuppressive activities of Obinutuzumab.,increase,no risk
Roflumilast,Ocrelizumab,Roflumilast may increase the immunosuppressive activities of Ocrelizumab.,increase,no risk
Roflumilast,Octinoxate,Roflumilast may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Roflumilast,Octreotide,The serum concentration of Roflumilast can be increased when it is combined with Octreotide.,increase,no risk
Roflumilast,Ofatumumab,Roflumilast may increase the immunosuppressive activities of Ofatumumab.,increase,no risk
Roflumilast,Ofloxacin,The serum concentration of Roflumilast can be increased when it is combined with Ofloxacin.,increase,no risk
Roflumilast,Olanzapine,The metabolism of Roflumilast can be decreased when combined with Olanzapine.,decrease,no risk
Roflumilast,Olaparib,The serum concentration of Roflumilast can be increased when it is combined with Olaparib.,increase,no risk
Roflumilast,Olsalazine,Olsalazine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Olutasidenib,The metabolism of Roflumilast can be increased when combined with Olutasidenib.,increase,no risk
Roflumilast,Omaveloxolone,The serum concentration of Roflumilast can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Roflumilast,Ondansetron,The metabolism of Roflumilast can be decreased when combined with Ondansetron.,decrease,no risk
Roflumilast,Opium,Roflumilast may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Roflumilast,Oritavancin,The metabolism of Roflumilast can be increased when combined with Oritavancin.,increase,no risk
Roflumilast,Orphenadrine,The serum concentration of Roflumilast can be increased when it is combined with Orphenadrine.,increase,no risk
Roflumilast,Oseltamivir,Oseltamivir may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Osilodrostat,The serum concentration of Roflumilast can be increased when it is combined with Osilodrostat.,increase,no risk
Roflumilast,Osimertinib,The serum concentration of Roflumilast can be decreased when it is combined with Osimertinib.,decrease,no risk
Roflumilast,Oxacillin,Oxacillin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Oxaliplatin,Roflumilast may increase the immunosuppressive activities of Oxaliplatin.,increase,no risk
Roflumilast,Oxaprozin,Oxaprozin may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Oxazepam,Oxazepam may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Oxcarbazepine,The metabolism of Roflumilast can be increased when combined with Oxcarbazepine.,increase,no risk
Roflumilast,Oxetacaine,The serum concentration of Roflumilast can be increased when it is combined with Oxetacaine.,increase,no risk
Roflumilast,Oxtriphylline,The metabolism of Roflumilast can be decreased when combined with Oxtriphylline.,decrease,no risk
Roflumilast,Oxybenzone,Oxybenzone may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Oxybutynin,The serum concentration of Roflumilast can be increased when it is combined with Oxybutynin.,increase,no risk
Roflumilast,Oxymetholone,The serum concentration of Roflumilast can be increased when it is combined with Oxymetholone.,increase,no risk
Roflumilast,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Oxyquinoline,Roflumilast may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Roflumilast,Ozanimod,Roflumilast may increase the immunosuppressive activities of Ozanimod.,increase,no risk
Roflumilast,Quetiapine,Quetiapine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Quinethazone,Quinethazone may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Quinidine,The serum concentration of Roflumilast can be increased when it is combined with Quinidine.,increase,no risk
Roflumilast,Quinine,The serum concentration of Roflumilast can be increased when it is combined with Quinine.,increase,no risk
Roflumilast,Quinupristin,The serum concentration of Roflumilast can be increased when it is combined with Quinupristin.,increase,no risk
Roflumilast,Ublituximab,Roflumilast may increase the immunosuppressive activities of Ublituximab.,increase,no risk
Roflumilast,Upadacitinib,Roflumilast may increase the immunosuppressive activities of Upadacitinib.,increase,no risk
Roflumilast,Vaborbactam,Roflumilast may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Roflumilast,Vadadustat,The serum concentration of Roflumilast can be increased when it is combined with Vadadustat.,increase,no risk
Roflumilast,Valaciclovir,Valaciclovir may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Valbenazine,Roflumilast may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Roflumilast,Valdecoxib,Valdecoxib may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Valganciclovir,Valganciclovir may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Valproic acid,The serum concentration of Roflumilast can be increased when it is combined with Valproic acid.,increase,no risk
Roflumilast,Vancomycin,Roflumilast may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Roflumilast,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Varenicline,Varenicline may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Vedolizumab,Roflumilast may increase the immunosuppressive activities of Vedolizumab.,increase,no risk
Roflumilast,Vemurafenib,The serum concentration of Roflumilast can be increased when it is combined with Vemurafenib.,increase,no risk
Roflumilast,Venetoclax,The serum concentration of Roflumilast can be increased when it is combined with Venetoclax.,increase,no risk
Roflumilast,Venlafaxine,Venlafaxine may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Verapamil,The serum concentration of Roflumilast can be increased when it is combined with Verapamil.,increase,no risk
Roflumilast,Vilanterol,Roflumilast may increase the immunosuppressive activities of Vilanterol.,increase,no risk
Roflumilast,Viloxazine,The metabolism of Roflumilast can be decreased when combined with Viloxazine.,decrease,no risk
Roflumilast,Vinblastine,The serum concentration of Roflumilast can be increased when it is combined with Vinblastine.,increase,no risk
Roflumilast,Vincristine,Roflumilast may increase the immunosuppressive activities of Vincristine.,increase,no risk
Roflumilast,Vindesine,Roflumilast may increase the immunosuppressive activities of Vindesine.,increase,no risk
Roflumilast,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Vinorelbine,Roflumilast may increase the immunosuppressive activities of Vinorelbine.,increase,no risk
Roflumilast,Vitamin E,The metabolism of Roflumilast can be increased when combined with Vitamin E.,increase,no risk
Roflumilast,Voclosporin,Roflumilast may increase the immunosuppressive activities of Voclosporin.,increase,no risk
Roflumilast,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Voriconazole,The serum concentration of Roflumilast can be increased when it is combined with Voriconazole.,increase,no risk
Roflumilast,Vorinostat,Roflumilast may increase the immunosuppressive activities of Vorinostat.,increase,no risk
Roflumilast,Vortioxetine,Roflumilast may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Roflumilast,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Warfarin,Roflumilast may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Roflumilast,Zafirlukast,The serum concentration of Roflumilast can be increased when it is combined with Zafirlukast.,increase,no risk
Roflumilast,Zaleplon,Zaleplon may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Zanamivir,Zanamivir may decrease the excretion rate of Roflumilast which could result in a higher serum level.,decrease,no risk
Roflumilast,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Zidovudine,Roflumilast may increase the immunosuppressive activities of Zidovudine.,increase,no risk
Roflumilast,Zileuton,The metabolism of Roflumilast can be decreased when combined with Zileuton.,decrease,no risk
Roflumilast,Zimelidine,The serum concentration of Roflumilast can be increased when it is combined with Zimelidine.,increase,no risk
Roflumilast,Ziprasidone,The serum concentration of Roflumilast can be increased when it is combined with Ziprasidone.,increase,no risk
Roflumilast,Zolmitriptan,The metabolism of Roflumilast can be decreased when combined with Zolmitriptan.,decrease,no risk
Roflumilast,Zolpidem,The metabolism of Roflumilast can be decreased when combined with Zolpidem.,decrease,no risk
Roflumilast,Zonisamide,Zonisamide may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Roflumilast,Zotepine,The metabolism of Zotepine can be decreased when combined with Roflumilast.,decrease,no risk
Roflumilast,Zucapsaicin,The serum concentration of Roflumilast can be increased when it is combined with Zucapsaicin.,increase,no risk
Roflumilast,Zuclopenthixol,The metabolism of Roflumilast can be decreased when combined with Zuclopenthixol.,decrease,no risk
8-azaguanine,Gabapentin,Gabapentin may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Ganaxolone,Ganaxolone may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Gatifloxacin,The metabolism of 8-azaguanine can be decreased when combined with Gatifloxacin.,decrease,no risk
8-azaguanine,Gemfibrozil,The metabolism of 8-azaguanine can be decreased when combined with Gemfibrozil.,decrease,no risk
8-azaguanine,Gemifloxacin,The metabolism of 8-azaguanine can be decreased when combined with Gemifloxacin.,decrease,no risk
8-azaguanine,Givosiran,The serum concentration of 8-azaguanine can be increased when it is combined with Givosiran.,increase,no risk
8-azaguanine,Glofitamab,The serum concentration of 8-azaguanine can be increased when it is combined with Glofitamab.,increase,no risk
8-azaguanine,Golimumab,The metabolism of 8-azaguanine can be increased when combined with Golimumab.,increase,no risk
8-azaguanine,Grepafloxacin,The metabolism of 8-azaguanine can be decreased when combined with Grepafloxacin.,decrease,no risk
8-azaguanine,Guanabenz,The metabolism of 8-azaguanine can be decreased when combined with Guanabenz.,decrease,no risk
8-azaguanine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with 8-azaguanine.,decrease,no risk
8-azaguanine,Haloperidol,The metabolism of 8-azaguanine can be decreased when combined with Haloperidol.,decrease,no risk
8-azaguanine,Human interferon beta,The metabolism of 8-azaguanine can be decreased when combined with Human interferon beta.,decrease,no risk
8-azaguanine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 8-azaguanine.,increase,risk
8-azaguanine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with 8-azaguanine.,decrease,no risk
8-azaguanine,Ketoconazole,The metabolism of 8-azaguanine can be decreased when combined with Ketoconazole.,decrease,no risk
8-azaguanine,Obeticholic acid,The metabolism of 8-azaguanine can be decreased when combined with Obeticholic acid.,decrease,no risk
8-azaguanine,Ofloxacin,The metabolism of 8-azaguanine can be decreased when combined with Ofloxacin.,decrease,no risk
8-azaguanine,Olanzapine,The metabolism of 8-azaguanine can be decreased when combined with Olanzapine.,decrease,no risk
8-azaguanine,Olodaterol,8-azaguanine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
8-azaguanine,Ondansetron,The metabolism of 8-azaguanine can be decreased when combined with Ondansetron.,decrease,no risk
8-azaguanine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with 8-azaguanine.,increase,risk
8-azaguanine,Orphenadrine,The metabolism of 8-azaguanine can be decreased when combined with Orphenadrine.,decrease,no risk
8-azaguanine,Osilodrostat,The metabolism of 8-azaguanine can be decreased when combined with Osilodrostat.,decrease,no risk
8-azaguanine,Osimertinib,The serum concentration of 8-azaguanine can be decreased when it is combined with Osimertinib.,decrease,no risk
8-azaguanine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with 8-azaguanine.,decrease,no risk
8-azaguanine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 8-azaguanine is combined with Oxetacaine.,increase,risk
8-azaguanine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with 8-azaguanine.,increase,risk
8-azaguanine,Oxtriphylline,The metabolism of 8-azaguanine can be decreased when combined with Oxtriphylline.,decrease,no risk
8-azaguanine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 8-azaguanine is combined with Oxybuprocaine.,increase,risk
8-azaguanine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 8-azaguanine.,increase,risk
8-azaguanine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with 8-azaguanine.,decrease,no risk
8-azaguanine,Quinidine,The serum concentration of 8-azaguanine can be increased when it is combined with Quinidine.,increase,no risk
8-azaguanine,Quinine,The serum concentration of 8-azaguanine can be increased when it is combined with Quinine.,increase,no risk
8-azaguanine,Valproic acid,Valproic acid may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Vemurafenib,The serum concentration of 8-azaguanine can be increased when it is combined with Vemurafenib.,increase,no risk
8-azaguanine,Verapamil,The metabolism of 8-azaguanine can be decreased when combined with Verapamil.,decrease,no risk
8-azaguanine,Vigabatrin,Vigabatrin may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Vilanterol,The risk or severity of hypokalemia can be increased when 8-azaguanine is combined with Vilanterol.,increase,risk
8-azaguanine,Viloxazine,The metabolism of 8-azaguanine can be decreased when combined with Viloxazine.,decrease,no risk
8-azaguanine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with 8-azaguanine.,decrease,no risk
8-azaguanine,Warfarin,The metabolism of 8-azaguanine can be decreased when combined with Warfarin.,decrease,no risk
8-azaguanine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with 8-azaguanine.,decrease,no risk
8-azaguanine,Zaleplon,Zaleplon may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Zileuton,The metabolism of 8-azaguanine can be decreased when combined with Zileuton.,decrease,no risk
8-azaguanine,Zolmitriptan,The metabolism of 8-azaguanine can be decreased when combined with Zolmitriptan.,decrease,no risk
8-azaguanine,Zolpidem,The metabolism of 8-azaguanine can be decreased when combined with Zolpidem.,decrease,no risk
8-azaguanine,Zonisamide,Zonisamide may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
8-azaguanine,Zotepine,The metabolism of Zotepine can be decreased when combined with 8-azaguanine.,decrease,no risk
Virginiamycin M1,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Virginiamycin M1.,decrease,no risk
Virginiamycin M1,Benzocaine,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Benzocaine.,increase,risk
Virginiamycin M1,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Benzyl alcohol.,increase,risk
Virginiamycin M1,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Bupivacaine.,increase,risk
Virginiamycin M1,Butacaine,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Butacaine.,increase,risk
Virginiamycin M1,Butamben,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Butamben.,increase,risk
Virginiamycin M1,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Oxetacaine.,increase,risk
Virginiamycin M1,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Virginiamycin M1 is combined with Oxybuprocaine.,increase,risk
Virginiamycin M1,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Virginiamycin M1.,decrease,no risk
Virginiamycin M1,Warfarin,The risk or severity of bleeding can be increased when Virginiamycin M1 is combined with Warfarin.,increase,risk
Topiroxostat,Bismuth subgallate,Topiroxostat may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bisoprolol,Bisoprolol may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bisoxatin,Topiroxostat may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bleomycin,Bleomycin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Bosentan,The metabolism of Bosentan can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Bromazepam,Bromazepam may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bromotheophylline,Bromotheophylline may increase the excretion rate of Topiroxostat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiroxostat,Budesonide,Budesonide may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bumadizone,Bumadizone may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Bumetanide,The excretion of Bumetanide can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Bupropion,The metabolism of Bupropion can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Buspirone,Buspirone may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Butabarbital,Butabarbital may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gabapentin enacarbil,Topiroxostat may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gadodiamide,Gadodiamide may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gadofosveset trisodium,Topiroxostat may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gadoteric acid,Topiroxostat may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gadoteridol,Gadoteridol may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Ganciclovir,Ganciclovir may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gefitinib,Topiroxostat may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gemcitabine,Gemcitabine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gentamicin,Topiroxostat may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Gimeracil,Topiroxostat may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Topiroxostat,Givosiran,Givosiran may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Glecaprevir,Topiroxostat may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Topiroxostat,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Glipizide,The metabolism of Glipizide can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Glyburide,Topiroxostat may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Topiroxostat,Glycerol phenylbutyrate,Topiroxostat may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Topiroxostat,Golodirsen,Topiroxostat may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Topiroxostat,Goserelin,Goserelin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Guanethidine,Guanethidine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Guanfacine,Guanfacine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Halothane,The metabolism of Halothane can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Hydralazine,Hydralazine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Topiroxostat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiroxostat,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Hydroxyethyl Starch,Topiroxostat may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Topiroxostat,Kanamycin,Topiroxostat may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Topiroxostat,Ketamine,The metabolism of Ketamine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Ketazolam,Ketazolam may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Ketoprofen,Ketoprofen may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Octinoxate,Topiroxostat may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Topiroxostat,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Olsalazine,Olsalazine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Opium,Topiroxostat may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Oxacillin,Oxacillin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxaliplatin,Topiroxostat may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxaprozin,Oxaprozin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxazepam,Oxazepam may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxybenzone,Oxybenzone may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxyquinoline,Topiroxostat may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Topiroxostat,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Ozanimod,Topiroxostat may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Topiroxostat,Quetiapine,Quetiapine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Quinapril,The excretion of Quinapril can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Quinethazone,Quinethazone may increase the excretion rate of Topiroxostat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiroxostat,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Quinine,The metabolism of Quinine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vaborbactam,Topiroxostat may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Topiroxostat,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Valbenazine,Topiroxostat may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Topiroxostat,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Valganciclovir,Valganciclovir may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Valproic acid,The excretion of Valproic acid can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Valsartan,The metabolism of Valsartan can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Vancomycin,Topiroxostat may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Topiroxostat,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Varenicline,Varenicline may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Venlafaxine,Venlafaxine may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Verapamil,Verapamil may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Vilanterol,Topiroxostat may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Topiroxostat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Viloxazine,Topiroxostat may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Topiroxostat,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zaleplon,Zaleplon may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Zanamivir,Zanamivir may decrease the excretion rate of Topiroxostat which could result in a higher serum level.,decrease,no risk
Topiroxostat,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Topiroxostat.,increase,no risk
Topiroxostat,Zidovudine,The excretion of Zidovudine can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zileuton,The metabolism of Zileuton can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zonisamide,Zonisamide may increase the excretion rate of Topiroxostat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Topiroxostat,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Topiroxostat.,decrease,no risk
Topiroxostat,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Topiroxostat.,decrease,no risk
Uric acid,Ofloxacin,The metabolism of Uric acid can be decreased when combined with Ofloxacin.,decrease,no risk
Uric acid,Olodaterol,Uric acid may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Uric acid,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Uric acid.,increase,risk
Uric acid,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Uric acid.,decrease,no risk
Uric acid,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Uric acid,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Uric acid.,increase,risk
Uric acid,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Uric acid.,increase,risk
Uric acid,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Uric acid.,decrease,no risk
Uric acid,Quinidine,The serum concentration of Uric acid can be increased when it is combined with Quinidine.,increase,no risk
Uric acid,Quinine,The serum concentration of Uric acid can be increased when it is combined with Quinine.,increase,no risk
Uric acid,Valproic acid,Valproic acid may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Uric acid,Vigabatrin,Vigabatrin may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Uric acid,Vilanterol,The risk or severity of hypokalemia can be increased when Uric acid is combined with Vilanterol.,increase,risk
Uric acid,Viloxazine,The serum concentration of Uric acid can be increased when it is combined with Viloxazine.,increase,no risk
Uric acid,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Uric acid.,decrease,no risk
Uric acid,Zaleplon,Zaleplon may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Uric acid,Zonisamide,Zonisamide may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rutin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Rutin.,increase,no risk
Rutin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Rutin.,increase,no risk
Rutin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Rutin.,decrease,no risk
Rutin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Rutin.,increase,no risk
Rutin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Rutin.,increase,no risk
Rutin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Rutin.,decrease,no risk
AICA ribonucleotide,Gatifloxacin,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Gatifloxacin.,increase,no risk
AICA ribonucleotide,Gefapixant,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Gefapixant.,increase,no risk
AICA ribonucleotide,Gemifloxacin,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Gemifloxacin.,increase,no risk
AICA ribonucleotide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Glymidine,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Glymidine.,increase,no risk
AICA ribonucleotide,Goserelin,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Goserelin.,decrease,no risk
AICA ribonucleotide,Grepafloxacin,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Grepafloxacin.,increase,no risk
AICA ribonucleotide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Haloperidol,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Haloperidol.,decrease,no risk
AICA ribonucleotide,Histrelin,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Histrelin.,decrease,no risk
AICA ribonucleotide,Hydrochlorothiazide,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
AICA ribonucleotide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Hydroflumethiazide,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
AICA ribonucleotide,Hydroxychloroquine,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
AICA ribonucleotide,Hydroxyprogesterone caproate,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
AICA ribonucleotide,Octreotide,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Octreotide.,decrease,no risk
AICA ribonucleotide,Ofloxacin,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Ofloxacin.,increase,no risk
AICA ribonucleotide,Olanzapine,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Olanzapine.,decrease,no risk
AICA ribonucleotide,Olsalazine,Olsalazine may increase the hypoglycemic activities of AICA ribonucleotide.,increase,no risk
AICA ribonucleotide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of AICA ribonucleotide.,increase,no risk
AICA ribonucleotide,Oxprenolol,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Oxprenolol.,increase,no risk
AICA ribonucleotide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of AICA ribonucleotide.,increase,no risk
AICA ribonucleotide,Quetiapine,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Quetiapine.,decrease,no risk
AICA ribonucleotide,Quinethazone,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Quinethazone.,decrease,no risk
AICA ribonucleotide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of AICA ribonucleotide.,decrease,no risk
AICA ribonucleotide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Udenafil,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Udenafil.,increase,no risk
AICA ribonucleotide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Valdecoxib,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Valdecoxib.,increase,no risk
AICA ribonucleotide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Vemurafenib,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Vemurafenib.,increase,no risk
AICA ribonucleotide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Vildagliptin,The risk or severity of hypoglycemia can be increased when AICA ribonucleotide is combined with Vildagliptin.,increase,risk
AICA ribonucleotide,Vorinostat,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Vorinostat.,decrease,no risk
AICA ribonucleotide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with AICA ribonucleotide.,increase,risk
AICA ribonucleotide,Ziprasidone,The therapeutic efficacy of AICA ribonucleotide can be decreased when used in combination with Ziprasidone.,decrease,no risk
AICA ribonucleotide,Zonisamide,The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Zonisamide.,increase,no risk
Prasterone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Prasterone.,increase,no risk
Prasterone,Glofitamab,The serum concentration of Prasterone can be increased when it is combined with Glofitamab.,increase,no risk
Prasterone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Prasterone.,increase,no risk
Prasterone,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Prasterone.,decrease,no risk
Prasterone,Omaveloxolone,The serum concentration of Prasterone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Prasterone,Oteseconazole,The serum concentration of Prasterone can be increased when it is combined with Oteseconazole.,increase,no risk
Prasterone,Quinestrol,The risk or severity of adverse effects can be increased when Prasterone is combined with Quinestrol.,increase,risk
Prasterone,Vadadustat,The serum concentration of Prasterone can be increased when it is combined with Vadadustat.,increase,no risk
Prasterone,Viloxazine,The metabolism of Prasterone can be decreased when combined with Viloxazine.,decrease,no risk
Dalfopristin,Olaparib,The metabolism of Olaparib can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dalfopristin is combined with Oxetacaine.,increase,risk
Dalfopristin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dalfopristin is combined with Oxybuprocaine.,increase,risk
Dalfopristin,Quinidine,The metabolism of Quinidine can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dalfopristin.,increase,no risk
Dalfopristin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dalfopristin.,decrease,no risk
Dalfopristin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vincristine,The metabolism of Vincristine can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vindesine,The metabolism of Vindesine can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dalfopristin.,increase,no risk
Dalfopristin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dalfopristin.,increase,no risk
Dalfopristin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dalfopristin.,decrease,no risk
Dalfopristin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Dalfopristin.,decrease,no risk
Pantothenic acid,Bemiparin,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Bemiparin.,decrease,no risk
Pantothenic acid,Betrixaban,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Betrixaban.,decrease,no risk
Pantothenic acid,Bivalirudin,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Bivalirudin.,decrease,no risk
Pantothenic acid,Heparin,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Heparin.,decrease,no risk
Pantothenic acid,Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Pantothenic acid.,increase,no risk
Pantothenic acid,Urokinase,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Urokinase.,decrease,no risk
Pantothenic acid,Vorapaxar,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Vorapaxar.,decrease,no risk
Pantothenic acid,Warfarin,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Warfarin.,decrease,no risk
Pantothenic acid,Ximelagatran,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Ximelagatran.,decrease,no risk
Castanospermine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Castanospermine.,increase,risk
Castanospermine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Castanospermine.,increase,risk
Castanospermine,Glatiramer,The risk or severity of adverse effects can be increased when Castanospermine is combined with Glatiramer.,increase,risk
Castanospermine,Golimumab,The risk or severity of adverse effects can be increased when Castanospermine is combined with Golimumab.,increase,risk
Castanospermine,Guselkumab,The risk or severity of adverse effects can be increased when Castanospermine is combined with Guselkumab.,increase,risk
Castanospermine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Castanospermine.,increase,risk
Castanospermine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Castanospermine is combined with Hydrocortisone acetate.,increase,risk
Castanospermine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Castanospermine is combined with Hydrocortisone butyrate.,increase,risk
Castanospermine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Castanospermine is combined with Hydrocortisone succinate.,increase,risk
Castanospermine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Castanospermine.,increase,risk
Castanospermine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Castanospermine.,increase,risk
Castanospermine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Obinutuzumab,The risk or severity of adverse effects can be increased when Castanospermine is combined with Obinutuzumab.,increase,risk
Castanospermine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Castanospermine.,increase,no risk
Castanospermine,Ofatumumab,The risk or severity of adverse effects can be increased when Castanospermine is combined with Ofatumumab.,increase,risk
Castanospermine,Olaparib,The risk or severity of adverse effects can be increased when Castanospermine is combined with Olaparib.,increase,risk
Castanospermine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Castanospermine.,increase,risk
Castanospermine,Ozanimod,The risk or severity of adverse effects can be increased when Castanospermine is combined with Ozanimod.,increase,risk
Castanospermine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Castanospermine.,increase,risk
Castanospermine,Upadacitinib,The risk or severity of adverse effects can be increased when Castanospermine is combined with Upadacitinib.,increase,risk
Castanospermine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Castanospermine.,increase,risk
Castanospermine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Vedolizumab,The risk or severity of adverse effects can be increased when Castanospermine is combined with Vedolizumab.,increase,risk
Castanospermine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Castanospermine.,decrease,no risk
Castanospermine,Vilanterol,The risk or severity of adverse effects can be increased when Castanospermine is combined with Vilanterol.,increase,risk
Castanospermine,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Castanospermine.,increase,risk
Castanospermine,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Castanospermine.,increase,risk
Castanospermine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Castanospermine.,increase,risk
Castanospermine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Castanospermine.,increase,risk
Castanospermine,Voclosporin,The risk or severity of adverse effects can be increased when Castanospermine is combined with Voclosporin.,increase,risk
Castanospermine,Vorinostat,The risk or severity of adverse effects can be increased when Castanospermine is combined with Vorinostat.,increase,risk
Castanospermine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Castanospermine.,increase,risk
Castanospermine,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Castanospermine.,increase,risk
Epothilone D,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Epothilone D.,decrease,no risk
Epothilone D,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Epothilone D is combined with Oxetacaine.,increase,risk
Epothilone D,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Epothilone D.,decrease,no risk
Epothilone D,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Epothilone D is combined with Oxybuprocaine.,increase,risk
Epothilone D,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Quinine,The serum concentration of Quinine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Epothilone D.,decrease,no risk
Epothilone D,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Epothilone D.,decrease,no risk
Epothilone D,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Epothilone D.,decrease,no risk
Epothilone D,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Epothilone D.,increase,no risk
Epothilone D,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Epothilone D.,decrease,no risk
Epothilone D,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Epothilone D.,decrease,no risk
Epothilone D,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Epothilone D.,decrease,no risk
Hyperforin,Belantamab mafodotin,The excretion of Belantamab mafodotin can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Bosentan,The excretion of Bosentan can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Hyperforin.,increase,no risk
Hyperforin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Ouabain,The excretion of Ouabain can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Valsartan,The excretion of Valsartan can be decreased when combined with Hyperforin.,decrease,no risk
Hyperforin,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Hyperforin.,decrease,no risk
Sinefungin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Sinefungin.,increase,no risk
Huperzine A,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Oxprenolol,Huperzine A may increase the bradycardic activities of Oxprenolol.,increase,no risk
Huperzine A,Oxybuprocaine,Huperzine A may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Huperzine A,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Vamorolone,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Vamorolone.,decrease,no risk
Huperzine A,Varenicline,The risk or severity of adverse effects can be increased when Huperzine A is combined with Varenicline.,increase,risk
Huperzine A,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Huperzine A.,decrease,no risk
Huperzine A,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Huperzine A.,decrease,no risk
7-Hydroxystaurosporine,Benzocaine,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Benzocaine.,increase,risk
7-Hydroxystaurosporine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Benzyl alcohol.,increase,risk
7-Hydroxystaurosporine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Bupivacaine.,increase,risk
7-Hydroxystaurosporine,Butacaine,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Butacaine.,increase,risk
7-Hydroxystaurosporine,Butamben,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Butamben.,increase,risk
7-Hydroxystaurosporine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Oxetacaine.,increase,risk
7-Hydroxystaurosporine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 7-Hydroxystaurosporine is combined with Oxybuprocaine.,increase,risk
Formic acid,Bemiparin,The therapeutic efficacy of Formic acid can be decreased when used in combination with Bemiparin.,decrease,no risk
Formic acid,Betrixaban,The therapeutic efficacy of Formic acid can be decreased when used in combination with Betrixaban.,decrease,no risk
Formic acid,Bivalirudin,The therapeutic efficacy of Formic acid can be decreased when used in combination with Bivalirudin.,decrease,no risk
Formic acid,Heparin,The therapeutic efficacy of Formic acid can be decreased when used in combination with Heparin.,decrease,no risk
Formic acid,Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Formic acid.,increase,no risk
Formic acid,Urokinase,The therapeutic efficacy of Formic acid can be decreased when used in combination with Urokinase.,decrease,no risk
Formic acid,Vorapaxar,The therapeutic efficacy of Formic acid can be decreased when used in combination with Vorapaxar.,decrease,no risk
Formic acid,Warfarin,The therapeutic efficacy of Formic acid can be decreased when used in combination with Warfarin.,decrease,no risk
Formic acid,Ximelagatran,The therapeutic efficacy of Formic acid can be decreased when used in combination with Ximelagatran.,decrease,no risk
Rolipram,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Rolipram.,increase,risk
Rolipram,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Rolipram is combined with Gabapentin enacarbil.,increase,risk
Rolipram,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Rolipram.,increase,risk
Rolipram,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Rolipram is combined with Ganaxolone.",increase,risk
Rolipram,Gepirone,The risk or severity of CNS depression can be increased when Rolipram is combined with Gepirone.,increase,risk
Rolipram,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Rolipram.,increase,risk
Rolipram,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Rolipram.,increase,risk
Rolipram,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Rolipram.,increase,risk
Rolipram,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Rolipram.,increase,risk
Rolipram,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Rolipram.,increase,risk
Rolipram,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Rolipram.,increase,risk
Rolipram,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Rolipram.,increase,risk
Rolipram,Hydrocodone,Rolipram may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Rolipram,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Rolipram.,increase,risk
Rolipram,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rolipram.,increase,no risk
Rolipram,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Rolipram.,increase,risk
Rolipram,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Rolipram.,increase,risk
Rolipram,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Rolipram.,increase,risk
Rolipram,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Rolipram is combined with Oliceridine.",increase,risk
Rolipram,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Rolipram.,increase,risk
Rolipram,Opium,The risk or severity of CNS depression can be increased when Rolipram is combined with Opium.,increase,risk
Rolipram,Orphenadrine,Rolipram may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Rolipram,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Rolipram.,increase,risk
Rolipram,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Rolipram.,increase,risk
Rolipram,Oxitriptan,The risk or severity of CNS depression can be increased when Rolipram is combined with Oxitriptan.,increase,risk
Rolipram,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Rolipram.,increase,risk
Rolipram,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Rolipram.,increase,risk
Rolipram,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Rolipram.,increase,risk
Rolipram,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Rolipram.,increase,risk
Rolipram,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Rolipram.,increase,risk
Rolipram,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Rolipram.,increase,risk
Rolipram,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Rolipram.,increase,risk
Rolipram,Quinupramine,The risk or severity of CNS depression can be increased when Rolipram is combined with Quinupramine.,increase,risk
Rolipram,Urethane,The risk or severity of CNS depression can be increased when Rolipram is combined with Urethane.,increase,risk
Rolipram,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Rolipram.,increase,risk
Rolipram,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Rolipram.,increase,risk
Rolipram,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Rolipram.,increase,risk
Rolipram,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Rolipram.,increase,risk
Rolipram,Vilazodone,The risk or severity of CNS depression can be increased when Rolipram is combined with Vilazodone.,increase,risk
Rolipram,Viloxazine,The risk or severity of CNS depression can be increased when Rolipram is combined with Viloxazine.,increase,risk
Rolipram,Vortioxetine,The risk or severity of CNS depression can be increased when Rolipram is combined with Vortioxetine.,increase,risk
Rolipram,Warfarin,The risk or severity of adverse effects can be increased when Rolipram is combined with Warfarin.,increase,risk
Rolipram,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Rolipram.,increase,risk
Rolipram,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Rolipram.,increase,risk
Rolipram,Ziconotide,The risk or severity of CNS depression can be increased when Rolipram is combined with Ziconotide.,increase,risk
Rolipram,Zimelidine,The risk or severity of adverse effects can be increased when Rolipram is combined with Zimelidine.,increase,risk
Rolipram,Ziprasidone,The risk or severity of adverse effects can be increased when Rolipram is combined with Ziprasidone.,increase,risk
Rolipram,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Rolipram.,increase,risk
Rolipram,Zolpidem,Rolipram may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Rolipram,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Rolipram.,increase,risk
Rolipram,Zopiclone,The risk or severity of adverse effects can be increased when Rolipram is combined with Zopiclone.,increase,risk
Rolipram,Zotepine,The risk or severity of CNS depression can be increased when Rolipram is combined with Zotepine.,increase,risk
Rolipram,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Rolipram.,increase,risk
Rolipram,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Rolipram.,increase,risk
"7,9-Dimethylguanine",Ofloxacin,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Ofloxacin.",decrease,no risk
"7,9-Dimethylguanine",Olodaterol,"7,9-Dimethylguanine may increase the hyperkalemic activities of Olodaterol.",increase,no risk
"7,9-Dimethylguanine",Orciprenaline,"The risk or severity of adverse effects can be increased when Orciprenaline is combined with 7,9-Dimethylguanine.",increase,risk
"7,9-Dimethylguanine",Oxazepam,"The therapeutic efficacy of Oxazepam can be decreased when used in combination with 7,9-Dimethylguanine.",decrease,no risk
"7,9-Dimethylguanine",Oxcarbazepine,"Oxcarbazepine may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.",increase,no risk
"7,9-Dimethylguanine",Oxprenolol,"The risk or severity of adverse effects can be increased when Oxprenolol is combined with 7,9-Dimethylguanine.",increase,risk
"7,9-Dimethylguanine",Oxymetazoline,"The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 7,9-Dimethylguanine.",increase,risk
"7,9-Dimethylguanine",Quazepam,"The therapeutic efficacy of Quazepam can be decreased when used in combination with 7,9-Dimethylguanine.",decrease,no risk
"7,9-Dimethylguanine",Quinidine,"The serum concentration of 7,9-Dimethylguanine can be increased when it is combined with Quinidine.",increase,no risk
"7,9-Dimethylguanine",Quinine,"The serum concentration of 7,9-Dimethylguanine can be increased when it is combined with Quinine.",increase,no risk
"7,9-Dimethylguanine",Valproic acid,"Valproic acid may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.",increase,no risk
"7,9-Dimethylguanine",Vigabatrin,"Vigabatrin may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.",increase,no risk
"7,9-Dimethylguanine",Vilanterol,"The risk or severity of hypokalemia can be increased when 7,9-Dimethylguanine is combined with Vilanterol.",increase,risk
"7,9-Dimethylguanine",Viloxazine,"The serum concentration of 7,9-Dimethylguanine can be increased when it is combined with Viloxazine.",increase,no risk
"7,9-Dimethylguanine",Zafirlukast,"The serum concentration of Zafirlukast can be decreased when it is combined with 7,9-Dimethylguanine.",decrease,no risk
"7,9-Dimethylguanine",Zaleplon,"Zaleplon may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.",increase,no risk
"7,9-Dimethylguanine",Zonisamide,"Zonisamide may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy.",increase,no risk
Phenylbutyric acid,Galantamine,The metabolism of Galantamine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Phenylbutyric acid.,increase,no risk
Phenylbutyric acid,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Hydrocortisone,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Phenylbutyric acid,Hydrocortisone acetate,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Phenylbutyric acid,Hydrocortisone butyrate,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Phenylbutyric acid,Hydrocortisone cypionate,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Phenylbutyric acid,Hydrocortisone succinate,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Phenylbutyric acid,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Phenylbutyric acid.,increase,no risk
Phenylbutyric acid,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Opium,The metabolism of Opium can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Quinine,The metabolism of Quinine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Valproic acid,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Valproic acid.,decrease,no risk
Phenylbutyric acid,Vamorolone,The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Vamorolone.,decrease,no risk
Phenylbutyric acid,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Phenylbutyric acid.,decrease,no risk
Phenylbutyric acid,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Phenylbutyric acid.,decrease,no risk
"(6S)-5,6,7,8-tetrahydrofolic acid",Glucarpidase,"The serum concentration of the active metabolites of (6S)-5,6,7,8-tetrahydrofolic acid can be reduced when (6S)-5,6,7,8-tetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy.", ,no risk
"(6S)-5,6,7,8-tetrahydrofolic acid",Valproic acid,"The serum concentration of (6S)-5,6,7,8-tetrahydrofolic acid can be decreased when it is combined with Valproic acid.",decrease,no risk
Epicaptopril,Guanabenz,Epicaptopril may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Epicaptopril,Guanadrel,Epicaptopril may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Epicaptopril,Guanethidine,Epicaptopril may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Epicaptopril,Guanfacine,Epicaptopril may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Epicaptopril,Guanoxan,Epicaptopril may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Epicaptopril,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Epicaptopril.,increase,risk
Epicaptopril,Hydralazine,Epicaptopril may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Epicaptopril,Hydrochlorothiazide,Epicaptopril may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Epicaptopril,Hydroflumethiazide,Epicaptopril may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Epicaptopril,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Epicaptopril.,increase,risk
Epicaptopril,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Epicaptopril.,increase,risk
Epicaptopril,Olmesartan,Epicaptopril may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Epicaptopril,Olodaterol,The risk or severity of hypertension can be increased when Epicaptopril is combined with Olodaterol.,increase,risk
Epicaptopril,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Epicaptopril.,increase,risk
Epicaptopril,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Epicaptopril.,increase,risk
Epicaptopril,Oxprenolol,Epicaptopril may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Epicaptopril,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Epicaptopril.,increase,risk
Epicaptopril,Oxyphenbutazone,The risk or severity of hypertension can be increased when Epicaptopril is combined with Oxyphenbutazone.,increase,risk
Epicaptopril,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Epicaptopril.,increase,risk
Epicaptopril,Quinapril,Epicaptopril may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Epicaptopril,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Epicaptopril.,increase,risk
Epicaptopril,Quinupramine,The risk or severity of hypertension can be increased when Epicaptopril is combined with Quinupramine.,increase,risk
Epicaptopril,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Epicaptopril.,increase,risk
Epicaptopril,Valsartan,Epicaptopril may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Epicaptopril,Vilanterol,The risk or severity of hypertension can be increased when Epicaptopril is combined with Vilanterol.,increase,risk
Epicaptopril,Vilazodone,The risk or severity of hypertension can be increased when Epicaptopril is combined with Vilazodone.,increase,risk
Epicaptopril,Vortioxetine,The risk or severity of hypertension can be increased when Epicaptopril is combined with Vortioxetine.,increase,risk
Epicaptopril,Xamoterol,The risk or severity of hypertension can be increased when Epicaptopril is combined with Xamoterol.,increase,risk
Epicaptopril,Xylometazoline,The risk or severity of hypertension can be increased when Epicaptopril is combined with Xylometazoline.,increase,risk
Epicaptopril,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Epicaptopril.,increase,risk
Epicaptopril,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Epicaptopril.,increase,risk
Epicaptopril,Zofenopril,Epicaptopril may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Epicaptopril,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Epicaptopril.,increase,risk
Epicaptopril,Zuclopenthixol,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Epicaptopril.,increase,risk
Prostaglandin D2,Balsalazide,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Balsalazide.,decrease,no risk
Prostaglandin D2,Benorilate,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Benorilate.,decrease,no risk
Prostaglandin D2,Benoxaprofen,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Prostaglandin D2,Benzydamine,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Benzydamine.,decrease,no risk
Prostaglandin D2,Bumadizone,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Bumadizone.,decrease,no risk
Prostaglandin D2,Glycol salicylate,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Prostaglandin D2,Ketoprofen,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Ketoprofen.,decrease,no risk
Prostaglandin D2,Ketorolac,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Ketorolac.,decrease,no risk
Prostaglandin D2,Oxaprozin,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Oxaprozin.,decrease,no risk
Prostaglandin D2,Oxyphenbutazone,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Prostaglandin D2,Valdecoxib,The therapeutic efficacy of Prostaglandin D2 can be decreased when used in combination with Valdecoxib.,decrease,no risk
3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone,Voriconazole,The serum concentration of 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone can be increased when it is combined with Voriconazole.,increase,no risk
Triglu-5-formyl-tetrahydrofolate,Glucarpidase,The serum concentration of the active metabolites of Triglu-5-formyl-tetrahydrofolate can be reduced when Triglu-5-formyl-tetrahydrofolate is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
Triglu-5-formyl-tetrahydrofolate,Valproic acid,The serum concentration of Triglu-5-formyl-tetrahydrofolate can be decreased when it is combined with Valproic acid.,decrease,no risk
"3,5-Dinitrocatechol",Brexpiprazole,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Brexpiprazole.",decrease,no risk
"3,5-Dinitrocatechol",Bupropion,"The risk or severity of adverse effects can be increased when Bupropion is combined with 3,5-Dinitrocatechol.",increase,risk
"3,5-Dinitrocatechol",Haloperidol,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Haloperidol.",decrease,no risk
"3,5-Dinitrocatechol",Olanzapine,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Olanzapine.",decrease,no risk
"3,5-Dinitrocatechol",Quetiapine,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Quetiapine.",decrease,no risk
"3,5-Dinitrocatechol",Ziprasidone,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Ziprasidone.",decrease,no risk
"3,5-Dinitrocatechol",Zotepine,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Zotepine.",decrease,no risk
"3,5-Dinitrocatechol",Zuclopenthixol,"The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Zuclopenthixol.",decrease,no risk
Hadacidin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Benzocaine.,increase,risk
Hadacidin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Benzyl alcohol.,increase,risk
Hadacidin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Bupivacaine.,increase,risk
Hadacidin,Butacaine,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Butacaine.,increase,risk
Hadacidin,Butamben,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Butamben.,increase,risk
Hadacidin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Oxetacaine.,increase,risk
Hadacidin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Hadacidin is combined with Oxybuprocaine.,increase,risk
Daidzin,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Daidzin.,increase,no risk
Daidzin,Binimetinib,Daidzin may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Daidzin,Brigatinib,Daidzin may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Daidzin,Gefitinib,Daidzin may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Daidzin,Glasdegib,Daidzin may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Daidzin,Glecaprevir,Daidzin may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Daidzin,Glyburide,Daidzin may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Daidzin,Ombitasvir,Daidzin may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Daidzin,Osimertinib,Daidzin may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Daidzin,Oxaliplatin,Daidzin may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Daidzin,Ozanimod,Daidzin may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Daidzin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Daidzin.,increase,no risk
Daidzin,Velpatasvir,Daidzin may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Daidzin,Vemurafenib,Daidzin may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Daidzin,Venetoclax,Daidzin may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Daidzin,Vincristine,Daidzin may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Daidzin,Voxilaprevir,Daidzin may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Daidzin,Zidovudine,Daidzin may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Glycochenodeoxycholic Acid.,increase,risk
Glycochenodeoxycholic Acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Glycochenodeoxycholic Acid,Kaolin,Kaolin can cause a decrease in the absorption of Glycochenodeoxycholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Glycochenodeoxycholic Acid,Ketoconazole,Ketoconazole may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Ofloxacin,Ofloxacin may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Olmesartan,Olmesartan may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Quinidine,Quinidine may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycochenodeoxycholic Acid.,increase,risk
Glycochenodeoxycholic Acid,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Vinblastine,Vinblastine may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Vincristine,Vincristine may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.,decrease,no risk
Glycochenodeoxycholic Acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Glycochenodeoxycholic Acid.,increase,risk
Glycochenodeoxycholic Acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Glycochenodeoxycholic Acid.,increase,risk
Glycochenodeoxycholic Acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Glycochenodeoxycholic Acid.,increase,risk
Xanthine,Gabapentin,Gabapentin may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Ganaxolone,Ganaxolone may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Gatifloxacin,The metabolism of Xanthine can be decreased when combined with Gatifloxacin.,decrease,no risk
Xanthine,Gemfibrozil,The metabolism of Xanthine can be decreased when combined with Gemfibrozil.,decrease,no risk
Xanthine,Gemifloxacin,The metabolism of Xanthine can be decreased when combined with Gemifloxacin.,decrease,no risk
Xanthine,Givosiran,The serum concentration of Xanthine can be increased when it is combined with Givosiran.,increase,no risk
Xanthine,Glofitamab,The serum concentration of Xanthine can be increased when it is combined with Glofitamab.,increase,no risk
Xanthine,Golimumab,The metabolism of Xanthine can be increased when combined with Golimumab.,increase,no risk
Xanthine,Grepafloxacin,The metabolism of Xanthine can be decreased when combined with Grepafloxacin.,decrease,no risk
Xanthine,Guanabenz,The metabolism of Xanthine can be decreased when combined with Guanabenz.,decrease,no risk
Xanthine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Xanthine.,decrease,no risk
Xanthine,Haloperidol,The metabolism of Xanthine can be decreased when combined with Haloperidol.,decrease,no risk
Xanthine,Human interferon beta,The metabolism of Xanthine can be decreased when combined with Human interferon beta.,decrease,no risk
Xanthine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Xanthine.,increase,risk
Xanthine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with Xanthine.,decrease,no risk
Xanthine,Ketoconazole,The metabolism of Xanthine can be decreased when combined with Ketoconazole.,decrease,no risk
Xanthine,Obeticholic acid,The metabolism of Xanthine can be decreased when combined with Obeticholic acid.,decrease,no risk
Xanthine,Ofloxacin,The metabolism of Xanthine can be decreased when combined with Ofloxacin.,decrease,no risk
Xanthine,Olanzapine,The metabolism of Xanthine can be decreased when combined with Olanzapine.,decrease,no risk
Xanthine,Olodaterol,Xanthine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Xanthine,Ondansetron,The metabolism of Xanthine can be decreased when combined with Ondansetron.,decrease,no risk
Xanthine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Xanthine.,increase,risk
Xanthine,Orphenadrine,The metabolism of Xanthine can be decreased when combined with Orphenadrine.,decrease,no risk
Xanthine,Osilodrostat,The metabolism of Xanthine can be decreased when combined with Osilodrostat.,decrease,no risk
Xanthine,Osimertinib,The serum concentration of Xanthine can be decreased when it is combined with Osimertinib.,decrease,no risk
Xanthine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Xanthine.,decrease,no risk
Xanthine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Xanthine.,increase,risk
Xanthine,Oxtriphylline,The metabolism of Xanthine can be decreased when combined with Oxtriphylline.,decrease,no risk
Xanthine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Xanthine.,increase,risk
Xanthine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Xanthine.,decrease,no risk
Xanthine,Quinidine,The serum concentration of Xanthine can be increased when it is combined with Quinidine.,increase,no risk
Xanthine,Quinine,The serum concentration of Xanthine can be increased when it is combined with Quinine.,increase,no risk
Xanthine,Valproic acid,Valproic acid may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Vemurafenib,The serum concentration of Xanthine can be increased when it is combined with Vemurafenib.,increase,no risk
Xanthine,Verapamil,The metabolism of Xanthine can be decreased when combined with Verapamil.,decrease,no risk
Xanthine,Vigabatrin,Vigabatrin may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Vilanterol,The risk or severity of hypokalemia can be increased when Xanthine is combined with Vilanterol.,increase,risk
Xanthine,Viloxazine,The metabolism of Xanthine can be decreased when combined with Viloxazine.,decrease,no risk
Xanthine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Xanthine.,decrease,no risk
Xanthine,Warfarin,The metabolism of Xanthine can be decreased when combined with Warfarin.,decrease,no risk
Xanthine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Xanthine.,decrease,no risk
Xanthine,Zaleplon,Zaleplon may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Zileuton,The metabolism of Xanthine can be decreased when combined with Zileuton.,decrease,no risk
Xanthine,Zolmitriptan,The metabolism of Xanthine can be decreased when combined with Zolmitriptan.,decrease,no risk
Xanthine,Zolpidem,The metabolism of Xanthine can be decreased when combined with Zolpidem.,decrease,no risk
Xanthine,Zonisamide,Zonisamide may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Xanthine,Zotepine,The metabolism of Zotepine can be decreased when combined with Xanthine.,decrease,no risk
Cephalosporin analog,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Cephalosporin analog.,increase,risk
Cephalosporin analog,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cephalosporin analog.,increase,risk
Cephalosporin analog,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Cephalosporin analog,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Cephalosporin analog.,decrease,no risk
Zinc trihydroxide,Gatifloxacin,Zinc trihydroxide can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc trihydroxide,Gemifloxacin,Zinc trihydroxide can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc trihydroxide,Grepafloxacin,Zinc trihydroxide can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc trihydroxide,Halofantrine,Zinc trihydroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc trihydroxide,Ofloxacin,Zinc trihydroxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc trihydroxide,Omadacycline,Zinc trihydroxide can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc trihydroxide,Oxytetracycline,Zinc trihydroxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
7-Nitroindazole,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Gabapentin enacarbil.,increase,risk
7-Nitroindazole,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Gamolenic acid,The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Gamolenic acid.,decrease,no risk
7-Nitroindazole,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when 7-Nitroindazole is combined with Ganaxolone.",increase,risk
7-Nitroindazole,Ganciclovir,The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Ganciclovir.,decrease,no risk
7-Nitroindazole,Gepirone,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Gepirone.,increase,risk
7-Nitroindazole,Gestrinone,The metabolism of Gestrinone can be increased when combined with 7-Nitroindazole.,increase,no risk
7-Nitroindazole,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Halofantrine,The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Halofantrine.,decrease,no risk
7-Nitroindazole,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Hydrocodone,7-Nitroindazole may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
7-Nitroindazole,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Hydroxychloroquine,The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
7-Nitroindazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with 7-Nitroindazole.,increase,no risk
7-Nitroindazole,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of 7-Nitroindazole.,increase,no risk
7-Nitroindazole,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when 7-Nitroindazole is combined with Oliceridine.",increase,risk
7-Nitroindazole,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Opium,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Opium.,increase,risk
7-Nitroindazole,Orlistat,Orlistat can cause a decrease in the absorption of 7-Nitroindazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
7-Nitroindazole,Orphenadrine,7-Nitroindazole may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
7-Nitroindazole,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 7-Nitroindazole is combined with Oxetacaine.,increase,risk
7-Nitroindazole,Oxitriptan,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Oxitriptan.,increase,risk
7-Nitroindazole,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Oxtriphylline,7-Nitroindazole may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
7-Nitroindazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 7-Nitroindazole is combined with Oxybuprocaine.,increase,risk
7-Nitroindazole,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Quinidine,The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Quinidine.,decrease,no risk
7-Nitroindazole,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Quinupramine,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Quinupramine.,increase,risk
7-Nitroindazole,Ulipristal,The metabolism of Ulipristal can be increased when combined with 7-Nitroindazole.,increase,no risk
7-Nitroindazole,Urethane,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Urethane.,increase,risk
7-Nitroindazole,Valganciclovir,The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Valganciclovir.,decrease,no risk
7-Nitroindazole,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Vilazodone,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Vilazodone.,increase,risk
7-Nitroindazole,Viloxazine,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Viloxazine.,increase,risk
7-Nitroindazole,Vortioxetine,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Vortioxetine.,increase,risk
7-Nitroindazole,Yohimbine,The therapeutic efficacy of 7-Nitroindazole can be increased when used in combination with Yohimbine.,increase,no risk
7-Nitroindazole,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Ziconotide,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Ziconotide.,increase,risk
7-Nitroindazole,Zimelidine,The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Zimelidine.,increase,risk
7-Nitroindazole,Ziprasidone,The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Ziprasidone.,increase,risk
7-Nitroindazole,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Zolpidem,7-Nitroindazole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
7-Nitroindazole,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Zopiclone,The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Zopiclone.,increase,risk
7-Nitroindazole,Zotepine,The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Zotepine.,increase,risk
7-Nitroindazole,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with 7-Nitroindazole.,increase,risk
7-Nitroindazole,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with 7-Nitroindazole.,increase,risk
Taxifolin,Gatifloxacin,Taxifolin may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Taxifolin,Gemifloxacin,Taxifolin may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Taxifolin,Gentamicin,The risk or severity of nephrotoxicity can be increased when Taxifolin is combined with Gentamicin.,increase,risk
Taxifolin,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Taxifolin.,decrease,no risk
Taxifolin,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Taxifolin.,decrease,no risk
Taxifolin,Glipizide,The protein binding of Glipizide can be decreased when combined with Taxifolin.,decrease,no risk
Taxifolin,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Taxifolin.,decrease,no risk
Taxifolin,Glyburide,The protein binding of Glyburide can be decreased when combined with Taxifolin.,decrease,no risk
Taxifolin,Glycol salicylate,The risk or severity of adverse effects can be increased when Taxifolin is combined with Glycol salicylate.,increase,risk
Taxifolin,Grepafloxacin,Taxifolin may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Taxifolin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Taxifolin.,increase,no risk
Taxifolin,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Taxifolin.,increase,risk
Taxifolin,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Heparin.,increase,risk
Taxifolin,Hydralazine,Taxifolin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Taxifolin,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Taxifolin.,increase,risk
Taxifolin,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Taxifolin.,increase,risk
Taxifolin,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Taxifolin.,increase,risk
Taxifolin,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Taxifolin.,increase,risk
Taxifolin,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Taxifolin.,increase,risk
Taxifolin,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Taxifolin.,decrease,no risk
Taxifolin,Kanamycin,The risk or severity of nephrotoxicity can be increased when Taxifolin is combined with Kanamycin.,increase,risk
Taxifolin,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Taxifolin.,increase,risk
Taxifolin,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Taxifolin.,increase,risk
S-Ethylisothiourea,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Gabapentin enacarbil.,increase,risk
S-Ethylisothiourea,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when S-Ethylisothiourea is combined with Ganaxolone.",increase,risk
S-Ethylisothiourea,Gepirone,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Gepirone.,increase,risk
S-Ethylisothiourea,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Hydrocodone,S-Ethylisothiourea may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
S-Ethylisothiourea,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of S-Ethylisothiourea.,increase,no risk
S-Ethylisothiourea,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when S-Ethylisothiourea is combined with Oliceridine.",increase,risk
S-Ethylisothiourea,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Opium,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Opium.,increase,risk
S-Ethylisothiourea,Orphenadrine,S-Ethylisothiourea may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
S-Ethylisothiourea,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oxitriptan,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Oxitriptan.,increase,risk
S-Ethylisothiourea,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Oxytocin,The risk or severity of hypertension can be increased when S-Ethylisothiourea is combined with Oxytocin.,increase,risk
S-Ethylisothiourea,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Quinupramine,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Quinupramine.,increase,risk
S-Ethylisothiourea,Urethane,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Urethane.,increase,risk
S-Ethylisothiourea,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Vilazodone,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Vilazodone.,increase,risk
S-Ethylisothiourea,Viloxazine,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Viloxazine.,increase,risk
S-Ethylisothiourea,Vortioxetine,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Vortioxetine.,increase,risk
S-Ethylisothiourea,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Ziconotide,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Ziconotide.,increase,risk
S-Ethylisothiourea,Zimelidine,The risk or severity of adverse effects can be increased when S-Ethylisothiourea is combined with Zimelidine.,increase,risk
S-Ethylisothiourea,Ziprasidone,The risk or severity of adverse effects can be increased when S-Ethylisothiourea is combined with Ziprasidone.,increase,risk
S-Ethylisothiourea,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Zolpidem,S-Ethylisothiourea may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
S-Ethylisothiourea,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Zopiclone,The risk or severity of adverse effects can be increased when S-Ethylisothiourea is combined with Zopiclone.,increase,risk
S-Ethylisothiourea,Zotepine,The risk or severity of CNS depression can be increased when S-Ethylisothiourea is combined with Zotepine.,increase,risk
S-Ethylisothiourea,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with S-Ethylisothiourea.,increase,risk
S-Ethylisothiourea,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with S-Ethylisothiourea.,increase,risk
Maltotetraose,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Maltotetraose.,decrease,no risk
Maltotetraose,Benzocaine,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Benzocaine.,increase,risk
Maltotetraose,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Benzyl alcohol.,increase,risk
Maltotetraose,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Bupivacaine.,increase,risk
Maltotetraose,Butacaine,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Butacaine.,increase,risk
Maltotetraose,Butamben,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Butamben.,increase,risk
Maltotetraose,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Oxetacaine.,increase,risk
Maltotetraose,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Maltotetraose is combined with Oxybuprocaine.,increase,risk
Maltotetraose,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Maltotetraose.,decrease,no risk
Maltotetraose,Warfarin,The risk or severity of bleeding can be increased when Maltotetraose is combined with Warfarin.,increase,risk
7-Deazaguanine,Ofloxacin,The metabolism of 7-Deazaguanine can be decreased when combined with Ofloxacin.,decrease,no risk
7-Deazaguanine,Olodaterol,7-Deazaguanine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
7-Deazaguanine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with 7-Deazaguanine.,increase,risk
7-Deazaguanine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with 7-Deazaguanine.,decrease,no risk
7-Deazaguanine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
7-Deazaguanine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with 7-Deazaguanine.,increase,risk
7-Deazaguanine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 7-Deazaguanine.,increase,risk
7-Deazaguanine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with 7-Deazaguanine.,decrease,no risk
7-Deazaguanine,Quinidine,The serum concentration of 7-Deazaguanine can be increased when it is combined with Quinidine.,increase,no risk
7-Deazaguanine,Quinine,The serum concentration of 7-Deazaguanine can be increased when it is combined with Quinine.,increase,no risk
7-Deazaguanine,Valproic acid,Valproic acid may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
7-Deazaguanine,Vigabatrin,Vigabatrin may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
7-Deazaguanine,Vilanterol,The risk or severity of hypokalemia can be increased when 7-Deazaguanine is combined with Vilanterol.,increase,risk
7-Deazaguanine,Viloxazine,The serum concentration of 7-Deazaguanine can be increased when it is combined with Viloxazine.,increase,no risk
7-Deazaguanine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with 7-Deazaguanine.,decrease,no risk
7-Deazaguanine,Zaleplon,Zaleplon may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
7-Deazaguanine,Zonisamide,Zonisamide may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hydrolyzed Cephalothin,Gabapentin enacarbil,Hydrolyzed Cephalothin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gadobenic acid,Hydrolyzed Cephalothin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gadodiamide,Hydrolyzed Cephalothin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gadofosveset trisodium,Hydrolyzed Cephalothin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gadopentetic acid,Hydrolyzed Cephalothin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gadoteric acid,Hydrolyzed Cephalothin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gadoteridol,Hydrolyzed Cephalothin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Ganciclovir,Hydrolyzed Cephalothin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gemcitabine,Hydrolyzed Cephalothin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gemfibrozil,Hydrolyzed Cephalothin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gentamicin,Hydrolyzed Cephalothin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Gimeracil,Hydrolyzed Cephalothin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Givosiran,The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Givosiran.,increase,risk
Hydrolyzed Cephalothin,Glipizide,Hydrolyzed Cephalothin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Glycerol phenylbutyrate,Hydrolyzed Cephalothin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Golodirsen,Hydrolyzed Cephalothin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Goserelin,Hydrolyzed Cephalothin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Guanethidine,Hydrolyzed Cephalothin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Guanfacine,Hydrolyzed Cephalothin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Haloperidol,Hydrolyzed Cephalothin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Hydralazine,Hydrolyzed Cephalothin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Hydromorphone,Hydrolyzed Cephalothin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Hydroxocobalamin,Hydrolyzed Cephalothin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Hydroxyethyl Starch,Hydrolyzed Cephalothin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Kanamycin,Hydrolyzed Cephalothin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Ketamine,Hydrolyzed Cephalothin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Ketazolam,Hydrolyzed Cephalothin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Octinoxate,Hydrolyzed Cephalothin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Olsalazine.,increase,risk
Hydrolyzed Cephalothin,Opium,Hydrolyzed Cephalothin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Oseltamivir,Hydrolyzed Cephalothin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Oxacillin,Hydrolyzed Cephalothin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Oxazepam,Hydrolyzed Cephalothin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Oxybenzone,Hydrolyzed Cephalothin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Hydrolyzed Cephalothin is combined with Oxyphenbutazone.,increase,risk
Hydrolyzed Cephalothin,Oxyquinoline,Hydrolyzed Cephalothin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Quetiapine,Hydrolyzed Cephalothin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Quinidine,Hydrolyzed Cephalothin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Vaborbactam,Hydrolyzed Cephalothin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Valbenazine,Hydrolyzed Cephalothin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Hydrolyzed Cephalothin.,increase,risk
Hydrolyzed Cephalothin,Valganciclovir,Hydrolyzed Cephalothin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Vancomycin,Hydrolyzed Cephalothin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Varenicline,Hydrolyzed Cephalothin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Venlafaxine,Hydrolyzed Cephalothin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Verapamil,Hydrolyzed Cephalothin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Vilanterol,Hydrolyzed Cephalothin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Viloxazine,Hydrolyzed Cephalothin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Vortioxetine,Hydrolyzed Cephalothin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Warfarin,Hydrolyzed Cephalothin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Zaleplon,Hydrolyzed Cephalothin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Zanamivir,Hydrolyzed Cephalothin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Hydrolyzed Cephalothin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrolyzed Cephalothin is combined with Zoledronic acid.,increase,risk
Hydrolyzed Cephalothin,Zonisamide,Hydrolyzed Cephalothin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Platelet Activating Factor,Bemiparin,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Bemiparin.,decrease,no risk
Platelet Activating Factor,Betrixaban,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Betrixaban.,decrease,no risk
Platelet Activating Factor,Bivalirudin,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Bivalirudin.,decrease,no risk
Platelet Activating Factor,Heparin,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Heparin.,decrease,no risk
Platelet Activating Factor,Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Platelet Activating Factor.,increase,no risk
Platelet Activating Factor,Urokinase,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Urokinase.,decrease,no risk
Platelet Activating Factor,Vorapaxar,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Vorapaxar.,decrease,no risk
Platelet Activating Factor,Warfarin,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Warfarin.,decrease,no risk
Platelet Activating Factor,Ximelagatran,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Ximelagatran.,decrease,no risk
Flufenamic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Flufenamic acid.,increase,no risk
5'-S-methyl-5'-thioadenosine,Benzocaine,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Benzocaine.,increase,risk
5'-S-methyl-5'-thioadenosine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Benzyl alcohol.,increase,risk
5'-S-methyl-5'-thioadenosine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Bupivacaine.,increase,risk
5'-S-methyl-5'-thioadenosine,Butacaine,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Butacaine.,increase,risk
5'-S-methyl-5'-thioadenosine,Butamben,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Butamben.,increase,risk
5'-S-methyl-5'-thioadenosine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Oxetacaine.,increase,risk
5'-S-methyl-5'-thioadenosine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 5'-S-methyl-5'-thioadenosine is combined with Oxybuprocaine.,increase,risk
Protoporphyrin,Verteporfin,Protoporphyrin may increase the photosensitizing activities of Verteporfin.,increase,no risk
Prostaglandin B2,Balsalazide,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Balsalazide.,decrease,no risk
Prostaglandin B2,Benorilate,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Benorilate.,decrease,no risk
Prostaglandin B2,Benoxaprofen,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Prostaglandin B2,Benzydamine,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Benzydamine.,decrease,no risk
Prostaglandin B2,Bumadizone,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Bumadizone.,decrease,no risk
Prostaglandin B2,Glycol salicylate,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Prostaglandin B2,Ketoprofen,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Ketoprofen.,decrease,no risk
Prostaglandin B2,Ketorolac,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Ketorolac.,decrease,no risk
Prostaglandin B2,Oxaprozin,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Oxaprozin.,decrease,no risk
Prostaglandin B2,Oxyphenbutazone,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Prostaglandin B2,Valdecoxib,The therapeutic efficacy of Prostaglandin B2 can be decreased when used in combination with Valdecoxib.,decrease,no risk
Bivalirudin,Gemcitabine,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemcitabine.,increase,risk
Bivalirudin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemtuzumab ozogamicin.,increase,risk
Bivalirudin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Bivalirudin.,increase,risk
Bivalirudin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Bivalirudin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Bivalirudin.,increase,risk
Bivalirudin,Hemin,Hemin may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Bivalirudin,Heparin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Heparin.,increase,risk
Bivalirudin,Hydrochlorothiazide,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Bivalirudin,Hydroflumethiazide,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Bivalirudin,Hydroxyprogesterone caproate,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Bivalirudin,Hydroxyurea,The risk or severity of bleeding can be increased when Bivalirudin is combined with Hydroxyurea.,increase,risk
Bivalirudin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Bivalirudin.,increase,risk
Bivalirudin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Bivalirudin.,increase,risk
Bivalirudin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Obeticholic acid.,increase,risk
Bivalirudin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Obinutuzumab.,increase,risk
Bivalirudin,Olaparib,The risk or severity of bleeding can be increased when Bivalirudin is combined with Olaparib.,increase,risk
Bivalirudin,Olive oil,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Olive oil.,decrease,no risk
Bivalirudin,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Bivalirudin.,increase,risk
Bivalirudin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Bivalirudin is combined with Omacetaxine mepesuccinate.,increase,risk
Bivalirudin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Bivalirudin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Bivalirudin.,increase,risk
Bivalirudin,Omega-3-carboxylic acids,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Bivalirudin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Bivalirudin.,increase,risk
Bivalirudin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Bivalirudin.,increase,risk
Bivalirudin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Bivalirudin.,increase,risk
Bivalirudin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Bivalirudin.,decrease,no risk
Bivalirudin,Quinidine,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinidine.,increase,no risk
Bivalirudin,Quinine,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinine.,increase,no risk
Bivalirudin,Ulipristal,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Ulipristal.,decrease,no risk
Bivalirudin,Urokinase,Urokinase may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Bivalirudin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Bivalirudin is combined with Ursodeoxycholic acid.,increase,risk
Bivalirudin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Bivalirudin.,increase,risk
Bivalirudin,Venlafaxine,The risk or severity of bleeding can be increased when Bivalirudin is combined with Venlafaxine.,increase,risk
Bivalirudin,Vinblastine,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinblastine.,increase,risk
Bivalirudin,Vindesine,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vindesine.,increase,risk
Bivalirudin,Vinorelbine,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinorelbine.,increase,risk
Bivalirudin,Vitamin E,Vitamin E may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Bivalirudin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Bivalirudin.,decrease,no risk
Bivalirudin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Bivalirudin.,increase,risk
Bivalirudin,Vorinostat,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vorinostat.,increase,risk
Bivalirudin,Warfarin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Warfarin.,increase,risk
Bivalirudin,Ximelagatran,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ximelagatran.,increase,risk
Bivalirudin,Zidovudine,The risk or severity of bleeding can be increased when Bivalirudin is combined with Zidovudine.,increase,risk
Bivalirudin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Bivalirudin.,increase,risk
"1,10-Phenanthroline",Olanzapine,"The therapeutic efficacy of Olanzapine can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Orphenadrine,"The therapeutic efficacy of Orphenadrine can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Oxprenolol,"1,10-Phenanthroline may increase the bradycardic activities of Oxprenolol.",increase,no risk
"1,10-Phenanthroline",Oxybuprocaine,"1,10-Phenanthroline may increase the neuromuscular blocking activities of Oxybuprocaine.",increase,no risk
"1,10-Phenanthroline",Oxybutynin,"The therapeutic efficacy of Oxybutynin can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Oxyphencyclimine,"The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Oxyphenonium,"The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Quetiapine,"The therapeutic efficacy of Quetiapine can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Quinidine,"The therapeutic efficacy of Quinidine can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Umeclidinium,"The therapeutic efficacy of Umeclidinium can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Vamorolone,"The therapeutic efficacy of 1,10-Phenanthroline can be decreased when used in combination with Vamorolone.",decrease,no risk
"1,10-Phenanthroline",Varenicline,"The risk or severity of adverse effects can be increased when 1,10-Phenanthroline is combined with Varenicline.",increase,risk
"1,10-Phenanthroline",Vecuronium,"The therapeutic efficacy of Vecuronium can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"1,10-Phenanthroline",Ziprasidone,"The therapeutic efficacy of Ziprasidone can be decreased when used in combination with 1,10-Phenanthroline.",decrease,no risk
"3-Aza-2,3-Dihydrogeranyl Diphosphate",Hydrotalcite,"Hydrotalcite can cause a decrease in the absorption of 3-Aza-2,3-Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Guanine,Ofloxacin,The metabolism of Guanine can be decreased when combined with Ofloxacin.,decrease,no risk
Guanine,Olodaterol,Guanine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Guanine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Guanine.,increase,risk
Guanine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Guanine.,decrease,no risk
Guanine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Guanine.,increase,risk
Guanine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Guanine.,increase,risk
Guanine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Guanine.,decrease,no risk
Guanine,Quinidine,The serum concentration of Guanine can be increased when it is combined with Quinidine.,increase,no risk
Guanine,Quinine,The serum concentration of Guanine can be increased when it is combined with Quinine.,increase,no risk
Guanine,Valproic acid,Valproic acid may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanine,Vigabatrin,Vigabatrin may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanine,Vilanterol,The risk or severity of hypokalemia can be increased when Guanine is combined with Vilanterol.,increase,risk
Guanine,Viloxazine,The serum concentration of Guanine can be increased when it is combined with Viloxazine.,increase,no risk
Guanine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Guanine.,decrease,no risk
Guanine,Zaleplon,Zaleplon may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Guanine,Zonisamide,Zonisamide may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thiopyrophosphate,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Thiopyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Geldanamycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Benzocaine.,increase,risk
Geldanamycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Benzyl alcohol.,increase,risk
Geldanamycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Bupivacaine.,increase,risk
Geldanamycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Butacaine.,increase,risk
Geldanamycin,Butamben,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Butamben.,increase,risk
Geldanamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Oxetacaine.,increase,risk
Geldanamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Geldanamycin is combined with Oxybuprocaine.,increase,risk
Geldanamycin,Voriconazole,The serum concentration of Geldanamycin can be increased when it is combined with Voriconazole.,increase,no risk
Carbocisteine,Gliclazide,The risk or severity of adverse effects can be increased when Gliclazide is combined with Carbocisteine.,increase,risk
Carbocisteine,Glimepiride,The risk or severity of adverse effects can be increased when Glimepiride is combined with Carbocisteine.,increase,risk
Carbocisteine,Glipizide,The risk or severity of adverse effects can be increased when Glipizide is combined with Carbocisteine.,increase,risk
Carbocisteine,Gliquidone,The risk or severity of adverse effects can be increased when Gliquidone is combined with Carbocisteine.,increase,risk
Carbocisteine,Glyburide,The risk or severity of adverse effects can be increased when Glyburide is combined with Carbocisteine.,increase,risk
Carbocisteine,Griseofulvin,The risk or severity of adverse effects can be increased when Griseofulvin is combined with Carbocisteine.,increase,risk
Carbocisteine,Ketoconazole,The risk or severity of adverse effects can be increased when Ketoconazole is combined with Carbocisteine.,increase,risk
9-Methylguanine,Gabapentin,Gabapentin may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Ganaxolone,Ganaxolone may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Gatifloxacin,The metabolism of 9-Methylguanine can be decreased when combined with Gatifloxacin.,decrease,no risk
9-Methylguanine,Gemfibrozil,The metabolism of 9-Methylguanine can be decreased when combined with Gemfibrozil.,decrease,no risk
9-Methylguanine,Gemifloxacin,The metabolism of 9-Methylguanine can be decreased when combined with Gemifloxacin.,decrease,no risk
9-Methylguanine,Givosiran,The serum concentration of 9-Methylguanine can be increased when it is combined with Givosiran.,increase,no risk
9-Methylguanine,Glofitamab,The serum concentration of 9-Methylguanine can be increased when it is combined with Glofitamab.,increase,no risk
9-Methylguanine,Golimumab,The metabolism of 9-Methylguanine can be increased when combined with Golimumab.,increase,no risk
9-Methylguanine,Grepafloxacin,The metabolism of 9-Methylguanine can be decreased when combined with Grepafloxacin.,decrease,no risk
9-Methylguanine,Guanabenz,The metabolism of 9-Methylguanine can be decreased when combined with Guanabenz.,decrease,no risk
9-Methylguanine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with 9-Methylguanine.,decrease,no risk
9-Methylguanine,Haloperidol,The metabolism of 9-Methylguanine can be decreased when combined with Haloperidol.,decrease,no risk
9-Methylguanine,Human interferon beta,The metabolism of 9-Methylguanine can be decreased when combined with Human interferon beta.,decrease,no risk
9-Methylguanine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 9-Methylguanine.,increase,risk
9-Methylguanine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with 9-Methylguanine.,decrease,no risk
9-Methylguanine,Ketoconazole,The metabolism of 9-Methylguanine can be decreased when combined with Ketoconazole.,decrease,no risk
9-Methylguanine,Obeticholic acid,The metabolism of 9-Methylguanine can be decreased when combined with Obeticholic acid.,decrease,no risk
9-Methylguanine,Ofloxacin,The metabolism of 9-Methylguanine can be decreased when combined with Ofloxacin.,decrease,no risk
9-Methylguanine,Olanzapine,The metabolism of 9-Methylguanine can be decreased when combined with Olanzapine.,decrease,no risk
9-Methylguanine,Olodaterol,9-Methylguanine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
9-Methylguanine,Ondansetron,The metabolism of 9-Methylguanine can be decreased when combined with Ondansetron.,decrease,no risk
9-Methylguanine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with 9-Methylguanine.,increase,risk
9-Methylguanine,Orphenadrine,The metabolism of 9-Methylguanine can be decreased when combined with Orphenadrine.,decrease,no risk
9-Methylguanine,Osilodrostat,The metabolism of 9-Methylguanine can be decreased when combined with Osilodrostat.,decrease,no risk
9-Methylguanine,Osimertinib,The serum concentration of 9-Methylguanine can be decreased when it is combined with Osimertinib.,decrease,no risk
9-Methylguanine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with 9-Methylguanine.,decrease,no risk
9-Methylguanine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with 9-Methylguanine.,increase,risk
9-Methylguanine,Oxtriphylline,The metabolism of 9-Methylguanine can be decreased when combined with Oxtriphylline.,decrease,no risk
9-Methylguanine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 9-Methylguanine.,increase,risk
9-Methylguanine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with 9-Methylguanine.,decrease,no risk
9-Methylguanine,Quinidine,The serum concentration of 9-Methylguanine can be increased when it is combined with Quinidine.,increase,no risk
9-Methylguanine,Quinine,The serum concentration of 9-Methylguanine can be increased when it is combined with Quinine.,increase,no risk
9-Methylguanine,Valproic acid,Valproic acid may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Vemurafenib,The serum concentration of 9-Methylguanine can be increased when it is combined with Vemurafenib.,increase,no risk
9-Methylguanine,Verapamil,The metabolism of 9-Methylguanine can be decreased when combined with Verapamil.,decrease,no risk
9-Methylguanine,Vigabatrin,Vigabatrin may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Vilanterol,The risk or severity of hypokalemia can be increased when 9-Methylguanine is combined with Vilanterol.,increase,risk
9-Methylguanine,Viloxazine,The metabolism of 9-Methylguanine can be decreased when combined with Viloxazine.,decrease,no risk
9-Methylguanine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with 9-Methylguanine.,decrease,no risk
9-Methylguanine,Warfarin,The metabolism of 9-Methylguanine can be decreased when combined with Warfarin.,decrease,no risk
9-Methylguanine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with 9-Methylguanine.,decrease,no risk
9-Methylguanine,Zaleplon,Zaleplon may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Zileuton,The metabolism of 9-Methylguanine can be decreased when combined with Zileuton.,decrease,no risk
9-Methylguanine,Zolmitriptan,The metabolism of 9-Methylguanine can be decreased when combined with Zolmitriptan.,decrease,no risk
9-Methylguanine,Zolpidem,The metabolism of 9-Methylguanine can be decreased when combined with Zolpidem.,decrease,no risk
9-Methylguanine,Zonisamide,Zonisamide may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Methylguanine,Zotepine,The metabolism of Zotepine can be decreased when combined with 9-Methylguanine.,decrease,no risk
(S)-Warfarin,Belzutifan,The metabolism of Belzutifan can be decreased when combined with (S)-Warfarin.,decrease,no risk
(S)-Warfarin,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Bendamustine,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Bendamustine.,increase,risk
(S)-Warfarin,Bendroflumethiazide,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
(S)-Warfarin,Benorilate,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Benzocaine,The metabolism of (S)-Warfarin can be decreased when combined with Benzocaine.,decrease,no risk
(S)-Warfarin,Benzoic acid,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Benzoic acid.,increase,no risk
(S)-Warfarin,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Benzthiazide,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Benzthiazide.,decrease,no risk
(S)-Warfarin,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Benzyl alcohol,The metabolism of (S)-Warfarin can be decreased when combined with Benzyl alcohol.,decrease,no risk
(S)-Warfarin,Benzylpenicillin,Benzylpenicillin may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Benzylpenicilloyl polylysine,Benzylpenicilloyl polylysine may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with (S)-Warfarin.,decrease,no risk
(S)-Warfarin,Berotralstat,The metabolism of (S)-Warfarin can be decreased when combined with Berotralstat.,decrease,no risk
(S)-Warfarin,Betamethasone,Betamethasone may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Betamethasone phosphate,Betamethasone phosphate may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Bexarotene,The metabolism of (S)-Warfarin can be increased when combined with Bexarotene.,increase,no risk
(S)-Warfarin,Bezafibrate,The risk or severity of bleeding can be increased when Bezafibrate is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Bicalutamide,The serum concentration of (S)-Warfarin can be increased when it is combined with Bicalutamide.,increase,no risk
(S)-Warfarin,Bifonazole,The serum concentration of (S)-Warfarin can be increased when it is combined with Bifonazole.,increase,no risk
(S)-Warfarin,Bimekizumab,The metabolism of (S)-Warfarin can be increased when combined with Bimekizumab.,increase,no risk
(S)-Warfarin,Bismuth subsalicylate,Bismuth subsalicylate may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Blinatumomab,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Blinatumomab.,increase,risk
(S)-Warfarin,Boceprevir,The metabolism of (S)-Warfarin can be decreased when combined with Boceprevir.,decrease,no risk
(S)-Warfarin,Bortezomib,The metabolism of (S)-Warfarin can be decreased when combined with Bortezomib.,decrease,no risk
(S)-Warfarin,Bosentan,The metabolism of (S)-Warfarin can be increased when combined with Bosentan.,increase,no risk
(S)-Warfarin,Bosutinib,The serum concentration of (S)-Warfarin can be increased when it is combined with Bosutinib.,increase,no risk
(S)-Warfarin,Brentuximab vedotin,The serum concentration of (S)-Warfarin can be increased when it is combined with Brentuximab vedotin.,increase,no risk
(S)-Warfarin,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Brexpiprazole,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Brigatinib,The metabolism of (S)-Warfarin can be increased when combined with Brigatinib.,increase,no risk
(S)-Warfarin,Brivaracetam,The metabolism of (S)-Warfarin can be decreased when combined with Brivaracetam.,decrease,no risk
(S)-Warfarin,Bromocriptine,The serum concentration of (S)-Warfarin can be increased when it is combined with Bromocriptine.,increase,no risk
(S)-Warfarin,Budesonide,Budesonide may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Buprenorphine,The serum concentration of (S)-Warfarin can be increased when it is combined with Buprenorphine.,increase,no risk
(S)-Warfarin,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Busulfan,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Busulfan.,increase,risk
(S)-Warfarin,Butabarbital,The metabolism of (S)-Warfarin can be increased when combined with Butabarbital.,increase,no risk
(S)-Warfarin,Butalbital,The metabolism of (S)-Warfarin can be increased when combined with Butalbital.,increase,no risk
(S)-Warfarin,Butriptyline,The risk or severity of bleeding can be increased when Butriptyline is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Gatifloxacin,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Gatifloxacin.,increase,no risk
(S)-Warfarin,Gefitinib,Gefitinib may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Gemcitabine,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Gemcitabine.,increase,no risk
(S)-Warfarin,Gemfibrozil,The metabolism of (S)-Warfarin can be decreased when combined with Gemfibrozil.,decrease,no risk
(S)-Warfarin,Gemifloxacin,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Gemifloxacin.,increase,no risk
(S)-Warfarin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Gemtuzumab ozogamicin.,increase,risk
(S)-Warfarin,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Glasdegib,The metabolism of (S)-Warfarin can be decreased when combined with Glasdegib.,decrease,no risk
(S)-Warfarin,Gliclazide,The metabolism of (S)-Warfarin can be decreased when combined with Gliclazide.,decrease,no risk
(S)-Warfarin,Glimepiride,Glimepiride may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Glipizide,Glipizide may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Gliquidone,Gliquidone may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Glofitamab,The serum concentration of (S)-Warfarin can be increased when it is combined with Glofitamab.,increase,no risk
(S)-Warfarin,Glucagon,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Glucagon.,increase,no risk
(S)-Warfarin,Glucosamine,Glucosamine may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Glutethimide,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Glutethimide.,decrease,no risk
(S)-Warfarin,Glyburide,The serum concentration of (S)-Warfarin can be increased when it is combined with Glyburide.,increase,no risk
(S)-Warfarin,Glycerol phenylbutyrate,The metabolism of (S)-Warfarin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
(S)-Warfarin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Golimumab,The metabolism of (S)-Warfarin can be increased when combined with Golimumab.,increase,no risk
(S)-Warfarin,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Grepafloxacin,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Grepafloxacin.,increase,no risk
(S)-Warfarin,Griseofulvin,The metabolism of (S)-Warfarin can be increased when combined with Griseofulvin.,increase,no risk
(S)-Warfarin,Halofantrine,The metabolism of (S)-Warfarin can be decreased when combined with Halofantrine.,decrease,no risk
(S)-Warfarin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with (S)-Warfarin.,increase,no risk
(S)-Warfarin,Haloprogin,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Haloprogin.,increase,no risk
(S)-Warfarin,Halothane,The metabolism of (S)-Warfarin can be decreased when combined with Halothane.,decrease,no risk
(S)-Warfarin,Hemin,Hemin may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Hetacillin,Hetacillin may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Hexetidine,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Hexetidine.,increase,no risk
(S)-Warfarin,Hydralazine,The serum concentration of (S)-Warfarin can be increased when it is combined with Hydralazine.,increase,no risk
(S)-Warfarin,Hydrochlorothiazide,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
(S)-Warfarin,Hydrocortamate,The metabolism of (S)-Warfarin can be increased when combined with Hydrocortamate.,increase,no risk
(S)-Warfarin,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Hydroflumethiazide,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
(S)-Warfarin,Hydromorphone,The metabolism of (S)-Warfarin can be decreased when combined with Hydromorphone.,decrease,no risk
(S)-Warfarin,Hydroxychloroquine,The metabolism of (S)-Warfarin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
(S)-Warfarin,Hydroxyprogesterone caproate,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
(S)-Warfarin,Hydroxyurea,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Hydroxyurea.,increase,risk
(S)-Warfarin,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Ketamine,The metabolism of (S)-Warfarin can be increased when combined with Ketamine.,increase,no risk
(S)-Warfarin,Ketazolam,The serum concentration of (S)-Warfarin can be increased when it is combined with Ketazolam.,increase,no risk
(S)-Warfarin,Ketoconazole,The metabolism of (S)-Warfarin can be decreased when combined with Ketoconazole.,decrease,no risk
(S)-Warfarin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Obeticholic acid,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Obeticholic acid.,decrease,no risk
(S)-Warfarin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when (S)-Warfarin is combined with Obinutuzumab.,increase,risk
(S)-Warfarin,Octreotide,The serum concentration of (S)-Warfarin can be increased when it is combined with Octreotide.,increase,no risk
(S)-Warfarin,Ofloxacin,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Ofloxacin.,increase,no risk
(S)-Warfarin,Olanzapine,The metabolism of (S)-Warfarin can be decreased when combined with Olanzapine.,decrease,no risk
(S)-Warfarin,Olaparib,The serum concentration of (S)-Warfarin can be increased when it is combined with Olaparib.,increase,no risk
(S)-Warfarin,Olive oil,The therapeutic efficacy of (S)-Warfarin can be decreased when used in combination with Olive oil.,decrease,no risk
(S)-Warfarin,Olodaterol,The metabolism of (S)-Warfarin can be decreased when combined with Olodaterol.,decrease,no risk
(S)-Warfarin,Olsalazine,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Olsalazine.,increase,risk
(S)-Warfarin,Olutasidenib,The metabolism of (S)-Warfarin can be increased when combined with Olutasidenib.,increase,no risk
(S)-Warfarin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Omacetaxine mepesuccinate.,increase,risk
(S)-Warfarin,Omadacycline,Omadacycline may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Omaveloxolone,The serum concentration of (S)-Warfarin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
(S)-Warfarin,Ombitasvir,The metabolism of (S)-Warfarin can be decreased when combined with Ombitasvir.,decrease,no risk
(S)-Warfarin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Omega-3-carboxylic acids,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
(S)-Warfarin,Omeprazole,The metabolism of (S)-Warfarin can be decreased when combined with Omeprazole.,decrease,no risk
(S)-Warfarin,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Oritavancin,The risk or severity of bleeding can be increased when Oritavancin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Orlistat,Orlistat may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Orphenadrine,The serum concentration of (S)-Warfarin can be increased when it is combined with Orphenadrine.,increase,no risk
(S)-Warfarin,Osilodrostat,The serum concentration of (S)-Warfarin can be increased when it is combined with Osilodrostat.,increase,no risk
(S)-Warfarin,Ospemifene,The metabolism of (S)-Warfarin can be decreased when combined with Ospemifene.,decrease,no risk
(S)-Warfarin,Oxacillin,Oxacillin may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Oxandrolone,Oxandrolone may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Oxcarbazepine,The metabolism of (S)-Warfarin can be increased when combined with Oxcarbazepine.,increase,no risk
(S)-Warfarin,Oxetacaine,The serum concentration of (S)-Warfarin can be increased when it is combined with Oxetacaine.,increase,no risk
(S)-Warfarin,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Oxybutynin,The serum concentration of (S)-Warfarin can be increased when it is combined with Oxybutynin.,increase,no risk
(S)-Warfarin,Oxymetholone,The serum concentration of (S)-Warfarin can be increased when it is combined with Oxymetholone.,increase,no risk
(S)-Warfarin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with (S)-Warfarin.,increase,risk
(S)-Warfarin,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of (S)-Warfarin.,increase,no risk
(S)-Warfarin,Ozanimod,The metabolism of (S)-Warfarin can be decreased when combined with Ozanimod.,decrease,no risk
Thymol,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Thymol.,increase,no risk
Ditiocarb,Galantamine,The metabolism of Galantamine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Glyburide,The metabolism of Glyburide can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Granisetron,The metabolism of Granisetron can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Halothane,The metabolism of Halothane can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Ketamine,The metabolism of Ketamine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Olaparib,The metabolism of Olaparib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Opium,The metabolism of Opium can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Quazepam,The metabolism of Quazepam can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Quinidine,The metabolism of Quinidine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Quinine,The metabolism of Quinine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Udenafil,The metabolism of Udenafil can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Verapamil,The metabolism of Verapamil can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vincristine,The metabolism of Vincristine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vindesine,The metabolism of Vindesine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ditiocarb.,increase,no risk
Ditiocarb,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Warfarin,The metabolism of Warfarin can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zileuton,The metabolism of Zileuton can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zotepine,The metabolism of Zotepine can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ditiocarb.,decrease,no risk
Ditiocarb,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Ditiocarb.,increase,no risk
Cyclic adenosine monophosphate,Quinidine,The excretion of Cyclic adenosine monophosphate can be decreased when combined with Quinidine.,decrease,no risk
Cyclic adenosine monophosphate,Vadadustat,The serum concentration of Cyclic adenosine monophosphate can be increased when it is combined with Vadadustat.,increase,no risk
Cyclic adenosine monophosphate,Valproic acid,The excretion of Cyclic adenosine monophosphate can be decreased when combined with Valproic acid.,decrease,no risk
Cyclic adenosine monophosphate,Zidovudine,The excretion of Cyclic adenosine monophosphate can be decreased when combined with Zidovudine.,decrease,no risk
Pimagedine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Pimagedine.,increase,no risk
Pimagedine,Histamine,The serum concentration of Histamine can be increased when it is combined with Pimagedine.,increase,no risk
Pimagedine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Pimagedine.,increase,no risk
Pimagedine,Varenicline,The excretion of Varenicline can be decreased when combined with Pimagedine.,decrease,no risk
Vorinostat,Brodalumab,The risk or severity of adverse effects can be increased when Vorinostat is combined with Brodalumab.,increase,risk
Vorinostat,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Vorinostat.,decrease,no risk
Vorinostat,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Vorinostat.,increase,risk
Vorinostat,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vorinostat.,increase,risk
Vorinostat,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Vorinostat.,increase,risk
Vorinostat,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Bupivacaine.,increase,risk
Vorinostat,Buserelin,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Buserelin.,increase,risk
Vorinostat,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Vorinostat.,increase,risk
Vorinostat,Butacaine,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Butacaine.,increase,risk
Vorinostat,Butamben,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Butamben.,increase,risk
Vorinostat,Butriptyline,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Butriptyline.,increase,risk
Vorinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Gadobenic acid.,increase,risk
Vorinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vorinostat.,increase,risk
Vorinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Vorinostat.,increase,risk
Vorinostat,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vorinostat.,increase,risk
Vorinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Gemifloxacin.,increase,risk
Geranyl Diphosphate,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Geranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
PD173955,Voriconazole,The serum concentration of PD173955 can be increased when it is combined with Voriconazole.,increase,no risk
Peldesine,Gabapentin,Gabapentin may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Ganaxolone,Ganaxolone may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Gatifloxacin,The metabolism of Peldesine can be decreased when combined with Gatifloxacin.,decrease,no risk
Peldesine,Gemfibrozil,The metabolism of Peldesine can be decreased when combined with Gemfibrozil.,decrease,no risk
Peldesine,Gemifloxacin,The metabolism of Peldesine can be decreased when combined with Gemifloxacin.,decrease,no risk
Peldesine,Givosiran,The serum concentration of Peldesine can be increased when it is combined with Givosiran.,increase,no risk
Peldesine,Glofitamab,The serum concentration of Peldesine can be increased when it is combined with Glofitamab.,increase,no risk
Peldesine,Golimumab,The metabolism of Peldesine can be increased when combined with Golimumab.,increase,no risk
Peldesine,Grepafloxacin,The metabolism of Peldesine can be decreased when combined with Grepafloxacin.,decrease,no risk
Peldesine,Guanabenz,The metabolism of Peldesine can be decreased when combined with Guanabenz.,decrease,no risk
Peldesine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Peldesine.,decrease,no risk
Peldesine,Haloperidol,The metabolism of Peldesine can be decreased when combined with Haloperidol.,decrease,no risk
Peldesine,Human interferon beta,The metabolism of Peldesine can be decreased when combined with Human interferon beta.,decrease,no risk
Peldesine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Peldesine.,increase,risk
Peldesine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with Peldesine.,decrease,no risk
Peldesine,Ketoconazole,The metabolism of Peldesine can be decreased when combined with Ketoconazole.,decrease,no risk
Peldesine,Obeticholic acid,The metabolism of Peldesine can be decreased when combined with Obeticholic acid.,decrease,no risk
Peldesine,Ofloxacin,The metabolism of Peldesine can be decreased when combined with Ofloxacin.,decrease,no risk
Peldesine,Olanzapine,The metabolism of Peldesine can be decreased when combined with Olanzapine.,decrease,no risk
Peldesine,Olodaterol,Peldesine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Peldesine,Ondansetron,The metabolism of Peldesine can be decreased when combined with Ondansetron.,decrease,no risk
Peldesine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Peldesine.,increase,risk
Peldesine,Orphenadrine,The metabolism of Peldesine can be decreased when combined with Orphenadrine.,decrease,no risk
Peldesine,Osilodrostat,The metabolism of Peldesine can be decreased when combined with Osilodrostat.,decrease,no risk
Peldesine,Osimertinib,The serum concentration of Peldesine can be decreased when it is combined with Osimertinib.,decrease,no risk
Peldesine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Peldesine.,decrease,no risk
Peldesine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Peldesine.,increase,risk
Peldesine,Oxtriphylline,The metabolism of Peldesine can be decreased when combined with Oxtriphylline.,decrease,no risk
Peldesine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Peldesine.,increase,risk
Peldesine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Peldesine.,decrease,no risk
Peldesine,Quinidine,The serum concentration of Peldesine can be increased when it is combined with Quinidine.,increase,no risk
Peldesine,Quinine,The serum concentration of Peldesine can be increased when it is combined with Quinine.,increase,no risk
Peldesine,Valproic acid,Valproic acid may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Vemurafenib,The serum concentration of Peldesine can be increased when it is combined with Vemurafenib.,increase,no risk
Peldesine,Verapamil,The metabolism of Peldesine can be decreased when combined with Verapamil.,decrease,no risk
Peldesine,Vigabatrin,Vigabatrin may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Vilanterol,The risk or severity of hypokalemia can be increased when Peldesine is combined with Vilanterol.,increase,risk
Peldesine,Viloxazine,The metabolism of Peldesine can be decreased when combined with Viloxazine.,decrease,no risk
Peldesine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Peldesine.,decrease,no risk
Peldesine,Warfarin,The metabolism of Peldesine can be decreased when combined with Warfarin.,decrease,no risk
Peldesine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Peldesine.,decrease,no risk
Peldesine,Zaleplon,Zaleplon may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Zileuton,The metabolism of Peldesine can be decreased when combined with Zileuton.,decrease,no risk
Peldesine,Zolmitriptan,The metabolism of Peldesine can be decreased when combined with Zolmitriptan.,decrease,no risk
Peldesine,Zolpidem,The metabolism of Peldesine can be decreased when combined with Zolpidem.,decrease,no risk
Peldesine,Zonisamide,Zonisamide may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peldesine,Zotepine,The metabolism of Zotepine can be decreased when combined with Peldesine.,decrease,no risk
Oseltamivir acid,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Oseltamivir acid,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Oseltamivir acid.,decrease,no risk
Terlipressin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Terlipressin.,increase,risk
Terlipressin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Terlipressin.,increase,risk
Terlipressin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Terlipressin.,increase,risk
Terlipressin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Terlipressin.,increase,risk
Terlipressin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Terlipressin.,increase,risk
Terlipressin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Gilteritinib.,increase,risk
Terlipressin,Glasdegib,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Glasdegib.,increase,risk
Terlipressin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Terlipressin.,increase,risk
Terlipressin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Terlipressin.,increase,risk
Terlipressin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Grepafloxacin.,increase,risk
Terlipressin,Halofantrine,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Halofantrine.,increase,risk
Terlipressin,Haloperidol,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Haloperidol.,increase,risk
Terlipressin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Terlipressin.,increase,risk
Terlipressin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Terlipressin.,increase,risk
Terlipressin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Terlipressin.,increase,risk
Terlipressin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Hydroxyzine.,increase,risk
Terlipressin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Terlipressin.,increase,risk
Terlipressin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Terlipressin.,increase,risk
Terlipressin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Terlipressin.,increase,risk
Terlipressin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Terlipressin.,increase,risk
Terlipressin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Terlipressin.,increase,risk
Terlipressin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Terlipressin.,increase,risk
Terlipressin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Terlipressin.,increase,risk
Terlipressin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Terlipressin.,increase,risk
Terlipressin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Terlipressin.,increase,risk
Terlipressin,Oxatomide,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Oxatomide.,increase,risk
Terlipressin,Oxytocin,The risk or severity of hypertension can be increased when Terlipressin is combined with Oxytocin.,increase,risk
Terlipressin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Terlipressin.,increase,risk
Terlipressin,Quinidine,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Quinidine.,increase,risk
Terlipressin,Quinine,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Quinine.,increase,risk
Terlipressin,Quizartinib,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Quizartinib.,increase,risk
Terlipressin,Valproic acid,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Valproic acid.,increase,risk
Terlipressin,Vandetanib,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Vandetanib.,increase,risk
Terlipressin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Terlipressin.,increase,risk
Terlipressin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Vemurafenib.,increase,risk
Terlipressin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Terlipressin.,increase,risk
Terlipressin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Terlipressin.,increase,risk
Terlipressin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Terlipressin.,increase,risk
Terlipressin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Terlipressin.,increase,risk
Terlipressin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Ziprasidone.,increase,risk
Terlipressin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Terlipressin.,increase,risk
Terlipressin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Zuclopenthixol.,increase,risk
Fumagillin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Benzocaine.,increase,risk
Fumagillin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Benzyl alcohol.,increase,risk
Fumagillin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Bupivacaine.,increase,risk
Fumagillin,Butacaine,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Butacaine.,increase,risk
Fumagillin,Butamben,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Butamben.,increase,risk
Fumagillin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Oxetacaine.,increase,risk
Fumagillin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Oxybuprocaine.,increase,risk
Fumagillin,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Fumagillin is combined with Zoledronic acid.,increase,risk
Cholic Acid,Gadoxetic acid,The excretion of Gadoxetic acid can be increased when combined with Cholic Acid.,increase,no risk
Cholic Acid,Ganciclovir,The excretion of Cholic Acid can be decreased when combined with Ganciclovir.,decrease,no risk
Cholic Acid,Gemfibrozil,The therapeutic efficacy of Cholic Acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Cholic Acid,Gestrinone,The therapeutic efficacy of Cholic Acid can be decreased when used in combination with Gestrinone.,decrease,no risk
Cholic Acid,Glecaprevir,The excretion of Glecaprevir can be increased when combined with Cholic Acid.,increase,no risk
Cholic Acid,Glimepiride,Cholic Acid may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Cholic Acid,Glipizide,Cholic Acid may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cholic Acid,Glyburide,Glyburide may decrease the excretion rate of Cholic Acid which could result in a higher serum level.,decrease,no risk
Cholic Acid,Glycyrrhizic acid,Cholic Acid may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Cholic Acid,Grazoprevir,The excretion of Grazoprevir can be increased when combined with Cholic Acid.,increase,no risk
Cholic Acid,Guanidine,The excretion of Cholic Acid can be decreased when combined with Guanidine.,decrease,no risk
Cholic Acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Cholic Acid.,increase,risk
Cholic Acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Cholic Acid.,decrease,no risk
Cholic Acid,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Cholic Acid.,decrease,no risk
Cholic Acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cholic Acid,Kaolin,Kaolin can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cholic Acid,Ketoconazole,Ketoconazole may decrease the excretion rate of Cholic Acid which could result in a higher serum level.,decrease,no risk
Cholic Acid,Ketoprofen,The excretion of Cholic Acid can be decreased when combined with Ketoprofen.,decrease,no risk
Cholic Acid,Obeticholic acid,The risk or severity of adverse effects can be increased when Cholic Acid is combined with Obeticholic acid.,increase,risk
Cholic Acid,Ofloxacin,Cholic Acid may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Cholic Acid,Olmesartan,Olmesartan may decrease the excretion rate of Cholic Acid which could result in a higher serum level.,decrease,no risk
Cholic Acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Cholic Acid.,decrease,no risk
Cholic Acid,Ouabain,The excretion of Cholic Acid can be decreased when combined with Ouabain.,decrease,no risk
Cholic Acid,Oxytetracycline,The excretion of Cholic Acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Cholic Acid,Quinapril,The excretion of Quinapril can be decreased when combined with Cholic Acid.,decrease,no risk
Cholic Acid,Quinidine,Quinidine may decrease the excretion rate of Cholic Acid which could result in a higher serum level.,decrease,no risk
Cholic Acid,Quinine,The excretion of Cholic Acid can be decreased when combined with Quinine.,decrease,no risk
Cholic Acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Cholic Acid.,increase,risk
Cholic Acid,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Cholic Acid which could result in a higher serum level.,decrease,no risk
Cholic Acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Cholic Acid.,increase,no risk
Cholic Acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Cholic Acid.,decrease,no risk
Cholic Acid,Valproic acid,The excretion of Valproic acid can be decreased when combined with Cholic Acid.,decrease,no risk
Cholic Acid,Valsartan,The excretion of Valsartan can be increased when combined with Cholic Acid.,increase,no risk
Cholic Acid,Velpatasvir,The excretion of Cholic Acid can be decreased when combined with Velpatasvir.,decrease,no risk
Cholic Acid,Venetoclax,The excretion of Cholic Acid can be decreased when combined with Venetoclax.,decrease,no risk
Cholic Acid,Vinblastine,Cholic Acid may decrease the excretion rate of Vinblastine which could result in a higher serum level.,decrease,no risk
Cholic Acid,Vincristine,Cholic Acid may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Cholic Acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Cholic Acid.,increase,risk
Cholic Acid,Voxilaprevir,The excretion of Voxilaprevir can be increased when combined with Cholic Acid.,increase,no risk
Cholic Acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Cholic Acid.,increase,risk
Cholic Acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Cholic Acid.,increase,risk
Cholic Acid,Zidovudine,The excretion of Cholic Acid can be decreased when combined with Zidovudine.,decrease,no risk
Glycocholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycocholic acid.,increase,risk
Glycocholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Glycocholic acid.,increase,risk
Glycocholic acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Glycocholic acid.,increase,risk
Glycocholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Glycocholic acid.,increase,risk
4-Oxoretinol,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with 4-Oxoretinol.,decrease,no risk
4-Oxoretinol,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with 4-Oxoretinol.,decrease,no risk
4-Oxoretinol,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when 4-Oxoretinol is combined with Omadacycline.,increase,risk
4-Oxoretinol,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when 4-Oxoretinol is combined with Oxytetracycline.,increase,risk
4-Oxoretinol,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of 4-Oxoretinol.,increase,no risk
4-Oxoretinol,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with 4-Oxoretinol.,increase,risk
Fusidic acid,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Budesonide,Fusidic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Fusidic acid,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Fusidic acid.",increase,risk
Fusidic acid,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Bupropion,The metabolism of Fusidic acid can be decreased when combined with Bupropion.,decrease,no risk
Fusidic acid,Buspirone,The metabolism of Buspirone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Busulfan,The metabolism of Busulfan can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Butacaine,The risk or severity of methemoglobinemia can be increased when Fusidic acid is combined with Butacaine.,increase,risk
Fusidic acid,Butamben,The risk or severity of methemoglobinemia can be increased when Fusidic acid is combined with Butamben.,increase,risk
Fusidic acid,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Galantamine,The metabolism of Galantamine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Fusidic acid.",increase,risk
Fusidic acid,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Givosiran,The serum concentration of Fusidic acid can be increased when it is combined with Givosiran.,increase,no risk
Fusidic acid,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Glecaprevir,Fusidic acid may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Fusidic acid,Glimepiride,Fusidic acid may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Fusidic acid,Glipizide,Fusidic acid may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Fusidic acid,Glofitamab,The serum concentration of Fusidic acid can be increased when it is combined with Glofitamab.,increase,no risk
Fusidic acid,Glyburide,Fusidic acid may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Fusidic acid,Glycerol phenylbutyrate,The metabolism of Fusidic acid can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Fusidic acid,Glycyrrhizic acid,Fusidic acid may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Fusidic acid,Golimumab,The metabolism of Fusidic acid can be increased when combined with Golimumab.,increase,no risk
Fusidic acid,Granisetron,The metabolism of Granisetron can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Halofantrine,The metabolism of Fusidic acid can be decreased when combined with Halofantrine.,decrease,no risk
Fusidic acid,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ketamine,The metabolism of Ketamine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ketoconazole,The metabolism of Fusidic acid can be decreased when combined with Ketoconazole.,decrease,no risk
Fusidic acid,Obeticholic acid,The risk or severity of adverse effects can be increased when Fusidic acid is combined with Obeticholic acid.,increase,risk
Fusidic acid,Ofloxacin,Fusidic acid may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Fusidic acid,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Olaparib,The metabolism of Olaparib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Olmesartan,The risk or severity of liver damage can be increased when Olmesartan is combined with Fusidic acid.,increase,risk
Fusidic acid,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Ombitasvir,Fusidic acid may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Fusidic acid,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Opium,The metabolism of Opium can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Oritavancin,The metabolism of Fusidic acid can be decreased when combined with Oritavancin.,decrease,no risk
Fusidic acid,Orphenadrine,The metabolism of Fusidic acid can be decreased when combined with Orphenadrine.,decrease,no risk
Fusidic acid,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ouabain,The excretion of Ouabain can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Oxaliplatin,Fusidic acid may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Fusidic acid,Oxamniquine,The metabolism of Fusidic acid can be decreased when combined with Oxamniquine.,decrease,no risk
Fusidic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fusidic acid is combined with Oxetacaine.,increase,risk
Fusidic acid,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fusidic acid is combined with Oxybuprocaine.,increase,risk
Fusidic acid,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ozanimod,Fusidic acid may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Fusidic acid,Quazepam,The metabolism of Quazepam can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Quinidine,The metabolism of Quinidine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Quinine,The metabolism of Fusidic acid can be decreased when combined with Quinine.,decrease,no risk
Fusidic acid,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Ubidecarenone.",increase,risk
Fusidic acid,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Udenafil,The metabolism of Udenafil can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Ursodeoxycholic acid,Fusidic acid may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Fusidic acid,Vadadustat,The serum concentration of Fusidic acid can be increased when it is combined with Vadadustat.,increase,no risk
Fusidic acid,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Valproic acid,The metabolism of Fusidic acid can be decreased when combined with Valproic acid.,decrease,no risk
Fusidic acid,Valsartan,The excretion of Valsartan can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Venlafaxine,The metabolism of Fusidic acid can be decreased when combined with Venlafaxine.,decrease,no risk
Fusidic acid,Verapamil,The metabolism of Fusidic acid can be decreased when combined with Verapamil.,decrease,no risk
Fusidic acid,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fusidic acid.,decrease,no risk
Fusidic acid,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Viloxazine,The metabolism of Fusidic acid can be decreased when combined with Viloxazine.,decrease,no risk
Fusidic acid,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vincristine,The metabolism of Vincristine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vindesine,The metabolism of Vindesine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Voriconazole,The metabolism of Fusidic acid can be decreased when combined with Voriconazole.,decrease,no risk
Fusidic acid,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Fusidic acid.,increase,no risk
Fusidic acid,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zidovudine,The metabolism of Fusidic acid can be increased when combined with Zidovudine.,increase,no risk
Fusidic acid,Zileuton,The metabolism of Zileuton can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zimelidine,The metabolism of Fusidic acid can be decreased when combined with Zimelidine.,decrease,no risk
Fusidic acid,Ziprasidone,The metabolism of Fusidic acid can be decreased when combined with Ziprasidone.,decrease,no risk
Fusidic acid,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zotepine,The metabolism of Zotepine can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Fusidic acid.,decrease,no risk
Fusidic acid,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Fusidic acid.,decrease,no risk
Resveratrol,Gemcitabine,The risk or severity of bleeding can be increased when Resveratrol is combined with Gemcitabine.,increase,risk
Resveratrol,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Resveratrol is combined with Gemtuzumab ozogamicin.,increase,risk
Resveratrol,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Resveratrol.,increase,no risk
Resveratrol,Glucosamine,Glucosamine may increase the antiplatelet activities of Resveratrol.,increase,no risk
Resveratrol,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Resveratrol.,increase,risk
Resveratrol,Heparin,The risk or severity of bleeding can be increased when Resveratrol is combined with Heparin.,increase,risk
Resveratrol,Hydroxyurea,The risk or severity of bleeding can be increased when Resveratrol is combined with Hydroxyurea.,increase,risk
Resveratrol,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Resveratrol.,increase,risk
Resveratrol,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Resveratrol.,increase,risk
Resveratrol,Obeticholic acid,The risk or severity of adverse effects can be increased when Resveratrol is combined with Obeticholic acid.,increase,risk
Resveratrol,Obinutuzumab,The risk or severity of adverse effects can be increased when Resveratrol is combined with Obinutuzumab.,increase,risk
Resveratrol,Olaparib,The risk or severity of bleeding can be increased when Resveratrol is combined with Olaparib.,increase,risk
Resveratrol,Olsalazine,The risk or severity of bleeding can be increased when Resveratrol is combined with Olsalazine.,increase,risk
Resveratrol,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Resveratrol.,increase,no risk
Resveratrol,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Resveratrol.,increase,risk
Resveratrol,Oxaliplatin,The risk or severity of bleeding can be increased when Resveratrol is combined with Oxaliplatin.,increase,risk
Resveratrol,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Resveratrol.,increase,risk
Resveratrol,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Resveratrol.,increase,risk
Resveratrol,Urokinase,Resveratrol may increase the anticoagulant activities of Urokinase.,increase,no risk
Resveratrol,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Resveratrol is combined with Ursodeoxycholic acid.,increase,risk
Resveratrol,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Resveratrol.,increase,risk
Resveratrol,Venlafaxine,The risk or severity of bleeding can be increased when Resveratrol is combined with Venlafaxine.,increase,risk
Resveratrol,Vinblastine,The risk or severity of bleeding can be increased when Resveratrol is combined with Vinblastine.,increase,risk
Resveratrol,Vindesine,The risk or severity of bleeding can be increased when Resveratrol is combined with Vindesine.,increase,risk
Resveratrol,Vinorelbine,The risk or severity of bleeding can be increased when Resveratrol is combined with Vinorelbine.,increase,risk
Resveratrol,Vitamin E,Vitamin E may increase the antiplatelet activities of Resveratrol.,increase,no risk
Resveratrol,Vorapaxar,The risk or severity of bleeding can be increased when Resveratrol is combined with Vorapaxar.,increase,risk
Resveratrol,Vorinostat,The risk or severity of bleeding can be increased when Resveratrol is combined with Vorinostat.,increase,risk
Resveratrol,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Resveratrol.,increase,risk
Resveratrol,Warfarin,The risk or severity of bleeding can be increased when Resveratrol is combined with Warfarin.,increase,risk
Resveratrol,Ximelagatran,The risk or severity of bleeding can be increased when Resveratrol is combined with Ximelagatran.,increase,risk
Resveratrol,Zidovudine,The risk or severity of bleeding can be increased when Resveratrol is combined with Zidovudine.,increase,risk
Resveratrol,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Resveratrol.,increase,risk
Resveratrol,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Resveratrol is combined with Zoledronic acid.,increase,risk
Resveratrol,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Resveratrol.,decrease,no risk
Oxalic Acid,Benzoic acid,The excretion of Oxalic Acid can be decreased when combined with Benzoic acid.,decrease,no risk
Oxalic Acid,Benzylpenicillin,The excretion of Oxalic Acid can be decreased when combined with Benzylpenicillin.,decrease,no risk
Oxalic Acid,Bumetanide,The excretion of Oxalic Acid can be decreased when combined with Bumetanide.,decrease,no risk
Oxalic Acid,Ganciclovir,The excretion of Oxalic Acid can be decreased when combined with Ganciclovir.,decrease,no risk
Oxalic Acid,Gemfibrozil,The excretion of Oxalic Acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Oxalic Acid,Guanidine,The excretion of Oxalic Acid can be decreased when combined with Guanidine.,decrease,no risk
Oxalic Acid,Ketoprofen,The excretion of Oxalic Acid can be decreased when combined with Ketoprofen.,decrease,no risk
Oxalic Acid,Ouabain,The excretion of Oxalic Acid can be decreased when combined with Ouabain.,decrease,no risk
Oxalic Acid,Oxytetracycline,The excretion of Oxalic Acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Oxalic Acid,Quinidine,The excretion of Oxalic Acid can be decreased when combined with Quinidine.,decrease,no risk
Oxalic Acid,Vadadustat,The serum concentration of Oxalic Acid can be increased when it is combined with Vadadustat.,increase,no risk
Oxalic Acid,Valproic acid,The excretion of Oxalic Acid can be decreased when combined with Valproic acid.,decrease,no risk
Oxalic Acid,Zidovudine,The excretion of Oxalic Acid can be decreased when combined with Zidovudine.,decrease,no risk
Pyroquilon,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Pyroquilon.,increase,no risk
Pregnenolone,Viloxazine,The metabolism of Pregnenolone can be decreased when combined with Viloxazine.,decrease,no risk
Pregnenolone,Voriconazole,The metabolism of Pregnenolone can be decreased when combined with Voriconazole.,decrease,no risk
Pregnenolone,Zimelidine,The metabolism of Pregnenolone can be decreased when combined with Zimelidine.,decrease,no risk
Pregnenolone,Ziprasidone,The metabolism of Pregnenolone can be decreased when combined with Ziprasidone.,decrease,no risk
2-Methoxyethanol,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Glatiramer,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Glatiramer.,increase,risk
2-Methoxyethanol,Golimumab,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Golimumab.,increase,risk
2-Methoxyethanol,Guselkumab,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Guselkumab.,increase,risk
2-Methoxyethanol,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Hydrocortisone acetate.,increase,risk
2-Methoxyethanol,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Hydrocortisone butyrate.,increase,risk
2-Methoxyethanol,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Hydrocortisone succinate.,increase,risk
2-Methoxyethanol,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Obinutuzumab,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Obinutuzumab.,increase,risk
2-Methoxyethanol,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of 2-Methoxyethanol.,increase,no risk
2-Methoxyethanol,Ofatumumab,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Ofatumumab.,increase,risk
2-Methoxyethanol,Olaparib,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Olaparib.,increase,risk
2-Methoxyethanol,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Ozanimod,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Ozanimod.,increase,risk
2-Methoxyethanol,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Upadacitinib,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Upadacitinib.,increase,risk
2-Methoxyethanol,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Vedolizumab,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Vedolizumab.,increase,risk
2-Methoxyethanol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with 2-Methoxyethanol.,decrease,no risk
2-Methoxyethanol,Vilanterol,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Vilanterol.,increase,risk
2-Methoxyethanol,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Voclosporin,The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Voclosporin.,increase,risk
2-Methoxyethanol,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with 2-Methoxyethanol.,increase,risk
2-Methoxyethanol,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with 2-Methoxyethanol.,increase,risk
Methylphosphinic Acid,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Oxprenolol,Methylphosphinic Acid may increase the bradycardic activities of Oxprenolol.,increase,no risk
Methylphosphinic Acid,Oxybuprocaine,Methylphosphinic Acid may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Methylphosphinic Acid,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Vamorolone,The therapeutic efficacy of Methylphosphinic Acid can be decreased when used in combination with Vamorolone.,decrease,no risk
Methylphosphinic Acid,Varenicline,The risk or severity of adverse effects can be increased when Methylphosphinic Acid is combined with Varenicline.,increase,risk
Methylphosphinic Acid,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Methylphosphinic Acid,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Methylphosphinic Acid.,decrease,no risk
Domoic Acid,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Domoic Acid.,increase,risk
Domoic Acid,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Gabapentin enacarbil.,increase,risk
Domoic Acid,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Domoic Acid.,increase,risk
Domoic Acid,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Domoic Acid is combined with Ganaxolone.",increase,risk
Domoic Acid,Gepirone,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Gepirone.,increase,risk
Domoic Acid,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Domoic Acid.,increase,risk
Domoic Acid,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Domoic Acid.,increase,risk
Domoic Acid,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Domoic Acid.,increase,risk
Domoic Acid,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Domoic Acid.,increase,risk
Domoic Acid,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Domoic Acid.,increase,risk
Domoic Acid,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Domoic Acid.,increase,risk
Domoic Acid,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Domoic Acid.,increase,risk
Domoic Acid,Hydrocodone,Domoic Acid may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Domoic Acid,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Domoic Acid.,increase,risk
Domoic Acid,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Domoic Acid.,increase,no risk
Domoic Acid,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Domoic Acid.,increase,risk
Domoic Acid,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Domoic Acid.,increase,risk
Domoic Acid,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Domoic Acid.,increase,risk
Domoic Acid,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Domoic Acid is combined with Oliceridine.",increase,risk
Domoic Acid,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Domoic Acid.,increase,risk
Domoic Acid,Opium,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Opium.,increase,risk
Domoic Acid,Orphenadrine,Domoic Acid may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Domoic Acid,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Domoic Acid.,increase,risk
Domoic Acid,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Domoic Acid.,increase,risk
Domoic Acid,Oxitriptan,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Oxitriptan.,increase,risk
Domoic Acid,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Domoic Acid.,increase,risk
Domoic Acid,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Domoic Acid.,increase,risk
Domoic Acid,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Domoic Acid.,increase,risk
Domoic Acid,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Domoic Acid.,increase,risk
Domoic Acid,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Domoic Acid.,increase,risk
Domoic Acid,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Domoic Acid.,increase,risk
Domoic Acid,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Domoic Acid.,increase,risk
Domoic Acid,Quinupramine,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Quinupramine.,increase,risk
Domoic Acid,Urethane,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Urethane.,increase,risk
Domoic Acid,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Domoic Acid.,increase,risk
Domoic Acid,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Domoic Acid.,increase,risk
Domoic Acid,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Domoic Acid.,increase,risk
Domoic Acid,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Domoic Acid.,increase,risk
Domoic Acid,Vilazodone,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Vilazodone.,increase,risk
Domoic Acid,Viloxazine,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Viloxazine.,increase,risk
Domoic Acid,Vortioxetine,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Vortioxetine.,increase,risk
Domoic Acid,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Domoic Acid.,increase,risk
Domoic Acid,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Domoic Acid.,increase,risk
Domoic Acid,Ziconotide,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Ziconotide.,increase,risk
Domoic Acid,Zimelidine,The risk or severity of adverse effects can be increased when Domoic Acid is combined with Zimelidine.,increase,risk
Domoic Acid,Ziprasidone,The risk or severity of adverse effects can be increased when Domoic Acid is combined with Ziprasidone.,increase,risk
Domoic Acid,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Domoic Acid.,increase,risk
Domoic Acid,Zolpidem,Domoic Acid may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Domoic Acid,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Domoic Acid.,increase,risk
Domoic Acid,Zopiclone,The risk or severity of adverse effects can be increased when Domoic Acid is combined with Zopiclone.,increase,risk
Domoic Acid,Zotepine,The risk or severity of CNS depression can be increased when Domoic Acid is combined with Zotepine.,increase,risk
Domoic Acid,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Domoic Acid.,increase,risk
Domoic Acid,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Domoic Acid.,increase,risk
Calyculin A,Oxytocin,The risk or severity of hypertension can be increased when Calyculin A is combined with Oxytocin.,increase,risk
Stanolone,Quinine,Stanolone may increase the hypoglycemic activities of Quinine.,increase,no risk
Stanolone,Urokinase,Stanolone may increase the anticoagulant activities of Urokinase.,increase,no risk
Stanolone,Vamorolone,The risk or severity of edema formation can be increased when Stanolone is combined with Vamorolone.,increase,risk
Stanolone,Vildagliptin,Stanolone may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Stanolone,Vorapaxar,Stanolone may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Stanolone,Warfarin,Stanolone may increase the anticoagulant activities of Warfarin.,increase,no risk
Stanolone,Ximelagatran,Stanolone may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Piretanide,Gabapentin enacarbil,Piretanide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gadobenic acid,Piretanide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gadodiamide,Piretanide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gadofosveset trisodium,Piretanide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gadopentetic acid,Piretanide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gadoteric acid,Piretanide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gadoteridol,Piretanide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gallamine triethiodide,Piretanide may decrease the neuromuscular blocking activities of Gallamine triethiodide.,decrease,no risk
Piretanide,Ganciclovir,Piretanide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gemcitabine,Piretanide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gemfibrozil,Piretanide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Piretanide.,increase,no risk
Piretanide,Gimeracil,Piretanide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Piretanide.,increase,no risk
Piretanide,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Piretanide.,increase,no risk
Piretanide,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Piretanide.,increase,no risk
Piretanide,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Piretanide.,increase,no risk
Piretanide,Gluconic Acid,The risk or severity of dehydration can be increased when Piretanide is combined with Gluconic Acid.,increase,risk
Piretanide,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Piretanide.,increase,no risk
Piretanide,Glycerin,The risk or severity of dehydration can be increased when Piretanide is combined with Glycerin.,increase,risk
Piretanide,Glycerol phenylbutyrate,Piretanide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Glycol salicylate,The therapeutic efficacy of Piretanide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Piretanide,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Piretanide.,increase,no risk
Piretanide,Golodirsen,Piretanide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Goserelin,Piretanide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Guanethidine,Piretanide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Guanfacine,Piretanide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Haloperidol,Piretanide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Hydralazine,Piretanide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Hydrocodone,The therapeutic efficacy of Piretanide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Piretanide,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Piretanide.,increase,risk
Piretanide,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Piretanide.,increase,risk
Piretanide,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Piretanide.,increase,risk
Piretanide,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Piretanide.,increase,risk
Piretanide,Hydromorphone,Piretanide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Hydroxocobalamin,Piretanide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Hydroxyethyl Starch,Piretanide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Kanamycin,The serum concentration of Kanamycin can be increased when it is combined with Piretanide.,increase,no risk
Piretanide,Ketamine,Piretanide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Ketazolam,Piretanide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Piretanide,Ketoprofen,The therapeutic efficacy of Piretanide can be decreased when used in combination with Ketoprofen.,decrease,no risk
Piretanide,Ketorolac,The therapeutic efficacy of Piretanide can be decreased when used in combination with Ketorolac.,decrease,no risk
Fosmidomycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Fosmidomycin.,decrease,no risk
Fosmidomycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Benzocaine.,increase,risk
Fosmidomycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Benzyl alcohol.,increase,risk
Fosmidomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Bupivacaine.,increase,risk
Fosmidomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Butacaine.,increase,risk
Fosmidomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Butamben.,increase,risk
Fosmidomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Oxetacaine.,increase,risk
Fosmidomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fosmidomycin is combined with Oxybuprocaine.,increase,risk
Fosmidomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fosmidomycin.,decrease,no risk
Fosmidomycin,Warfarin,The risk or severity of bleeding can be increased when Fosmidomycin is combined with Warfarin.,increase,risk
Oxitriptan,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Oxitriptan.,increase,risk
Oxitriptan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Gabapentin enacarbil.,increase,risk
Oxitriptan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Oxitriptan.,increase,risk
Oxitriptan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxitriptan is combined with Ganaxolone.",increase,risk
Oxitriptan,Gepirone,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Gepirone.,increase,risk
Oxitriptan,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Oxitriptan.,increase,risk
Oxitriptan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Oxitriptan.,increase,risk
Oxitriptan,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Oxitriptan.,increase,risk
Oxitriptan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Oxitriptan.,increase,risk
Oxitriptan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Oxitriptan.,increase,risk
Oxitriptan,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Oxitriptan.,increase,risk
Oxitriptan,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Oxitriptan.,increase,risk
Oxitriptan,Hydrocodone,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Oxitriptan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Oxitriptan.,increase,risk
Oxitriptan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Oxitriptan,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Oxitriptan.,increase,risk
Oxitriptan,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Oxitriptan.,increase,risk
Oxitriptan,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Oxitriptan.,increase,risk
Oxitriptan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Oxitriptan is combined with Oliceridine.",increase,risk
Oxitriptan,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Oxitriptan.,increase,risk
Oxitriptan,Opium,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Opium.,increase,risk
Oxitriptan,Orphenadrine,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Oxitriptan,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Oxitriptan.,increase,risk
Oxitriptan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Oxitriptan.,increase,risk
Oxitriptan,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Oxitriptan.,increase,risk
Oxitriptan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Oxitriptan.,increase,risk
Oxitriptan,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Oxitriptan.,increase,risk
Oxitriptan,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Oxitriptan.,increase,risk
Oxitriptan,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Oxitriptan.,increase,risk
Oxitriptan,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Oxitriptan.,increase,risk
Oxitriptan,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Oxitriptan.,increase,risk
Oxitriptan,Quinupramine,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Quinupramine.,increase,risk
Oxitriptan,Urethane,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Urethane.,increase,risk
Oxitriptan,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Oxitriptan.,increase,risk
Oxitriptan,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Oxitriptan.,increase,risk
Oxitriptan,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Oxitriptan.,increase,risk
Oxitriptan,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Oxitriptan.,increase,risk
Oxitriptan,Vilazodone,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Vilazodone.,increase,risk
Oxitriptan,Viloxazine,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Viloxazine.,increase,risk
Oxitriptan,Vortioxetine,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Vortioxetine.,increase,risk
Oxitriptan,Warfarin,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Warfarin.,increase,risk
Oxitriptan,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Oxitriptan.,increase,risk
Oxitriptan,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Oxitriptan.,increase,risk
Oxitriptan,Ziconotide,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Ziconotide.,increase,risk
Oxitriptan,Zimelidine,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Zimelidine.,increase,risk
Oxitriptan,Ziprasidone,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Ziprasidone.,increase,risk
Oxitriptan,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Oxitriptan.,increase,risk
Oxitriptan,Zolpidem,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Oxitriptan,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Oxitriptan.,increase,risk
Oxitriptan,Zopiclone,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Zopiclone.,increase,risk
Oxitriptan,Zotepine,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Zotepine.,increase,risk
Oxitriptan,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Oxitriptan.,increase,risk
Oxitriptan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Oxitriptan.,increase,risk
Penicillin G Acyl-Serine,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Penicillin G Acyl-Serine.,increase,risk
Penicillin G Acyl-Serine,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Penicillin G Acyl-Serine.,increase,risk
Penicillin G Acyl-Serine,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Penicillin G Acyl-Serine.,increase,risk
Penicillin G Acyl-Serine,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Penicillin G Acyl-Serine is combined with Oxyphenbutazone.,increase,risk
Penicillin G Acyl-Serine,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Penicillin G Acyl-Serine.,increase,risk
Penicillin G Acyl-Serine,Valdecoxib,The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Penicillin G Acyl-Serine.,increase,risk
Penicillin G Acyl-Serine,Valsartan,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Penicillin G Acyl-Serine.,increase,risk
Penicillin G Acyl-Serine,Zofenopril,The risk or severity of hyperkalemia can be increased when Penicillin G Acyl-Serine is combined with Zofenopril.,increase,risk
Penicillin G Acyl-Serine,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Penicillin G Acyl-Serine.,increase,risk
GE-2270A,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with GE-2270A.,decrease,no risk
GE-2270A,Benzocaine,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Benzocaine.,increase,risk
GE-2270A,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Benzyl alcohol.,increase,risk
GE-2270A,Bupivacaine,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Bupivacaine.,increase,risk
GE-2270A,Butacaine,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Butacaine.,increase,risk
GE-2270A,Butamben,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Butamben.,increase,risk
GE-2270A,Oxetacaine,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Oxetacaine.,increase,risk
GE-2270A,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when GE-2270A is combined with Oxybuprocaine.,increase,risk
GE-2270A,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with GE-2270A.,decrease,no risk
GE-2270A,Warfarin,The risk or severity of bleeding can be increased when GE-2270A is combined with Warfarin.,increase,risk
Patupilone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Patupilone.,decrease,no risk
Patupilone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Patupilone is combined with Oxetacaine.,increase,risk
Patupilone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Patupilone.,decrease,no risk
Patupilone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Patupilone is combined with Oxybuprocaine.,increase,risk
Patupilone,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Quinine,The serum concentration of Quinine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Patupilone.,decrease,no risk
Patupilone,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Patupilone.,decrease,no risk
Patupilone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Patupilone.,decrease,no risk
Patupilone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Patupilone.,increase,no risk
Patupilone,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Patupilone.,decrease,no risk
Patupilone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Patupilone.,decrease,no risk
Patupilone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Patupilone.,decrease,no risk
D-Levofloxacin,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with D-Levofloxacin.,increase,no risk
D-Levofloxacin,Histamine,The serum concentration of Histamine can be increased when it is combined with D-Levofloxacin.,increase,no risk
D-Levofloxacin,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with D-Levofloxacin.,increase,no risk
D-Levofloxacin,Varenicline,The excretion of Varenicline can be decreased when combined with D-Levofloxacin.,decrease,no risk
Acetylcholine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Acetylcholine.,increase,risk
Acetylcholine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Acetylcholine.,increase,risk
Acetylcholine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Acetylcholine.,increase,risk
Acetic acid,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Acetic acid.,decrease,no risk
Acetic acid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Benzocaine.,increase,risk
Acetic acid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Benzyl alcohol.,increase,risk
Acetic acid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Bupivacaine.,increase,risk
Acetic acid,Butacaine,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Butacaine.,increase,risk
Acetic acid,Butamben,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Butamben.,increase,risk
Acetic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Oxetacaine.,increase,risk
Acetic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Oxybuprocaine.,increase,risk
Acetic acid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Acetic acid.,decrease,no risk
Acetic acid,Warfarin,The risk or severity of bleeding can be increased when Acetic acid is combined with Warfarin.,increase,risk
Tubercidin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Benzocaine.,increase,risk
Tubercidin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Benzyl alcohol.,increase,risk
Tubercidin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Bupivacaine.,increase,risk
Tubercidin,Butacaine,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Butacaine.,increase,risk
Tubercidin,Butamben,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Butamben.,increase,risk
Tubercidin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Oxetacaine.,increase,risk
Tubercidin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tubercidin is combined with Oxybuprocaine.,increase,risk
Phenol,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Phenol.,increase,risk
Phenol,Ganaxolone,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Phenol.,increase,risk
Phenol,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Phenol.,increase,risk
Phenol,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Phenol.,increase,risk
Phenol,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Phenol.,increase,risk
Phenol,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Phenol.,increase,risk
Phenol,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Phenol.,increase,risk
Phenol,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Phenol.,increase,risk
Phenol,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Phenol.,increase,risk
Phenol,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Phenol.,increase,risk
Phenol,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Phenol.,increase,risk
Phenol,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Phenol.,increase,risk
Phenol,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Phenol.,increase,risk
Phenol,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Phenol.,increase,risk
Phenol,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Phenol.,increase,risk
Phenol,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Phenol resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Phenol,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Phenol resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Phenol,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Phenol resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Phenol,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Phenol.,increase,risk
Phenol,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Phenol.,increase,risk
Phenol,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Phenol.,increase,risk
Phenol,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Phenol.,increase,risk
Phenol,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Phenol.,increase,risk
Phenol,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Phenol.,increase,risk
Phenol,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Phenol.,increase,risk
Phenol,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Phenol.,increase,risk
Phenol,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Phenol.,increase,risk
Phenol,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Phenol.,increase,risk
Phenol,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Phenol.,increase,risk
Phenol,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Phenol.,increase,risk
Phenol,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Phenol.,increase,risk
Phenol,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Phenol.,increase,risk
Phenol,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Phenol.,increase,risk
Phenol,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Phenol.,increase,risk
Phenol,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Phenol.,increase,risk
Phenol,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Phenol.,increase,risk
Phenol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Phenol is combined with Oxetacaine.,increase,risk
Phenol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Phenol.,increase,risk
Phenol,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Phenol.,increase,risk
Phenol,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Phenol.,increase,risk
Phenol,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Phenol.,increase,risk
Phenol,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Phenol.,increase,risk
Phenol,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Phenol.,increase,risk
Phenol,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Phenol.,increase,risk
Phenol,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Phenol.,increase,risk
Phenol,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Phenol.,increase,risk
Phenol,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Phenol.,increase,risk
Phenol,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Phenol.,increase,risk
Phenol,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Phenol.,increase,risk
Phenol,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Phenol.,increase,risk
Phenol,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Phenol.,increase,risk
Phenol,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Phenol.,increase,risk
Phenol,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Phenol.,increase,risk
Phenol,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Phenol.,increase,risk
Phenol,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Phenol.,increase,risk
Phenol,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Phenol.,increase,risk
Phenol,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Phenol.,increase,risk
Phenol,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Phenol.,increase,risk
Phenol,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Phenol.,increase,risk
Phenol,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Phenol.,increase,risk
Phenol,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Phenol.,increase,risk
Phenol,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Phenol.,increase,risk
Phenol,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Phenol.,increase,risk
Phenol,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Phenol.,increase,risk
(6R)-Folinic acid,Glucarpidase,The serum concentration of the active metabolites of (6R)-Folinic acid can be reduced when (6R)-Folinic acid is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
(6R)-Folinic acid,Valproic acid,The serum concentration of (6R)-Folinic acid can be decreased when it is combined with Valproic acid.,decrease,no risk
Brivudine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Brivudine.,decrease,no risk
Brivudine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Brivudine.,decrease,no risk
Cephalosporin C,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Cephalosporin C.,increase,risk
Cephalosporin C,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cephalosporin C.,increase,risk
Cephalosporin C,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Cephalosporin C,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Cephalosporin C.,decrease,no risk
Dexpropranolol,Galantamine,Galantamine may increase the bradycardic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Glucagon,The therapeutic efficacy of Dexpropranolol can be decreased when used in combination with Glucagon.,decrease,no risk
Dexpropranolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Guanadrel,Guanadrel may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Guanethidine,Guanethidine may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Guanoxan,Dexpropranolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Dexpropranolol,Halothane,Halothane may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Dexpropranolol.,increase,risk
Dexpropranolol,Huperzine A,Huperzine A may increase the bradycardic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Hydralazine,Hydralazine may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Hydrochlorothiazide,The therapeutic efficacy of Dexpropranolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Dexpropranolol,Hydroflumethiazide,The therapeutic efficacy of Dexpropranolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Dexpropranolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Dexpropranolol.,decrease,risk
Dexpropranolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Ketamine,Ketamine may increase the bradycardic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Dexpropranolol.,increase,risk
Dexpropranolol,Obinutuzumab,Dexpropranolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Dexpropranolol,Olanzapine,Dexpropranolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Dexpropranolol,Olmesartan,Olmesartan may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Opicapone,Opicapone may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Ouabain,Dexpropranolol may increase the bradycardic activities of Ouabain.,increase,no risk
Dexpropranolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Dexpropranolol is combined with Oxtriphylline.,increase,risk
Dexpropranolol,Oxymetazoline,The therapeutic efficacy of Dexpropranolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Dexpropranolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Quetiapine,Quetiapine may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Quinapril,Quinapril may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Udenafil,Udenafil may increase the antihypertensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Unoprostone,Dexpropranolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Dexpropranolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Dexpropranolol.,increase,risk
Dexpropranolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Valsartan,Valsartan may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Varenicline,The risk or severity of adverse effects can be increased when Dexpropranolol is combined with Varenicline.,increase,risk
Dexpropranolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Dexpropranolol.,increase,risk
Dexpropranolol,Vericiguat,Vericiguat may increase the hypotensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Vernakalant,Dexpropranolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Dexpropranolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Vilazodone,Vilazodone may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Dexpropranolol.,increase,no risk
Dexpropranolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Dexpropranolol.,decrease,no risk
Dexpropranolol,Xylometazoline,Dexpropranolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Dexpropranolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Ziconotide,Dexpropranolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Dexpropranolol,Zimelidine,The serum concentration of Dexpropranolol can be increased when it is combined with Zimelidine.,increase,no risk
Dexpropranolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Zofenopril,Dexpropranolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Dexpropranolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Dexpropranolol.,decrease,no risk
Dexpropranolol,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Dexpropranolol.,increase,no risk
Dexpropranolol,Zuclopenthixol,Dexpropranolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
"3,5-Diiodotyrosine",Glyburide,"The therapeutic efficacy of Glyburide can be decreased when used in combination with 3,5-Diiodotyrosine.",decrease,no risk
"3,5-Diiodotyrosine",Heparin,"3,5-Diiodotyrosine may increase the anticoagulant activities of Heparin.",increase,no risk
"3,5-Diiodotyrosine",Orciprenaline,"The risk or severity of adverse effects can be increased when Orciprenaline is combined with 3,5-Diiodotyrosine.",increase,risk
"3,5-Diiodotyrosine",Osimertinib,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Osimertinib.",decrease,no risk
"3,5-Diiodotyrosine",Ouabain,"The serum concentration of Ouabain can be increased when it is combined with 3,5-Diiodotyrosine.",increase,no risk
"3,5-Diiodotyrosine",Oxtriphylline,"3,5-Diiodotyrosine may decrease the excretion rate of Oxtriphylline which could result in a higher serum level.",decrease,no risk
"3,5-Diiodotyrosine",Oxymetazoline,"The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 3,5-Diiodotyrosine.",increase,risk
"3,5-Diiodotyrosine",Quinupramine,"The risk or severity of Cardiac Arrhythmia can be increased when 3,5-Diiodotyrosine is combined with Quinupramine.",increase,risk
"3,5-Diiodotyrosine",Quizartinib,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Quizartinib.",decrease,no risk
"3,5-Diiodotyrosine",Urokinase,"3,5-Diiodotyrosine may increase the anticoagulant activities of Urokinase.",increase,no risk
"3,5-Diiodotyrosine",Vandetanib,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Vandetanib.",decrease,no risk
"3,5-Diiodotyrosine",Vemurafenib,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Vemurafenib.",decrease,no risk
"3,5-Diiodotyrosine",Vorapaxar,"3,5-Diiodotyrosine may increase the anticoagulant activities of Vorapaxar.",increase,no risk
"3,5-Diiodotyrosine",Warfarin,"3,5-Diiodotyrosine may increase the anticoagulant activities of Warfarin.",increase,no risk
"3,5-Diiodotyrosine",Ximelagatran,"3,5-Diiodotyrosine may increase the anticoagulant activities of Ximelagatran.",increase,no risk
"3,5-Diiodotyrosine",Zanubrutinib,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Zanubrutinib.",decrease,no risk
"3,5-Diiodotyrosine",Zimelidine,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Zimelidine.",decrease,no risk
Enalkiren,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalkiren is combined with Olmesartan.",increase,risk
Enalkiren,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Enalkiren is combined with Valsartan.",increase,risk
Hemin,Bemiparin,Hemin may increase the anticoagulant activities of Bemiparin.,increase,no risk
Hemin,Betrixaban,Hemin may increase the anticoagulant activities of Betrixaban.,increase,no risk
Hemin,Bivalirudin,Hemin may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Hemin,Heparin,Hemin may increase the anticoagulant activities of Heparin.,increase,no risk
Hemin,Urokinase,Hemin may increase the anticoagulant activities of Urokinase.,increase,no risk
Hemin,Vorapaxar,Hemin may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Hemin,Warfarin,Hemin may increase the anticoagulant activities of Warfarin.,increase,no risk
Hemin,Ximelagatran,Hemin may increase the anticoagulant activities of Ximelagatran.,increase,no risk
4-hydroxycoumarin,Gatifloxacin,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Gatifloxacin.,increase,no risk
4-hydroxycoumarin,Gefitinib,Gefitinib may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Gemcitabine,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Gemcitabine.,increase,no risk
4-hydroxycoumarin,Gemfibrozil,The risk or severity of bleeding can be increased when Gemfibrozil is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Gemifloxacin,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Gemifloxacin.,increase,no risk
4-hydroxycoumarin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Gemtuzumab ozogamicin.,increase,risk
4-hydroxycoumarin,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Glucagon,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Glucagon.,increase,no risk
4-hydroxycoumarin,Glutethimide,The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Glutethimide.,decrease,no risk
4-hydroxycoumarin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Grepafloxacin,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Grepafloxacin.,increase,no risk
4-hydroxycoumarin,Griseofulvin,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Griseofulvin.,increase,no risk
4-hydroxycoumarin,Haloprogin,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Haloprogin.,increase,no risk
4-hydroxycoumarin,Hemin,Hemin may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Hetacillin,Hetacillin may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Hexetidine,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Hexetidine.,increase,no risk
4-hydroxycoumarin,Hydrochlorothiazide,The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
4-hydroxycoumarin,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Hydroflumethiazide,The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
4-hydroxycoumarin,Hydroxyprogesterone caproate,The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
4-hydroxycoumarin,Hydroxyurea,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Hydroxyurea.,increase,risk
4-hydroxycoumarin,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Ketoconazole,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Ketoconazole.,increase,no risk
4-hydroxycoumarin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when 4-hydroxycoumarin is combined with Obeticholic acid.,increase,risk
4-hydroxycoumarin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when 4-hydroxycoumarin is combined with Obinutuzumab.,increase,risk
4-hydroxycoumarin,Ofloxacin,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Ofloxacin.,increase,no risk
4-hydroxycoumarin,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Olaparib,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Olaparib.,increase,risk
4-hydroxycoumarin,Olive oil,The therapeutic efficacy of 4-hydroxycoumarin can be decreased when used in combination with Olive oil.,decrease,no risk
4-hydroxycoumarin,Olsalazine,Olsalazine may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Omacetaxine mepesuccinate.,increase,risk
4-hydroxycoumarin,Omadacycline,Omadacycline may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Omega-3-carboxylic acids,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
4-hydroxycoumarin,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Oritavancin,The risk or severity of bleeding can be increased when Oritavancin is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Oxacillin,Oxacillin may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Oxandrolone,Oxandrolone may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Oxymetholone,Oxymetholone may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of 4-hydroxycoumarin.,increase,no risk
4-hydroxycoumarin,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Quinestrol,Quinestrol may decrease the anticoagulant activities of 4-hydroxycoumarin.,decrease,no risk
4-hydroxycoumarin,Quinidine,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Quinidine.,increase,no risk
4-hydroxycoumarin,Quinine,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Quinine.,increase,no risk
4-hydroxycoumarin,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with 4-hydroxycoumarin.,increase,risk
4-hydroxycoumarin,Quinupristin,The risk or severity of bleeding can be increased when Quinupristin is combined with 4-hydroxycoumarin.,increase,risk
Uracil,Gemcitabine,The serum concentration of Uracil can be increased when it is combined with Gemcitabine.,increase,no risk
Uracil,Gimeracil,The serum concentration of Uracil can be increased when it is combined with Gimeracil.,increase,no risk
Uracil,Warfarin,The risk or severity of bleeding can be increased when Uracil is combined with Warfarin.,increase,risk
Ubenimex,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Ubenimex.,decrease,no risk
Ubenimex,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Benzocaine.,increase,risk
Ubenimex,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Benzyl alcohol.,increase,risk
Ubenimex,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Bupivacaine.,increase,risk
Ubenimex,Butacaine,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Butacaine.,increase,risk
Ubenimex,Butamben,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Butamben.,increase,risk
Ubenimex,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Oxetacaine.,increase,risk
Ubenimex,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ubenimex is combined with Oxybuprocaine.,increase,risk
Ubenimex,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ubenimex.,decrease,no risk
Ubenimex,Warfarin,The risk or severity of bleeding can be increased when Ubenimex is combined with Warfarin.,increase,risk
Cephalothin Group,Gabapentin enacarbil,Cephalothin Group may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gadobenic acid,Cephalothin Group may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gadodiamide,Cephalothin Group may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gadofosveset trisodium,Cephalothin Group may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gadopentetic acid,Cephalothin Group may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gadoteric acid,Cephalothin Group may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gadoteridol,Cephalothin Group may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Ganciclovir,Cephalothin Group may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gemcitabine,Cephalothin Group may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gemfibrozil,Cephalothin Group may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gentamicin,Cephalothin Group may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Gimeracil,Cephalothin Group may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Givosiran,The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Givosiran.,increase,risk
Cephalothin Group,Glipizide,Cephalothin Group may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Glycerol phenylbutyrate,Cephalothin Group may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Golodirsen,Cephalothin Group may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Goserelin,Cephalothin Group may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Guanethidine,Cephalothin Group may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Guanfacine,Cephalothin Group may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Haloperidol,Cephalothin Group may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Hydralazine,Cephalothin Group may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Hydromorphone,Cephalothin Group may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Hydroxocobalamin,Cephalothin Group may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Hydroxyethyl Starch,Cephalothin Group may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Kanamycin,Cephalothin Group may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Ketamine,Cephalothin Group may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Ketazolam,Cephalothin Group may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Octinoxate,Cephalothin Group may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Olsalazine.,increase,risk
Cephalothin Group,Opium,Cephalothin Group may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Oseltamivir,Cephalothin Group may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Oxacillin,Cephalothin Group may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Oxazepam,Cephalothin Group may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Oxybenzone,Cephalothin Group may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cephalothin Group is combined with Oxyphenbutazone.,increase,risk
Cephalothin Group,Oxyquinoline,Cephalothin Group may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Quetiapine,Cephalothin Group may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Quinidine,Cephalothin Group may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Vaborbactam,Cephalothin Group may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Valbenazine,Cephalothin Group may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cephalothin Group.,increase,risk
Cephalothin Group,Valganciclovir,Cephalothin Group may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Vancomycin,Cephalothin Group may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Varenicline,Cephalothin Group may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Venlafaxine,Cephalothin Group may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Verapamil,Cephalothin Group may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Vilanterol,Cephalothin Group may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Viloxazine,Cephalothin Group may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Vortioxetine,Cephalothin Group may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Warfarin,Cephalothin Group may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Zaleplon,Cephalothin Group may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Zanamivir,Cephalothin Group may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cephalothin Group,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalothin Group is combined with Zoledronic acid.,increase,risk
Cephalothin Group,Zonisamide,Cephalothin Group may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Lexacalcitol,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Glatiramer,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Glatiramer.,increase,risk
Lexacalcitol,Golimumab,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Golimumab.,increase,risk
Lexacalcitol,Guselkumab,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Guselkumab.,increase,risk
Lexacalcitol,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Hydrocortisone acetate.,increase,risk
Lexacalcitol,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Hydrocortisone butyrate.,increase,risk
Lexacalcitol,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Hydrocortisone succinate.,increase,risk
Lexacalcitol,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Obinutuzumab,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Obinutuzumab.,increase,risk
Lexacalcitol,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Lexacalcitol.,increase,no risk
Lexacalcitol,Ofatumumab,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Ofatumumab.,increase,risk
Lexacalcitol,Olaparib,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Olaparib.,increase,risk
Lexacalcitol,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Ozanimod,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Ozanimod.,increase,risk
Lexacalcitol,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Upadacitinib,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Upadacitinib.,increase,risk
Lexacalcitol,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Vedolizumab,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Vedolizumab.,increase,risk
Lexacalcitol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Lexacalcitol.,decrease,no risk
Lexacalcitol,Vilanterol,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Vilanterol.,increase,risk
Lexacalcitol,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Voclosporin,The risk or severity of adverse effects can be increased when Lexacalcitol is combined with Voclosporin.,increase,risk
Lexacalcitol,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Lexacalcitol.,increase,risk
Lexacalcitol,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Lexacalcitol.,increase,risk
Sparfosic acid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Benzocaine.,increase,risk
Sparfosic acid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Benzyl alcohol.,increase,risk
Sparfosic acid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Bupivacaine.,increase,risk
Sparfosic acid,Butacaine,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Butacaine.,increase,risk
Sparfosic acid,Butamben,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Butamben.,increase,risk
Sparfosic acid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Oxetacaine.,increase,risk
Sparfosic acid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sparfosic acid is combined with Oxybuprocaine.,increase,risk
Naringenin,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Naringenin.,increase,no risk
Naringenin,Binimetinib,Naringenin may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Naringenin,Brigatinib,Naringenin may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Naringenin,Gefitinib,Naringenin may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Naringenin,Glasdegib,Naringenin may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Naringenin,Glecaprevir,Naringenin may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Naringenin,Glyburide,Naringenin may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Naringenin,Ombitasvir,Naringenin may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Naringenin,Osimertinib,Naringenin may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Naringenin,Oxaliplatin,Naringenin may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Naringenin,Ozanimod,Naringenin may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Naringenin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Naringenin.,increase,no risk
Naringenin,Velpatasvir,Naringenin may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Naringenin,Vemurafenib,Naringenin may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Naringenin,Venetoclax,Naringenin may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Naringenin,Vincristine,Naringenin may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Naringenin,Voxilaprevir,Naringenin may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Naringenin,Zidovudine,Naringenin may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Alvocidib,Ombitasvir,The metabolism of Alvocidib can be decreased when combined with Ombitasvir.,decrease,no risk
Alvocidib,Osimertinib,Osimertinib may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Oteseconazole,The serum concentration of Alvocidib can be increased when it is combined with Oteseconazole.,increase,no risk
Alvocidib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Alvocidib is combined with Oxetacaine.,increase,risk
Alvocidib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Alvocidib is combined with Oxybuprocaine.,increase,risk
Alvocidib,Quizartinib,The metabolism of Alvocidib can be decreased when combined with Quizartinib.,decrease,no risk
Alvocidib,Vadadustat,Vadadustat may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Valproic acid,The metabolism of Alvocidib can be decreased when combined with Valproic acid.,decrease,no risk
Alvocidib,Vandetanib,Vandetanib may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Velpatasvir,Velpatasvir may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Vemurafenib,Vemurafenib may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Venetoclax,Venetoclax may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Venlafaxine,Venlafaxine may increase the excretion rate of Alvocidib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alvocidib,Vismodegib,Vismodegib may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Alvocidib which could result in a higher serum level.,decrease,no risk
Alvocidib,Zidovudine,The metabolism of Alvocidib can be increased when combined with Zidovudine.,increase,no risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Benzocaine.,increase,risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Benzyl alcohol.,increase,risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Bupivacaine.,increase,risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Butacaine,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Butacaine.,increase,risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Butamben,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Butamben.,increase,risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Oxetacaine.,increase,risk
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide is combined with Oxybuprocaine.,increase,risk
Equilenin,Viloxazine,The metabolism of Equilenin can be decreased when combined with Viloxazine.,decrease,no risk
Equilenin,Voriconazole,The metabolism of Equilenin can be decreased when combined with Voriconazole.,decrease,no risk
Equilenin,Zimelidine,The metabolism of Equilenin can be decreased when combined with Zimelidine.,decrease,no risk
Equilenin,Ziprasidone,The metabolism of Equilenin can be decreased when combined with Ziprasidone.,decrease,no risk
Brequinar,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brequinar.,increase,risk
Brequinar,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brequinar.,increase,risk
Brequinar,Glatiramer,The risk or severity of adverse effects can be increased when Brequinar is combined with Glatiramer.,increase,risk
Brequinar,Golimumab,The risk or severity of adverse effects can be increased when Brequinar is combined with Golimumab.,increase,risk
Brequinar,Guselkumab,The risk or severity of adverse effects can be increased when Brequinar is combined with Guselkumab.,increase,risk
Brequinar,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Brequinar.,increase,risk
Brequinar,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Brequinar is combined with Hydrocortisone acetate.,increase,risk
Brequinar,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Brequinar is combined with Hydrocortisone butyrate.,increase,risk
Brequinar,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Brequinar is combined with Hydrocortisone succinate.,increase,risk
Brequinar,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brequinar.,increase,risk
Brequinar,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Brequinar.,increase,risk
Brequinar,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Obinutuzumab,The risk or severity of adverse effects can be increased when Brequinar is combined with Obinutuzumab.,increase,risk
Brequinar,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Brequinar.,increase,no risk
Brequinar,Ofatumumab,The risk or severity of adverse effects can be increased when Brequinar is combined with Ofatumumab.,increase,risk
Brequinar,Olaparib,The risk or severity of adverse effects can be increased when Brequinar is combined with Olaparib.,increase,risk
Brequinar,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Brequinar.,increase,risk
Brequinar,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Brequinar is combined with Oxetacaine.,increase,risk
Brequinar,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Brequinar is combined with Oxybuprocaine.,increase,risk
Brequinar,Ozanimod,The risk or severity of adverse effects can be increased when Brequinar is combined with Ozanimod.,increase,risk
Brequinar,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Brequinar.,increase,risk
Brequinar,Upadacitinib,The risk or severity of adverse effects can be increased when Brequinar is combined with Upadacitinib.,increase,risk
Brequinar,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Brequinar.,increase,risk
Brequinar,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Vedolizumab,The risk or severity of adverse effects can be increased when Brequinar is combined with Vedolizumab.,increase,risk
Brequinar,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Brequinar.,decrease,no risk
Brequinar,Vilanterol,The risk or severity of adverse effects can be increased when Brequinar is combined with Vilanterol.,increase,risk
Brequinar,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Brequinar.,increase,risk
Brequinar,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Brequinar.,increase,risk
Brequinar,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Brequinar.,increase,risk
Brequinar,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Brequinar.,increase,risk
Brequinar,Voclosporin,The risk or severity of adverse effects can be increased when Brequinar is combined with Voclosporin.,increase,risk
Brequinar,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Brequinar.,increase,risk
Brequinar,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Brequinar.,increase,risk
Brequinar,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Brequinar.,increase,risk
Glutaric Acid,Ofloxacin,The excretion of Glutaric Acid can be decreased when combined with Ofloxacin.,decrease,no risk
Glutaric Acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Glutaric Acid.,decrease,no risk
Glutaric Acid,Ouabain,The excretion of Glutaric Acid can be decreased when combined with Ouabain.,decrease,no risk
Glutaric Acid,Oxyphenbutazone,The excretion of Glutaric Acid can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Glutaric Acid,Oxytetracycline,The excretion of Glutaric Acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Glutaric Acid,Quinapril,The excretion of Quinapril can be decreased when combined with Glutaric Acid.,decrease,no risk
Glutaric Acid,Quinidine,The excretion of Glutaric Acid can be decreased when combined with Quinidine.,decrease,no risk
Glutaric Acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Glutaric Acid.,increase,no risk
Glutaric Acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Glutaric Acid.,decrease,no risk
Glutaric Acid,Valproic acid,The excretion of Valproic acid can be decreased when combined with Glutaric Acid.,decrease,no risk
Glutaric Acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Glutaric Acid.,decrease,no risk
Glutaric Acid,Zidovudine,The excretion of Glutaric Acid can be decreased when combined with Zidovudine.,decrease,no risk
Spermidine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Spermidine.,increase,risk
Spermidine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Spermidine.,increase,risk
Spermidine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Spermidine.,increase,risk
Spermidine,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Spermidine.,increase,risk
Spermidine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Spermidine.,increase,risk
Spermidine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Spermidine.,increase,risk
Spermidine,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Spermidine.,increase,risk
Phencyclidine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Phencyclidine.,increase,risk
Phencyclidine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Gabapentin enacarbil.,increase,risk
Phencyclidine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Phencyclidine.,increase,risk
Phencyclidine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Phencyclidine is combined with Ganaxolone.",increase,risk
Phencyclidine,Gepirone,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Gepirone.,increase,risk
Phencyclidine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Phencyclidine.,increase,risk
Phencyclidine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Phencyclidine.,increase,risk
Phencyclidine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Phencyclidine.,increase,risk
Phencyclidine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Phencyclidine.,increase,risk
Phencyclidine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Phencyclidine.,increase,risk
Phencyclidine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Phencyclidine.,increase,risk
Phencyclidine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Phencyclidine.,increase,risk
Phencyclidine,Hydrocodone,Phencyclidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Phencyclidine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Phencyclidine.,increase,risk
Phencyclidine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phencyclidine.,increase,no risk
Phencyclidine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Phencyclidine.,increase,risk
Phencyclidine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Phencyclidine.,increase,risk
Phencyclidine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Phencyclidine.,increase,risk
Phencyclidine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Phencyclidine is combined with Oliceridine.",increase,risk
Phencyclidine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Phencyclidine.,increase,risk
Phencyclidine,Opium,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Opium.,increase,risk
Phencyclidine,Orphenadrine,Phencyclidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Phencyclidine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Phencyclidine.,decrease,no risk
Phencyclidine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Phencyclidine.,decrease,no risk
Phencyclidine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Phencyclidine.,increase,risk
Phencyclidine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Phencyclidine.,increase,risk
Phencyclidine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Phencyclidine.,increase,risk
Phencyclidine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Phencyclidine.,increase,risk
Phencyclidine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Phencyclidine.,increase,risk
Phencyclidine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Phencyclidine.,increase,risk
Phencyclidine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Phencyclidine.,increase,risk
Phencyclidine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Phencyclidine.,increase,risk
Phencyclidine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Phencyclidine.,increase,risk
Phencyclidine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Phencyclidine.,increase,risk
Phencyclidine,Quinupramine,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Quinupramine.,increase,risk
Phencyclidine,Urethane,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Urethane.,increase,risk
Phencyclidine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Phencyclidine.,increase,risk
Phencyclidine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Phencyclidine.,increase,risk
Phencyclidine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Phencyclidine.,decrease,no risk
Phencyclidine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Phencyclidine.,increase,risk
Phencyclidine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Phencyclidine.,increase,risk
Phencyclidine,Vilazodone,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Vilazodone.,increase,risk
Phencyclidine,Viloxazine,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Viloxazine.,increase,risk
Phencyclidine,Vortioxetine,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Vortioxetine.,increase,risk
Phencyclidine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Phencyclidine.,decrease,no risk
Phencyclidine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Phencyclidine.,increase,risk
Phencyclidine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Phencyclidine.,increase,risk
Phencyclidine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Phencyclidine.,decrease,no risk
Phencyclidine,Ziconotide,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Ziconotide.,increase,risk
Phencyclidine,Zimelidine,The risk or severity of adverse effects can be increased when Phencyclidine is combined with Zimelidine.,increase,risk
Phencyclidine,Ziprasidone,The risk or severity of adverse effects can be increased when Phencyclidine is combined with Ziprasidone.,increase,risk
Phencyclidine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Phencyclidine.,increase,risk
Phencyclidine,Zolpidem,Phencyclidine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Phencyclidine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Phencyclidine.,increase,risk
Phencyclidine,Zopiclone,The risk or severity of adverse effects can be increased when Phencyclidine is combined with Zopiclone.,increase,risk
Phencyclidine,Zotepine,The risk or severity of CNS depression can be increased when Phencyclidine is combined with Zotepine.,increase,risk
Phencyclidine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Phencyclidine.,increase,risk
Phencyclidine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Phencyclidine.,increase,risk
Oxyphenbutazone,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Bismuth subgallate,Oxyphenbutazone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Bisoprolol,Oxyphenbutazone may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Oxyphenbutazone,Bisoxatin,Oxyphenbutazone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Bivalirudin.,increase,risk
Oxyphenbutazone,Bleomycin,Oxyphenbutazone may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Brexpiprazole,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Brexpiprazole.,increase,risk
Oxyphenbutazone,Brivaracetam,Oxyphenbutazone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Bromazepam,Oxyphenbutazone may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Bufexamac,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Bufexamac.,increase,risk
Oxyphenbutazone,Bumadizone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Bumadizone.,increase,risk
Oxyphenbutazone,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Bupropion,Oxyphenbutazone may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Butabarbital,Oxyphenbutazone may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Gabapentin enacarbil,Oxyphenbutazone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gadobenic acid,Oxyphenbutazone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gadodiamide,Oxyphenbutazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gadofosveset trisodium,Oxyphenbutazone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gadopentetic acid,Oxyphenbutazone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gadoteric acid,Oxyphenbutazone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gadoteridol,Oxyphenbutazone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Ganciclovir,Oxyphenbutazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gatifloxacin,Oxyphenbutazone may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Oxyphenbutazone,Gemcitabine,Oxyphenbutazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gemfibrozil,Oxyphenbutazone may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gemifloxacin,Oxyphenbutazone may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Oxyphenbutazone,Gentamicin,Oxyphenbutazone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Gimeracil,Oxyphenbutazone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Givosiran,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Givosiran.,increase,risk
Oxyphenbutazone,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Glipizide,The protein binding of Glipizide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Glyburide,The protein binding of Glyburide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Glycerol phenylbutyrate,Oxyphenbutazone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Glycol salicylate,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Glycol salicylate.,increase,risk
Oxyphenbutazone,Golodirsen,Oxyphenbutazone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Goserelin,Oxyphenbutazone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Grepafloxacin,Oxyphenbutazone may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Oxyphenbutazone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Oxyphenbutazone.,increase,no risk
Oxyphenbutazone,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Heparin.,increase,risk
Oxyphenbutazone,Hydralazine,Oxyphenbutazone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Oxyphenbutazone,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Oxyphenbutazone.,increase,risk
Oxyphenbutazone,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Oxyphenbutazone,Hydromorphone,Oxyphenbutazone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Hydroxocobalamin,Oxyphenbutazone may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Oxyphenbutazone,Hydroxyethyl Starch,Oxyphenbutazone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Capric acid,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Capric acid.,increase,no risk
Tiratricol,Gefitinib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Gefitinib.,decrease,no risk
Tiratricol,Gilteritinib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Tiratricol,Gliclazide,Tiratricol may decrease the hypoglycemic activities of Gliclazide.,decrease,no risk
Tiratricol,Glimepiride,Tiratricol may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Tiratricol,Glipizide,Tiratricol may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Tiratricol,Gliquidone,Tiratricol may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Tiratricol,Glyburide,Tiratricol may decrease the hypoglycemic activities of Glyburide.,decrease,no risk
Tiratricol,Glymidine,Tiratricol may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Tiratricol,Olsalazine,The therapeutic efficacy of Tiratricol can be increased when used in combination with Olsalazine.,increase,no risk
Tiratricol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Tiratricol.,increase,risk
Tiratricol,Osimertinib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Osimertinib.,decrease,no risk
Tiratricol,Oxprenolol,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Oxprenolol.,decrease,no risk
Tiratricol,Oxtriphylline,Tiratricol may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tiratricol,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Tiratricol.,increase,risk
Tiratricol,Quinestrol,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Quinestrol.,decrease,no risk
Tiratricol,Quinine,Tiratricol may decrease the hypoglycemic activities of Quinine.,decrease,no risk
Tiratricol,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Tiratricol is combined with Quinupramine.,increase,risk
Tiratricol,Quizartinib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Quizartinib.,decrease,no risk
Tiratricol,Vandetanib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Vandetanib.,decrease,no risk
Tiratricol,Vasopressin,Tiratricol may increase the vasoconstricting activities of Vasopressin.,increase,no risk
Tiratricol,Vemurafenib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Vemurafenib.,decrease,no risk
Tiratricol,Vildagliptin,Tiratricol may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Tiratricol,Warfarin,The risk or severity of bleeding can be increased when Tiratricol is combined with Warfarin.,increase,risk
Tiratricol,Xylometazoline,Tiratricol may increase the vasoconstricting activities of Xylometazoline.,increase,no risk
Tiratricol,Zanubrutinib,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Tiratricol,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Tiratricol.,increase,no risk
Tiratricol,Zimelidine,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Zimelidine.,decrease,no risk
Ribostamycin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gadodiamide,Gadodiamide may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gadoteridol,Gadoteridol may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Ribostamycin.,increase,no risk
Ribostamycin,Ganciclovir,Ganciclovir may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gemcitabine,Gemcitabine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gentamicin,Gentamicin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Gimeracil,Gimeracil may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Givosiran,Givosiran may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Glipizide,Glipizide may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Ribostamycin.,increase,risk
Ribostamycin,Golodirsen,Golodirsen may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Goserelin,Goserelin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Guanethidine,Guanethidine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Guanfacine,Guanfacine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Haloperidol,Haloperidol may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Heparin,The therapeutic efficacy of Ribostamycin can be decreased when used in combination with Heparin.,decrease,no risk
Ribostamycin,Hetacillin,The serum concentration of Ribostamycin can be decreased when it is combined with Hetacillin.,decrease,no risk
Ribostamycin,Hydralazine,Hydralazine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Hydromorphone,Hydromorphone may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Kanamycin,Kanamycin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Ketamine,Ketamine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Ketazolam,Ketazolam may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Ketoprofen,Ketoprofen may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Ketorolac,Ketorolac may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Octinoxate,Octinoxate may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ribostamycin is combined with Olsalazine.,increase,risk
Ribostamycin,Opium,Opium may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oseltamivir,Oseltamivir may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Ouabain,The risk or severity of adverse effects can be increased when Ribostamycin is combined with Ouabain.,increase,risk
Ribostamycin,Oxacillin,Oxacillin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ribostamycin.,increase,risk
Ribostamycin,Oxaprozin,Oxaprozin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oxazepam,Oxazepam may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ribostamycin is combined with Oxetacaine.,increase,risk
Ribostamycin,Oxybenzone,Oxybenzone may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ribostamycin is combined with Oxybuprocaine.,increase,risk
Ribostamycin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Ribostamycin.,increase,risk
Ribostamycin,Quetiapine,Quetiapine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Quinidine,Ribostamycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ribostamycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Ribostamycin.,increase,risk
Ribostamycin,Vaborbactam,Vaborbactam may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Valaciclovir,Valaciclovir may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Valbenazine,Valbenazine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Valdecoxib,Valdecoxib may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Valganciclovir,Valganciclovir may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Vancomycin,Vancomycin may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Varenicline,Varenicline may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Ribostamycin.,increase,no risk
Ribostamycin,Venlafaxine,Venlafaxine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Verapamil,Verapamil may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ribostamycin.,decrease,no risk
Ribostamycin,Vilanterol,Vilanterol may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Viloxazine,Viloxazine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Ribostamycin is combined with Viomycin.,increase,risk
Ribostamycin,Vortioxetine,Vortioxetine may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Warfarin,Ribostamycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Zaleplon,Zaleplon may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Zanamivir,Zanamivir may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Ribostamycin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ribostamycin is combined with Zoledronic acid.,increase,risk
Ribostamycin,Zonisamide,Zonisamide may decrease the excretion rate of Ribostamycin which could result in a higher serum level.,decrease,no risk
Deoxycholic acid,Kaolin,Kaolin can cause a decrease in the absorption of Deoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deoxycholic acid,Ketoconazole,Deoxycholic acid may increase the excretion rate of Ketoconazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deoxycholic acid,Ofloxacin,Deoxycholic acid may increase the excretion rate of Ofloxacin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deoxycholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Deoxycholic acid.,increase,risk
Deoxycholic acid,Ursodeoxycholic acid,Deoxycholic acid may increase the excretion rate of Ursodeoxycholic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deoxycholic acid,Vinblastine,Deoxycholic acid may increase the excretion rate of Vinblastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deoxycholic acid,Vincristine,Deoxycholic acid may increase the excretion rate of Vincristine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deoxycholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Deoxycholic acid.,increase,risk
Deoxycholic acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Deoxycholic acid.,increase,risk
Deoxycholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Deoxycholic acid.,increase,risk
Peramivir,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Peramivir.,decrease,no risk
Peramivir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Peramivir.,decrease,no risk
Piritrexim,Benzocaine,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Benzocaine.,increase,risk
Piritrexim,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Benzyl alcohol.,increase,risk
Piritrexim,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Bupivacaine.,increase,risk
Piritrexim,Butacaine,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Butacaine.,increase,risk
Piritrexim,Butamben,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Butamben.,increase,risk
Piritrexim,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Oxetacaine.,increase,risk
Piritrexim,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Piritrexim is combined with Oxybuprocaine.,increase,risk
Vanoxerine,Verapamil,The metabolism of Vanoxerine can be decreased when combined with Verapamil.,decrease,no risk
Vanoxerine,Viloxazine,The metabolism of Vanoxerine can be decreased when combined with Viloxazine.,decrease,no risk
Vanoxerine,Voriconazole,The metabolism of Vanoxerine can be decreased when combined with Voriconazole.,decrease,no risk
Vanoxerine,Zimelidine,The metabolism of Vanoxerine can be decreased when combined with Zimelidine.,decrease,no risk
Vanoxerine,Ziprasidone,The metabolism of Vanoxerine can be decreased when combined with Ziprasidone.,decrease,no risk
Doconexent,Gemfibrozil,The metabolism of Doconexent can be decreased when combined with Gemfibrozil.,decrease,no risk
Doconexent,Ginkgo biloba,The metabolism of Doconexent can be decreased when combined with Ginkgo biloba.,decrease,no risk
Doconexent,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Glipizide,The metabolism of Glipizide can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Glofitamab,The serum concentration of Doconexent can be increased when it is combined with Glofitamab.,increase,no risk
Doconexent,Glyburide,The metabolism of Doconexent can be decreased when combined with Glyburide.,decrease,no risk
Doconexent,Golimumab,The metabolism of Doconexent can be increased when combined with Golimumab.,increase,no risk
Doconexent,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Halothane,The metabolism of Halothane can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Ketamine,The metabolism of Ketamine can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Olanzapine,The metabolism of Doconexent can be decreased when combined with Olanzapine.,decrease,no risk
Doconexent,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Oritavancin,The metabolism of Doconexent can be decreased when combined with Oritavancin.,decrease,no risk
Doconexent,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Oxandrolone,The metabolism of Doconexent can be decreased when combined with Oxandrolone.,decrease,no risk
Doconexent,Quinidine,The metabolism of Doconexent can be decreased when combined with Quinidine.,decrease,no risk
Doconexent,Quinine,The metabolism of Quinine can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Vadadustat,The metabolism of Doconexent can be decreased when combined with Vadadustat.,decrease,no risk
Doconexent,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Valproic acid,The metabolism of Doconexent can be decreased when combined with Valproic acid.,decrease,no risk
Doconexent,Valsartan,The metabolism of Doconexent can be decreased when combined with Valsartan.,decrease,no risk
Doconexent,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Vemurafenib,The metabolism of Doconexent can be decreased when combined with Vemurafenib.,decrease,no risk
Doconexent,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Warfarin,The metabolism of Warfarin can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Zafirlukast,The metabolism of Doconexent can be decreased when combined with Zafirlukast.,decrease,no risk
Doconexent,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Zileuton,The metabolism of Zileuton can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Doconexent.,decrease,no risk
Doconexent,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Doconexent.,decrease,no risk
Radicicol,Voriconazole,The serum concentration of Radicicol can be increased when it is combined with Voriconazole.,increase,no risk
Radicicol,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Radicicol.,increase,no risk
Lonidamine,Gabapentin,The metabolism of Lonidamine can be increased when combined with Gabapentin.,increase,no risk
Lonidamine,Ganaxolone,The metabolism of Lonidamine can be increased when combined with Ganaxolone.,increase,no risk
Lonidamine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Glycerol phenylbutyrate,The metabolism of Lonidamine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Lonidamine,Griseofulvin,The metabolism of Lonidamine can be increased when combined with Griseofulvin.,increase,no risk
Lonidamine,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Hetacillin,The therapeutic efficacy of Lonidamine can be decreased when used in combination with Hetacillin.,decrease,no risk
Lonidamine,Hydrocortamate,The metabolism of Lonidamine can be increased when combined with Hydrocortamate.,increase,no risk
Lonidamine,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Lonidamine.,increase,no risk
Lonidamine,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Lonidamine.,increase,no risk
Lonidamine,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Lonidamine.,increase,no risk
Lonidamine,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Lonidamine.,increase,no risk
Lonidamine,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Lonidamine.,increase,no risk
Lonidamine,Olutasidenib,The metabolism of Lonidamine can be increased when combined with Olutasidenib.,increase,no risk
Lonidamine,Omadacycline,The serum concentration of Lonidamine can be decreased when it is combined with Omadacycline.,decrease,no risk
Lonidamine,Omaveloxolone,The therapeutic efficacy of Lonidamine can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Lonidamine,Oritavancin,The metabolism of Lonidamine can be increased when combined with Oritavancin.,increase,no risk
Lonidamine,Oxacillin,The therapeutic efficacy of Lonidamine can be decreased when used in combination with Oxacillin.,decrease,no risk
Lonidamine,Oxcarbazepine,The metabolism of Lonidamine can be increased when combined with Oxcarbazepine.,increase,no risk
Lonidamine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lonidamine is combined with Oxetacaine.,increase,risk
Lonidamine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lonidamine is combined with Oxybuprocaine.,increase,risk
Lonidamine,Oxytetracycline,The serum concentration of Lonidamine can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Lonidamine,Quinine,The metabolism of Lonidamine can be increased when combined with Quinine.,increase,no risk
Lonidamine,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Valproic acid,The metabolism of Lonidamine can be increased when combined with Valproic acid.,increase,no risk
Lonidamine,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Lonidamine.,increase,no risk
Lonidamine,Vemurafenib,The metabolism of Lonidamine can be increased when combined with Vemurafenib.,increase,no risk
Lonidamine,Vigabatrin,The metabolism of Lonidamine can be increased when combined with Vigabatrin.,increase,no risk
Lonidamine,Vinblastine,The metabolism of Lonidamine can be increased when combined with Vinblastine.,increase,no risk
Lonidamine,Vitamin E,The metabolism of Lonidamine can be increased when combined with Vitamin E.,increase,no risk
Lonidamine,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Lonidamine.,decrease,no risk
Lonidamine,Zaleplon,The metabolism of Lonidamine can be increased when combined with Zaleplon.,increase,no risk
Lonidamine,Zonisamide,The metabolism of Lonidamine can be increased when combined with Zonisamide.,increase,no risk
Phenacetin,Galantamine,The metabolism of Phenacetin can be decreased when combined with Galantamine.,decrease,no risk
Phenacetin,Gatifloxacin,The metabolism of Phenacetin can be decreased when combined with Gatifloxacin.,decrease,no risk
Phenacetin,Gefitinib,The metabolism of Phenacetin can be decreased when combined with Gefitinib.,decrease,no risk
Phenacetin,Gemfibrozil,The metabolism of Phenacetin can be decreased when combined with Gemfibrozil.,decrease,no risk
Phenacetin,Gemifloxacin,The metabolism of Phenacetin can be decreased when combined with Gemifloxacin.,decrease,no risk
Phenacetin,Ginkgo biloba,The metabolism of Phenacetin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Phenacetin,Givosiran,The serum concentration of Phenacetin can be increased when it is combined with Givosiran.,increase,no risk
Phenacetin,Gliclazide,The metabolism of Phenacetin can be decreased when combined with Gliclazide.,decrease,no risk
Phenacetin,Glimepiride,The metabolism of Phenacetin can be decreased when combined with Glimepiride.,decrease,no risk
Phenacetin,Glipizide,The metabolism of Phenacetin can be decreased when combined with Glipizide.,decrease,no risk
Phenacetin,Gliquidone,The metabolism of Phenacetin can be decreased when combined with Gliquidone.,decrease,no risk
Phenacetin,Glofitamab,The serum concentration of Phenacetin can be increased when it is combined with Glofitamab.,increase,no risk
Phenacetin,Glyburide,The metabolism of Phenacetin can be decreased when combined with Glyburide.,decrease,no risk
Phenacetin,Glycerol phenylbutyrate,The metabolism of Phenacetin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Phenacetin,Golimumab,The metabolism of Phenacetin can be increased when combined with Golimumab.,increase,no risk
Phenacetin,Grepafloxacin,The metabolism of Phenacetin can be decreased when combined with Grepafloxacin.,decrease,no risk
Phenacetin,Guanabenz,The metabolism of Phenacetin can be decreased when combined with Guanabenz.,decrease,no risk
Phenacetin,Halofantrine,The metabolism of Phenacetin can be decreased when combined with Halofantrine.,decrease,no risk
Phenacetin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Phenacetin.,increase,no risk
Phenacetin,Halothane,The metabolism of Phenacetin can be decreased when combined with Halothane.,decrease,no risk
Phenacetin,Hydrocortisone,The metabolism of Phenacetin can be increased when combined with Hydrocortisone.,increase,no risk
Phenacetin,Hydromorphone,The metabolism of Phenacetin can be decreased when combined with Hydromorphone.,decrease,no risk
Phenacetin,Hydroxychloroquine,The metabolism of Phenacetin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Phenacetin,Hydroxyzine,The metabolism of Phenacetin can be decreased when combined with Hydroxyzine.,decrease,no risk
Phenacetin,Ketamine,The metabolism of Phenacetin can be decreased when combined with Ketamine.,decrease,no risk
Phenacetin,Ketoconazole,The metabolism of Phenacetin can be decreased when combined with Ketoconazole.,decrease,no risk
Phenacetin,Ketorolac,The metabolism of Phenacetin can be decreased when combined with Ketorolac.,decrease,no risk
Phenacetin,Obeticholic acid,The metabolism of Phenacetin can be decreased when combined with Obeticholic acid.,decrease,no risk
Phenacetin,Olanzapine,The metabolism of Phenacetin can be decreased when combined with Olanzapine.,decrease,no risk
Phenacetin,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Omaveloxolone,The serum concentration of Phenacetin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Phenacetin,Ondansetron,The metabolism of Phenacetin can be decreased when combined with Ondansetron.,decrease,no risk
Phenacetin,Opium,The metabolism of Opium can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Oritavancin,The metabolism of Phenacetin can be decreased when combined with Oritavancin.,decrease,no risk
Phenacetin,Orphenadrine,The metabolism of Phenacetin can be decreased when combined with Orphenadrine.,decrease,no risk
Phenacetin,Osilodrostat,The metabolism of Phenacetin can be decreased when combined with Osilodrostat.,decrease,no risk
Phenacetin,Osimertinib,The serum concentration of Phenacetin can be decreased when it is combined with Osimertinib.,decrease,no risk
Phenacetin,Ospemifene,The metabolism of Phenacetin can be decreased when combined with Ospemifene.,decrease,no risk
Phenacetin,Oxamniquine,The metabolism of Phenacetin can be decreased when combined with Oxamniquine.,decrease,no risk
Phenacetin,Oxandrolone,The metabolism of Phenacetin can be decreased when combined with Oxandrolone.,decrease,no risk
Phenacetin,Oxprenolol,The metabolism of Phenacetin can be decreased when combined with Oxprenolol.,decrease,no risk
Phenacetin,Oxtriphylline,The metabolism of Phenacetin can be decreased when combined with Oxtriphylline.,decrease,no risk
Phenacetin,Oxybutynin,The metabolism of Phenacetin can be decreased when combined with Oxybutynin.,decrease,no risk
Phenacetin,Oxycodone,The metabolism of Phenacetin can be decreased when combined with Oxycodone.,decrease,no risk
Phenacetin,Oxymorphone,The metabolism of Phenacetin can be decreased when combined with Oxymorphone.,decrease,no risk
Phenacetin,Quetiapine,The metabolism of Phenacetin can be decreased when combined with Quetiapine.,decrease,no risk
Phenacetin,Quinidine,The metabolism of Phenacetin can be decreased when combined with Quinidine.,decrease,no risk
Phenacetin,Quinine,The metabolism of Phenacetin can be decreased when combined with Quinine.,decrease,no risk
Phenacetin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Phenacetin.,increase,no risk
Phenacetin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Valdecoxib,The metabolism of Phenacetin can be decreased when combined with Valdecoxib.,decrease,no risk
Phenacetin,Valproic acid,The metabolism of Phenacetin can be decreased when combined with Valproic acid.,decrease,no risk
Phenacetin,Valsartan,The metabolism of Phenacetin can be decreased when combined with Valsartan.,decrease,no risk
Phenacetin,Vardenafil,The metabolism of Phenacetin can be decreased when combined with Vardenafil.,decrease,no risk
Phenacetin,Vemurafenib,The serum concentration of Phenacetin can be increased when it is combined with Vemurafenib.,increase,no risk
Phenacetin,Venetoclax,The metabolism of Phenacetin can be decreased when combined with Venetoclax.,decrease,no risk
Phenacetin,Venlafaxine,The metabolism of Phenacetin can be decreased when combined with Venlafaxine.,decrease,no risk
Phenacetin,Verapamil,The metabolism of Phenacetin can be decreased when combined with Verapamil.,decrease,no risk
Phenacetin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Vilazodone,The metabolism of Phenacetin can be decreased when combined with Vilazodone.,decrease,no risk
Phenacetin,Viloxazine,The metabolism of Phenacetin can be decreased when combined with Viloxazine.,decrease,no risk
Phenacetin,Vinblastine,The metabolism of Phenacetin can be decreased when combined with Vinblastine.,decrease,no risk
Phenacetin,Vinorelbine,The metabolism of Phenacetin can be decreased when combined with Vinorelbine.,decrease,no risk
Phenacetin,Voriconazole,The metabolism of Phenacetin can be decreased when combined with Voriconazole.,decrease,no risk
Phenacetin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Warfarin,The metabolism of Phenacetin can be decreased when combined with Warfarin.,decrease,no risk
Phenacetin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Yohimbine,The metabolism of Phenacetin can be decreased when combined with Yohimbine.,decrease,no risk
Phenacetin,Zafirlukast,The metabolism of Phenacetin can be decreased when combined with Zafirlukast.,decrease,no risk
Phenacetin,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Zidovudine,The metabolism of Phenacetin can be decreased when combined with Zidovudine.,decrease,no risk
Phenacetin,Zileuton,The metabolism of Phenacetin can be decreased when combined with Zileuton.,decrease,no risk
Phenacetin,Zimelidine,The metabolism of Phenacetin can be decreased when combined with Zimelidine.,decrease,no risk
Phenacetin,Ziprasidone,The metabolism of Phenacetin can be decreased when combined with Ziprasidone.,decrease,no risk
Phenacetin,Zolmitriptan,The metabolism of Phenacetin can be decreased when combined with Zolmitriptan.,decrease,no risk
Phenacetin,Zolpidem,The metabolism of Phenacetin can be decreased when combined with Zolpidem.,decrease,no risk
Phenacetin,Zopiclone,The metabolism of Phenacetin can be decreased when combined with Zopiclone.,decrease,no risk
Phenacetin,Zotepine,The metabolism of Zotepine can be decreased when combined with Phenacetin.,decrease,no risk
Phenacetin,Zuclopenthixol,The metabolism of Phenacetin can be decreased when combined with Zuclopenthixol.,decrease,no risk
Febuxostat,Quizartinib,The metabolism of Febuxostat can be decreased when combined with Quizartinib.,decrease,no risk
Febuxostat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Febuxostat.,increase,no risk
Febuxostat,Valproic acid,The metabolism of Febuxostat can be decreased when combined with Valproic acid.,decrease,no risk
Febuxostat,Velpatasvir,The excretion of Velpatasvir can be decreased when combined with Febuxostat.,decrease,no risk
Febuxostat,Vemurafenib,The excretion of Vemurafenib can be decreased when combined with Febuxostat.,decrease,no risk
Febuxostat,Venetoclax,The excretion of Venetoclax can be decreased when combined with Febuxostat.,decrease,no risk
Febuxostat,Verteporfin,Febuxostat may increase the photosensitizing activities of Verteporfin.,increase,no risk
Febuxostat,Vincristine,The excretion of Vincristine can be decreased when combined with Febuxostat.,decrease,no risk
Febuxostat,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Febuxostat.,decrease,no risk
Febuxostat,Zidovudine,The excretion of Zidovudine can be decreased when combined with Febuxostat.,decrease,no risk
Benzoic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Benzoic acid.,increase,no risk
Benzoic acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Benzoic acid.,decrease,no risk
Benzoic acid,Valproic acid,The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Valproic acid.,decrease,no risk
Benzoic acid,Vamorolone,The therapeutic efficacy of Benzoic acid can be decreased when used in combination with Vamorolone.,decrease,no risk
Benzoic acid,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Benzoic acid.,increase,no risk
Benzoic acid,Zidovudine,The excretion of Zidovudine can be decreased when combined with Benzoic acid.,decrease,no risk
Teriflunomide,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Teriflunomide.,increase,risk
Teriflunomide,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Teriflunomide.,increase,risk
Teriflunomide,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Teriflunomide.,increase,no risk
Teriflunomide,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Teriflunomide.,increase,risk
Teriflunomide,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Teriflunomide.,increase,risk
Teriflunomide,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Teriflunomide.,increase,risk
Teriflunomide,Belantamab mafodotin,The excretion of Belantamab mafodotin can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Teriflunomide.,increase,risk
Teriflunomide,Belimumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Teriflunomide.,increase,risk
Teriflunomide,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Teriflunomide.,increase,risk
Teriflunomide,Belumosudil,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Belumosudil.,increase,risk
Teriflunomide,Bendamustine,The serum concentration of Bendamustine can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Benzocaine,The serum concentration of Benzocaine can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Benzyl alcohol,The serum concentration of Benzyl alcohol can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Teriflunomide.,increase,no risk
Teriflunomide,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Teriflunomide.,increase,risk
Teriflunomide,Betaxolol,The serum concentration of Betaxolol can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Teriflunomide.,increase,risk
Teriflunomide,Bimekizumab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Bimekizumab.,increase,risk
Teriflunomide,Binimetinib,The serum concentration of Binimetinib can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Teriflunomide.,increase,risk
Teriflunomide,Blinatumomab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Blinatumomab.,increase,risk
Teriflunomide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Teriflunomide.",decrease,no risk
Teriflunomide,Bortezomib,The serum concentration of Bortezomib can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Bosentan,The excretion of Bosentan can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Bosutinib,The risk or severity of adverse effects can be increased when Bosutinib is combined with Teriflunomide.,increase,risk
Teriflunomide,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Teriflunomide.,increase,risk
Teriflunomide,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Teriflunomide.,increase,no risk
Teriflunomide,Brodalumab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Brodalumab.,increase,risk
Teriflunomide,Bromazepam,The serum concentration of Bromazepam can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Teriflunomide.,increase,risk
Teriflunomide,Bumetanide,The excretion of Bumetanide can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Teriflunomide.,increase,risk
Teriflunomide,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Gefitinib,Gefitinib may decrease the excretion rate of Teriflunomide which could result in a higher serum level.,decrease,no risk
Teriflunomide,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Teriflunomide.,increase,risk
Teriflunomide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Teriflunomide.,increase,risk
Teriflunomide,Gilteritinib,Gilteritinib may decrease the excretion rate of Teriflunomide which could result in a higher serum level.,decrease,no risk
Teriflunomide,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Teriflunomide.,increase,risk
Teriflunomide,Glecaprevir,Teriflunomide may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Teriflunomide,Glyburide,Teriflunomide may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Teriflunomide,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Teriflunomide.,increase,risk
Teriflunomide,Grazoprevir,Grazoprevir may decrease the excretion rate of Teriflunomide which could result in a higher serum level.,decrease,no risk
Teriflunomide,Grepafloxacin,The serum concentration of Grepafloxacin can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Guanabenz,The serum concentration of Guanabenz can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Guselkumab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Guselkumab.,increase,risk
Teriflunomide,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Haloperidol,The serum concentration of Haloperidol can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Teriflunomide.,increase,risk
Teriflunomide,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Hydrocortisone acetate.,increase,risk
Teriflunomide,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Hydrocortisone butyrate.,increase,risk
Teriflunomide,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Hydrocortisone succinate.,increase,risk
Teriflunomide,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Teriflunomide.,increase,risk
Teriflunomide,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Teriflunomide.,increase,risk
Teriflunomide,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Ketamine,The metabolism of Ketamine can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Obinutuzumab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Obinutuzumab.,increase,risk
Teriflunomide,Ocrelizumab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Ocrelizumab.,increase,risk
Teriflunomide,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Teriflunomide.,increase,risk
Teriflunomide,Olanzapine,The serum concentration of Olanzapine can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Olaparib,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Olaparib.,increase,risk
Teriflunomide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Ondansetron,The serum concentration of Ondansetron can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Osimertinib,Teriflunomide may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Teriflunomide,Oteseconazole,The serum concentration of Teriflunomide can be increased when it is combined with Oteseconazole.,increase,no risk
Teriflunomide,Ouabain,The excretion of Ouabain can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Teriflunomide.,increase,risk
Teriflunomide,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Ozanimod,Teriflunomide may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Teriflunomide,Quinapril,The excretion of Quinapril can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Quinine,The serum concentration of Quinine can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Teriflunomide.,increase,risk
Teriflunomide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Teriflunomide.,increase,no risk
Teriflunomide,Upadacitinib,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Upadacitinib.,increase,risk
Teriflunomide,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Teriflunomide.,increase,no risk
Teriflunomide,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Valproic acid,The excretion of Valproic acid can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Valsartan,The excretion of Valsartan can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Vandetanib,Vandetanib may decrease the excretion rate of Teriflunomide which could result in a higher serum level.,decrease,no risk
Teriflunomide,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Teriflunomide.,increase,risk
Teriflunomide,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Vedolizumab,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Vedolizumab.,increase,risk
Teriflunomide,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Vemurafenib,Teriflunomide may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Teriflunomide,Venetoclax,Teriflunomide may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Teriflunomide,Venlafaxine,Venlafaxine may increase the excretion rate of Teriflunomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Teriflunomide,Verapamil,The serum concentration of Verapamil can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Vilanterol,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Vilanterol.,increase,risk
Teriflunomide,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Teriflunomide.,increase,risk
Teriflunomide,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Teriflunomide.,increase,risk
Teriflunomide,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Teriflunomide.,increase,risk
Teriflunomide,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Teriflunomide.,increase,risk
Teriflunomide,Vismodegib,Vismodegib may decrease the excretion rate of Teriflunomide which could result in a higher serum level.,decrease,no risk
Teriflunomide,Voclosporin,The risk or severity of adverse effects can be increased when Teriflunomide is combined with Voclosporin.,increase,risk
Teriflunomide,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Teriflunomide.,increase,risk
Teriflunomide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Voxilaprevir,The serum concentration of Voxilaprevir can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Teriflunomide.,decrease,no risk
Teriflunomide,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Teriflunomide.,increase,risk
Teriflunomide,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Teriflunomide.,increase,risk
Teriflunomide,Zileuton,The serum concentration of Zileuton can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Zolmitriptan,The serum concentration of Zolmitriptan can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Zolpidem,The serum concentration of Zolpidem can be decreased when it is combined with Teriflunomide.,decrease,no risk
Teriflunomide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Teriflunomide.,decrease,no risk
Teriflunomide,Zotepine,The serum concentration of Zotepine can be decreased when it is combined with Teriflunomide.,decrease,no risk
Salicylhydroxamic Acid,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Salicylhydroxamic Acid.,increase,no risk
Rhodamine 6G,Benzocaine,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Benzocaine.,increase,risk
Rhodamine 6G,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Benzyl alcohol.,increase,risk
Rhodamine 6G,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Bupivacaine.,increase,risk
Rhodamine 6G,Butacaine,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Butacaine.,increase,risk
Rhodamine 6G,Butamben,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Butamben.,increase,risk
Rhodamine 6G,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Oxetacaine.,increase,risk
Rhodamine 6G,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rhodamine 6G is combined with Oxybuprocaine.,increase,risk
Prostaglandin G2,Balsalazide,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Balsalazide.,decrease,no risk
Prostaglandin G2,Benorilate,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Benorilate.,decrease,no risk
Prostaglandin G2,Benoxaprofen,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Prostaglandin G2,Benzydamine,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Benzydamine.,decrease,no risk
Prostaglandin G2,Bumadizone,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Bumadizone.,decrease,no risk
Prostaglandin G2,Glycol salicylate,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Prostaglandin G2,Ketoprofen,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Ketoprofen.,decrease,no risk
Prostaglandin G2,Ketorolac,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Ketorolac.,decrease,no risk
Prostaglandin G2,Oxaprozin,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Oxaprozin.,decrease,no risk
Prostaglandin G2,Oxyphenbutazone,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Prostaglandin G2,Valdecoxib,The therapeutic efficacy of Prostaglandin G2 can be decreased when used in combination with Valdecoxib.,decrease,no risk
Batimastat,Benzocaine,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Benzocaine.,increase,risk
Batimastat,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Benzyl alcohol.,increase,risk
Batimastat,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Bupivacaine.,increase,risk
Batimastat,Butacaine,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Butacaine.,increase,risk
Batimastat,Butamben,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Butamben.,increase,risk
Batimastat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Oxetacaine.,increase,risk
Batimastat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Batimastat is combined with Oxybuprocaine.,increase,risk
Fenretinide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Benzocaine.,increase,risk
Fenretinide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Benzyl alcohol.,increase,risk
Fenretinide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Bupivacaine.,increase,risk
Fenretinide,Butacaine,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Butacaine.,increase,risk
Fenretinide,Butamben,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Butamben.,increase,risk
Fenretinide,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Fenretinide.,decrease,no risk
Fenretinide,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Fenretinide.,decrease,no risk
Fenretinide,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Fenretinide is combined with Omadacycline.,increase,risk
Fenretinide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Oxetacaine.,increase,risk
Fenretinide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fenretinide is combined with Oxybuprocaine.,increase,risk
Fenretinide,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Fenretinide is combined with Oxytetracycline.,increase,risk
Fenretinide,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Fenretinide.,increase,no risk
Fenretinide,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Fenretinide.,increase,risk
Deacetoxycephalosporin C,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Deacetoxycephalosporin C.,increase,risk
Deacetoxycephalosporin C,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Deacetoxycephalosporin C.,increase,risk
Deacetoxycephalosporin C,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
Deacetoxycephalosporin C,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Deacetoxycephalosporin C.,decrease,no risk
"3,4-Dihydroxybenzoic Acid",Benzocaine,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Benzocaine.",increase,risk
"3,4-Dihydroxybenzoic Acid",Benzyl alcohol,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Benzyl alcohol.",increase,risk
"3,4-Dihydroxybenzoic Acid",Bupivacaine,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Bupivacaine.",increase,risk
"3,4-Dihydroxybenzoic Acid",Butacaine,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Butacaine.",increase,risk
"3,4-Dihydroxybenzoic Acid",Butamben,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Butamben.",increase,risk
"3,4-Dihydroxybenzoic Acid",Oxetacaine,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Oxetacaine.",increase,risk
"3,4-Dihydroxybenzoic Acid",Oxybuprocaine,"The risk or severity of methemoglobinemia can be increased when 3,4-Dihydroxybenzoic Acid is combined with Oxybuprocaine.",increase,risk
Clorobiocin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Clorobiocin.,increase,no risk
Clorobiocin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Clorobiocin.,increase,no risk
Clorobiocin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Clorobiocin.,increase,no risk
Clorobiocin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Clorobiocin.,increase,no risk
Clorobiocin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Clorobiocin.,increase,no risk
Clorgiline,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Clorgiline.,increase,risk
Clorgiline,Bumadizone,The risk or severity of hypertension can be increased when Clorgiline is combined with Bumadizone.,increase,risk
Clorgiline,Bumetanide,Clorgiline may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Clorgiline,Bupivacaine,Clorgiline may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Clorgiline,Buprenorphine,Clorgiline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Clorgiline,Bupropion,The risk or severity of adverse effects can be increased when Clorgiline is combined with Bupropion.,increase,risk
Clorgiline,Buspirone,The risk or severity of hypertension can be increased when Clorgiline is combined with Buspirone.,increase,risk
Clorgiline,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Clorgiline.,increase,risk
Clorgiline,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Clorgiline.,increase,risk
Clorgiline,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Clorgiline is combined with Butaperazine.,increase,risk
Clorgiline,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Clorgiline.,increase,risk
Clorgiline,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Clorgiline.,increase,risk
Clorgiline,Butriptyline,Clorgiline may increase the serotonergic activities of Butriptyline.,increase,no risk
Clorgiline,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Clorgiline.,increase,risk
Clorgiline,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Clorgiline is combined with Gabapentin enacarbil.,increase,risk
Clorgiline,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Clorgiline.,increase,risk
Clorgiline,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clorgiline is combined with Ganaxolone.",increase,risk
Clorgiline,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Clorgiline.,increase,risk
Clorgiline,Gliclazide,Clorgiline may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Clorgiline,Glimepiride,Clorgiline may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Clorgiline,Glipizide,Clorgiline may increase the hypoglycemic activities of Glipizide.,increase,no risk
Clorgiline,Gliquidone,Clorgiline may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Clorgiline,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Clorgiline.,increase,risk
Clorgiline,Glyburide,Clorgiline may increase the hypoglycemic activities of Glyburide.,increase,no risk
Clorgiline,Glymidine,Clorgiline may increase the hypoglycemic activities of Glymidine.,increase,no risk
Clorgiline,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Clorgiline.,increase,risk
Clorgiline,Guanabenz,Clorgiline may increase the hypotensive activities of Guanabenz.,increase,no risk
Clorgiline,Guanadrel,Clorgiline may increase the hypotensive activities of Guanadrel.,increase,no risk
Clorgiline,Guanethidine,Clorgiline may increase the hypotensive activities of Guanethidine.,increase,no risk
Clorgiline,Guanfacine,Clorgiline may increase the hypotensive activities of Guanfacine.,increase,no risk
Clorgiline,Guanoxan,Clorgiline may increase the hypotensive activities of Guanoxan.,increase,no risk
Clorgiline,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Clorgiline.,increase,risk
Clorgiline,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Clorgiline.,increase,risk
Clorgiline,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Clorgiline.,increase,risk
Clorgiline,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Heparin.,increase,risk
Clorgiline,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Clorgiline.,increase,risk
Clorgiline,Hydralazine,Clorgiline may increase the hypotensive activities of Hydralazine.,increase,no risk
Clorgiline,Hydrochlorothiazide,Clorgiline may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Clorgiline,Hydrocodone,Clorgiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Clorgiline,Hydroflumethiazide,Clorgiline may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Clorgiline,Hydromorphone,Clorgiline may increase the serotonergic activities of Hydromorphone.,increase,no risk
Clorgiline,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clorgiline.,increase,no risk
Clorgiline,Hyoscyamine,Clorgiline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Clorgiline,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Clorgiline.,increase,risk
Clorgiline,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Clorgiline.,increase,risk
Clorgiline,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Clorgiline.,increase,risk
Clorgiline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Clorgiline.,increase,risk
Clorgiline,Obinutuzumab,Clorgiline may increase the orthostatic hypotensive activities of Obinutuzumab.,increase,no risk
Clorgiline,Olanzapine,Clorgiline may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Clorgiline,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Clorgiline is combined with Oliceridine.",increase,risk
Clorgiline,Olmesartan,Clorgiline may increase the hypotensive activities of Olmesartan.,increase,no risk
Clorgiline,Olodaterol,The risk or severity of hypertension can be increased when Clorgiline is combined with Olodaterol.,increase,risk
Clorgiline,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Clorgiline.,increase,risk
Clorgiline,Opicapone,Clorgiline may increase the orthostatic hypotensive activities of Opicapone.,increase,no risk
Clorgiline,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Clorgiline.,increase,risk
Clorgiline,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Clorgiline.,increase,risk
Clorgiline,Orphenadrine,Clorgiline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Clorgiline,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Clorgiline.,increase,risk
Clorgiline,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Clorgiline.,increase,risk
Clorgiline,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Clorgiline.,increase,risk
Clorgiline,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Clorgiline.,increase,risk
Clorgiline,Oxprenolol,Clorgiline may increase the hypotensive activities of Oxprenolol.,increase,no risk
Clorgiline,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Clorgiline.,increase,risk
Clorgiline,Oxycodone,Clorgiline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Clorgiline,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Clorgiline.,increase,no risk
Clorgiline,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Clorgiline.,increase,risk
Clorgiline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Clorgiline.,increase,risk
Clorgiline,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Clorgiline.,increase,risk
Clorgiline,Quetiapine,Clorgiline may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Clorgiline,Quinapril,Clorgiline may increase the hypotensive activities of Quinapril.,increase,no risk
Clorgiline,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Clorgiline.,increase,risk
Clorgiline,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Clorgiline.,increase,risk
Clorgiline,Quinupramine,Clorgiline may increase the serotonergic activities of Quinupramine.,increase,no risk
Clorgiline,Urethane,The risk or severity of CNS depression can be increased when Clorgiline is combined with Urethane.,increase,risk
Clorgiline,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Urokinase.,increase,risk
Clorgiline,Valbenazine,The risk or severity of adverse effects can be increased when Clorgiline is combined with Valbenazine.,increase,risk
Clorgiline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Clorgiline.,increase,risk
Clorgiline,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Clorgiline is combined with Valproate bismuth.,increase,risk
Clorgiline,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Clorgiline.,increase,risk
Clorgiline,Valsartan,Clorgiline may increase the hypotensive activities of Valsartan.,increase,no risk
Clorgiline,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Clorgiline.,increase,risk
Clorgiline,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Clorgiline is combined with Venlafaxine.,increase,risk
Clorgiline,Verapamil,Clorgiline may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Clorgiline,Vericiguat,Clorgiline may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Clorgiline,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Clorgiline.,increase,risk
Clorgiline,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Clorgiline is combined with Vilanterol.,increase,risk
Clorgiline,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Clorgiline.,decrease,no risk
Clorgiline,Vildagliptin,Clorgiline may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Clorgiline,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Clorgiline.,increase,risk
Clorgiline,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Vorapaxar.,increase,risk
Clorgiline,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Clorgiline.,decrease,no risk
Clorgiline,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Warfarin.,increase,risk
Clorgiline,Xamoterol,The risk or severity of hypertension can be increased when Clorgiline is combined with Xamoterol.,increase,risk
Clorgiline,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Ximelagatran.,increase,risk
Clorgiline,Xylometazoline,Clorgiline may increase the hypertensive activities of Xylometazoline.,increase,no risk
Clorgiline,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Clorgiline.,increase,risk
Clorgiline,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Clorgiline.,increase,risk
Clorgiline,Ziconotide,The risk or severity of CNS depression can be increased when Clorgiline is combined with Ziconotide.,increase,risk
Clorgiline,Zimelidine,Clorgiline may increase the serotonergic activities of Zimelidine.,increase,no risk
Clorgiline,Ziprasidone,The risk or severity of adverse effects can be increased when Clorgiline is combined with Ziprasidone.,increase,risk
Clorgiline,Zofenopril,Clorgiline may increase the hypotensive activities of Zofenopril.,increase,no risk
Clorgiline,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Clorgiline is combined with Zolmitriptan.,increase,risk
Clorgiline,Zolpidem,Clorgiline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Clorgiline,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Clorgiline.,increase,risk
Clorgiline,Zopiclone,The risk or severity of adverse effects can be increased when Clorgiline is combined with Zopiclone.,increase,risk
Clorgiline,Zotepine,The risk or severity of CNS depression can be increased when Clorgiline is combined with Zotepine.,increase,risk
Clorgiline,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Clorgiline.,increase,risk
Clorgiline,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Clorgiline.,increase,risk
p-Coumaric acid,Gabapentin,The metabolism of p-Coumaric acid can be increased when combined with Gabapentin.,increase,no risk
p-Coumaric acid,Ganaxolone,The metabolism of p-Coumaric acid can be increased when combined with Ganaxolone.,increase,no risk
p-Coumaric acid,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Glycerol phenylbutyrate,The metabolism of p-Coumaric acid can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
p-Coumaric acid,Griseofulvin,The metabolism of p-Coumaric acid can be increased when combined with Griseofulvin.,increase,no risk
p-Coumaric acid,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Hetacillin,The therapeutic efficacy of p-Coumaric acid can be decreased when used in combination with Hetacillin.,decrease,no risk
p-Coumaric acid,Hydrocortamate,The metabolism of p-Coumaric acid can be increased when combined with Hydrocortamate.,increase,no risk
p-Coumaric acid,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with p-Coumaric acid.,increase,no risk
p-Coumaric acid,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with p-Coumaric acid.,increase,no risk
p-Coumaric acid,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with p-Coumaric acid.,increase,no risk
p-Coumaric acid,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with p-Coumaric acid.,increase,no risk
p-Coumaric acid,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with p-Coumaric acid.,increase,no risk
p-Coumaric acid,Olutasidenib,The metabolism of p-Coumaric acid can be increased when combined with Olutasidenib.,increase,no risk
p-Coumaric acid,Omadacycline,The serum concentration of p-Coumaric acid can be decreased when it is combined with Omadacycline.,decrease,no risk
p-Coumaric acid,Omaveloxolone,The therapeutic efficacy of p-Coumaric acid can be decreased when used in combination with Omaveloxolone.,decrease,no risk
p-Coumaric acid,Oritavancin,The metabolism of p-Coumaric acid can be increased when combined with Oritavancin.,increase,no risk
p-Coumaric acid,Oxacillin,The therapeutic efficacy of p-Coumaric acid can be decreased when used in combination with Oxacillin.,decrease,no risk
p-Coumaric acid,Oxcarbazepine,The metabolism of p-Coumaric acid can be increased when combined with Oxcarbazepine.,increase,no risk
p-Coumaric acid,Oxytetracycline,The serum concentration of p-Coumaric acid can be decreased when it is combined with Oxytetracycline.,decrease,no risk
p-Coumaric acid,Quinine,The metabolism of p-Coumaric acid can be increased when combined with Quinine.,increase,no risk
p-Coumaric acid,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Valproic acid,The metabolism of p-Coumaric acid can be increased when combined with Valproic acid.,increase,no risk
p-Coumaric acid,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with p-Coumaric acid.,increase,no risk
p-Coumaric acid,Vemurafenib,The metabolism of p-Coumaric acid can be increased when combined with Vemurafenib.,increase,no risk
p-Coumaric acid,Vigabatrin,The metabolism of p-Coumaric acid can be increased when combined with Vigabatrin.,increase,no risk
p-Coumaric acid,Vinblastine,The metabolism of p-Coumaric acid can be increased when combined with Vinblastine.,increase,no risk
p-Coumaric acid,Vitamin E,The metabolism of p-Coumaric acid can be increased when combined with Vitamin E.,increase,no risk
p-Coumaric acid,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with p-Coumaric acid.,decrease,no risk
p-Coumaric acid,Zaleplon,The metabolism of p-Coumaric acid can be increased when combined with Zaleplon.,increase,no risk
p-Coumaric acid,Zonisamide,The metabolism of p-Coumaric acid can be increased when combined with Zonisamide.,increase,no risk
6-Deoxyerythronolide B,Gepirone,The serum concentration of Gepirone can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Olaparib,The serum concentration of Olaparib can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Ouabain,The serum concentration of Ouabain can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 6-Deoxyerythronolide B is combined with Oxetacaine.,increase,risk
6-Deoxyerythronolide B,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 6-Deoxyerythronolide B is combined with Oxybuprocaine.,increase,risk
6-Deoxyerythronolide B,Quinidine,The serum concentration of Quinidine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Quinine,The serum concentration of Quinine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vardenafil,The metabolism of Vardenafil can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vincristine,The serum concentration of Vincristine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vindesine,The serum concentration of Vindesine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Warfarin,The serum concentration of Warfarin can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with 6-Deoxyerythronolide B.,increase,no risk
6-Deoxyerythronolide B,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Zopiclone,The metabolism of Zopiclone can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
6-Deoxyerythronolide B,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with 6-Deoxyerythronolide B.,decrease,no risk
Hypoxanthine,Gabapentin,Gabapentin may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Ganaxolone,Ganaxolone may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Gatifloxacin,The metabolism of Hypoxanthine can be decreased when combined with Gatifloxacin.,decrease,no risk
Hypoxanthine,Gemfibrozil,The metabolism of Hypoxanthine can be decreased when combined with Gemfibrozil.,decrease,no risk
Hypoxanthine,Gemifloxacin,The metabolism of Hypoxanthine can be decreased when combined with Gemifloxacin.,decrease,no risk
Hypoxanthine,Givosiran,The serum concentration of Hypoxanthine can be increased when it is combined with Givosiran.,increase,no risk
Hypoxanthine,Glofitamab,The serum concentration of Hypoxanthine can be increased when it is combined with Glofitamab.,increase,no risk
Hypoxanthine,Golimumab,The metabolism of Hypoxanthine can be increased when combined with Golimumab.,increase,no risk
Hypoxanthine,Grepafloxacin,The metabolism of Hypoxanthine can be decreased when combined with Grepafloxacin.,decrease,no risk
Hypoxanthine,Guanabenz,The metabolism of Hypoxanthine can be decreased when combined with Guanabenz.,decrease,no risk
Hypoxanthine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Hypoxanthine.,decrease,no risk
Hypoxanthine,Haloperidol,The metabolism of Hypoxanthine can be decreased when combined with Haloperidol.,decrease,no risk
Hypoxanthine,Human interferon beta,The metabolism of Hypoxanthine can be decreased when combined with Human interferon beta.,decrease,no risk
Hypoxanthine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Hypoxanthine.,increase,risk
Hypoxanthine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with Hypoxanthine.,decrease,no risk
Hypoxanthine,Ketoconazole,The metabolism of Hypoxanthine can be decreased when combined with Ketoconazole.,decrease,no risk
Hypoxanthine,Obeticholic acid,The metabolism of Hypoxanthine can be decreased when combined with Obeticholic acid.,decrease,no risk
Hypoxanthine,Ofloxacin,The metabolism of Hypoxanthine can be decreased when combined with Ofloxacin.,decrease,no risk
Hypoxanthine,Olanzapine,The metabolism of Hypoxanthine can be decreased when combined with Olanzapine.,decrease,no risk
Hypoxanthine,Olodaterol,Hypoxanthine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Hypoxanthine,Ondansetron,The metabolism of Hypoxanthine can be decreased when combined with Ondansetron.,decrease,no risk
Hypoxanthine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Hypoxanthine.,increase,risk
Hypoxanthine,Orphenadrine,The metabolism of Hypoxanthine can be decreased when combined with Orphenadrine.,decrease,no risk
Hypoxanthine,Osilodrostat,The metabolism of Hypoxanthine can be decreased when combined with Osilodrostat.,decrease,no risk
Hypoxanthine,Osimertinib,The serum concentration of Hypoxanthine can be decreased when it is combined with Osimertinib.,decrease,no risk
Hypoxanthine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Hypoxanthine.,decrease,no risk
Hypoxanthine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Hypoxanthine.,increase,risk
Hypoxanthine,Oxtriphylline,The metabolism of Hypoxanthine can be decreased when combined with Oxtriphylline.,decrease,no risk
Hypoxanthine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Hypoxanthine.,increase,risk
Hypoxanthine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Hypoxanthine.,decrease,no risk
Hypoxanthine,Quinidine,The serum concentration of Hypoxanthine can be increased when it is combined with Quinidine.,increase,no risk
Hypoxanthine,Quinine,The serum concentration of Hypoxanthine can be increased when it is combined with Quinine.,increase,no risk
Hypoxanthine,Valproic acid,Valproic acid may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Vemurafenib,The serum concentration of Hypoxanthine can be increased when it is combined with Vemurafenib.,increase,no risk
Hypoxanthine,Verapamil,The metabolism of Hypoxanthine can be decreased when combined with Verapamil.,decrease,no risk
Hypoxanthine,Vigabatrin,Vigabatrin may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Vilanterol,The risk or severity of hypokalemia can be increased when Hypoxanthine is combined with Vilanterol.,increase,risk
Hypoxanthine,Viloxazine,The metabolism of Hypoxanthine can be decreased when combined with Viloxazine.,decrease,no risk
Hypoxanthine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Hypoxanthine.,decrease,no risk
Hypoxanthine,Warfarin,The metabolism of Hypoxanthine can be decreased when combined with Warfarin.,decrease,no risk
Hypoxanthine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Hypoxanthine.,decrease,no risk
Hypoxanthine,Zaleplon,Zaleplon may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Zileuton,The metabolism of Hypoxanthine can be decreased when combined with Zileuton.,decrease,no risk
Hypoxanthine,Zolmitriptan,The metabolism of Hypoxanthine can be decreased when combined with Zolmitriptan.,decrease,no risk
Hypoxanthine,Zolpidem,The metabolism of Hypoxanthine can be decreased when combined with Zolpidem.,decrease,no risk
Hypoxanthine,Zonisamide,Zonisamide may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Hypoxanthine,Zotepine,The metabolism of Zotepine can be decreased when combined with Hypoxanthine.,decrease,no risk
Glycerin,Gallamine triethiodide,The therapeutic efficacy of Glycerin can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Glycerin,Glycopyrronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Glycerin,Halothane,The metabolism of Halothane can be increased when combined with Glycerin.,increase,no risk
Glycerin,Hexafluronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexafluronium.,decrease,no risk
Glycerin,Hexocyclium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexocyclium.,decrease,no risk
Glycerin,Homatropine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Homatropine.,decrease,no risk
Glycerin,Homatropine methylbromide,The therapeutic efficacy of Glycerin can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Glycerin,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Glycerin.,increase,risk
Glycerin,Hydrocodone,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hydrocodone.,decrease,no risk
Glycerin,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Glycerin.,increase,risk
Glycerin,Hydromorphone,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hydromorphone.,decrease,no risk
Glycerin,Hydrotalcite,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Glycerin,Hyoscyamine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Glycerin,Olanzapine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Olanzapine.,decrease,no risk
Glycerin,Oliceridine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oliceridine.,decrease,no risk
Glycerin,Opium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Opium.,decrease,no risk
Glycerin,Orphenadrine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Orphenadrine.,decrease,no risk
Glycerin,Oxybutynin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxybutynin.,decrease,no risk
Glycerin,Oxycodone,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxycodone.,decrease,no risk
Glycerin,Oxymorphone,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxymorphone.,decrease,no risk
Glycerin,Oxyphencyclimine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Glycerin,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Glycerin is combined with Oxyphenisatin acetate.,increase,risk
Glycerin,Oxyphenonium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Glycerin,Quetiapine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Quetiapine.,decrease,no risk
Glycerin,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Glycerin.,increase,risk
Glycerin,Quinidine,The therapeutic efficacy of Glycerin can be decreased when used in combination with Quinidine.,decrease,no risk
Glycerin,Umeclidinium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Umeclidinium.,decrease,no risk
Glycerin,Vecuronium,The therapeutic efficacy of Glycerin can be decreased when used in combination with Vecuronium.,decrease,no risk
Glycerin,Verapamil,The therapeutic efficacy of Glycerin can be decreased when used in combination with Verapamil.,decrease,no risk
Glycerin,Xylometazoline,The therapeutic efficacy of Glycerin can be decreased when used in combination with Xylometazoline.,decrease,no risk
Glycerin,Ziconotide,The therapeutic efficacy of Glycerin can be decreased when used in combination with Ziconotide.,decrease,no risk
Glycerin,Ziprasidone,The therapeutic efficacy of Glycerin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Glycerin,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Glycerin.,increase,risk
Fotemustine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Benzocaine.,increase,risk
Fotemustine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Benzyl alcohol.,increase,risk
Fotemustine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Bupivacaine.,increase,risk
Fotemustine,Butacaine,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Butacaine.,increase,risk
Fotemustine,Butamben,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Butamben.,increase,risk
Fotemustine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Oxetacaine.,increase,risk
Fotemustine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fotemustine is combined with Oxybuprocaine.,increase,risk
Aurodox,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Aurodox.,decrease,no risk
Aurodox,Benzocaine,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Benzocaine.,increase,risk
Aurodox,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Benzyl alcohol.,increase,risk
Aurodox,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Bupivacaine.,increase,risk
Aurodox,Butacaine,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Butacaine.,increase,risk
Aurodox,Butamben,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Butamben.,increase,risk
Aurodox,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Oxetacaine.,increase,risk
Aurodox,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aurodox is combined with Oxybuprocaine.,increase,risk
Aurodox,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Aurodox.,decrease,no risk
Aurodox,Warfarin,The risk or severity of bleeding can be increased when Aurodox is combined with Warfarin.,increase,risk
Pyrophosphoric acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Valpromide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Valpromide.,increase,risk
Valpromide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Valpromide is combined with Gabapentin enacarbil.,increase,risk
Valpromide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Valpromide.,increase,risk
Valpromide,Gamolenic acid,The therapeutic efficacy of Valpromide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Valpromide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Valpromide is combined with Ganaxolone.",increase,risk
Valpromide,Ganciclovir,The therapeutic efficacy of Valpromide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Valpromide,Gepirone,The risk or severity of CNS depression can be increased when Valpromide is combined with Gepirone.,increase,risk
Valpromide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Valpromide.,increase,no risk
Valpromide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Valpromide.,increase,risk
Valpromide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Valpromide.,increase,risk
Valpromide,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Valpromide.,increase,risk
Valpromide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Valpromide.,increase,risk
Valpromide,Halofantrine,The therapeutic efficacy of Valpromide can be decreased when used in combination with Halofantrine.,decrease,no risk
Valpromide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Valpromide.,increase,risk
Valpromide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Valpromide.,increase,risk
Valpromide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Valpromide.,increase,risk
Valpromide,Hydrocodone,Valpromide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Valpromide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Valpromide.,increase,risk
Valpromide,Hydroxychloroquine,The therapeutic efficacy of Valpromide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Valpromide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Valpromide.,increase,no risk
Valpromide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Valpromide.,increase,no risk
Valpromide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Valpromide.,increase,risk
Valpromide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Valpromide.,increase,risk
Valpromide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Valpromide.,increase,risk
Valpromide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Valpromide is combined with Oliceridine.",increase,risk
Valpromide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Valpromide.,increase,risk
Valpromide,Opium,The risk or severity of CNS depression can be increased when Valpromide is combined with Opium.,increase,risk
Valpromide,Orlistat,Orlistat can cause a decrease in the absorption of Valpromide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Valpromide,Orphenadrine,Valpromide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Valpromide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Valpromide.,increase,risk
Valpromide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Valpromide.,increase,risk
Valpromide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Valpromide is combined with Oxetacaine.,increase,risk
Valpromide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Valpromide.,increase,risk
Valpromide,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Valpromide.,increase,risk
Valpromide,Oxtriphylline,Valpromide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valpromide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Valpromide is combined with Oxybuprocaine.,increase,risk
Valpromide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Valpromide.,increase,risk
Valpromide,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Valpromide.,increase,risk
Valpromide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Valpromide.,increase,risk
Valpromide,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Valpromide.,increase,risk
Valpromide,Quinidine,The therapeutic efficacy of Valpromide can be decreased when used in combination with Quinidine.,decrease,no risk
Valpromide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Valpromide.,increase,risk
Valpromide,Quinupramine,The risk or severity of CNS depression can be increased when Valpromide is combined with Quinupramine.,increase,risk
Valpromide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Valpromide.,increase,no risk
Valpromide,Urethane,The risk or severity of CNS depression can be increased when Valpromide is combined with Urethane.,increase,risk
Valpromide,Valganciclovir,The therapeutic efficacy of Valpromide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Valpromide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Valpromide.,increase,risk
Valpromide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Valpromide.,increase,risk
Valpromide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Valpromide.,increase,risk
Valpromide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Valpromide.,increase,risk
Valpromide,Vilazodone,The risk or severity of CNS depression can be increased when Valpromide is combined with Vilazodone.,increase,risk
Valpromide,Viloxazine,The risk or severity of CNS depression can be increased when Valpromide is combined with Viloxazine.,increase,risk
Valpromide,Vortioxetine,The risk or severity of CNS depression can be increased when Valpromide is combined with Vortioxetine.,increase,risk
Valpromide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Valpromide.,increase,risk
Valpromide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Valpromide.,increase,risk
Valpromide,Ziconotide,The risk or severity of CNS depression can be increased when Valpromide is combined with Ziconotide.,increase,risk
Valpromide,Zimelidine,The risk or severity of adverse effects can be increased when Valpromide is combined with Zimelidine.,increase,risk
Valpromide,Ziprasidone,The risk or severity of adverse effects can be increased when Valpromide is combined with Ziprasidone.,increase,risk
Valpromide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Valpromide.,increase,risk
Valpromide,Zolpidem,Valpromide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Valpromide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Valpromide.,increase,risk
Valpromide,Zopiclone,The risk or severity of adverse effects can be increased when Valpromide is combined with Zopiclone.,increase,risk
Valpromide,Zotepine,The risk or severity of CNS depression can be increased when Valpromide is combined with Zotepine.,increase,risk
Valpromide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Valpromide.,increase,risk
Valpromide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Valpromide.,increase,risk
Dequalinium,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Dequalinium.,decrease,no risk
Dequalinium,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Benzyl alcohol.,increase,risk
Dequalinium,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Bupivacaine.,increase,risk
Dequalinium,Butacaine,The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Butacaine.,increase,risk
Dequalinium,Butamben,The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Butamben.,increase,risk
Dequalinium,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Oxetacaine.,increase,risk
Dequalinium,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Oxybuprocaine.,increase,risk
Dequalinium,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dequalinium.,decrease,no risk
Dequalinium,Warfarin,The risk or severity of bleeding can be increased when Dequalinium is combined with Warfarin.,increase,risk
Quercetin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Gefitinib,Quercetin may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Quercetin,Glasdegib,Quercetin may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Quercetin,Glecaprevir,Quercetin may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Quercetin,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Glipizide,The metabolism of Glipizide can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Glyburide,Quercetin may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Quercetin,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Quercetin.,increase,no risk
Quercetin,Halothane,The metabolism of Halothane can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ketamine,The metabolism of Ketamine can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ombitasvir,Quercetin may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Quercetin,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Opicapone,The metabolism of Quercetin can be decreased when combined with Opicapone.,decrease,no risk
Quercetin,Osimertinib,Quercetin may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Quercetin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ouabain,The excretion of Ouabain can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Oxaliplatin,Quercetin may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Quercetin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ozanimod,Quercetin may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Quercetin,Quinine,The metabolism of Quinine can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Quercetin.,increase,no risk
Quercetin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Valsartan,The excretion of Valsartan can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Velpatasvir,Quercetin may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Quercetin,Vemurafenib,Quercetin may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Quercetin,Venetoclax,Quercetin may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Quercetin,Verapamil,The metabolism of Verapamil can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Vincristine,Quercetin may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Quercetin,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Voxilaprevir,Quercetin may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Quercetin,Warfarin,The metabolism of Warfarin can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zidovudine,Quercetin may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Quercetin,Zileuton,The metabolism of Zileuton can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Quercetin.,decrease,no risk
Quercetin,Zotepine,The metabolism of Zotepine can be decreased when combined with Quercetin.,decrease,no risk
Sparsomycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Benzocaine.,increase,risk
Sparsomycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Benzyl alcohol.,increase,risk
Sparsomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Bupivacaine.,increase,risk
Sparsomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Butacaine.,increase,risk
Sparsomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Butamben.,increase,risk
Sparsomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Oxetacaine.,increase,risk
Sparsomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sparsomycin is combined with Oxybuprocaine.,increase,risk
Zinc Substituted Heme C,Gatifloxacin,Zinc Substituted Heme C can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc Substituted Heme C,Gemifloxacin,Zinc Substituted Heme C can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc Substituted Heme C,Grepafloxacin,Zinc Substituted Heme C can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc Substituted Heme C,Halofantrine,Zinc Substituted Heme C can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc Substituted Heme C,Ofloxacin,Zinc Substituted Heme C can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc Substituted Heme C,Omadacycline,Zinc Substituted Heme C can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Zinc Substituted Heme C,Oxytetracycline,Zinc Substituted Heme C can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Butyrylthiocholine,Benzonatate,The serum concentration of Butyrylthiocholine can be increased when it is combined with Benzonatate.,increase,no risk
Butyrylthiocholine,Betaine,Betaine may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Galantamine,Galantamine may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Ketamine,Ketamine may increase the neuromuscular blocking activities of Butyrylthiocholine.,increase,no risk
Butyrylthiocholine,Oxybuprocaine,The serum concentration of Butyrylthiocholine can be increased when it is combined with Oxybuprocaine.,increase,no risk
Tretazicar,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Benzocaine.,increase,risk
Tretazicar,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Benzyl alcohol.,increase,risk
Tretazicar,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Bupivacaine.,increase,risk
Tretazicar,Butacaine,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Butacaine.,increase,risk
Tretazicar,Butamben,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Butamben.,increase,risk
Tretazicar,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Oxetacaine.,increase,risk
Tretazicar,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tretazicar is combined with Oxybuprocaine.,increase,risk
Seocalcitol,Beclomethasone dipropionate,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Seocalcitol,Bendroflumethiazide,The risk or severity of hypercalcemia can be increased when Bendroflumethiazide is combined with Seocalcitol.,increase,risk
Seocalcitol,Benzocaine,The risk or severity of methemoglobinemia can be increased when Seocalcitol is combined with Benzocaine.,increase,risk
Seocalcitol,Benzthiazide,The risk or severity of hypercalcemia can be increased when Benzthiazide is combined with Seocalcitol.,increase,risk
Seocalcitol,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Seocalcitol is combined with Benzyl alcohol.,increase,risk
Seocalcitol,Betamethasone,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Betamethasone.,decrease,no risk
Seocalcitol,Betamethasone phosphate,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Seocalcitol,Budesonide,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Budesonide.,decrease,no risk
Seocalcitol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Seocalcitol is combined with Bupivacaine.,increase,risk
Seocalcitol,Butacaine,The risk or severity of methemoglobinemia can be increased when Seocalcitol is combined with Butacaine.,increase,risk
Seocalcitol,Butamben,The risk or severity of methemoglobinemia can be increased when Seocalcitol is combined with Butamben.,increase,risk
Seocalcitol,Hydrochlorothiazide,The risk or severity of hypercalcemia can be increased when Hydrochlorothiazide is combined with Seocalcitol.,increase,risk
Seocalcitol,Hydrocortisone,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Seocalcitol,Hydrocortisone acetate,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Seocalcitol,Hydrocortisone butyrate,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Seocalcitol,Hydrocortisone cypionate,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Seocalcitol,Hydrocortisone succinate,The therapeutic efficacy of Seocalcitol can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Seocalcitol,Hydroflumethiazide,The risk or severity of hypercalcemia can be increased when Hydroflumethiazide is combined with Seocalcitol.,increase,risk
Seocalcitol,Hydrotalcite,The serum concentration of Hydrotalcite can be increased when it is combined with Seocalcitol.,increase,no risk
Geneticin,Gabapentin enacarbil,Geneticin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Geneticin,Gadobenic acid,Geneticin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Geneticin,Gadodiamide,Geneticin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Geneticin,Gadofosveset trisodium,Geneticin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Geneticin,Gadopentetic acid,Geneticin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Geneticin,Gadoteric acid,Geneticin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Geneticin,Gadoteridol,Geneticin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Geneticin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Geneticin.,increase,no risk
Geneticin,Ganciclovir,Geneticin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Geneticin,Gemcitabine,Geneticin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Geneticin,Gemfibrozil,Geneticin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Geneticin,Gentamicin,Geneticin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Geneticin,Gimeracil,Geneticin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Geneticin,Givosiran,The risk or severity of nephrotoxicity can be increased when Geneticin is combined with Givosiran.,increase,risk
Geneticin,Glipizide,Geneticin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Geneticin,Glycerol phenylbutyrate,Geneticin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Geneticin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Geneticin.,increase,risk
Geneticin,Golodirsen,Geneticin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Geneticin,Goserelin,Geneticin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Geneticin,Guanethidine,Geneticin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Geneticin,Guanfacine,Geneticin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Geneticin,Haloperidol,Geneticin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Geneticin,Heparin,The therapeutic efficacy of Geneticin can be decreased when used in combination with Heparin.,decrease,no risk
Geneticin,Hetacillin,The serum concentration of Geneticin can be decreased when it is combined with Hetacillin.,decrease,no risk
Geneticin,Hydralazine,Geneticin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Geneticin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Geneticin.,increase,risk
Geneticin,Hydromorphone,Geneticin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Geneticin,Hydroxocobalamin,Geneticin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Geneticin,Hydroxyethyl Starch,Geneticin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Geneticin,Kanamycin,Geneticin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Geneticin,Ketamine,Geneticin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Geneticin,Ketazolam,Geneticin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Geneticin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Geneticin.,increase,risk
Geneticin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Geneticin.,increase,risk
Geneticin,Octinoxate,Geneticin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Geneticin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Geneticin is combined with Olsalazine.,increase,risk
Geneticin,Opium,Geneticin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Geneticin,Oseltamivir,Geneticin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Geneticin,Ouabain,The risk or severity of adverse effects can be increased when Geneticin is combined with Ouabain.,increase,risk
Geneticin,Oxacillin,The serum concentration of Geneticin can be decreased when it is combined with Oxacillin.,decrease,no risk
Geneticin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Geneticin.,increase,risk
Geneticin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Geneticin.,increase,risk
Geneticin,Oxazepam,Geneticin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Geneticin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Geneticin is combined with Oxetacaine.,increase,risk
Geneticin,Oxybenzone,Geneticin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Geneticin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Geneticin is combined with Oxybuprocaine.,increase,risk
Geneticin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Geneticin.,increase,risk
Geneticin,Oxyquinoline,Geneticin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Geneticin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Geneticin.,increase,risk
Geneticin,Quetiapine,Geneticin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Geneticin,Quinidine,Geneticin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Geneticin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Geneticin.,increase,risk
Geneticin,Vaborbactam,Geneticin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Geneticin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Geneticin.,increase,risk
Geneticin,Valbenazine,Geneticin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Geneticin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Geneticin.,increase,risk
Geneticin,Valganciclovir,Geneticin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Geneticin,Vancomycin,Geneticin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Geneticin,Varenicline,The therapeutic efficacy of Varenicline can be decreased when used in combination with Geneticin.,decrease,no risk
Geneticin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Geneticin.,increase,no risk
Geneticin,Venlafaxine,Geneticin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Geneticin,Verapamil,Geneticin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Geneticin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Geneticin.,decrease,no risk
Geneticin,Vilanterol,Geneticin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Geneticin,Viloxazine,Geneticin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Geneticin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Geneticin is combined with Viomycin.,increase,risk
Geneticin,Vortioxetine,Geneticin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Geneticin,Warfarin,Geneticin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Geneticin,Zaleplon,Geneticin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Geneticin,Zanamivir,Geneticin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Geneticin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Geneticin is combined with Zoledronic acid.,increase,risk
Geneticin,Zonisamide,Geneticin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Citric acid,Benzphetamine,The excretion of Benzphetamine can be decreased when combined with Citric acid.,decrease,no risk
Citric acid,Omadacycline,The therapeutic efficacy of Omadacycline can be decreased when used in combination with Citric acid.,decrease,no risk
Citric acid,Oxytetracycline,The therapeutic efficacy of Oxytetracycline can be decreased when used in combination with Citric acid.,decrease,no risk
Trichostatin A,Benzocaine,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Benzocaine.,increase,risk
Trichostatin A,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Benzyl alcohol.,increase,risk
Trichostatin A,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Bupivacaine.,increase,risk
Trichostatin A,Butacaine,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Butacaine.,increase,risk
Trichostatin A,Butamben,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Butamben.,increase,risk
Trichostatin A,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Oxetacaine.,increase,risk
Trichostatin A,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trichostatin A is combined with Oxybuprocaine.,increase,risk
Phenethylamine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Phenethylamine.,increase,risk
Phenethylamine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Gabapentin enacarbil.,increase,risk
Phenethylamine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Phenethylamine.,increase,risk
Phenethylamine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Phenethylamine is combined with Ganaxolone.",increase,risk
Phenethylamine,Gepirone,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Gepirone.,increase,risk
Phenethylamine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Phenethylamine.,increase,risk
Phenethylamine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Phenethylamine.,increase,risk
Phenethylamine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Phenethylamine.,increase,risk
Phenethylamine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Phenethylamine.,increase,risk
Phenethylamine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Phenethylamine.,increase,risk
Phenethylamine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Phenethylamine.,increase,risk
Phenethylamine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Phenethylamine.,increase,risk
Phenethylamine,Hydrocodone,Phenethylamine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Phenethylamine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Phenethylamine.,increase,risk
Phenethylamine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Phenethylamine.,increase,no risk
Phenethylamine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Phenethylamine.,increase,risk
Phenethylamine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Phenethylamine.,increase,risk
Phenethylamine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Phenethylamine.,increase,risk
Phenethylamine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Phenethylamine is combined with Oliceridine.",increase,risk
Phenethylamine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Phenethylamine.,increase,risk
Phenethylamine,Opium,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Opium.,increase,risk
Phenethylamine,Orphenadrine,Phenethylamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Phenethylamine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Phenethylamine.,increase,risk
Phenethylamine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Phenethylamine.,increase,risk
Phenethylamine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Phenethylamine.,increase,risk
Phenethylamine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Phenethylamine.,increase,risk
Phenethylamine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Phenethylamine.,increase,risk
Phenethylamine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Phenethylamine.,increase,risk
Phenethylamine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Phenethylamine.,increase,risk
Phenethylamine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Phenethylamine.,increase,risk
Phenethylamine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Phenethylamine.,increase,risk
Phenethylamine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Phenethylamine.,increase,risk
Phenethylamine,Quinupramine,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Quinupramine.,increase,risk
Phenethylamine,Urethane,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Urethane.,increase,risk
Phenethylamine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Phenethylamine.,increase,risk
Phenethylamine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Phenethylamine.,increase,risk
Phenethylamine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Phenethylamine.,increase,risk
Phenethylamine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Phenethylamine.,increase,risk
Phenethylamine,Vilazodone,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Vilazodone.,increase,risk
Phenethylamine,Viloxazine,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Viloxazine.,increase,risk
Phenethylamine,Vortioxetine,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Vortioxetine.,increase,risk
Phenethylamine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Phenethylamine.,increase,risk
Phenethylamine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Phenethylamine.,increase,risk
Phenethylamine,Ziconotide,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Ziconotide.,increase,risk
Phenethylamine,Zimelidine,The risk or severity of adverse effects can be increased when Phenethylamine is combined with Zimelidine.,increase,risk
Phenethylamine,Ziprasidone,The risk or severity of adverse effects can be increased when Phenethylamine is combined with Ziprasidone.,increase,risk
Phenethylamine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Phenethylamine.,increase,risk
Phenethylamine,Zolpidem,Phenethylamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Phenethylamine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Phenethylamine.,increase,risk
Phenethylamine,Zopiclone,The risk or severity of adverse effects can be increased when Phenethylamine is combined with Zopiclone.,increase,risk
Phenethylamine,Zotepine,The risk or severity of CNS depression can be increased when Phenethylamine is combined with Zotepine.,increase,risk
Phenethylamine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Phenethylamine.,increase,risk
Phenethylamine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Phenethylamine.,increase,risk
Monastrol,Benzocaine,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Benzocaine.,increase,risk
Monastrol,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Benzyl alcohol.,increase,risk
Monastrol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Bupivacaine.,increase,risk
Monastrol,Butacaine,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Butacaine.,increase,risk
Monastrol,Butamben,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Butamben.,increase,risk
Monastrol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Oxetacaine.,increase,risk
Monastrol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Monastrol is combined with Oxybuprocaine.,increase,risk
6-hydroxydopa quinone,Vasopressin,Vasopressin may increase the hypertensive activities of 6-hydroxydopa quinone.,increase,no risk
Taurocholic acid,Gadoxetic acid,The excretion of Gadoxetic acid can be increased when combined with Taurocholic acid.,increase,no risk
Taurocholic acid,Ganciclovir,The excretion of Taurocholic acid can be decreased when combined with Ganciclovir.,decrease,no risk
Taurocholic acid,Gefitinib,Taurocholic acid may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Gemfibrozil,The therapeutic efficacy of Taurocholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Taurocholic acid,Gentamicin,The excretion of Taurocholic acid can be decreased when combined with Gentamicin.,decrease,no risk
Taurocholic acid,Gestrinone,The therapeutic efficacy of Taurocholic acid can be decreased when used in combination with Gestrinone.,decrease,no risk
Taurocholic acid,Glasdegib,Taurocholic acid may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Glecaprevir,Taurocholic acid may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Glimepiride,Taurocholic acid may increase the excretion rate of Glimepiride which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taurocholic acid,Glipizide,Taurocholic acid may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taurocholic acid,Glyburide,Glyburide may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Glycyrrhizic acid,Taurocholic acid may increase the excretion rate of Glycyrrhizic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taurocholic acid,Grazoprevir,The excretion of Grazoprevir can be increased when combined with Taurocholic acid.,increase,no risk
Taurocholic acid,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Guanidine,The excretion of Taurocholic acid can be decreased when combined with Guanidine.,decrease,no risk
Taurocholic acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Taurocholic acid.,increase,risk
Taurocholic acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Taurocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Taurocholic acid,Kaolin,Kaolin can cause a decrease in the absorption of Taurocholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Taurocholic acid,Ketoconazole,Ketoconazole may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Ketoprofen,The excretion of Taurocholic acid can be decreased when combined with Ketoprofen.,decrease,no risk
Taurocholic acid,Ofloxacin,Taurocholic acid may increase the excretion rate of Ofloxacin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taurocholic acid,Olmesartan,Olmesartan may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Ombitasvir,Taurocholic acid may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Osimertinib,Taurocholic acid may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Ouabain,The excretion of Taurocholic acid can be decreased when combined with Ouabain.,decrease,no risk
Taurocholic acid,Oxaliplatin,Taurocholic acid may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Oxyphenbutazone,The excretion of Taurocholic acid can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Taurocholic acid,Oxytetracycline,The excretion of Taurocholic acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Taurocholic acid,Ozanimod,Taurocholic acid may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Quinapril,The excretion of Quinapril can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Quinidine,Quinidine may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Quinine,The excretion of Taurocholic acid can be decreased when combined with Quinine.,decrease,no risk
Taurocholic acid,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Taurocholic acid.,increase,no risk
Taurocholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurocholic acid.,increase,risk
Taurocholic acid,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Taurocholic acid.,increase,no risk
Taurocholic acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Valproic acid,The excretion of Valproic acid can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Valsartan,The excretion of Valsartan can be increased when combined with Taurocholic acid.,increase,no risk
Taurocholic acid,Velpatasvir,Taurocholic acid may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Vemurafenib,Taurocholic acid may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Venetoclax,Taurocholic acid may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Vinblastine,Taurocholic acid may increase the excretion rate of Vinblastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taurocholic acid,Vincristine,Taurocholic acid may increase the excretion rate of Vincristine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taurocholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Taurocholic acid.,increase,risk
Taurocholic acid,Voxilaprevir,Taurocholic acid may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Taurocholic acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Taurocholic acid.,increase,risk
Taurocholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Taurocholic acid.,increase,risk
Taurocholic acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Taurocholic acid.,decrease,no risk
Taurocholic acid,Zidovudine,The excretion of Taurocholic acid can be decreased when combined with Zidovudine.,decrease,no risk
9-Deazaguanine,Gabapentin,Gabapentin may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Ganaxolone,Ganaxolone may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Gatifloxacin,The metabolism of 9-Deazaguanine can be decreased when combined with Gatifloxacin.,decrease,no risk
9-Deazaguanine,Gemfibrozil,The metabolism of 9-Deazaguanine can be decreased when combined with Gemfibrozil.,decrease,no risk
9-Deazaguanine,Gemifloxacin,The metabolism of 9-Deazaguanine can be decreased when combined with Gemifloxacin.,decrease,no risk
9-Deazaguanine,Givosiran,The serum concentration of 9-Deazaguanine can be increased when it is combined with Givosiran.,increase,no risk
9-Deazaguanine,Glofitamab,The serum concentration of 9-Deazaguanine can be increased when it is combined with Glofitamab.,increase,no risk
9-Deazaguanine,Golimumab,The metabolism of 9-Deazaguanine can be increased when combined with Golimumab.,increase,no risk
9-Deazaguanine,Grepafloxacin,The metabolism of 9-Deazaguanine can be decreased when combined with Grepafloxacin.,decrease,no risk
9-Deazaguanine,Guanabenz,The metabolism of 9-Deazaguanine can be decreased when combined with Guanabenz.,decrease,no risk
9-Deazaguanine,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with 9-Deazaguanine.,decrease,no risk
9-Deazaguanine,Haloperidol,The metabolism of 9-Deazaguanine can be decreased when combined with Haloperidol.,decrease,no risk
9-Deazaguanine,Human interferon beta,The metabolism of 9-Deazaguanine can be decreased when combined with Human interferon beta.,decrease,no risk
9-Deazaguanine,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with 9-Deazaguanine.,increase,risk
9-Deazaguanine,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with 9-Deazaguanine.,decrease,no risk
9-Deazaguanine,Ketoconazole,The metabolism of 9-Deazaguanine can be decreased when combined with Ketoconazole.,decrease,no risk
9-Deazaguanine,Obeticholic acid,The metabolism of 9-Deazaguanine can be decreased when combined with Obeticholic acid.,decrease,no risk
9-Deazaguanine,Ofloxacin,The metabolism of 9-Deazaguanine can be decreased when combined with Ofloxacin.,decrease,no risk
9-Deazaguanine,Olanzapine,The metabolism of 9-Deazaguanine can be decreased when combined with Olanzapine.,decrease,no risk
9-Deazaguanine,Olodaterol,9-Deazaguanine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
9-Deazaguanine,Ondansetron,The metabolism of 9-Deazaguanine can be decreased when combined with Ondansetron.,decrease,no risk
9-Deazaguanine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with 9-Deazaguanine.,increase,risk
9-Deazaguanine,Orphenadrine,The metabolism of 9-Deazaguanine can be decreased when combined with Orphenadrine.,decrease,no risk
9-Deazaguanine,Osilodrostat,The metabolism of 9-Deazaguanine can be decreased when combined with Osilodrostat.,decrease,no risk
9-Deazaguanine,Osimertinib,The serum concentration of 9-Deazaguanine can be decreased when it is combined with Osimertinib.,decrease,no risk
9-Deazaguanine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with 9-Deazaguanine.,decrease,no risk
9-Deazaguanine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with 9-Deazaguanine.,increase,risk
9-Deazaguanine,Oxtriphylline,The metabolism of 9-Deazaguanine can be decreased when combined with Oxtriphylline.,decrease,no risk
9-Deazaguanine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 9-Deazaguanine.,increase,risk
9-Deazaguanine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with 9-Deazaguanine.,decrease,no risk
9-Deazaguanine,Quinidine,The serum concentration of 9-Deazaguanine can be increased when it is combined with Quinidine.,increase,no risk
9-Deazaguanine,Quinine,The serum concentration of 9-Deazaguanine can be increased when it is combined with Quinine.,increase,no risk
9-Deazaguanine,Valproic acid,Valproic acid may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Vemurafenib,The serum concentration of 9-Deazaguanine can be increased when it is combined with Vemurafenib.,increase,no risk
9-Deazaguanine,Verapamil,The metabolism of 9-Deazaguanine can be decreased when combined with Verapamil.,decrease,no risk
9-Deazaguanine,Vigabatrin,Vigabatrin may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Vilanterol,The risk or severity of hypokalemia can be increased when 9-Deazaguanine is combined with Vilanterol.,increase,risk
9-Deazaguanine,Viloxazine,The metabolism of 9-Deazaguanine can be decreased when combined with Viloxazine.,decrease,no risk
9-Deazaguanine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with 9-Deazaguanine.,decrease,no risk
9-Deazaguanine,Warfarin,The metabolism of 9-Deazaguanine can be decreased when combined with Warfarin.,decrease,no risk
9-Deazaguanine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with 9-Deazaguanine.,decrease,no risk
9-Deazaguanine,Zaleplon,Zaleplon may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Zileuton,The metabolism of 9-Deazaguanine can be decreased when combined with Zileuton.,decrease,no risk
9-Deazaguanine,Zolmitriptan,The metabolism of 9-Deazaguanine can be decreased when combined with Zolmitriptan.,decrease,no risk
9-Deazaguanine,Zolpidem,The metabolism of 9-Deazaguanine can be decreased when combined with Zolpidem.,decrease,no risk
9-Deazaguanine,Zonisamide,Zonisamide may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
9-Deazaguanine,Zotepine,The metabolism of Zotepine can be decreased when combined with 9-Deazaguanine.,decrease,no risk
Arecoline,Betaine,The risk or severity of adverse effects can be increased when Betaine is combined with Arecoline.,increase,risk
Arecoline,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Arecoline.,increase,risk
Arecoline,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Arecoline.,increase,risk
Arecoline,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Arecoline.,increase,risk
Arecoline,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Arecoline.,increase,risk
Arecoline,Gentamicin,The therapeutic efficacy of Arecoline can be decreased when used in combination with Gentamicin.,decrease,no risk
Arecoline,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Arecoline.,increase,risk
Arecoline,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Arecoline.,increase,risk
Arecoline,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Arecoline.,increase,risk
Arecoline,Kanamycin,The therapeutic efficacy of Arecoline can be decreased when used in combination with Kanamycin.,decrease,no risk
Arecoline,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Arecoline.,increase,risk
Arecoline,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Arecoline.,increase,risk
Nebularine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Benzocaine.,increase,risk
Nebularine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Benzyl alcohol.,increase,risk
Nebularine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Bupivacaine.,increase,risk
Nebularine,Butacaine,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Butacaine.,increase,risk
Nebularine,Butamben,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Butamben.,increase,risk
Nebularine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Oxetacaine.,increase,risk
Nebularine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nebularine is combined with Oxybuprocaine.,increase,risk
Afimoxifene,Benzocaine,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Benzocaine.,increase,risk
Afimoxifene,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Benzyl alcohol.,increase,risk
Afimoxifene,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Bupivacaine.,increase,risk
Afimoxifene,Butacaine,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Butacaine.,increase,risk
Afimoxifene,Butamben,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Butamben.,increase,risk
Afimoxifene,Ospemifene,The risk or severity of adverse effects can be increased when Afimoxifene is combined with Ospemifene.,increase,risk
Afimoxifene,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Oxetacaine.,increase,risk
Afimoxifene,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Afimoxifene is combined with Oxybuprocaine.,increase,risk
Caprylic acid,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Caprylic acid.,increase,no risk
Caprylic acid,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Bumetanide,The excretion of Bumetanide can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Quinapril,The excretion of Quinapril can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Caprylic acid.,increase,no risk
Caprylic acid,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Valproic acid,The excretion of Valproic acid can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Caprylic acid.,decrease,no risk
Caprylic acid,Zidovudine,The excretion of Zidovudine can be decreased when combined with Caprylic acid.,decrease,no risk
Cholesterol,Berotralstat,Cholesterol may increase the excretion rate of Berotralstat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Binimetinib,Cholesterol may increase the excretion rate of Binimetinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Brigatinib,Cholesterol may increase the excretion rate of Brigatinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Gefitinib,Cholesterol may increase the excretion rate of Gefitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Glasdegib,Cholesterol may increase the excretion rate of Glasdegib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Glecaprevir,Cholesterol may increase the excretion rate of Glecaprevir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Glyburide,Cholesterol may increase the excretion rate of Glyburide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Ombitasvir,Cholesterol may increase the excretion rate of Ombitasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Osimertinib,Cholesterol may increase the excretion rate of Osimertinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Oxaliplatin,Cholesterol may increase the excretion rate of Oxaliplatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Ozanimod,Cholesterol may increase the excretion rate of Ozanimod which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Ubrogepant,Cholesterol may increase the excretion rate of Ubrogepant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Velpatasvir,Cholesterol may increase the excretion rate of Velpatasvir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Vemurafenib,Cholesterol may increase the excretion rate of Vemurafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Venetoclax,Cholesterol may increase the excretion rate of Venetoclax which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Vincristine,Cholesterol may increase the excretion rate of Vincristine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Voxilaprevir,Cholesterol may increase the excretion rate of Voxilaprevir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cholesterol,Zidovudine,Cholesterol may increase the excretion rate of Zidovudine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Niflumic acid,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Bicisate,Niflumic acid may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Niflumic acid,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Bismuth subgallate,Niflumic acid may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Niflumic acid,Bisoprolol,Niflumic acid may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Niflumic acid,Bisoxatin,Niflumic acid may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Bivalirudin.,increase,risk
Niflumic acid,Bleomycin,Niflumic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Brexpiprazole,The risk or severity of hypertension can be increased when Niflumic acid is combined with Brexpiprazole.,increase,risk
Niflumic acid,Brivaracetam,Niflumic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Niflumic acid,Bromazepam,Niflumic acid may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Niflumic acid,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Niflumic acid.,increase,risk
Niflumic acid,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Niflumic acid.,increase,risk
Niflumic acid,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Niflumic acid.,increase,risk
Niflumic acid,Bufexamac,The risk or severity of adverse effects can be increased when Niflumic acid is combined with Bufexamac.,increase,risk
Niflumic acid,Bumadizone,The risk or severity of adverse effects can be increased when Niflumic acid is combined with Bumadizone.,increase,risk
Niflumic acid,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Bupropion,Niflumic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Niflumic acid,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Niflumic acid.,increase,risk
Niflumic acid,Butabarbital,Niflumic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Niflumic acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Niflumic acid.,increase,risk
Niflumic acid,Gabapentin enacarbil,Niflumic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gadobenic acid,Niflumic acid may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gadodiamide,Niflumic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gadofosveset trisodium,Niflumic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gadopentetic acid,Niflumic acid may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gadoteric acid,Niflumic acid may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gadoteridol,Niflumic acid may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Niflumic acid,Ganciclovir,Niflumic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gatifloxacin,Niflumic acid may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Niflumic acid,Gemcitabine,Niflumic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Gemifloxacin,Niflumic acid may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Niflumic acid,Gentamicin,Niflumic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Gimeracil,Niflumic acid may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Niflumic acid,Givosiran,The risk or severity of nephrotoxicity can be increased when Niflumic acid is combined with Givosiran.,increase,risk
Niflumic acid,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Glipizide,The protein binding of Glipizide can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Glyburide,The protein binding of Glyburide can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Glycerol phenylbutyrate,Niflumic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Niflumic acid,Glycol salicylate,The risk or severity of adverse effects can be increased when Niflumic acid is combined with Glycol salicylate.,increase,risk
Niflumic acid,Golodirsen,Niflumic acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Niflumic acid,Goserelin,Niflumic acid may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Grepafloxacin,Niflumic acid may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Niflumic acid,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Niflumic acid.,increase,no risk
Niflumic acid,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Niflumic acid.,increase,risk
Niflumic acid,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Heparin.,increase,risk
Niflumic acid,Hydralazine,Niflumic acid may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Niflumic acid,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Niflumic acid.,increase,risk
Niflumic acid,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Niflumic acid.,increase,risk
Niflumic acid,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Niflumic acid.,increase,risk
Niflumic acid,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Niflumic acid.,increase,risk
Niflumic acid,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Niflumic acid.,increase,risk
Niflumic acid,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Niflumic acid.,decrease,no risk
Niflumic acid,Hydromorphone,Niflumic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Niflumic acid,Hydroxocobalamin,Niflumic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Hydroxyethyl Starch,Niflumic acid may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Niflumic acid,Kanamycin,Niflumic acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Ketamine,Niflumic acid may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Niflumic acid,Ketazolam,Niflumic acid may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Niflumic acid,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Niflumic acid.,increase,risk
Niflumic acid,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Niflumic acid.,increase,risk
Niflumic acid,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Niflumic acid.,increase,risk
Niflumic acid,Octinoxate,Niflumic acid may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Niflumic acid,Ofloxacin,Niflumic acid may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Niflumic acid,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Niflumic acid.",increase,risk
Niflumic acid,Olodaterol,The risk or severity of hypertension can be increased when Niflumic acid is combined with Olodaterol.,increase,risk
Niflumic acid,Olsalazine,The risk or severity of nephrotoxicity can be increased when Niflumic acid is combined with Olsalazine.,increase,risk
Niflumic acid,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Niflumic acid is combined with Omacetaxine mepesuccinate.,increase,risk
Niflumic acid,Opium,Niflumic acid may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Niflumic acid,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Niflumic acid.,increase,risk
Niflumic acid,Oseltamivir,Niflumic acid may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Niflumic acid,Oxacillin,Niflumic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Niflumic acid,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Niflumic acid.,increase,risk
Niflumic acid,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Niflumic acid.,increase,risk
Niflumic acid,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Niflumic acid.,decrease,no risk
Niflumic acid,Oxprenolol,Niflumic acid may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Niflumic acid,Oxybenzone,Niflumic acid may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Niflumic acid,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Niflumic acid.,increase,risk
Niflumic acid,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Niflumic acid.,increase,risk
Niflumic acid,Oxyquinoline,Niflumic acid may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Arachidonic Acid,Gemfibrozil,The metabolism of Arachidonic Acid can be decreased when combined with Gemfibrozil.,decrease,no risk
Arachidonic Acid,Ginkgo biloba,The metabolism of Arachidonic Acid can be decreased when combined with Ginkgo biloba.,decrease,no risk
Arachidonic Acid,Gliclazide,The metabolism of Arachidonic Acid can be decreased when combined with Gliclazide.,decrease,no risk
Arachidonic Acid,Glimepiride,The metabolism of Arachidonic Acid can be decreased when combined with Glimepiride.,decrease,no risk
Arachidonic Acid,Glipizide,The metabolism of Arachidonic Acid can be decreased when combined with Glipizide.,decrease,no risk
Arachidonic Acid,Gliquidone,The metabolism of Arachidonic Acid can be decreased when combined with Gliquidone.,decrease,no risk
Arachidonic Acid,Glofitamab,The serum concentration of Arachidonic Acid can be increased when it is combined with Glofitamab.,increase,no risk
Arachidonic Acid,Glyburide,The metabolism of Arachidonic Acid can be decreased when combined with Glyburide.,decrease,no risk
Arachidonic Acid,Golimumab,The metabolism of Arachidonic Acid can be increased when combined with Golimumab.,increase,no risk
Arachidonic Acid,Haloperidol,The metabolism of Arachidonic Acid can be decreased when combined with Haloperidol.,decrease,no risk
Arachidonic Acid,Halothane,The metabolism of Arachidonic Acid can be decreased when combined with Halothane.,decrease,no risk
Arachidonic Acid,Hydromorphone,The metabolism of Arachidonic Acid can be decreased when combined with Hydromorphone.,decrease,no risk
Arachidonic Acid,Ketamine,The metabolism of Arachidonic Acid can be decreased when combined with Ketamine.,decrease,no risk
Arachidonic Acid,Ketorolac,The metabolism of Arachidonic Acid can be decreased when combined with Ketorolac.,decrease,no risk
Arachidonic Acid,Olanzapine,The metabolism of Arachidonic Acid can be decreased when combined with Olanzapine.,decrease,no risk
Arachidonic Acid,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Arachidonic Acid.,decrease,no risk
Arachidonic Acid,Ondansetron,The metabolism of Arachidonic Acid can be decreased when combined with Ondansetron.,decrease,no risk
Arachidonic Acid,Oritavancin,The metabolism of Arachidonic Acid can be decreased when combined with Oritavancin.,decrease,no risk
Arachidonic Acid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Arachidonic Acid.,decrease,no risk
Arachidonic Acid,Oxandrolone,The metabolism of Arachidonic Acid can be decreased when combined with Oxandrolone.,decrease,no risk
Arachidonic Acid,Quinidine,The metabolism of Arachidonic Acid can be decreased when combined with Quinidine.,decrease,no risk
Arachidonic Acid,Quinine,The metabolism of Arachidonic Acid can be decreased when combined with Quinine.,decrease,no risk
Arachidonic Acid,Vadadustat,The metabolism of Arachidonic Acid can be decreased when combined with Vadadustat.,decrease,no risk
Arachidonic Acid,Valdecoxib,The metabolism of Arachidonic Acid can be decreased when combined with Valdecoxib.,decrease,no risk
Arachidonic Acid,Valproic acid,The metabolism of Arachidonic Acid can be decreased when combined with Valproic acid.,decrease,no risk
Arachidonic Acid,Valsartan,The metabolism of Arachidonic Acid can be decreased when combined with Valsartan.,decrease,no risk
Arachidonic Acid,Vardenafil,The metabolism of Arachidonic Acid can be decreased when combined with Vardenafil.,decrease,no risk
Arachidonic Acid,Vemurafenib,The metabolism of Arachidonic Acid can be decreased when combined with Vemurafenib.,decrease,no risk
Arachidonic Acid,Voriconazole,The metabolism of Arachidonic Acid can be decreased when combined with Voriconazole.,decrease,no risk
Arachidonic Acid,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Arachidonic Acid.,decrease,no risk
Arachidonic Acid,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Arachidonic Acid.,decrease,no risk
Arachidonic Acid,Warfarin,The metabolism of Arachidonic Acid can be increased when combined with Warfarin.,increase,no risk
Arachidonic Acid,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Arachidonic Acid.,decrease,no risk
Arachidonic Acid,Zafirlukast,The metabolism of Arachidonic Acid can be decreased when combined with Zafirlukast.,decrease,no risk
Arachidonic Acid,Zidovudine,The metabolism of Arachidonic Acid can be decreased when combined with Zidovudine.,decrease,no risk
Arachidonic Acid,Zileuton,The metabolism of Arachidonic Acid can be decreased when combined with Zileuton.,decrease,no risk
Arachidonic Acid,Zolpidem,The metabolism of Arachidonic Acid can be decreased when combined with Zolpidem.,decrease,no risk
Arachidonic Acid,Zopiclone,The metabolism of Arachidonic Acid can be decreased when combined with Zopiclone.,decrease,no risk
Latamoxef,Gabapentin enacarbil,Latamoxef may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Latamoxef,Gadobenic acid,Latamoxef may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Latamoxef,Gadodiamide,Latamoxef may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Latamoxef,Gadofosveset trisodium,Latamoxef may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Latamoxef,Gadopentetic acid,Latamoxef may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Latamoxef,Gadoteric acid,Latamoxef may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Latamoxef,Gadoteridol,Latamoxef may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Latamoxef,Ganciclovir,Latamoxef may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Latamoxef,Gemcitabine,Latamoxef may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Latamoxef,Gemfibrozil,Latamoxef may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Latamoxef,Gentamicin,Latamoxef may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Latamoxef,Gimeracil,Latamoxef may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Latamoxef,Givosiran,The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Givosiran.,increase,risk
Latamoxef,Glipizide,Latamoxef may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Latamoxef,Glycerol phenylbutyrate,Latamoxef may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Latamoxef,Golodirsen,Latamoxef may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Latamoxef,Goserelin,Latamoxef may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Latamoxef,Guanethidine,Latamoxef may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Latamoxef,Guanfacine,Latamoxef may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Latamoxef,Haloperidol,Latamoxef may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Latamoxef,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Latamoxef.,decrease,no risk
Latamoxef,Hydralazine,Latamoxef may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Latamoxef,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Latamoxef.,increase,risk
Latamoxef,Hydromorphone,Latamoxef may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Latamoxef,Hydroxocobalamin,Latamoxef may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Latamoxef,Hydroxyethyl Starch,Latamoxef may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Latamoxef,Kanamycin,Latamoxef may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Latamoxef,Ketamine,Latamoxef may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Latamoxef,Ketazolam,Latamoxef may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Latamoxef,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Latamoxef.,increase,risk
Latamoxef,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Latamoxef.,increase,risk
Latamoxef,Octinoxate,Latamoxef may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Latamoxef,Olsalazine,The risk or severity of nephrotoxicity can be increased when Latamoxef is combined with Olsalazine.,increase,risk
Latamoxef,Opium,Latamoxef may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Latamoxef,Oseltamivir,Latamoxef may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Latamoxef,Oxacillin,Latamoxef may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Latamoxef,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Latamoxef.,increase,risk
Latamoxef,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Latamoxef.,increase,risk
Latamoxef,Oxazepam,Latamoxef may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Latamoxef,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Latamoxef is combined with Oxetacaine.,increase,risk
Latamoxef,Oxybenzone,Latamoxef may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Latamoxef,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Latamoxef is combined with Oxybuprocaine.,increase,risk
Latamoxef,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Latamoxef.,increase,risk
Latamoxef,Oxyquinoline,Latamoxef may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Latamoxef,Quetiapine,Latamoxef may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Latamoxef,Quinidine,Latamoxef may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Latamoxef,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Latamoxef.,decrease,no risk
Latamoxef,Vaborbactam,Latamoxef may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Latamoxef,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Latamoxef.,increase,risk
Latamoxef,Valbenazine,Latamoxef may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Latamoxef,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Latamoxef.,increase,risk
Latamoxef,Valganciclovir,Latamoxef may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Latamoxef,Vancomycin,Latamoxef may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Latamoxef,Varenicline,Latamoxef may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Latamoxef,Venlafaxine,Latamoxef may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Latamoxef,Verapamil,Latamoxef may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Latamoxef,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Latamoxef.,decrease,no risk
Latamoxef,Vilanterol,Latamoxef may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Latamoxef,Viloxazine,Latamoxef may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Latamoxef,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Latamoxef.,decrease,no risk
Latamoxef,Vortioxetine,Latamoxef may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Latamoxef,Warfarin,Latamoxef may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Latamoxef,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Latamoxef.,decrease,no risk
Latamoxef,Zaleplon,Latamoxef may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Latamoxef,Zanamivir,Latamoxef may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Latamoxef,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Latamoxef is combined with Zoledronic acid.,increase,risk
Latamoxef,Zonisamide,Latamoxef may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Trioxsalen,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Trioxsalen.,increase,no risk
Trioxsalen,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Trioxsalen.,increase,no risk
Trioxsalen,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Trioxsalen.,increase,no risk
Trioxsalen,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Trioxsalen.,increase,no risk
Trioxsalen,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Trioxsalen.,increase,no risk
Trioxsalen,Verteporfin,Trioxsalen may increase the photosensitizing activities of Verteporfin.,increase,no risk
Thiotepa,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Thiotepa.,increase,risk
Thiotepa,Bexarotene,The metabolism of Thiotepa can be increased when combined with Bexarotene.,increase,no risk
Thiotepa,Bicalutamide,The metabolism of Thiotepa can be decreased when combined with Bicalutamide.,decrease,no risk
Thiotepa,Bifonazole,The metabolism of Thiotepa can be decreased when combined with Bifonazole.,decrease,no risk
Thiotepa,Bimekizumab,The metabolism of Thiotepa can be increased when combined with Bimekizumab.,increase,no risk
Thiotepa,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Bisoprolol,Thiotepa may increase the bradycardic activities of Bisoprolol.,increase,no risk
Thiotepa,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Thiotepa.,increase,risk
Thiotepa,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Thiotepa.,increase,risk
Thiotepa,Blinatumomab,The risk or severity of adverse effects can be increased when Thiotepa is combined with Blinatumomab.,increase,risk
Thiotepa,Boceprevir,The metabolism of Thiotepa can be decreased when combined with Boceprevir.,decrease,no risk
Thiotepa,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Thiotepa.",decrease,no risk
Thiotepa,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Thiotepa.,increase,risk
Thiotepa,Bosentan,The metabolism of Thiotepa can be increased when combined with Bosentan.,increase,no risk
Thiotepa,Bosutinib,The metabolism of Thiotepa can be decreased when combined with Bosutinib.,decrease,no risk
Thiotepa,Brentuximab vedotin,The serum concentration of Thiotepa can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Thiotepa,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Thiotepa.,decrease,no risk
Thiotepa,Brodalumab,The risk or severity of adverse effects can be increased when Thiotepa is combined with Brodalumab.,increase,risk
Thiotepa,Brompheniramine,The metabolism of Brompheniramine can be decreased when combined with Thiotepa.,decrease,no risk
Thiotepa,Buclizine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Budesonide,The therapeutic efficacy of Thiotepa can be decreased when used in combination with Budesonide.,decrease,no risk
Thiotepa,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Bupivacaine.,increase,risk
Thiotepa,Buprenorphine,The metabolism of Thiotepa can be decreased when combined with Buprenorphine.,decrease,no risk
Thiotepa,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Thiotepa.,increase,no risk
Thiotepa,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Thiotepa.,increase,risk
Thiotepa,Butabarbital,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Butacaine,The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Butacaine.,increase,risk
Thiotepa,Butalbital,The metabolism of Thiotepa can be increased when combined with Butalbital.,increase,no risk
Thiotepa,Butamben,The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Butamben.,increase,risk
Thiotepa,Butobarbital,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Thiotepa.,increase,risk
Thiotepa,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Thiotepa.,increase,risk
Thiotepa,Gilteritinib,The metabolism of Thiotepa can be decreased when combined with Gilteritinib.,decrease,no risk
Thiotepa,Ginkgo biloba,The metabolism of Thiotepa can be decreased when combined with Ginkgo biloba.,decrease,no risk
Thiotepa,Glatiramer,The risk or severity of adverse effects can be increased when Thiotepa is combined with Glatiramer.,increase,risk
Thiotepa,Glecaprevir,The metabolism of Thiotepa can be decreased when combined with Glecaprevir.,decrease,no risk
Thiotepa,Glofitamab,The serum concentration of Thiotepa can be increased when it is combined with Glofitamab.,increase,no risk
Thiotepa,Glyburide,The metabolism of Thiotepa can be decreased when combined with Glyburide.,decrease,no risk
Thiotepa,Glycerol phenylbutyrate,The metabolism of Thiotepa can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Thiotepa,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Golimumab,The metabolism of Thiotepa can be increased when combined with Golimumab.,increase,no risk
Thiotepa,Grapefruit,The serum concentration of Thiotepa can be increased when it is combined with Grapefruit.,increase,no risk
Thiotepa,Griseofulvin,The metabolism of Thiotepa can be increased when combined with Griseofulvin.,increase,no risk
Thiotepa,Guselkumab,The risk or severity of adverse effects can be increased when Thiotepa is combined with Guselkumab.,increase,risk
Thiotepa,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Thiotepa.,increase,no risk
Thiotepa,Halothane,The metabolism of Halothane can be decreased when combined with Thiotepa.,decrease,no risk
Thiotepa,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Thiotepa.,increase,risk
Thiotepa,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Thiotepa.,increase,risk
Thiotepa,Hydralazine,The serum concentration of Thiotepa can be increased when it is combined with Hydralazine.,increase,no risk
Thiotepa,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Thiotepa.,increase,risk
Thiotepa,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Thiotepa.,decrease,no risk
Thiotepa,Hydrocortamate,The metabolism of Thiotepa can be increased when combined with Hydrocortamate.,increase,no risk
Thiotepa,Hydrocortisone,The therapeutic efficacy of Thiotepa can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Thiotepa,Hydrocortisone acetate,The therapeutic efficacy of Thiotepa can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Thiotepa,Hydrocortisone butyrate,The therapeutic efficacy of Thiotepa can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Thiotepa,Hydrocortisone cypionate,The therapeutic efficacy of Thiotepa can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Thiotepa,Hydrocortisone succinate,The therapeutic efficacy of Thiotepa can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Thiotepa,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Thiotepa.,increase,risk
Thiotepa,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Thiotepa.,increase,risk
Thiotepa,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Thiotepa.,increase,risk
Thiotepa,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Ketamine,The metabolism of Ketamine can be decreased when combined with Thiotepa.,decrease,no risk
Thiotepa,Ketazolam,The serum concentration of Thiotepa can be increased when it is combined with Ketazolam.,increase,no risk
Thiotepa,Ketoconazole,The metabolism of Thiotepa can be decreased when combined with Ketoconazole.,decrease,no risk
Thiotepa,Obinutuzumab,The risk or severity of adverse effects can be increased when Thiotepa is combined with Obinutuzumab.,increase,risk
Thiotepa,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Thiotepa.,increase,no risk
Thiotepa,Octreotide,The serum concentration of Thiotepa can be increased when it is combined with Octreotide.,increase,no risk
Thiotepa,Ofatumumab,The risk or severity of adverse effects can be increased when Thiotepa is combined with Ofatumumab.,increase,risk
Thiotepa,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Olaparib,The metabolism of Thiotepa can be decreased when combined with Olaparib.,decrease,no risk
Thiotepa,Olutasidenib,The metabolism of Thiotepa can be increased when combined with Olutasidenib.,increase,no risk
Thiotepa,Omaveloxolone,The serum concentration of Thiotepa can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Thiotepa,Oritavancin,The metabolism of Thiotepa can be increased when combined with Oritavancin.,increase,no risk
Thiotepa,Orphenadrine,The metabolism of Thiotepa can be decreased when combined with Orphenadrine.,decrease,no risk
Thiotepa,Osilodrostat,The metabolism of Thiotepa can be decreased when combined with Osilodrostat.,decrease,no risk
Thiotepa,Osimertinib,The metabolism of Thiotepa can be decreased when combined with Osimertinib.,decrease,no risk
Thiotepa,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Thiotepa.,decrease,no risk
Thiotepa,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Thiotepa.,increase,risk
Thiotepa,Oxcarbazepine,The metabolism of Thiotepa can be increased when combined with Oxcarbazepine.,increase,no risk
Thiotepa,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Oxetacaine.,increase,risk
Thiotepa,Oxprenolol,Thiotepa may increase the bradycardic activities of Oxprenolol.,increase,no risk
Thiotepa,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Oxybuprocaine.,increase,risk
Thiotepa,Oxybutynin,The serum concentration of Thiotepa can be increased when it is combined with Oxybutynin.,increase,no risk
Thiotepa,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Ozanimod,The risk or severity of adverse effects can be increased when Thiotepa is combined with Ozanimod.,increase,risk
Thiotepa,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Thiotepa.,decrease,no risk
Thiotepa,Quinidine,The metabolism of Thiotepa can be decreased when combined with Quinidine.,decrease,no risk
Thiotepa,Quinine,The metabolism of Thiotepa can be increased when combined with Quinine.,increase,no risk
Thiotepa,Quinupristin,The metabolism of Thiotepa can be decreased when combined with Quinupristin.,decrease,no risk
Estriol,Galcanezumab,Estriol may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Estriol,Gemtuzumab ozogamicin,Estriol may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Estriol,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Glofitamab,Estriol may increase the thrombogenic activities of Glofitamab.,increase,no risk
Estriol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Golimumab,Estriol may increase the thrombogenic activities of Golimumab.,increase,no risk
Estriol,Guselkumab,Estriol may increase the thrombogenic activities of Guselkumab.,increase,no risk
Estriol,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Hepatitis B immune globulin,Estriol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Estriol,Human cytomegalovirus immune globulin,Estriol may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Estriol,Human immunoglobulin G,Estriol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Estriol,Human Rho(D) immune globulin,Estriol may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Estriol,Human varicella-zoster immune globulin,Estriol may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Estriol,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Estriol.,decrease,no risk
Estriol,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Estriol.,increase,no risk
Estriol,Obiltoxaximab,Estriol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Estriol,Obinutuzumab,Estriol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Estriol,Ocrelizumab,Estriol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Estriol,Odesivimab,Estriol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Estriol,Ofatumumab,Estriol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Estriol,Olaratumab,Estriol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Estriol,Omalizumab,Estriol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Estriol,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Estriol is combined with Ombitasvir.,increase,risk
Estriol,Ospemifene,The risk or severity of adverse effects can be increased when Estriol is combined with Ospemifene.,increase,risk
Estriol,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Estriol.,increase,no risk
Estriol,Ublituximab,Estriol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Estriol,Urokinase,Estriol may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Estriol,Ustekinumab,Estriol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Estriol,Valdecoxib,Valdecoxib may increase the thrombogenic activities of Estriol.,increase,no risk
Estriol,Vedolizumab,Estriol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Estriol,Vorapaxar,Estriol may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Estriol,Warfarin,Estriol may decrease the anticoagulant activities of Warfarin.,decrease,no risk
Estriol,Ximelagatran,Estriol may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Estriol,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Estriol.,decrease,no risk
Estrone sulfate,Bacampicillin,The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Bacampicillin.,decrease,no risk
Estrone sulfate,Bacitracin,Bacitracin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Baclofen,Baclofen may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Balsalazide,Balsalazide may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Bamlanivimab,Estrone sulfate may increase the thrombogenic activities of Bamlanivimab.,increase,no risk
Estrone sulfate,Baricitinib,The excretion of Baricitinib can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Basiliximab,Estrone sulfate may increase the thrombogenic activities of Basiliximab.,increase,no risk
Estrone sulfate,Beclomethasone dipropionate,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Belantamab mafodotin,Estrone sulfate may increase the thrombogenic activities of Belantamab mafodotin.,increase,no risk
Estrone sulfate,Belimumab,Estrone sulfate may increase the thrombogenic activities of Belimumab.,increase,no risk
Estrone sulfate,Belinostat,The metabolism of Estrone sulfate can be increased when combined with Belinostat.,increase,no risk
Estrone sulfate,Belzutifan,The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Belzutifan.,decrease,no risk
Estrone sulfate,Bemiparin,Estrone sulfate may decrease the anticoagulant activities of Bemiparin.,decrease,no risk
Estrone sulfate,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estrone sulfate,Benorilate,Benorilate may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Benralizumab,Estrone sulfate may increase the thrombogenic activities of Benralizumab.,increase,no risk
Estrone sulfate,Benserazide,Estrone sulfate may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Benzatropine,Benzatropine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Benznidazole,Estrone sulfate may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Benzthiazide,Benzthiazide may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estrone sulfate,Benzydamine,Benzydamine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Benzylpenicillin,The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Benzylpenicillin.,decrease,no risk
Estrone sulfate,Benzylpenicilloyl polylysine,The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Benzylpenicilloyl polylysine.,decrease,no risk
Estrone sulfate,Bepotastine,Estrone sulfate may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Berotralstat,The metabolism of Estrone sulfate can be decreased when combined with Berotralstat.,decrease,no risk
Estrone sulfate,Besilesomab,Estrone sulfate may increase the thrombogenic activities of Besilesomab.,increase,no risk
Estrone sulfate,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Betrixaban,Estrone sulfate may decrease the anticoagulant activities of Betrixaban.,decrease,no risk
Estrone sulfate,Bevacizumab,Estrone sulfate may increase the thrombogenic activities of Bevacizumab.,increase,no risk
Estrone sulfate,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bexarotene,The metabolism of Estrone sulfate can be increased when combined with Bexarotene.,increase,no risk
Estrone sulfate,Bezlotoxumab,Estrone sulfate may increase the thrombogenic activities of Bezlotoxumab.,increase,no risk
Estrone sulfate,Bicisate,Estrone sulfate may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Bictegravir,The excretion of Estrone sulfate can be decreased when combined with Bictegravir.,decrease,no risk
Estrone sulfate,Bimekizumab,The metabolism of Estrone sulfate can be increased when combined with Bimekizumab.,increase,no risk
Estrone sulfate,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bismuth subgallate,Estrone sulfate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Bisoprolol,Bisoprolol may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Bisoxatin,Estrone sulfate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Bivalirudin,Estrone sulfate may decrease the anticoagulant activities of Bivalirudin.,decrease,no risk
Estrone sulfate,Bleomycin,Bleomycin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Blinatumomab,Estrone sulfate may increase the thrombogenic activities of Blinatumomab.,increase,no risk
Estrone sulfate,Boceprevir,The serum concentration of Estrone sulfate can be increased when it is combined with Boceprevir.,increase,no risk
Estrone sulfate,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bosentan,The serum concentration of Estrone sulfate can be decreased when it is combined with Bosentan.,decrease,no risk
Estrone sulfate,Brentuximab vedotin,Estrone sulfate may increase the thrombogenic activities of Brentuximab vedotin.,increase,no risk
Estrone sulfate,Brexanolone,The metabolism of Estrone sulfate can be increased when combined with Brexanolone.,increase,no risk
Estrone sulfate,Brigatinib,The excretion of Estrone sulfate can be decreased when combined with Brigatinib.,decrease,no risk
Estrone sulfate,Brivaracetam,The metabolism of Estrone sulfate can be increased when combined with Brivaracetam.,increase,no risk
Estrone sulfate,Brodalumab,Estrone sulfate may increase the thrombogenic activities of Brodalumab.,increase,no risk
Estrone sulfate,Brolucizumab,Estrone sulfate may increase the thrombogenic activities of Brolucizumab.,increase,no risk
Estrone sulfate,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bromotheophylline,Bromotheophylline may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estrone sulfate,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Bumadizone,Bumadizone may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Bumetanide,Bumetanide may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estrone sulfate,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Bupropion,The metabolism of Bupropion can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Burosumab,Estrone sulfate may increase the thrombogenic activities of Burosumab.,increase,no risk
Estrone sulfate,Buspirone,Buspirone may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Butabarbital,Butabarbital may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Butalbital,The metabolism of Estrone sulfate can be increased when combined with Butalbital.,increase,no risk
Estrone sulfate,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Gabapentin,The metabolism of Estrone sulfate can be increased when combined with Gabapentin.,increase,no risk
Estrone sulfate,Gabapentin enacarbil,Estrone sulfate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gadodiamide,Gadodiamide may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gadofosveset trisodium,Estrone sulfate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gadoteric acid,Estrone sulfate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gadoteridol,Gadoteridol may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Galcanezumab,Estrone sulfate may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Estrone sulfate,Ganaxolone,The metabolism of Estrone sulfate can be increased when combined with Ganaxolone.,increase,no risk
Estrone sulfate,Ganciclovir,The excretion of Estrone sulfate can be decreased when combined with Ganciclovir.,decrease,no risk
Estrone sulfate,Gatifloxacin,The metabolism of Estrone sulfate can be decreased when combined with Gatifloxacin.,decrease,no risk
Estrone sulfate,Gemcitabine,Gemcitabine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gemfibrozil,The metabolism of Estrone sulfate can be decreased when combined with Gemfibrozil.,decrease,no risk
Estrone sulfate,Gemifloxacin,The metabolism of Estrone sulfate can be decreased when combined with Gemifloxacin.,decrease,no risk
Estrone sulfate,Gemtuzumab ozogamicin,Estrone sulfate may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Estrone sulfate,Gentamicin,Estrone sulfate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Gilteritinib,The excretion of Estrone sulfate can be decreased when combined with Gilteritinib.,decrease,no risk
Estrone sulfate,Gimeracil,Estrone sulfate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Ginkgo biloba,The metabolism of Estrone sulfate can be decreased when combined with Ginkgo biloba.,decrease,no risk
Estrone sulfate,Givosiran,The serum concentration of Estrone sulfate can be increased when it is combined with Givosiran.,increase,no risk
Estrone sulfate,Glasdegib,The excretion of Estrone sulfate can be decreased when combined with Glasdegib.,decrease,no risk
Estrone sulfate,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Glofitamab,The serum concentration of Estrone sulfate can be increased when it is combined with Glofitamab.,increase,no risk
Estrone sulfate,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Glycerol phenylbutyrate,The metabolism of Estrone sulfate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Estrone sulfate,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Golimumab,The metabolism of Estrone sulfate can be increased when combined with Golimumab.,increase,no risk
Estrone sulfate,Golodirsen,Estrone sulfate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Goserelin,Goserelin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Grepafloxacin,The metabolism of Estrone sulfate can be decreased when combined with Grepafloxacin.,decrease,no risk
Estrone sulfate,Griseofulvin,The metabolism of Estrone sulfate can be increased when combined with Griseofulvin.,increase,no risk
Estrone sulfate,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Guanethidine,Guanethidine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Guanfacine,Guanfacine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Guanidine,The excretion of Estrone sulfate can be decreased when combined with Guanidine.,decrease,no risk
Estrone sulfate,Guselkumab,Estrone sulfate may increase the thrombogenic activities of Guselkumab.,increase,no risk
Estrone sulfate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Halothane,The metabolism of Halothane can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Hepatitis B immune globulin,Estrone sulfate may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Estrone sulfate,Hetacillin,The therapeutic efficacy of Estrone sulfate can be decreased when used in combination with Hetacillin.,decrease,no risk
Estrone sulfate,Human cytomegalovirus immune globulin,Estrone sulfate may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Estrone sulfate,Human immunoglobulin G,Estrone sulfate may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Estrone sulfate,Human Rho(D) immune globulin,Estrone sulfate may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Estrone sulfate,Human varicella-zoster immune globulin,Estrone sulfate may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Estrone sulfate,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Estrone sulfate.,decrease,no risk
Estrone sulfate,Hydralazine,Hydralazine may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estrone sulfate,Hydrocortamate,The metabolism of Estrone sulfate can be increased when combined with Hydrocortamate.,increase,no risk
Estrone sulfate,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Estrone sulfate.,increase,no risk
Estrone sulfate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Estrone sulfate,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Hydroxyethyl Starch,Estrone sulfate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Kanamycin,Estrone sulfate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Ketamine,The metabolism of Ketamine can be decreased when combined with Estrone sulfate.,decrease,no risk
Estrone sulfate,Ketazolam,Ketazolam may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Ketoconazole,The metabolism of Estrone sulfate can be decreased when combined with Ketoconazole.,decrease,no risk
Estrone sulfate,Ketoprofen,Ketoprofen may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.,decrease,no risk
Estrone sulfate,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Estrone sulfate.,decrease,no risk
Quinestrol,Galcanezumab,Quinestrol may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Quinestrol,Gemtuzumab ozogamicin,Quinestrol may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Quinestrol,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Glofitamab,Quinestrol may increase the thrombogenic activities of Glofitamab.,increase,no risk
Quinestrol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Golimumab,Quinestrol may increase the thrombogenic activities of Golimumab.,increase,no risk
Quinestrol,Guselkumab,Quinestrol may increase the thrombogenic activities of Guselkumab.,increase,no risk
Quinestrol,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Hepatitis B immune globulin,Quinestrol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Quinestrol,Human cytomegalovirus immune globulin,Quinestrol may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Quinestrol,Human immunoglobulin G,Quinestrol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Quinestrol,Human Rho(D) immune globulin,Quinestrol may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Quinestrol,Human varicella-zoster immune globulin,Quinestrol may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Quinestrol,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Quinestrol.,decrease,no risk
Quinestrol,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Quinestrol.,increase,no risk
Quinestrol,Obiltoxaximab,Quinestrol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Quinestrol,Obinutuzumab,Quinestrol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Quinestrol,Ocrelizumab,Quinestrol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Quinestrol,Odesivimab,Quinestrol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Quinestrol,Ofatumumab,Quinestrol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Quinestrol,Olaratumab,Quinestrol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Quinestrol,Omalizumab,Quinestrol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Quinestrol,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Quinestrol is combined with Ombitasvir.,increase,risk
Quinestrol,Ospemifene,The risk or severity of adverse effects can be increased when Quinestrol is combined with Ospemifene.,increase,risk
Quinestrol,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Quinestrol.,increase,no risk
Quinestrol,Ublituximab,Quinestrol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Quinestrol,Urokinase,Quinestrol may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Quinestrol,Ustekinumab,Quinestrol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Quinestrol,Valdecoxib,Valdecoxib may increase the thrombogenic activities of Quinestrol.,increase,no risk
Quinestrol,Vedolizumab,Quinestrol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Quinestrol,Vorapaxar,Quinestrol may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Quinestrol,Warfarin,Quinestrol may decrease the anticoagulant activities of Warfarin.,decrease,no risk
Quinestrol,Ximelagatran,Quinestrol may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Quinestrol,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Quinestrol.,decrease,no risk
Fleroxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Gadobenic acid.,increase,risk
Fleroxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Fleroxacin.,increase,risk
Fleroxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Fleroxacin.,increase,risk
Fleroxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Gemifloxacin.,increase,risk
Fleroxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Fleroxacin.,increase,risk
Fleroxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Gilteritinib.,increase,risk
Fleroxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Glasdegib.,increase,risk
Fleroxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Fleroxacin.,increase,no risk
Fleroxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Goserelin.,increase,risk
Fleroxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Granisetron.,increase,risk
Fleroxacin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Grepafloxacin.,increase,risk
Fleroxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Halofantrine.,increase,risk
Fleroxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Haloperidol.,increase,risk
Fleroxacin,Hetacillin,The serum concentration of Fleroxacin can be increased when it is combined with Hetacillin.,increase,no risk
Fleroxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Histrelin.,increase,risk
Fleroxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Fleroxacin.,increase,risk
Fleroxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Hydroxyzine.,increase,risk
Fleroxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Fleroxacin.,increase,risk
Fleroxacin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Fleroxacin.,increase,risk
Fleroxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Fleroxacin.,increase,no risk
Fleroxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Fleroxacin.,increase,no risk
Fleroxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Fleroxacin.,increase,risk
Fleroxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Ofloxacin.,increase,risk
Fleroxacin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Fleroxacin.,increase,risk
Fleroxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Olodaterol.,increase,risk
Fleroxacin,Ondansetron,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Ondansetron.,increase,risk
Fleroxacin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Fleroxacin.,increase,risk
Fleroxacin,Oxacillin,The serum concentration of Fleroxacin can be increased when it is combined with Oxacillin.,increase,no risk
Fleroxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Fleroxacin.,increase,risk
Fleroxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Fleroxacin.,increase,no risk
Fleroxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Oxatomide.,increase,risk
Fleroxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fleroxacin is combined with Oxetacaine.,increase,risk
Fleroxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Fleroxacin.,decrease,no risk
Fleroxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fleroxacin is combined with Oxybuprocaine.,increase,risk
Fleroxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Fleroxacin.,increase,no risk
Fleroxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Fleroxacin.,increase,risk
Fleroxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Quetiapine.,increase,risk
Fleroxacin,Quinapril,Quinapril can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Quinidine.,increase,risk
Fleroxacin,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Quizartinib.,increase,risk
Fleroxacin,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Fleroxacin.,increase,no risk
Fleroxacin,Valproic acid,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Valproic acid.,increase,risk
Fleroxacin,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Fleroxacin.,increase,risk
Fleroxacin,Vandetanib,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Vandetanib.,increase,risk
Fleroxacin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Fleroxacin.,increase,risk
Fleroxacin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Fleroxacin.,increase,risk
Fleroxacin,Vernakalant,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Vernakalant.,increase,risk
Fleroxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fleroxacin.,decrease,no risk
Fleroxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Fleroxacin.,increase,risk
Fleroxacin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Fleroxacin.,increase,risk
Fleroxacin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Fleroxacin.,increase,risk
Fleroxacin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Fleroxacin.,increase,no risk
Fleroxacin,Zinc,Zinc can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Fleroxacin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Fleroxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Ziprasidone.,increase,risk
Fleroxacin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Fleroxacin.,increase,risk
1-benzylimidazole,Guanabenz,1-benzylimidazole may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
1-benzylimidazole,Guanadrel,1-benzylimidazole may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
1-benzylimidazole,Guanethidine,1-benzylimidazole may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
1-benzylimidazole,Guanfacine,1-benzylimidazole may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
1-benzylimidazole,Guanoxan,1-benzylimidazole may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
1-benzylimidazole,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Hydralazine,1-benzylimidazole may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
1-benzylimidazole,Hydrochlorothiazide,1-benzylimidazole may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
1-benzylimidazole,Hydroflumethiazide,1-benzylimidazole may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
1-benzylimidazole,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Olmesartan,1-benzylimidazole may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
1-benzylimidazole,Olodaterol,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Olodaterol.,increase,risk
1-benzylimidazole,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Oxprenolol,1-benzylimidazole may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
1-benzylimidazole,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Quinapril,1-benzylimidazole may decrease the antihypertensive activities of Quinapril.,decrease,no risk
1-benzylimidazole,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Quinupramine,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Quinupramine.,increase,risk
1-benzylimidazole,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Valsartan,1-benzylimidazole may decrease the antihypertensive activities of Valsartan.,decrease,no risk
1-benzylimidazole,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with 1-benzylimidazole.,decrease,no risk
1-benzylimidazole,Vilanterol,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Vilanterol.,increase,risk
1-benzylimidazole,Vilazodone,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Vilazodone.,increase,risk
1-benzylimidazole,Vortioxetine,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Vortioxetine.,increase,risk
1-benzylimidazole,Xamoterol,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Xamoterol.,increase,risk
1-benzylimidazole,Xylometazoline,The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Xylometazoline.,increase,risk
1-benzylimidazole,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Zofenopril,1-benzylimidazole may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
1-benzylimidazole,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with 1-benzylimidazole.,increase,risk
1-benzylimidazole,Zuclopenthixol,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with 1-benzylimidazole.,increase,risk
Aniracetam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Aniracetam.,increase,risk
Aniracetam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Aniracetam is combined with Gabapentin enacarbil.,increase,risk
Aniracetam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Aniracetam.,increase,risk
Aniracetam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Aniracetam is combined with Ganaxolone.",increase,risk
Aniracetam,Gepirone,The risk or severity of CNS depression can be increased when Aniracetam is combined with Gepirone.,increase,risk
Aniracetam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Aniracetam.,increase,risk
Aniracetam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Aniracetam.,increase,risk
Aniracetam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Aniracetam.,increase,risk
Aniracetam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Aniracetam.,increase,risk
Aniracetam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Aniracetam.,increase,risk
Aniracetam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Aniracetam.,increase,risk
Aniracetam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Aniracetam.,increase,risk
Aniracetam,Hydrocodone,Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Aniracetam,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Aniracetam.,increase,risk
Aniracetam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Aniracetam.,increase,no risk
Aniracetam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Aniracetam.,increase,risk
Aniracetam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Aniracetam.,increase,risk
Aniracetam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Aniracetam.,increase,risk
Aniracetam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Aniracetam is combined with Oliceridine.",increase,risk
Aniracetam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Aniracetam.,increase,risk
Aniracetam,Opium,The risk or severity of CNS depression can be increased when Aniracetam is combined with Opium.,increase,risk
Aniracetam,Orphenadrine,Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Aniracetam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Aniracetam.,increase,risk
Aniracetam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Aniracetam.,increase,risk
Aniracetam,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Aniracetam.,increase,risk
Aniracetam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Aniracetam.,increase,risk
Aniracetam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Aniracetam.,increase,risk
Aniracetam,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Aniracetam.,increase,risk
Aniracetam,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Aniracetam.,increase,risk
Aniracetam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Aniracetam.,increase,risk
Aniracetam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Aniracetam.,increase,risk
Aniracetam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Aniracetam.,increase,risk
Aniracetam,Quinupramine,The risk or severity of CNS depression can be increased when Aniracetam is combined with Quinupramine.,increase,risk
Aniracetam,Urethane,The risk or severity of CNS depression can be increased when Aniracetam is combined with Urethane.,increase,risk
Aniracetam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Aniracetam.,increase,risk
Aniracetam,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Aniracetam.,increase,risk
Aniracetam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Aniracetam.,increase,risk
Aniracetam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Aniracetam.,increase,risk
Aniracetam,Vilazodone,The risk or severity of CNS depression can be increased when Aniracetam is combined with Vilazodone.,increase,risk
Aniracetam,Viloxazine,The risk or severity of CNS depression can be increased when Aniracetam is combined with Viloxazine.,increase,risk
Aniracetam,Vortioxetine,The risk or severity of CNS depression can be increased when Aniracetam is combined with Vortioxetine.,increase,risk
Aniracetam,Warfarin,The risk or severity of adverse effects can be increased when Aniracetam is combined with Warfarin.,increase,risk
Aniracetam,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Aniracetam.,increase,risk
Aniracetam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Aniracetam.,increase,risk
Aniracetam,Ziconotide,The risk or severity of CNS depression can be increased when Aniracetam is combined with Ziconotide.,increase,risk
Aniracetam,Zimelidine,The risk or severity of adverse effects can be increased when Aniracetam is combined with Zimelidine.,increase,risk
Aniracetam,Ziprasidone,The risk or severity of adverse effects can be increased when Aniracetam is combined with Ziprasidone.,increase,risk
Aniracetam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Aniracetam.,increase,risk
Aniracetam,Zolpidem,Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Aniracetam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Aniracetam.,increase,risk
Aniracetam,Zopiclone,The risk or severity of adverse effects can be increased when Aniracetam is combined with Zopiclone.,increase,risk
Aniracetam,Zotepine,The risk or severity of CNS depression can be increased when Aniracetam is combined with Zotepine.,increase,risk
Aniracetam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Aniracetam.,increase,risk
Aniracetam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Aniracetam.,increase,risk
Acetophenone,Verteporfin,Acetophenone may increase the photosensitizing activities of Verteporfin.,increase,no risk
Apramycin,Gabapentin enacarbil,Apramycin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Apramycin,Gadobenic acid,Apramycin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Apramycin,Gadodiamide,Apramycin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Apramycin,Gadofosveset trisodium,Apramycin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Apramycin,Gadopentetic acid,Apramycin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Apramycin,Gadoteric acid,Apramycin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Apramycin,Gadoteridol,Apramycin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Apramycin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Apramycin.,increase,no risk
Apramycin,Ganciclovir,Apramycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Apramycin,Gemcitabine,Apramycin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Apramycin,Gemfibrozil,Apramycin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Apramycin,Gentamicin,Apramycin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Apramycin,Gimeracil,Apramycin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Apramycin,Givosiran,The risk or severity of nephrotoxicity can be increased when Apramycin is combined with Givosiran.,increase,risk
Apramycin,Glipizide,Apramycin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Apramycin,Glycerol phenylbutyrate,Apramycin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Apramycin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Apramycin.,increase,risk
Apramycin,Golodirsen,Apramycin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Apramycin,Goserelin,Apramycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Apramycin,Guanethidine,Apramycin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Apramycin,Guanfacine,Apramycin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Apramycin,Haloperidol,Apramycin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Apramycin,Heparin,The therapeutic efficacy of Apramycin can be decreased when used in combination with Heparin.,decrease,no risk
Apramycin,Hetacillin,The serum concentration of Apramycin can be decreased when it is combined with Hetacillin.,decrease,no risk
Apramycin,Hydralazine,Apramycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Apramycin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Apramycin.,increase,risk
Apramycin,Hydromorphone,Apramycin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Apramycin,Hydroxocobalamin,Apramycin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Apramycin,Hydroxyethyl Starch,Apramycin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Apramycin,Kanamycin,Apramycin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Apramycin,Ketamine,Apramycin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Apramycin,Ketazolam,Apramycin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Apramycin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Apramycin.,increase,risk
Apramycin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Apramycin.,increase,risk
Apramycin,Octinoxate,Apramycin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Apramycin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Apramycin is combined with Olsalazine.,increase,risk
Apramycin,Opium,Apramycin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Apramycin,Oseltamivir,Apramycin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Apramycin,Ouabain,The risk or severity of adverse effects can be increased when Apramycin is combined with Ouabain.,increase,risk
Apramycin,Oxacillin,The serum concentration of Apramycin can be decreased when it is combined with Oxacillin.,decrease,no risk
Apramycin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Apramycin.,increase,risk
Apramycin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Apramycin.,increase,risk
Apramycin,Oxazepam,Apramycin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Apramycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Apramycin is combined with Oxetacaine.,increase,risk
Apramycin,Oxybenzone,Apramycin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Apramycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Apramycin is combined with Oxybuprocaine.,increase,risk
Apramycin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Apramycin.,increase,risk
Apramycin,Oxyquinoline,Apramycin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Apramycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Apramycin.,increase,risk
Apramycin,Quetiapine,Apramycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Apramycin,Quinidine,Apramycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Apramycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Apramycin.,increase,risk
Apramycin,Vaborbactam,Apramycin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Apramycin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Apramycin.,increase,risk
Apramycin,Valbenazine,Apramycin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Apramycin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Apramycin.,increase,risk
Apramycin,Valganciclovir,Apramycin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Apramycin,Vancomycin,Apramycin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Apramycin,Varenicline,The therapeutic efficacy of Varenicline can be decreased when used in combination with Apramycin.,decrease,no risk
Apramycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Apramycin.,increase,no risk
Apramycin,Venlafaxine,Apramycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Apramycin,Verapamil,Apramycin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Apramycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Apramycin.,decrease,no risk
Apramycin,Vilanterol,Apramycin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Apramycin,Viloxazine,Apramycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Apramycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Apramycin is combined with Viomycin.,increase,risk
Apramycin,Vortioxetine,Apramycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Apramycin,Warfarin,Apramycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Apramycin,Zaleplon,Apramycin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Apramycin,Zanamivir,Apramycin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Apramycin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Apramycin is combined with Zoledronic acid.,increase,risk
Apramycin,Zonisamide,Apramycin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Aldosterone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Aldosterone is combined with Gatifloxacin.,increase,risk
Aldosterone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Aldosterone.,increase,risk
Aldosterone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Aldosterone is combined with Gemifloxacin.,increase,risk
Aldosterone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Aldosterone.,increase,risk
Aldosterone,Gestrinone,The serum concentration of Aldosterone can be increased when it is combined with Gestrinone.,increase,no risk
Aldosterone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Glatiramer,The risk or severity of adverse effects can be increased when Aldosterone is combined with Glatiramer.,increase,risk
Aldosterone,Gliclazide,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Gliclazide.,increase,risk
Aldosterone,Glimepiride,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Glimepiride.,increase,risk
Aldosterone,Glipizide,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Glipizide.,increase,risk
Aldosterone,Gliquidone,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Gliquidone.,increase,risk
Aldosterone,Glofitamab,The serum concentration of Aldosterone can be increased when it is combined with Glofitamab.,increase,no risk
Aldosterone,Glyburide,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Glyburide.,increase,risk
Aldosterone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Glycol salicylate.,increase,risk
Aldosterone,Glymidine,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Glymidine.,increase,risk
Aldosterone,Golimumab,The risk or severity of adverse effects can be increased when Aldosterone is combined with Golimumab.,increase,risk
Aldosterone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Aldosterone is combined with Grepafloxacin.,increase,risk
Aldosterone,Guselkumab,The risk or severity of adverse effects can be increased when Aldosterone is combined with Guselkumab.,increase,risk
Aldosterone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Aldosterone.,increase,no risk
Aldosterone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Aldosterone is combined with Hydrochlorothiazide.,increase,risk
Aldosterone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Aldosterone is combined with Hydrocortisone acetate.,increase,risk
Aldosterone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Aldosterone is combined with Hydrocortisone butyrate.,increase,risk
Aldosterone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Aldosterone is combined with Hydrocortisone succinate.,increase,risk
Aldosterone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Aldosterone is combined with Hydroflumethiazide.,increase,risk
Aldosterone,Hydrotalcite,The bioavailability of Aldosterone can be decreased when combined with Hydrotalcite.,decrease,no risk
Aldosterone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Aldosterone.,increase,risk
Aldosterone,Hydroxyprogesterone caproate,The serum concentration of Aldosterone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Aldosterone,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Aldosterone.,increase,risk
Aldosterone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Aldosterone.,decrease,no risk
Aldosterone,Ketoconazole,The metabolism of Aldosterone can be decreased when combined with Ketoconazole.,decrease,no risk
Aldosterone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Ketoprofen.,increase,risk
Aldosterone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Ketorolac.,increase,risk
Aldosterone,Obinutuzumab,The risk or severity of adverse effects can be increased when Aldosterone is combined with Obinutuzumab.,increase,risk
Aldosterone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Aldosterone.,increase,no risk
Aldosterone,Ofatumumab,The risk or severity of adverse effects can be increased when Aldosterone is combined with Ofatumumab.,increase,risk
Aldosterone,Ofloxacin,The risk or severity of tendinopathy can be increased when Aldosterone is combined with Ofloxacin.,increase,risk
Aldosterone,Olaparib,The risk or severity of adverse effects can be increased when Aldosterone is combined with Olaparib.,increase,risk
Aldosterone,Olodaterol,The risk or severity of hypokalemia can be increased when Aldosterone is combined with Olodaterol.,increase,risk
Aldosterone,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Aldosterone.,decrease,no risk
Aldosterone,Omaveloxolone,The serum concentration of Aldosterone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Aldosterone,Orciprenaline,The risk or severity of hypokalemia can be increased when Aldosterone is combined with Orciprenaline.,increase,risk
Aldosterone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Aldosterone.,increase,risk
Aldosterone,Oxandrolone,The risk or severity of fluid retention can be increased when Aldosterone is combined with Oxandrolone.,increase,risk
Aldosterone,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Oxaprozin.,increase,risk
Aldosterone,Oxymetholone,The risk or severity of fluid retention can be increased when Aldosterone is combined with Oxymetholone.,increase,risk
Aldosterone,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Aldosterone is combined with Oxyphenbutazone.,increase,risk
Aldosterone,Ozanimod,The risk or severity of adverse effects can be increased when Aldosterone is combined with Ozanimod.,increase,risk
Aldosterone,Quinestrol,The serum concentration of Aldosterone can be increased when it is combined with Quinestrol.,increase,no risk
Aldosterone,Quinethazone,Aldosterone may increase the hypokalemic activities of Quinethazone.,increase,no risk
Aldosterone,Quinine,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Quinine.,increase,risk
Corticosterone,Viloxazine,The metabolism of Corticosterone can be decreased when combined with Viloxazine.,decrease,no risk
Corticosterone,Voriconazole,The metabolism of Corticosterone can be decreased when combined with Voriconazole.,decrease,no risk
Corticosterone,Zimelidine,The metabolism of Corticosterone can be decreased when combined with Zimelidine.,decrease,no risk
Corticosterone,Ziprasidone,The metabolism of Corticosterone can be decreased when combined with Ziprasidone.,decrease,no risk
Metoprine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Benzocaine.,increase,risk
Metoprine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Benzyl alcohol.,increase,risk
Metoprine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Bupivacaine.,increase,risk
Metoprine,Butacaine,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Butacaine.,increase,risk
Metoprine,Butamben,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Butamben.,increase,risk
Metoprine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Oxetacaine.,increase,risk
Metoprine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Metoprine is combined with Oxybuprocaine.,increase,risk
Coumarin,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Coumarin.,decrease,no risk
Coumarin,Betamethasone,Betamethasone may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Betamethasone phosphate,Betamethasone phosphate may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Betrixaban,The risk or severity of bleeding can be increased when Coumarin is combined with Betrixaban.,increase,risk
Coumarin,Bexarotene,The risk or severity of bleeding can be increased when Coumarin is combined with Bexarotene.,increase,risk
Coumarin,Bezafibrate,The risk or severity of bleeding can be increased when Bezafibrate is combined with Coumarin.,increase,risk
Coumarin,Bifonazole,The therapeutic efficacy of Coumarin can be increased when used in combination with Bifonazole.,increase,no risk
Coumarin,Bimekizumab,The metabolism of Coumarin can be increased when combined with Bimekizumab.,increase,no risk
Coumarin,Bismuth subsalicylate,Bismuth subsalicylate may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Coumarin.,increase,risk
Coumarin,Blinatumomab,The risk or severity of bleeding can be increased when Coumarin is combined with Blinatumomab.,increase,risk
Coumarin,Bortezomib,The risk or severity of bleeding can be increased when Coumarin is combined with Bortezomib.,increase,risk
Coumarin,Bosentan,The metabolism of Coumarin can be increased when combined with Bosentan.,increase,no risk
Coumarin,Bosutinib,The risk or severity of bleeding can be increased when Coumarin is combined with Bosutinib.,increase,risk
Coumarin,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Coumarin.,increase,risk
Coumarin,Brexpiprazole,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Coumarin.,increase,risk
Coumarin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Coumarin.,decrease,no risk
Coumarin,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Coumarin.,increase,risk
Coumarin,Budesonide,Budesonide may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Coumarin.,increase,risk
Coumarin,Buprenorphine,The metabolism of Coumarin can be decreased when combined with Buprenorphine.,decrease,no risk
Coumarin,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Coumarin.,increase,risk
Coumarin,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Coumarin.,increase,risk
Coumarin,Busulfan,The risk or severity of bleeding can be increased when Coumarin is combined with Busulfan.,increase,risk
Coumarin,Butabarbital,The metabolism of Coumarin can be increased when combined with Butabarbital.,increase,no risk
Coumarin,Butalbital,The metabolism of Coumarin can be increased when combined with Butalbital.,increase,no risk
Coumarin,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Coumarin.,increase,risk
Coumarin,Gatifloxacin,The therapeutic efficacy of Coumarin can be increased when used in combination with Gatifloxacin.,increase,no risk
Coumarin,Gefitinib,Gefitinib may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Gemcitabine,The therapeutic efficacy of Coumarin can be increased when used in combination with Gemcitabine.,increase,no risk
Coumarin,Gemfibrozil,The metabolism of Coumarin can be decreased when combined with Gemfibrozil.,decrease,no risk
Coumarin,Gemifloxacin,The therapeutic efficacy of Coumarin can be increased when used in combination with Gemifloxacin.,increase,no risk
Coumarin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Coumarin is combined with Gemtuzumab ozogamicin.,increase,risk
Coumarin,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with Coumarin.,increase,risk
Coumarin,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with Coumarin.,increase,risk
Coumarin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Coumarin.,increase,risk
Coumarin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Gliclazide,Gliclazide may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Glimepiride,Glimepiride may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Glipizide,Glipizide may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Gliquidone,Gliquidone may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Glofitamab,The serum concentration of Coumarin can be increased when it is combined with Glofitamab.,increase,no risk
Coumarin,Glucagon,The therapeutic efficacy of Coumarin can be increased when used in combination with Glucagon.,increase,no risk
Coumarin,Glutethimide,The therapeutic efficacy of Coumarin can be decreased when used in combination with Glutethimide.,decrease,no risk
Coumarin,Glyburide,The metabolism of Coumarin can be decreased when combined with Glyburide.,decrease,no risk
Coumarin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Coumarin.,increase,risk
Coumarin,Golimumab,The metabolism of Coumarin can be increased when combined with Golimumab.,increase,no risk
Coumarin,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with Coumarin.,increase,risk
Coumarin,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Coumarin.,increase,risk
Coumarin,Grepafloxacin,The therapeutic efficacy of Coumarin can be increased when used in combination with Grepafloxacin.,increase,no risk
Coumarin,Griseofulvin,The therapeutic efficacy of Coumarin can be increased when used in combination with Griseofulvin.,increase,no risk
Coumarin,Haloperidol,The metabolism of Coumarin can be decreased when combined with Haloperidol.,decrease,no risk
Coumarin,Haloprogin,The therapeutic efficacy of Coumarin can be increased when used in combination with Haloprogin.,increase,no risk
Coumarin,Halothane,The metabolism of Coumarin can be decreased when combined with Halothane.,decrease,no risk
Coumarin,Hemin,Hemin may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Coumarin.,increase,risk
Coumarin,Hetacillin,Hetacillin may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Hexetidine,The therapeutic efficacy of Coumarin can be increased when used in combination with Hexetidine.,increase,no risk
Coumarin,Hydrochlorothiazide,The therapeutic efficacy of Coumarin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Coumarin,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Hydroflumethiazide,The therapeutic efficacy of Coumarin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Coumarin,Hydromorphone,The metabolism of Coumarin can be decreased when combined with Hydromorphone.,decrease,no risk
Coumarin,Hydroxyprogesterone caproate,The therapeutic efficacy of Coumarin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Coumarin,Hydroxyurea,The risk or severity of bleeding can be increased when Coumarin is combined with Hydroxyurea.,increase,risk
Coumarin,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with Coumarin.,increase,risk
Coumarin,Ketamine,The metabolism of Coumarin can be decreased when combined with Ketamine.,decrease,no risk
Coumarin,Ketoconazole,The therapeutic efficacy of Coumarin can be increased when used in combination with Ketoconazole.,increase,no risk
Coumarin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Coumarin.,increase,risk
Coumarin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Coumarin.,increase,risk
Coumarin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Coumarin is combined with Obeticholic acid.,increase,risk
Coumarin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Coumarin is combined with Obinutuzumab.,increase,risk
Coumarin,Ofloxacin,The therapeutic efficacy of Coumarin can be increased when used in combination with Ofloxacin.,increase,no risk
Coumarin,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Coumarin.,increase,risk
Coumarin,Olaparib,The risk or severity of bleeding can be increased when Coumarin is combined with Olaparib.,increase,risk
Coumarin,Olive oil,The therapeutic efficacy of Coumarin can be decreased when used in combination with Olive oil.,decrease,no risk
Coumarin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Coumarin.,decrease,no risk
Coumarin,Olsalazine,Olsalazine may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Coumarin is combined with Omacetaxine mepesuccinate.,increase,risk
Coumarin,Omadacycline,Omadacycline may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Coumarin.,increase,risk
Coumarin,Omega-3-carboxylic acids,The therapeutic efficacy of Coumarin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Coumarin,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Coumarin.,increase,risk
Coumarin,Oritavancin,The risk or severity of bleeding can be increased when Oritavancin is combined with Coumarin.,increase,risk
Coumarin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Coumarin.,decrease,no risk
Coumarin,Oxacillin,Oxacillin may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Coumarin.,increase,risk
Coumarin,Oxandrolone,Oxandrolone may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Coumarin.,increase,risk
Coumarin,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Coumarin.,increase,risk
Coumarin,Oxymetholone,Oxymetholone may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Coumarin.,increase,risk
Coumarin,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Coumarin.,increase,risk
Coumarin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Coumarin.,decrease,no risk
Coumarin,Quinidine,The therapeutic efficacy of Coumarin can be increased when used in combination with Quinidine.,increase,no risk
Coumarin,Quinine,The therapeutic efficacy of Coumarin can be increased when used in combination with Quinine.,increase,no risk
Coumarin,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Coumarin.,increase,risk
Coumarin,Quinupristin,The risk or severity of bleeding can be increased when Quinupristin is combined with Coumarin.,increase,risk
Coumarin,Ubidecarenone,The therapeutic efficacy of Coumarin can be decreased when used in combination with Ubidecarenone.,decrease,no risk
Coumarin,Ulipristal,The therapeutic efficacy of Coumarin can be decreased when used in combination with Ulipristal.,decrease,no risk
Coumarin,Urokinase,Urokinase may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Coumarin is combined with Ursodeoxycholic acid.,increase,risk
Coumarin,Vadadustat,The metabolism of Coumarin can be decreased when combined with Vadadustat.,decrease,no risk
Coumarin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Coumarin.,increase,risk
Coumarin,Valproic acid,The metabolism of Coumarin can be decreased when combined with Valproic acid.,decrease,no risk
Coumarin,Valsartan,The metabolism of Coumarin can be decreased when combined with Valsartan.,decrease,no risk
Coumarin,Vamorolone,Vamorolone may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Vancomycin,The risk or severity of bleeding can be increased when Vancomycin is combined with Coumarin.,increase,risk
Coumarin,Vardenafil,The metabolism of Coumarin can be decreased when combined with Vardenafil.,decrease,no risk
Coumarin,Vemurafenib,The metabolism of Coumarin can be decreased when combined with Vemurafenib.,decrease,no risk
Coumarin,Venlafaxine,The risk or severity of bleeding can be increased when Coumarin is combined with Venlafaxine.,increase,risk
Coumarin,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Coumarin.,increase,risk
Coumarin,Viloxazine,The risk or severity of adverse effects can be increased when Viloxazine is combined with Coumarin.,increase,risk
Coumarin,Vinblastine,The risk or severity of bleeding can be increased when Coumarin is combined with Vinblastine.,increase,risk
Coumarin,Vindesine,The risk or severity of bleeding can be increased when Coumarin is combined with Vindesine.,increase,risk
Coumarin,Vinorelbine,The risk or severity of bleeding can be increased when Coumarin is combined with Vinorelbine.,increase,risk
Coumarin,Viomycin,The risk or severity of bleeding can be increased when Viomycin is combined with Coumarin.,increase,risk
Coumarin,Vitamin E,Vitamin E may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Coumarin.,decrease,no risk
Coumarin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Coumarin.,increase,risk
Coumarin,Voriconazole,The therapeutic efficacy of Coumarin can be increased when used in combination with Voriconazole.,increase,no risk
Coumarin,Vorinostat,Vorinostat may increase the anticoagulant activities of Coumarin.,increase,no risk
Coumarin,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Coumarin.,increase,risk
Coumarin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Coumarin.,decrease,no risk
Coumarin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Coumarin.,increase,risk
Coumarin,Ximelagatran,The risk or severity of bleeding can be increased when Coumarin is combined with Ximelagatran.,increase,risk
Coumarin,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Coumarin.,increase,risk
Coumarin,Zafirlukast,The metabolism of Coumarin can be decreased when combined with Zafirlukast.,decrease,no risk
Coumarin,Zidovudine,The risk or severity of bleeding can be increased when Coumarin is combined with Zidovudine.,increase,risk
Coumarin,Zileuton,The metabolism of Coumarin can be decreased when combined with Zileuton.,decrease,no risk
Coumarin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Coumarin.,increase,risk
Coumarin,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Coumarin.,increase,risk
Coumarin,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Coumarin.,increase,risk
Coumarin,Zolpidem,The metabolism of Coumarin can be decreased when combined with Zolpidem.,decrease,no risk
Coumarin,Zopiclone,The metabolism of Coumarin can be decreased when combined with Zopiclone.,decrease,no risk
Coumarin,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Coumarin.,increase,risk
Coumarin,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Coumarin.,increase,risk
Octylphenoxy polyethoxyethanol,Gabapentin,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Gabapentin.,increase,no risk
Octylphenoxy polyethoxyethanol,Ganaxolone,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Ganaxolone.,increase,no risk
Octylphenoxy polyethoxyethanol,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Glycerol phenylbutyrate,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Octylphenoxy polyethoxyethanol,Griseofulvin,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Griseofulvin.,increase,no risk
Octylphenoxy polyethoxyethanol,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Hetacillin,The therapeutic efficacy of Octylphenoxy polyethoxyethanol can be decreased when used in combination with Hetacillin.,decrease,no risk
Octylphenoxy polyethoxyethanol,Hydrocortamate,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Hydrocortamate.,increase,no risk
Octylphenoxy polyethoxyethanol,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Octylphenoxy polyethoxyethanol.,increase,no risk
Octylphenoxy polyethoxyethanol,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Octylphenoxy polyethoxyethanol.,increase,no risk
Octylphenoxy polyethoxyethanol,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Octylphenoxy polyethoxyethanol.,increase,no risk
Octylphenoxy polyethoxyethanol,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Octylphenoxy polyethoxyethanol.,increase,no risk
Octylphenoxy polyethoxyethanol,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Octylphenoxy polyethoxyethanol.,increase,no risk
Octylphenoxy polyethoxyethanol,Olutasidenib,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Olutasidenib.,increase,no risk
Octylphenoxy polyethoxyethanol,Omadacycline,The serum concentration of Octylphenoxy polyethoxyethanol can be decreased when it is combined with Omadacycline.,decrease,no risk
Octylphenoxy polyethoxyethanol,Omaveloxolone,The therapeutic efficacy of Octylphenoxy polyethoxyethanol can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Octylphenoxy polyethoxyethanol,Oritavancin,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Oritavancin.,increase,no risk
Octylphenoxy polyethoxyethanol,Oxacillin,The therapeutic efficacy of Octylphenoxy polyethoxyethanol can be decreased when used in combination with Oxacillin.,decrease,no risk
Octylphenoxy polyethoxyethanol,Oxcarbazepine,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Oxcarbazepine.,increase,no risk
Octylphenoxy polyethoxyethanol,Oxytetracycline,The serum concentration of Octylphenoxy polyethoxyethanol can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Octylphenoxy polyethoxyethanol,Quinine,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Quinine.,increase,no risk
Octylphenoxy polyethoxyethanol,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Valproic acid,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Valproic acid.,increase,no risk
Octylphenoxy polyethoxyethanol,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Octylphenoxy polyethoxyethanol.,increase,no risk
Octylphenoxy polyethoxyethanol,Vemurafenib,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Vemurafenib.,increase,no risk
Octylphenoxy polyethoxyethanol,Vigabatrin,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Vigabatrin.,increase,no risk
Octylphenoxy polyethoxyethanol,Vinblastine,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Vinblastine.,increase,no risk
Octylphenoxy polyethoxyethanol,Vitamin E,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Vitamin E.,increase,no risk
Octylphenoxy polyethoxyethanol,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Octylphenoxy polyethoxyethanol.,decrease,no risk
Octylphenoxy polyethoxyethanol,Zaleplon,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Zaleplon.,increase,no risk
Octylphenoxy polyethoxyethanol,Zonisamide,The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Zonisamide.,increase,no risk
Camptothecin,Vadadustat,Vadadustat may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Camptothecin,Vandetanib,Vandetanib may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Camptothecin,Velpatasvir,Velpatasvir may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Camptothecin,Vemurafenib,Vemurafenib may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Camptothecin,Venetoclax,Venetoclax may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Camptothecin,Venlafaxine,Venlafaxine may increase the excretion rate of Camptothecin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Camptothecin,Vismodegib,Vismodegib may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Camptothecin,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Camptothecin which could result in a higher serum level.,decrease,no risk
Farnesyl thiopyrophosphate,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Gadobenic acid.,increase,risk
Farnesyl thiopyrophosphate,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Gemifloxacin.,increase,risk
Farnesyl thiopyrophosphate,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Gilteritinib,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Gilteritinib.,increase,risk
Farnesyl thiopyrophosphate,Glasdegib,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Glasdegib.,increase,risk
Farnesyl thiopyrophosphate,Goserelin,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Goserelin.,increase,risk
Farnesyl thiopyrophosphate,Granisetron,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Granisetron.,increase,risk
Farnesyl thiopyrophosphate,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Grepafloxacin.,increase,risk
Farnesyl thiopyrophosphate,Halofantrine,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Halofantrine.,increase,risk
Farnesyl thiopyrophosphate,Haloperidol,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Haloperidol.,increase,risk
Farnesyl thiopyrophosphate,Histrelin,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Histrelin.,increase,risk
Farnesyl thiopyrophosphate,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Hydroxyzine.,increase,risk
Farnesyl thiopyrophosphate,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Ofloxacin,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Ofloxacin.,increase,risk
Farnesyl thiopyrophosphate,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Olodaterol,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Olodaterol.,increase,risk
Farnesyl thiopyrophosphate,Ondansetron,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Ondansetron.,increase,risk
Farnesyl thiopyrophosphate,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Oxatomide,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Oxatomide.,increase,risk
Farnesyl thiopyrophosphate,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Quetiapine,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Quetiapine.,increase,risk
Farnesyl thiopyrophosphate,Quinidine,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Quinidine.,increase,risk
Farnesyl thiopyrophosphate,Quinine,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Quinine.,increase,risk
Farnesyl thiopyrophosphate,Quizartinib,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Quizartinib.,increase,risk
Farnesyl thiopyrophosphate,Valproic acid,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Valproic acid.,increase,risk
Farnesyl thiopyrophosphate,Vandetanib,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Vandetanib.,increase,risk
Farnesyl thiopyrophosphate,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Vernakalant,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Vernakalant.,increase,risk
Farnesyl thiopyrophosphate,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Ziprasidone,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Ziprasidone.,increase,risk
Farnesyl thiopyrophosphate,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Farnesyl thiopyrophosphate.,increase,risk
Farnesyl thiopyrophosphate,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Zuclopenthixol.,increase,risk
Hydroxyfasudil,Benzylpenicillin,Hydroxyfasudil may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Hydroxyfasudil,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Hydroxyfasudil.,increase,risk
Hydroxyfasudil,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Hydroxyfasudil,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Hydroxyfasudil.,increase,no risk
Licofelone,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Licofelone.,increase,risk
Licofelone,Gatifloxacin,Licofelone may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Licofelone,Gemfibrozil,The metabolism of Licofelone can be decreased when combined with Gemfibrozil.,decrease,no risk
Licofelone,Gemifloxacin,Licofelone may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Licofelone,Gentamicin,The risk or severity of nephrotoxicity can be increased when Licofelone is combined with Gentamicin.,increase,risk
Licofelone,Ginkgo biloba,The metabolism of Licofelone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Licofelone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Glipizide,The protein binding of Glipizide can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Glofitamab,The serum concentration of Licofelone can be increased when it is combined with Glofitamab.,increase,no risk
Licofelone,Glyburide,The protein binding of Glyburide can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Glycol salicylate,The risk or severity of adverse effects can be increased when Licofelone is combined with Glycol salicylate.,increase,risk
Licofelone,Golimumab,The metabolism of Licofelone can be increased when combined with Golimumab.,increase,no risk
Licofelone,Grepafloxacin,Licofelone may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Licofelone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Licofelone.,increase,no risk
Licofelone,Halothane,The metabolism of Licofelone can be decreased when combined with Halothane.,decrease,no risk
Licofelone,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Heparin.,increase,risk
Licofelone,Hydralazine,Licofelone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Licofelone,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Licofelone.,increase,risk
Licofelone,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Licofelone.,increase,risk
Licofelone,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Licofelone.,increase,risk
Licofelone,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Licofelone.,increase,risk
Licofelone,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Licofelone.,increase,risk
Licofelone,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Hydromorphone,The metabolism of Licofelone can be decreased when combined with Hydromorphone.,decrease,no risk
Licofelone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Kanamycin,The risk or severity of nephrotoxicity can be increased when Licofelone is combined with Kanamycin.,increase,risk
Licofelone,Ketamine,The metabolism of Ketamine can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Ketoconazole,The metabolism of Licofelone can be decreased when combined with Ketoconazole.,decrease,no risk
Licofelone,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Licofelone.,increase,risk
Licofelone,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Licofelone.,increase,risk
Licofelone,Ofloxacin,Licofelone may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Licofelone,Olanzapine,The metabolism of Licofelone can be decreased when combined with Olanzapine.,decrease,no risk
Licofelone,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Licofelone.",increase,risk
Licofelone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Licofelone is combined with Omacetaxine mepesuccinate.,increase,risk
Licofelone,Omaveloxolone,The serum concentration of Licofelone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Licofelone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Ondansetron,The metabolism of Licofelone can be decreased when combined with Ondansetron.,decrease,no risk
Licofelone,Oritavancin,The metabolism of Licofelone can be decreased when combined with Oritavancin.,decrease,no risk
Licofelone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Oxandrolone,The metabolism of Licofelone can be decreased when combined with Oxandrolone.,decrease,no risk
Licofelone,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Licofelone.,increase,risk
Licofelone,Oxprenolol,Licofelone may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Licofelone,Oxybutynin,The metabolism of Licofelone can be decreased when combined with Oxybutynin.,decrease,no risk
Licofelone,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Licofelone.,increase,risk
Licofelone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Licofelone is combined with Quinapril.",increase,risk
Licofelone,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Quinidine,The metabolism of Licofelone can be decreased when combined with Quinidine.,decrease,no risk
Licofelone,Quinine,The metabolism of Licofelone can be decreased when combined with Quinine.,decrease,no risk
Licofelone,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Licofelone.,increase,risk
Licofelone,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Licofelone.,decrease,no risk
Licofelone,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Urokinase.,increase,risk
Licofelone,Vadadustat,The serum concentration of Licofelone can be increased when it is combined with Vadadustat.,increase,no risk
Licofelone,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Licofelone.,increase,risk
Licofelone,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Licofelone.",increase,risk
Licofelone,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Licofelone.,increase,risk
Licofelone,Vancomycin,Licofelone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Licofelone,Vardenafil,The metabolism of Licofelone can be decreased when combined with Vardenafil.,decrease,no risk
Licofelone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Vemurafenib,The metabolism of Licofelone can be decreased when combined with Vemurafenib.,decrease,no risk
Licofelone,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Vorapaxar.,increase,risk
Licofelone,Voriconazole,The serum concentration of Licofelone can be increased when it is combined with Voriconazole.,increase,no risk
Licofelone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Licofelone.,decrease,no risk
Licofelone,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Warfarin.,increase,risk
Licofelone,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Ximelagatran.,increase,risk
Licofelone,Zafirlukast,The metabolism of Licofelone can be decreased when combined with Zafirlukast.,decrease,no risk
Licofelone,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Licofelone.,increase,risk
Licofelone,Zileuton,The metabolism of Licofelone can be decreased when combined with Zileuton.,decrease,no risk
Licofelone,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Licofelone.,increase,risk
Licofelone,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Licofelone is combined with Zofenopril.",increase,risk
Licofelone,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Licofelone is combined with Zoledronic acid.,increase,risk
Licofelone,Zolpidem,The metabolism of Licofelone can be decreased when combined with Zolpidem.,decrease,no risk
Gentamicin C1a,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gadodiamide,Gadodiamide may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gadoteridol,Gadoteridol may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Gentamicin C1a.,increase,no risk
Gentamicin C1a,Ganciclovir,Ganciclovir may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gemcitabine,Gemcitabine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gentamicin,Gentamicin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Gimeracil,Gimeracil may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Givosiran,Givosiran may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Glipizide,Glipizide may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Gentamicin C1a.,increase,risk
Gentamicin C1a,Golodirsen,Golodirsen may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Goserelin,Goserelin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Guanethidine,Guanethidine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Guanfacine,Guanfacine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Haloperidol,Haloperidol may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Heparin,The therapeutic efficacy of Gentamicin C1a can be decreased when used in combination with Heparin.,decrease,no risk
Gentamicin C1a,Hetacillin,The serum concentration of Gentamicin C1a can be decreased when it is combined with Hetacillin.,decrease,no risk
Gentamicin C1a,Hydralazine,Hydralazine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Hydromorphone,Hydromorphone may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Kanamycin,Kanamycin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Ketamine,Ketamine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Ketazolam,Ketazolam may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Ketoprofen,Ketoprofen may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Ketorolac,Ketorolac may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Octinoxate,Octinoxate may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Olsalazine,The risk or severity of nephrotoxicity can be increased when Gentamicin C1a is combined with Olsalazine.,increase,risk
Gentamicin C1a,Opium,Opium may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oseltamivir,Oseltamivir may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Ouabain,The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Ouabain.,increase,risk
Gentamicin C1a,Oxacillin,Oxacillin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Gentamicin C1a.,increase,risk
Gentamicin C1a,Oxaprozin,Oxaprozin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oxazepam,Oxazepam may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Gentamicin C1a is combined with Oxetacaine.,increase,risk
Gentamicin C1a,Oxybenzone,Oxybenzone may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Gentamicin C1a is combined with Oxybuprocaine.,increase,risk
Gentamicin C1a,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Gentamicin C1a.,increase,risk
Gentamicin C1a,Quetiapine,Quetiapine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Quinidine,Gentamicin C1a may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Gentamicin C1a.,increase,risk
Gentamicin C1a,Vaborbactam,Vaborbactam may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Valaciclovir,Valaciclovir may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Valbenazine,Valbenazine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Valdecoxib,Valdecoxib may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Valganciclovir,Valganciclovir may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Vancomycin,Vancomycin may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Varenicline,Varenicline may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Gentamicin C1a.,increase,no risk
Gentamicin C1a,Venlafaxine,Venlafaxine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Verapamil,Verapamil may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Gentamicin C1a.,decrease,no risk
Gentamicin C1a,Vilanterol,Vilanterol may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Viloxazine,Viloxazine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Viomycin,The risk or severity of neuromuscular blockade can be increased when Gentamicin C1a is combined with Viomycin.,increase,risk
Gentamicin C1a,Vortioxetine,Vortioxetine may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Warfarin,Gentamicin C1a may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Zaleplon,Zaleplon may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Zanamivir,Zanamivir may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Gentamicin C1a,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin C1a is combined with Zoledronic acid.,increase,risk
Gentamicin C1a,Zonisamide,Zonisamide may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level.,decrease,no risk
Myxothiazol,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Myxothiazol.,increase,no risk
Nimesulide,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nimesulide is combined with Benazepril.",increase,risk
Nimesulide,Bendamustine,The risk or severity of bleeding can be increased when Nimesulide is combined with Bendamustine.,increase,risk
Nimesulide,Bendazac,The risk or severity of adverse effects can be increased when Nimesulide is combined with Bendazac.,increase,risk
Nimesulide,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Benorilate,The risk or severity of adverse effects can be increased when Nimesulide is combined with Benorilate.,increase,risk
Nimesulide,Benoxaprofen,The risk or severity of adverse effects can be increased when Nimesulide is combined with Benoxaprofen.,increase,risk
Nimesulide,Benserazide,Nimesulide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Nimesulide,Benzatropine,Nimesulide may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Nimesulide,Benznidazole,Nimesulide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Nimesulide,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Nimesulide.,increase,risk
Nimesulide,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Benzydamine,The risk or severity of adverse effects can be increased when Nimesulide is combined with Benzydamine.,increase,risk
Nimesulide,Bepotastine,Nimesulide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Nimesulide,Bepridil,Bepridil may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Nimesulide,Beractant,Nimesulide may increase the bradycardic activities of Beractant.,increase,no risk
Nimesulide,Berotralstat,The metabolism of Nimesulide can be decreased when combined with Berotralstat.,decrease,no risk
Nimesulide,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Nimesulide.,increase,risk
Nimesulide,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Nimesulide.,increase,risk
Nimesulide,Betaxolol,Nimesulide may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Nimesulide,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Nimesulide.,increase,risk
Nimesulide,Betulinic Acid,The risk or severity of adverse effects can be increased when Nimesulide is combined with Betulinic Acid.,increase,risk
Nimesulide,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Bexagliflozin.,increase,risk
Nimesulide,Bexarotene,The risk or severity of bleeding can be increased when Nimesulide is combined with Bexarotene.,increase,risk
Nimesulide,Bicisate,Nimesulide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Nimesulide,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Nimesulide.,increase,no risk
Nimesulide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Bioallethrin,Nimesulide may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Nimesulide,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Bismuth subgallate,Nimesulide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Nimesulide,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Nimesulide is combined with Bismuth subsalicylate.,increase,risk
Nimesulide,Bisoprolol,The therapeutic efficacy of Nimesulide can be increased when used in combination with Bisoprolol.,increase,no risk
Nimesulide,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Nimesulide is combined with Bivalirudin.,increase,risk
Nimesulide,Bleomycin,Nimesulide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Nimesulide,Blinatumomab,The risk or severity of bleeding can be increased when Nimesulide is combined with Blinatumomab.,increase,risk
Nimesulide,Boceprevir,The serum concentration of Nimesulide can be increased when it is combined with Boceprevir.,increase,no risk
Nimesulide,Bortezomib,The risk or severity of bleeding can be increased when Nimesulide is combined with Bortezomib.,increase,risk
Nimesulide,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Bosutinib,The risk or severity of bleeding can be increased when Nimesulide is combined with Bosutinib.,increase,risk
Nimesulide,Bretylium,Bretylium may increase the arrhythmogenic activities of Nimesulide.,increase,no risk
Nimesulide,Brexpiprazole,The risk or severity of hypertension can be increased when Nimesulide is combined with Brexpiprazole.,increase,risk
Nimesulide,Brivaracetam,Nimesulide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nimesulide,Bromazepam,Nimesulide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Nimesulide,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Nimesulide.,increase,risk
Nimesulide,Bromocriptine,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Bromocriptine.,increase,risk
Nimesulide,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Nimesulide.,increase,risk
Nimesulide,Bufexamac,The risk or severity of adverse effects can be increased when Nimesulide is combined with Bufexamac.,increase,risk
Nimesulide,Bumadizone,The risk or severity of adverse effects can be increased when Nimesulide is combined with Bumadizone.,increase,risk
Nimesulide,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nimesulide.,decrease,no risk
Nimesulide,Bupropion,Nimesulide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Nimesulide,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Nimesulide.,increase,risk
Nimesulide,Busulfan,The risk or severity of bleeding can be increased when Nimesulide is combined with Busulfan.,increase,risk
Nimesulide,Butabarbital,The metabolism of Nimesulide can be increased when combined with Butabarbital.,increase,no risk
Nimesulide,Butalbital,The metabolism of Nimesulide can be increased when combined with Butalbital.,increase,no risk
Nimesulide,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Nimesulide.,increase,risk
Lawsone,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Lawsone.,increase,no risk
Streptolydigin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Streptolydigin.,decrease,no risk
Streptolydigin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Benzocaine.,increase,risk
Streptolydigin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Benzyl alcohol.,increase,risk
Streptolydigin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Bupivacaine.,increase,risk
Streptolydigin,Butacaine,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Butacaine.,increase,risk
Streptolydigin,Butamben,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Butamben.,increase,risk
Streptolydigin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Oxetacaine.,increase,risk
Streptolydigin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Streptolydigin is combined with Oxybuprocaine.,increase,risk
Streptolydigin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Streptolydigin.,decrease,no risk
Streptolydigin,Warfarin,The risk or severity of bleeding can be increased when Streptolydigin is combined with Warfarin.,increase,risk
Suramin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Benzocaine.,increase,risk
Suramin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Benzyl alcohol.,increase,risk
Suramin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Bupivacaine.,increase,risk
Suramin,Butacaine,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Butacaine.,increase,risk
Suramin,Butamben,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Butamben.,increase,risk
Suramin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Oxetacaine.,increase,risk
Suramin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Suramin is combined with Oxybuprocaine.,increase,risk
5-methyltetrahydrofolic acid,Glucarpidase,The serum concentration of the active metabolites of 5-methyltetrahydrofolic acid can be reduced when 5-methyltetrahydrofolic acid is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
5-methyltetrahydrofolic acid,Valproic acid,The serum concentration of 5-methyltetrahydrofolic acid can be decreased when it is combined with Valproic acid.,decrease,no risk
Bifonazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Bifonazole.,increase,no risk
Bifonazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Bifonazole.,increase,no risk
Bifonazole,Halothane,The metabolism of Halothane can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bifonazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bifonazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Quinidine,The metabolism of Quinidine can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Bifonazole.,increase,no risk
Bifonazole,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Verapamil,The therapeutic efficacy of Bifonazole can be increased when used in combination with Verapamil.,increase,no risk
Bifonazole,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vincristine,The metabolism of Vincristine can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vindesine,The metabolism of Vindesine can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Bifonazole.,increase,no risk
Bifonazole,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Bifonazole.,increase,no risk
Bifonazole,Xylometazoline,The therapeutic efficacy of Bifonazole can be increased when used in combination with Xylometazoline.,increase,no risk
Bifonazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Ziconotide,The therapeutic efficacy of Bifonazole can be increased when used in combination with Ziconotide.,increase,no risk
Bifonazole,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Zonisamide,The therapeutic efficacy of Bifonazole can be increased when used in combination with Zonisamide.,increase,no risk
Bifonazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Bifonazole.,decrease,no risk
Bifonazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Bifonazole.,decrease,no risk
Inecalcitol,Vamorolone,The therapeutic efficacy of Inecalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Inecalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Inecalcitol is combined with Vitamin D.,increase,risk
Neamine,Gabapentin enacarbil,Neamine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Neamine,Gadobenic acid,Neamine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Neamine,Gadodiamide,Neamine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Neamine,Gadofosveset trisodium,Neamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Neamine,Gadopentetic acid,Neamine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Neamine,Gadoteric acid,Neamine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Neamine,Gadoteridol,Neamine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Neamine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Neamine.,increase,no risk
Neamine,Ganciclovir,Neamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Neamine,Gemcitabine,Neamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Neamine,Gemfibrozil,Neamine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Neamine,Gentamicin,Neamine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Neamine,Gimeracil,Neamine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Neamine,Givosiran,The risk or severity of nephrotoxicity can be increased when Neamine is combined with Givosiran.,increase,risk
Neamine,Glipizide,Neamine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Neamine,Glycerol phenylbutyrate,Neamine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Neamine,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Neamine.,increase,risk
Neamine,Golodirsen,Neamine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Neamine,Goserelin,Neamine may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Neamine,Guanethidine,Neamine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Neamine,Guanfacine,Neamine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Neamine,Haloperidol,Neamine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Neamine,Heparin,The therapeutic efficacy of Neamine can be decreased when used in combination with Heparin.,decrease,no risk
Neamine,Hetacillin,The serum concentration of Neamine can be decreased when it is combined with Hetacillin.,decrease,no risk
Neamine,Hydralazine,Neamine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Neamine,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Neamine.,increase,risk
Neamine,Hydromorphone,Neamine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Neamine,Hydroxocobalamin,Neamine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Neamine,Hydroxyethyl Starch,Neamine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Neamine,Kanamycin,Neamine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Neamine,Ketamine,Neamine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Neamine,Ketazolam,Neamine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Neamine,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Neamine.,increase,risk
Neamine,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Neamine.,increase,risk
Neamine,Octinoxate,Neamine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Neamine,Olsalazine,The risk or severity of nephrotoxicity can be increased when Neamine is combined with Olsalazine.,increase,risk
Neamine,Opium,Neamine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Neamine,Oseltamivir,Neamine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Neamine,Ouabain,The risk or severity of adverse effects can be increased when Neamine is combined with Ouabain.,increase,risk
Neamine,Oxacillin,The serum concentration of Neamine can be decreased when it is combined with Oxacillin.,decrease,no risk
Neamine,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Neamine.,increase,risk
Neamine,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Neamine.,increase,risk
Neamine,Oxazepam,Neamine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Neamine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Neamine is combined with Oxetacaine.,increase,risk
Neamine,Oxybenzone,Neamine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Neamine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Neamine is combined with Oxybuprocaine.,increase,risk
Neamine,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Neamine.,increase,risk
Neamine,Oxyquinoline,Neamine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Neamine,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Neamine.,increase,risk
Neamine,Quetiapine,Neamine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Neamine,Quinidine,Neamine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Neamine,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Neamine.,increase,risk
Neamine,Vaborbactam,Neamine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Neamine,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Neamine.,increase,risk
Neamine,Valbenazine,Neamine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Neamine,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Neamine.,increase,risk
Neamine,Valganciclovir,Neamine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Neamine,Vancomycin,Neamine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Neamine,Varenicline,The therapeutic efficacy of Varenicline can be decreased when used in combination with Neamine.,decrease,no risk
Neamine,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Neamine.,increase,no risk
Neamine,Venlafaxine,Neamine may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Neamine,Verapamil,Neamine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Neamine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Neamine.,decrease,no risk
Neamine,Vilanterol,Neamine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Neamine,Viloxazine,Neamine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Neamine,Viomycin,The risk or severity of neuromuscular blockade can be increased when Neamine is combined with Viomycin.,increase,risk
Neamine,Vortioxetine,Neamine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Neamine,Warfarin,Neamine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Neamine,Zaleplon,Neamine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Neamine,Zanamivir,Neamine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Neamine,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Neamine is combined with Zoledronic acid.,increase,risk
Neamine,Zonisamide,Neamine may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Bisoprolol,Benoxaprofen may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Benoxaprofen,Bisoxatin,Benoxaprofen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Bivalirudin.,increase,risk
Benoxaprofen,Bleomycin,Benoxaprofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Benoxaprofen,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Benoxaprofen,Brexpiprazole,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Brexpiprazole.,increase,risk
Benoxaprofen,Brivaracetam,Benoxaprofen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Bromazepam,Benoxaprofen may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Benoxaprofen.,increase,risk
Benoxaprofen,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Benoxaprofen.,increase,risk
Benoxaprofen,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Benoxaprofen.,increase,risk
Benoxaprofen,Bufexamac,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Bufexamac.,increase,risk
Benoxaprofen,Bumadizone,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Bumadizone.,increase,risk
Benoxaprofen,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Benoxaprofen,Bupropion,Benoxaprofen may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Benoxaprofen.,increase,risk
Benoxaprofen,Butabarbital,Benoxaprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Benoxaprofen,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Benoxaprofen.,increase,risk
Dantron,Glycerin,The risk or severity of adverse effects can be increased when Dantron is combined with Glycerin.,increase,risk
Dantron,Glycopyrronium,The therapeutic efficacy of Dantron can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Dantron,Hexafluronium,The therapeutic efficacy of Dantron can be decreased when used in combination with Hexafluronium.,decrease,no risk
Dantron,Hexocyclium,The therapeutic efficacy of Dantron can be decreased when used in combination with Hexocyclium.,decrease,no risk
Dantron,Homatropine,The therapeutic efficacy of Dantron can be decreased when used in combination with Homatropine.,decrease,no risk
Dantron,Homatropine methylbromide,The therapeutic efficacy of Dantron can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Dantron,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Dantron.,increase,risk
Dantron,Hydrocodone,The therapeutic efficacy of Dantron can be decreased when used in combination with Hydrocodone.,decrease,no risk
Dantron,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Dantron.,increase,risk
Dantron,Hydromorphone,The therapeutic efficacy of Dantron can be decreased when used in combination with Hydromorphone.,decrease,no risk
Dantron,Hyoscyamine,The therapeutic efficacy of Dantron can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Dantron,Olanzapine,The therapeutic efficacy of Dantron can be decreased when used in combination with Olanzapine.,decrease,no risk
Dantron,Oliceridine,The therapeutic efficacy of Dantron can be decreased when used in combination with Oliceridine.,decrease,no risk
Dantron,Opium,The therapeutic efficacy of Dantron can be decreased when used in combination with Opium.,decrease,no risk
Dantron,Orphenadrine,The therapeutic efficacy of Dantron can be decreased when used in combination with Orphenadrine.,decrease,no risk
Dantron,Oxybutynin,The therapeutic efficacy of Dantron can be decreased when used in combination with Oxybutynin.,decrease,no risk
Dantron,Oxycodone,The therapeutic efficacy of Dantron can be decreased when used in combination with Oxycodone.,decrease,no risk
Dantron,Oxymorphone,The therapeutic efficacy of Dantron can be decreased when used in combination with Oxymorphone.,decrease,no risk
Dantron,Oxyphencyclimine,The therapeutic efficacy of Dantron can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Dantron,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Dantron is combined with Oxyphenisatin acetate.,increase,risk
Dantron,Oxyphenonium,The therapeutic efficacy of Dantron can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Dantron,Quetiapine,The therapeutic efficacy of Dantron can be decreased when used in combination with Quetiapine.,decrease,no risk
Dantron,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Dantron.,increase,risk
Dantron,Quinidine,The therapeutic efficacy of Dantron can be decreased when used in combination with Quinidine.,decrease,no risk
Dantron,Umeclidinium,The therapeutic efficacy of Dantron can be decreased when used in combination with Umeclidinium.,decrease,no risk
Dantron,Vecuronium,The therapeutic efficacy of Dantron can be decreased when used in combination with Vecuronium.,decrease,no risk
Dantron,Verapamil,The therapeutic efficacy of Dantron can be decreased when used in combination with Verapamil.,decrease,no risk
Dantron,Xylometazoline,The therapeutic efficacy of Dantron can be decreased when used in combination with Xylometazoline.,decrease,no risk
Dantron,Ziconotide,The therapeutic efficacy of Dantron can be decreased when used in combination with Ziconotide.,decrease,no risk
Dantron,Ziprasidone,The therapeutic efficacy of Dantron can be decreased when used in combination with Ziprasidone.,decrease,no risk
Dantron,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Dantron.,increase,risk
Metamizole,Butabarbital,Metamizole may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Metamizole,Butriptyline,The risk or severity of hypertension can be increased when Metamizole is combined with Butriptyline.,increase,risk
Metamizole,Gabapentin enacarbil,Metamizole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Metamizole,Gadobenic acid,Metamizole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Metamizole,Gadodiamide,Metamizole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Metamizole,Gadofosveset trisodium,Metamizole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Metamizole,Gadopentetic acid,Metamizole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Metamizole,Gadoteric acid,Metamizole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Metamizole,Gadoteridol,Metamizole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Metamizole,Ganciclovir,Metamizole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Metamizole,Gemcitabine,Metamizole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Metamizole,Gemfibrozil,Metamizole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Metamizole,Gentamicin,Metamizole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Metamizole,Gimeracil,Metamizole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Metamizole,Givosiran,The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Givosiran.,increase,risk
Metamizole,Glipizide,Metamizole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Metamizole,Glycerol phenylbutyrate,Metamizole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Metamizole,Golodirsen,Metamizole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Metamizole,Goserelin,Metamizole may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Metamizole,Guanabenz,Metamizole may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Metamizole,Guanadrel,Metamizole may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Metamizole,Guanethidine,Metamizole may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Metamizole,Guanfacine,Metamizole may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Metamizole,Guanoxan,Metamizole may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Metamizole,Haloperidol,Metamizole may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Metamizole,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Metamizole.,increase,risk
Metamizole,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Metamizole.,increase,risk
Metamizole,Hydralazine,Metamizole may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Metamizole,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Metamizole.,increase,risk
Metamizole,Hydroflumethiazide,Metamizole may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Metamizole,Hydromorphone,Metamizole may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Metamizole,Hydroxocobalamin,Metamizole may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Metamizole,Hydroxyethyl Starch,Metamizole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Metamizole,Hydroxyurea,The risk or severity of myelosuppression can be increased when Metamizole is combined with Hydroxyurea.,increase,risk
Metamizole,Kanamycin,Metamizole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Metamizole,Ketamine,Metamizole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Metamizole,Ketazolam,Metamizole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Metamizole,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Metamizole.,increase,risk
Metamizole,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Metamizole.,increase,risk
Metamizole,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Metamizole.,increase,risk
Metamizole,Octinoxate,Metamizole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Metamizole,Olaparib,The risk or severity of myelosuppression can be increased when Metamizole is combined with Olaparib.,increase,risk
Metamizole,Olmesartan,Metamizole may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Metamizole,Olodaterol,The risk or severity of hypertension can be increased when Metamizole is combined with Olodaterol.,increase,risk
Metamizole,Olsalazine,The risk or severity of nephrotoxicity can be increased when Metamizole is combined with Olsalazine.,increase,risk
Metamizole,Opium,Metamizole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Metamizole,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Metamizole.,increase,risk
Metamizole,Oseltamivir,Metamizole may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Metamizole,Oxacillin,Metamizole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Metamizole,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Metamizole.,increase,risk
Metamizole,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Metamizole.,increase,risk
Metamizole,Oxazepam,Metamizole may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Metamizole,Oxprenolol,Metamizole may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Metamizole,Oxybenzone,Metamizole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Metamizole,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Metamizole.,increase,risk
Metamizole,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Metamizole.,increase,risk
Metamizole,Oxyquinoline,Metamizole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Metamizole,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Metamizole.,increase,risk
Metamizole,Quinapril,Metamizole may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Metamizole,Quinidine,Metamizole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Metamizole,Quinupramine,The risk or severity of hypertension can be increased when Metamizole is combined with Quinupramine.,increase,risk
Metamizole,Vaborbactam,Metamizole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Metamizole,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Metamizole.,increase,risk
Metamizole,Valbenazine,Metamizole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Metamizole,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Metamizole.,increase,risk
Metamizole,Valganciclovir,Metamizole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Metamizole,Valsartan,Metamizole may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Metamizole,Vancomycin,Metamizole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Metamizole,Varenicline,Metamizole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Metamizole,Venlafaxine,Metamizole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Metamizole,Verapamil,Metamizole may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Metamizole,Vilanterol,The risk or severity of hypertension can be increased when Metamizole is combined with Vilanterol.,increase,risk
Metamizole,Vilazodone,The risk or severity of hypertension can be increased when Metamizole is combined with Vilazodone.,increase,risk
Metamizole,Viloxazine,Metamizole may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Metamizole,Vinorelbine,The risk or severity of myelosuppression can be increased when Metamizole is combined with Vinorelbine.,increase,risk
Metamizole,Vorinostat,The risk or severity of myelosuppression can be increased when Metamizole is combined with Vorinostat.,increase,risk
Metamizole,Vortioxetine,The risk or severity of hypertension can be increased when Metamizole is combined with Vortioxetine.,increase,risk
Metamizole,Warfarin,Metamizole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Metamizole,Xamoterol,The risk or severity of hypertension can be increased when Metamizole is combined with Xamoterol.,increase,risk
Metamizole,Xylometazoline,The risk or severity of hypertension can be increased when Metamizole is combined with Xylometazoline.,increase,risk
Metamizole,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Metamizole.,increase,risk
Metamizole,Zaleplon,Metamizole may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Metamizole,Zanamivir,Metamizole may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Metamizole,Zidovudine,The risk or severity of myelosuppression can be increased when Metamizole is combined with Zidovudine.,increase,risk
Metamizole,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Metamizole.,increase,risk
Metamizole,Zofenopril,Metamizole may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Metamizole,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Metamizole is combined with Zoledronic acid.,increase,risk
Metamizole,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Metamizole.,increase,risk
Metamizole,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Metamizole.,increase,risk
Metamizole,Zuclopenthixol,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Metamizole.,increase,risk
Iproniazid,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Bivalirudin.,increase,risk
Iproniazid,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Bosentan,Iproniazid may increase the hypotensive activities of Bosentan.,increase,no risk
Iproniazid,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Iproniazid.,increase,risk
Iproniazid,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Iproniazid.,increase,risk
Iproniazid,Bretylium,Iproniazid may increase the hypotensive activities of Bretylium.,increase,no risk
Iproniazid,Brexanolone,The risk or severity of CNS depression can be increased when Iproniazid is combined with Brexanolone.,increase,risk
Iproniazid,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Brimonidine,The metabolism of Brimonidine can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Brivaracetam,The risk or severity of CNS depression can be increased when Iproniazid is combined with Brivaracetam.,increase,risk
Iproniazid,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Iproniazid.,increase,risk
Iproniazid,Bromocriptine,Iproniazid may increase the hypertensive activities of Bromocriptine.,increase,no risk
Iproniazid,Bromperidol,The risk or severity of CNS depression can be increased when Iproniazid is combined with Bromperidol.,increase,risk
Iproniazid,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Iproniazid.,increase,risk
Iproniazid,Bumadizone,The risk or severity of hypertension can be increased when Iproniazid is combined with Bumadizone.,increase,risk
Iproniazid,Bumetanide,Iproniazid may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Iproniazid,Bupivacaine,Iproniazid may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Iproniazid,Buprenorphine,Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Iproniazid,Bupropion,The risk or severity of adverse effects can be increased when Iproniazid is combined with Bupropion.,increase,risk
Iproniazid,Buspirone,The risk or severity of hypertension can be increased when Iproniazid is combined with Buspirone.,increase,risk
Iproniazid,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Iproniazid.,increase,risk
Iproniazid,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Iproniazid.,increase,risk
Iproniazid,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Iproniazid is combined with Butaperazine.,increase,risk
Iproniazid,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Iproniazid.,increase,risk
Iproniazid,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Iproniazid.,increase,risk
Iproniazid,Butriptyline,Iproniazid may increase the serotonergic activities of Butriptyline.,increase,no risk
Iproniazid,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Iproniazid.,increase,risk
Iproniazid,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Iproniazid is combined with Gabapentin enacarbil.,increase,risk
Iproniazid,Galantamine,The metabolism of Galantamine can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Iproniazid.,increase,risk
Iproniazid,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Iproniazid is combined with Ganaxolone.",increase,risk
Iproniazid,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Iproniazid.,increase,risk
Iproniazid,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Glipizide,The metabolism of Glipizide can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Iproniazid.,increase,risk
Iproniazid,Glyburide,The metabolism of Glyburide can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Glymidine,Iproniazid may increase the hypoglycemic activities of Glymidine.,increase,no risk
Iproniazid,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Iproniazid.,increase,risk
Iproniazid,Guanabenz,Iproniazid may increase the hypotensive activities of Guanabenz.,increase,no risk
Iproniazid,Guanadrel,Iproniazid may increase the hypotensive activities of Guanadrel.,increase,no risk
Iproniazid,Guanethidine,Iproniazid may increase the hypotensive activities of Guanethidine.,increase,no risk
Iproniazid,Guanfacine,Iproniazid may increase the hypotensive activities of Guanfacine.,increase,no risk
Iproniazid,Guanoxan,Iproniazid may increase the hypotensive activities of Guanoxan.,increase,no risk
Iproniazid,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Iproniazid.,increase,risk
Iproniazid,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Iproniazid.,increase,risk
Iproniazid,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Iproniazid.,increase,risk
Iproniazid,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Heparin.,increase,risk
Iproniazid,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Iproniazid.,increase,risk
Iproniazid,Hydralazine,Iproniazid may increase the hypotensive activities of Hydralazine.,increase,no risk
Iproniazid,Hydrochlorothiazide,Iproniazid may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Iproniazid,Hydrocodone,Iproniazid may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Iproniazid,Hydroflumethiazide,Iproniazid may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Iproniazid,Hydromorphone,Iproniazid may increase the serotonergic activities of Hydromorphone.,increase,no risk
Iproniazid,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Iproniazid.,increase,risk
Iproniazid,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Iproniazid.,increase,no risk
Iproniazid,Hyoscyamine,Iproniazid may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Iproniazid,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Iproniazid.,increase,risk
Iproniazid,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Iproniazid.,increase,risk
Iproniazid,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Iproniazid.,increase,risk
Iproniazid,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Obinutuzumab,Iproniazid may increase the orthostatic hypotensive activities of Obinutuzumab.,increase,no risk
Iproniazid,Olanzapine,Iproniazid may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Iproniazid,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Iproniazid is combined with Oliceridine.",increase,risk
Iproniazid,Olmesartan,Iproniazid may increase the hypotensive activities of Olmesartan.,increase,no risk
Iproniazid,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Iproniazid.,increase,risk
Iproniazid,Opicapone,The risk or severity of adverse effects can be increased when Opicapone is combined with Iproniazid.,increase,risk
Iproniazid,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Iproniazid.,increase,risk
Iproniazid,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Iproniazid.,increase,risk
Iproniazid,Orphenadrine,Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Iproniazid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Iproniazid.,increase,risk
Iproniazid,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Iproniazid.,increase,risk
Iproniazid,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Iproniazid.,increase,risk
Iproniazid,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Iproniazid.,increase,risk
Iproniazid,Oxprenolol,Iproniazid may increase the hypotensive activities of Oxprenolol.,increase,no risk
Iproniazid,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Iproniazid.,increase,risk
Iproniazid,Oxycodone,Iproniazid may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Iproniazid,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Iproniazid.,increase,no risk
Iproniazid,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Iproniazid.,increase,risk
Iproniazid,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Iproniazid.,increase,risk
Iproniazid,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Iproniazid.,increase,risk
Iproniazid,Quetiapine,Iproniazid may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Iproniazid,Quinapril,Iproniazid may increase the hypotensive activities of Quinapril.,increase,no risk
Iproniazid,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Iproniazid.,increase,risk
Iproniazid,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Iproniazid.,increase,risk
Iproniazid,Quinupramine,Iproniazid may increase the serotonergic activities of Quinupramine.,increase,no risk
Iproniazid,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Urethane,The risk or severity of CNS depression can be increased when Iproniazid is combined with Urethane.,increase,risk
Iproniazid,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Urokinase.,increase,risk
Iproniazid,Valbenazine,The risk or severity of adverse effects can be increased when Iproniazid is combined with Valbenazine.,increase,risk
Iproniazid,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Valproate bismuth.,increase,risk
Iproniazid,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Iproniazid.,increase,risk
Iproniazid,Valsartan,Iproniazid may increase the hypotensive activities of Valsartan.,increase,no risk
Iproniazid,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Iproniazid.,increase,risk
Iproniazid,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Venlafaxine.,increase,risk
Iproniazid,Verapamil,Iproniazid may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Iproniazid,Vericiguat,Iproniazid may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Iproniazid,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Iproniazid.,increase,risk
Iproniazid,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Iproniazid is combined with Vilanterol.,increase,risk
Iproniazid,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Vildagliptin,Iproniazid may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Iproniazid,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Iproniazid.,increase,risk
Iproniazid,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Vorapaxar.,increase,risk
Iproniazid,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Warfarin,The metabolism of Warfarin can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Xamoterol,The risk or severity of hypertension can be increased when Iproniazid is combined with Xamoterol.,increase,risk
Iproniazid,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Xylometazoline,Iproniazid may increase the hypertensive activities of Xylometazoline.,increase,no risk
Iproniazid,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Iproniazid.,increase,risk
Iproniazid,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Iproniazid.,increase,risk
Iproniazid,Ziconotide,The risk or severity of CNS depression can be increased when Iproniazid is combined with Ziconotide.,increase,risk
Iproniazid,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Zileuton,The metabolism of Zileuton can be decreased when combined with Iproniazid.,decrease,no risk
Iproniazid,Zimelidine,Iproniazid may increase the serotonergic activities of Zimelidine.,increase,no risk
Iproniazid,Ziprasidone,The risk or severity of adverse effects can be increased when Iproniazid is combined with Ziprasidone.,increase,risk
Iproniazid,Zofenopril,Iproniazid may increase the hypotensive activities of Zofenopril.,increase,no risk
Iproniazid,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Zolmitriptan.,increase,risk
Iproniazid,Zolpidem,Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Iproniazid,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Iproniazid.,increase,risk
Iproniazid,Zopiclone,The risk or severity of adverse effects can be increased when Iproniazid is combined with Zopiclone.,increase,risk
Iproniazid,Zotepine,The risk or severity of CNS depression can be increased when Iproniazid is combined with Zotepine.,increase,risk
Iproniazid,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Iproniazid.,increase,risk
Iproniazid,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Iproniazid.,increase,risk
Methapyrilene,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Methapyrilene.,increase,risk
Methapyrilene,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Gabapentin enacarbil.,increase,risk
Methapyrilene,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Methapyrilene.,increase,risk
Methapyrilene,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Methapyrilene is combined with Ganaxolone.",increase,risk
Methapyrilene,Gepirone,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Gepirone.,increase,risk
Methapyrilene,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Methapyrilene.,increase,risk
Methapyrilene,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Methapyrilene.,increase,risk
Methapyrilene,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Methapyrilene.,increase,risk
Methapyrilene,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Methapyrilene.,increase,risk
Methapyrilene,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Methapyrilene.,increase,risk
Methapyrilene,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Methapyrilene.,increase,risk
Methapyrilene,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Methapyrilene.,increase,risk
Methapyrilene,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methapyrilene.,decrease,no risk
Methapyrilene,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Methapyrilene.,decrease,no risk
Methapyrilene,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Methapyrilene.,decrease,no risk
Methapyrilene,Hydrocodone,Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Methapyrilene,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Methapyrilene.,increase,risk
Methapyrilene,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methapyrilene.,increase,no risk
Methapyrilene,Hyoscyamine,Methapyrilene may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Methapyrilene,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Methapyrilene.,increase,risk
Methapyrilene,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Methapyrilene.,increase,risk
Methapyrilene,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Methapyrilene.,increase,risk
Methapyrilene,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Methapyrilene is combined with Oliceridine.",increase,risk
Methapyrilene,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Methapyrilene.,increase,risk
Methapyrilene,Opium,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Opium.,increase,risk
Methapyrilene,Orphenadrine,Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Methapyrilene,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Methapyrilene.,increase,risk
Methapyrilene,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Methapyrilene.,increase,risk
Methapyrilene,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Methapyrilene.,increase,risk
Methapyrilene,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Methapyrilene.,increase,risk
Methapyrilene,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Methapyrilene.,increase,risk
Methapyrilene,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Methapyrilene.,increase,risk
Methapyrilene,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Methapyrilene.,increase,risk
Methapyrilene,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Methapyrilene.,increase,risk
Methapyrilene,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Methapyrilene.,increase,risk
Methapyrilene,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Methapyrilene.,increase,risk
Methapyrilene,Quinupramine,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Quinupramine.,increase,risk
Methapyrilene,Urethane,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Urethane.,increase,risk
Methapyrilene,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Methapyrilene.,increase,risk
Methapyrilene,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Methapyrilene.,increase,risk
Methapyrilene,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Methapyrilene.,increase,risk
Methapyrilene,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Methapyrilene.,increase,risk
Methapyrilene,Vilazodone,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Vilazodone.,increase,risk
Methapyrilene,Viloxazine,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Viloxazine.,increase,risk
Methapyrilene,Vortioxetine,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Vortioxetine.,increase,risk
Methapyrilene,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Methapyrilene.,increase,risk
Methapyrilene,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Methapyrilene.,increase,risk
Methapyrilene,Ziconotide,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Ziconotide.,increase,risk
Methapyrilene,Zimelidine,The risk or severity of adverse effects can be increased when Methapyrilene is combined with Zimelidine.,increase,risk
Methapyrilene,Ziprasidone,The risk or severity of adverse effects can be increased when Methapyrilene is combined with Ziprasidone.,increase,risk
Methapyrilene,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Methapyrilene.,increase,risk
Methapyrilene,Zolpidem,Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Methapyrilene,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Methapyrilene.,increase,risk
Methapyrilene,Zopiclone,The risk or severity of adverse effects can be increased when Methapyrilene is combined with Zopiclone.,increase,risk
Methapyrilene,Zotepine,The risk or severity of CNS depression can be increased when Methapyrilene is combined with Zotepine.,increase,risk
Methapyrilene,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Methapyrilene.,increase,risk
Methapyrilene,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Methapyrilene.,increase,risk
Nialamide,Bromperidol,The risk or severity of CNS depression can be increased when Nialamide is combined with Bromperidol.,increase,risk
Nialamide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Nialamide.,increase,risk
Nialamide,Bumadizone,The risk or severity of hypertension can be increased when Nialamide is combined with Bumadizone.,increase,risk
Nialamide,Bumetanide,Nialamide may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Nialamide,Bupivacaine,Nialamide may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Nialamide,Buprenorphine,Nialamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Nialamide,Bupropion,The risk or severity of adverse effects can be increased when Nialamide is combined with Bupropion.,increase,risk
Nialamide,Buspirone,The risk or severity of hypertension can be increased when Nialamide is combined with Buspirone.,increase,risk
Nialamide,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Nialamide.,increase,risk
Nialamide,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Nialamide.,increase,risk
Nialamide,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Nialamide is combined with Butaperazine.,increase,risk
Nialamide,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Nialamide.,increase,risk
Nialamide,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Nialamide.,increase,risk
Nialamide,Butriptyline,Nialamide may increase the serotonergic activities of Butriptyline.,increase,no risk
Nialamide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Nialamide.,increase,risk
Nialamide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Nialamide is combined with Gabapentin enacarbil.,increase,risk
Nialamide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Nialamide.,increase,risk
Nialamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Nialamide is combined with Ganaxolone.",increase,risk
Nialamide,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Nialamide.,increase,risk
Nialamide,Gliclazide,Nialamide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Nialamide,Glimepiride,Nialamide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Nialamide,Glipizide,Nialamide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Nialamide,Gliquidone,Nialamide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Nialamide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Nialamide.,increase,risk
Nialamide,Glyburide,Nialamide may increase the hypoglycemic activities of Glyburide.,increase,no risk
Nialamide,Glymidine,Nialamide may increase the hypoglycemic activities of Glymidine.,increase,no risk
Nialamide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Nialamide.,increase,risk
Nialamide,Guanabenz,Nialamide may increase the hypotensive activities of Guanabenz.,increase,no risk
Nialamide,Guanadrel,Nialamide may increase the hypotensive activities of Guanadrel.,increase,no risk
Nialamide,Guanethidine,Nialamide may increase the hypotensive activities of Guanethidine.,increase,no risk
Nialamide,Guanfacine,Nialamide may increase the hypotensive activities of Guanfacine.,increase,no risk
Nialamide,Guanoxan,Nialamide may increase the hypotensive activities of Guanoxan.,increase,no risk
Nialamide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Nialamide.,increase,risk
Nialamide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Nialamide.,increase,risk
Nialamide,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Nialamide.,increase,risk
Nialamide,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Heparin.,increase,risk
Nialamide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Nialamide.,increase,risk
Nialamide,Hydralazine,Nialamide may increase the hypotensive activities of Hydralazine.,increase,no risk
Nialamide,Hydrochlorothiazide,Nialamide may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Nialamide,Hydrocodone,Nialamide may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Nialamide,Hydroflumethiazide,Nialamide may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Nialamide,Hydromorphone,Nialamide may increase the serotonergic activities of Hydromorphone.,increase,no risk
Nialamide,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Nialamide.,increase,risk
Nialamide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nialamide.,increase,no risk
Nialamide,Hyoscyamine,Nialamide may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Nialamide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Nialamide.,increase,risk
Nialamide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Nialamide.,increase,risk
Nialamide,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Nialamide.,increase,risk
Nialamide,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Nialamide.,increase,risk
Nialamide,Obinutuzumab,Nialamide may increase the orthostatic hypotensive activities of Obinutuzumab.,increase,no risk
Nialamide,Olanzapine,Nialamide may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Nialamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Nialamide is combined with Oliceridine.",increase,risk
Nialamide,Olmesartan,Nialamide may increase the hypotensive activities of Olmesartan.,increase,no risk
Nialamide,Olodaterol,The risk or severity of hypertension can be increased when Nialamide is combined with Olodaterol.,increase,risk
Nialamide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nialamide.,increase,risk
Nialamide,Opicapone,The risk or severity of adverse effects can be increased when Opicapone is combined with Nialamide.,increase,risk
Nialamide,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Nialamide.,increase,risk
Nialamide,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Nialamide.,increase,risk
Nialamide,Orphenadrine,Nialamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Nialamide,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Nialamide.,increase,risk
Nialamide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nialamide.,increase,risk
Nialamide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Nialamide.,increase,risk
Nialamide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Nialamide.,increase,risk
Nialamide,Oxprenolol,Nialamide may increase the hypotensive activities of Oxprenolol.,increase,no risk
Nialamide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Nialamide.,increase,risk
Nialamide,Oxycodone,Nialamide may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Nialamide,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Nialamide.,increase,no risk
Nialamide,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Nialamide.,increase,risk
Nialamide,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Nialamide.,increase,risk
Nialamide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Nialamide.,increase,risk
Nialamide,Quetiapine,Nialamide may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Nialamide,Quinapril,Nialamide may increase the hypotensive activities of Quinapril.,increase,no risk
Nialamide,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Nialamide.,increase,risk
Nialamide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Nialamide.,increase,risk
Nialamide,Quinupramine,Nialamide may increase the serotonergic activities of Quinupramine.,increase,no risk
Nialamide,Urethane,The risk or severity of CNS depression can be increased when Nialamide is combined with Urethane.,increase,risk
Nialamide,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Urokinase.,increase,risk
Nialamide,Valbenazine,The risk or severity of adverse effects can be increased when Nialamide is combined with Valbenazine.,increase,risk
Nialamide,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Nialamide.,increase,risk
Nialamide,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Valproate bismuth.,increase,risk
Nialamide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Nialamide.,increase,risk
Nialamide,Valsartan,Nialamide may increase the hypotensive activities of Valsartan.,increase,no risk
Nialamide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nialamide.,increase,risk
Nialamide,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Venlafaxine.,increase,risk
Nialamide,Verapamil,Nialamide may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Nialamide,Vericiguat,Nialamide may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Nialamide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Nialamide.,increase,risk
Nialamide,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Nialamide is combined with Vilanterol.,increase,risk
Nialamide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Nialamide.,decrease,no risk
Nialamide,Vildagliptin,Nialamide may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Nialamide,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Nialamide.,increase,risk
Nialamide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Vorapaxar.,increase,risk
Nialamide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Nialamide.,decrease,no risk
Nialamide,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Warfarin.,increase,risk
Nialamide,Xamoterol,The risk or severity of hypertension can be increased when Nialamide is combined with Xamoterol.,increase,risk
Nialamide,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Ximelagatran.,increase,risk
Nialamide,Xylometazoline,Nialamide may increase the hypertensive activities of Xylometazoline.,increase,no risk
Nialamide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Nialamide.,increase,risk
Nialamide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Nialamide.,increase,risk
Nialamide,Ziconotide,The risk or severity of CNS depression can be increased when Nialamide is combined with Ziconotide.,increase,risk
Nialamide,Zimelidine,Nialamide may increase the serotonergic activities of Zimelidine.,increase,no risk
Nialamide,Ziprasidone,The risk or severity of adverse effects can be increased when Nialamide is combined with Ziprasidone.,increase,risk
Nialamide,Zofenopril,Nialamide may increase the hypotensive activities of Zofenopril.,increase,no risk
Nialamide,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Zolmitriptan.,increase,risk
Nialamide,Zolpidem,Nialamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Nialamide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nialamide.,increase,risk
Nialamide,Zopiclone,The risk or severity of adverse effects can be increased when Nialamide is combined with Zopiclone.,increase,risk
Nialamide,Zotepine,The risk or severity of CNS depression can be increased when Nialamide is combined with Zotepine.,increase,risk
Nialamide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Nialamide.,increase,risk
Nialamide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Nialamide.,increase,risk
Nomifensine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Nomifensine.,increase,risk
Nomifensine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Nomifensine is combined with Gabapentin enacarbil.,increase,risk
Nomifensine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Nomifensine.,increase,risk
Nomifensine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Nomifensine is combined with Ganaxolone.",increase,risk
Nomifensine,Gepirone,The risk or severity of CNS depression can be increased when Nomifensine is combined with Gepirone.,increase,risk
Nomifensine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Nomifensine.,increase,risk
Nomifensine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Nomifensine.,increase,risk
Nomifensine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Nomifensine.,increase,risk
Nomifensine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Nomifensine.,increase,risk
Nomifensine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Nomifensine.,increase,risk
Nomifensine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Nomifensine.,increase,risk
Nomifensine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Nomifensine.,increase,risk
Nomifensine,Hydrocodone,Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Nomifensine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Nomifensine.,increase,risk
Nomifensine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nomifensine.,increase,no risk
Nomifensine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Nomifensine.,increase,risk
Nomifensine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Nomifensine.,increase,risk
Nomifensine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Nomifensine.,increase,risk
Nomifensine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Nomifensine is combined with Oliceridine.",increase,risk
Nomifensine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Nomifensine.,increase,risk
Nomifensine,Opium,The risk or severity of CNS depression can be increased when Nomifensine is combined with Opium.,increase,risk
Nomifensine,Orphenadrine,Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Nomifensine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Nomifensine.,increase,risk
Nomifensine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Nomifensine.,increase,risk
Nomifensine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Nomifensine.,increase,risk
Nomifensine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Nomifensine.,increase,risk
Nomifensine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Nomifensine.,increase,risk
Nomifensine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Nomifensine.,increase,risk
Nomifensine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Nomifensine.,increase,risk
Nomifensine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Nomifensine.,increase,risk
Nomifensine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Nomifensine.,increase,risk
Nomifensine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Nomifensine.,increase,risk
Nomifensine,Quinupramine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Quinupramine.,increase,risk
Nomifensine,Urethane,The risk or severity of CNS depression can be increased when Nomifensine is combined with Urethane.,increase,risk
Nomifensine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Nomifensine.,increase,risk
Nomifensine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Nomifensine.,increase,risk
Nomifensine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Nomifensine.,increase,risk
Nomifensine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Nomifensine.,increase,risk
Nomifensine,Vilazodone,The risk or severity of CNS depression can be increased when Nomifensine is combined with Vilazodone.,increase,risk
Nomifensine,Viloxazine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Viloxazine.,increase,risk
Nomifensine,Vortioxetine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Vortioxetine.,increase,risk
Nomifensine,Warfarin,The risk or severity of adverse effects can be increased when Nomifensine is combined with Warfarin.,increase,risk
Nomifensine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Nomifensine.,increase,risk
Nomifensine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Nomifensine.,increase,risk
Nomifensine,Ziconotide,The risk or severity of CNS depression can be increased when Nomifensine is combined with Ziconotide.,increase,risk
Nomifensine,Zimelidine,The risk or severity of adverse effects can be increased when Nomifensine is combined with Zimelidine.,increase,risk
Nomifensine,Ziprasidone,The risk or severity of adverse effects can be increased when Nomifensine is combined with Ziprasidone.,increase,risk
Nomifensine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Nomifensine.,increase,risk
Nomifensine,Zolpidem,Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Nomifensine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Nomifensine.,increase,risk
Nomifensine,Zopiclone,The risk or severity of adverse effects can be increased when Nomifensine is combined with Zopiclone.,increase,risk
Nomifensine,Zotepine,The risk or severity of CNS depression can be increased when Nomifensine is combined with Zotepine.,increase,risk
Nomifensine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Nomifensine.,increase,risk
Nomifensine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Nomifensine.,increase,risk
Oxyphenisatin,Gallamine triethiodide,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Oxyphenisatin,Glycerin,The risk or severity of adverse effects can be increased when Oxyphenisatin is combined with Glycerin.,increase,risk
Oxyphenisatin,Glycopyrronium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Oxyphenisatin,Hexafluronium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hexafluronium.,decrease,no risk
Oxyphenisatin,Hexocyclium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hexocyclium.,decrease,no risk
Oxyphenisatin,Homatropine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Homatropine.,decrease,no risk
Oxyphenisatin,Homatropine methylbromide,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Oxyphenisatin,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Oxyphenisatin.,increase,risk
Oxyphenisatin,Hydrocodone,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hydrocodone.,decrease,no risk
Oxyphenisatin,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Oxyphenisatin.,increase,risk
Oxyphenisatin,Hydromorphone,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hydromorphone.,decrease,no risk
Oxyphenisatin,Hyoscyamine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Oxyphenisatin,Olanzapine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Olanzapine.,decrease,no risk
Oxyphenisatin,Oliceridine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oliceridine.,decrease,no risk
Oxyphenisatin,Opium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Opium.,decrease,no risk
Oxyphenisatin,Orphenadrine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Orphenadrine.,decrease,no risk
Oxyphenisatin,Oxybutynin,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oxybutynin.,decrease,no risk
Oxyphenisatin,Oxycodone,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oxycodone.,decrease,no risk
Oxyphenisatin,Oxymorphone,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oxymorphone.,decrease,no risk
Oxyphenisatin,Oxyphencyclimine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Oxyphenisatin,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Oxyphenisatin is combined with Oxyphenisatin acetate.,increase,risk
Oxyphenisatin,Oxyphenonium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Oxyphenisatin,Quetiapine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Quetiapine.,decrease,no risk
Oxyphenisatin,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Oxyphenisatin.,increase,risk
Oxyphenisatin,Quinidine,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Quinidine.,decrease,no risk
Oxyphenisatin,Umeclidinium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Umeclidinium.,decrease,no risk
Oxyphenisatin,Vecuronium,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Vecuronium.,decrease,no risk
Oxyphenisatin,Verapamil,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Verapamil.,decrease,no risk
Oxyphenisatin,Xylometazoline,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Xylometazoline.,decrease,no risk
Oxyphenisatin,Ziconotide,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Ziconotide.,decrease,no risk
Oxyphenisatin,Ziprasidone,The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Oxyphenisatin,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Oxyphenisatin.,increase,risk
Phenolphthalein,Hexafluronium,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hexafluronium.,decrease,no risk
Phenolphthalein,Hexocyclium,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hexocyclium.,decrease,no risk
Phenolphthalein,Homatropine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Homatropine.,decrease,no risk
Phenolphthalein,Homatropine methylbromide,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Phenolphthalein,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Phenolphthalein.,increase,risk
Phenolphthalein,Hydrocodone,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hydrocodone.,decrease,no risk
Phenolphthalein,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Phenolphthalein.,increase,risk
Phenolphthalein,Hydromorphone,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hydromorphone.,decrease,no risk
Phenolphthalein,Hyoscyamine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Phenolphthalein,Olanzapine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Olanzapine.,decrease,no risk
Phenolphthalein,Oliceridine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oliceridine.,decrease,no risk
Phenolphthalein,Opium,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Opium.,decrease,no risk
Phenolphthalein,Orphenadrine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Orphenadrine.,decrease,no risk
Phenolphthalein,Oxybutynin,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oxybutynin.,decrease,no risk
Phenolphthalein,Oxycodone,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oxycodone.,decrease,no risk
Phenolphthalein,Oxymorphone,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oxymorphone.,decrease,no risk
Phenolphthalein,Oxyphencyclimine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Phenolphthalein,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Phenolphthalein is combined with Oxyphenisatin acetate.,increase,risk
Phenolphthalein,Oxyphenonium,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Phenolphthalein,Quetiapine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Quetiapine.,decrease,no risk
Phenolphthalein,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Phenolphthalein.,increase,risk
Phenolphthalein,Quinidine,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Quinidine.,decrease,no risk
Phenolphthalein,Umeclidinium,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Umeclidinium.,decrease,no risk
Phenolphthalein,Vecuronium,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Vecuronium.,decrease,no risk
Phenolphthalein,Verapamil,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Verapamil.,decrease,no risk
Phenolphthalein,Xylometazoline,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Xylometazoline.,decrease,no risk
Phenolphthalein,Ziconotide,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Ziconotide.,decrease,no risk
Phenolphthalein,Ziprasidone,The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Ziprasidone.,decrease,no risk
Phenolphthalein,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Phenolphthalein.,increase,risk
Prenylamine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Prenylamine.,increase,risk
Prenylamine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Prenylamine.,increase,risk
Prenylamine,Gallamine triethiodide,Prenylamine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Prenylamine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Prenylamine.,increase,risk
Prenylamine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Prenylamine.,increase,risk
Prenylamine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Prenylamine.,increase,risk
Prenylamine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Gilteritinib.,increase,risk
Prenylamine,Glasdegib,The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Glasdegib.,increase,risk
Prenylamine,Gliclazide,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Gliclazide.,increase,risk
Prenylamine,Glimepiride,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Glimepiride.,increase,risk
Prenylamine,Glipizide,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Glipizide.,increase,risk
Prenylamine,Gliquidone,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Gliquidone.,increase,risk
Prenylamine,Glofitamab,The serum concentration of Prenylamine can be increased when it is combined with Glofitamab.,increase,no risk
Prenylamine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Prenylamine.,decrease,no risk
Prenylamine,Glyburide,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Glyburide.,increase,risk
Prenylamine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Prenylamine.,decrease,no risk
Prenylamine,Glymidine,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Glymidine.,increase,risk
Prenylamine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Prenylamine.,increase,risk
Prenylamine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Prenylamine.,increase,risk
Prenylamine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Grepafloxacin.,increase,risk
Prenylamine,Guanfacine,Guanfacine may increase the bradycardic activities of Prenylamine.,increase,no risk
Prenylamine,Halofantrine,The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Halofantrine.,increase,risk
Prenylamine,Haloperidol,The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Haloperidol.,increase,risk
Prenylamine,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Prenylamine.,increase,risk
Prenylamine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Prenylamine.,increase,risk
Prenylamine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Prenylamine.,increase,risk
Prenylamine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Prenylamine.,increase,risk
Prenylamine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Prenylamine.,increase,risk
Prenylamine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Hydroxyzine.,increase,risk
Prenylamine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Prenylamine.,increase,no risk
Urethane,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Urethane.,increase,risk
Urethane,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Urethane is combined with Gabapentin enacarbil.,increase,risk
Urethane,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Urethane.,increase,risk
Urethane,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Urethane is combined with Ganaxolone.",increase,risk
Urethane,Gepirone,The risk or severity of CNS depression can be increased when Urethane is combined with Gepirone.,increase,risk
Urethane,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Urethane.,increase,risk
Urethane,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Urethane.,increase,risk
Urethane,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Urethane.,increase,risk
Urethane,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Urethane.,increase,risk
Urethane,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Urethane.,increase,risk
Urethane,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Urethane.,increase,risk
Urethane,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Urethane.,increase,risk
Urethane,Hydrocodone,Urethane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Urethane,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Urethane.,increase,risk
Urethane,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Urethane,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Urethane.,increase,risk
Urethane,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Urethane.,increase,risk
Urethane,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Urethane.,increase,risk
Urethane,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Urethane is combined with Oliceridine.",increase,risk
Urethane,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Urethane.,increase,risk
Urethane,Opium,The risk or severity of CNS depression can be increased when Urethane is combined with Opium.,increase,risk
Urethane,Orphenadrine,Urethane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Urethane,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Urethane.,increase,risk
Urethane,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Urethane.,increase,risk
Urethane,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Oxetacaine.,increase,risk
Urethane,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Urethane.,increase,risk
Urethane,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Urethane.,increase,risk
Urethane,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Oxybuprocaine.,increase,risk
Urethane,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Urethane.,increase,risk
Urethane,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Urethane.,increase,risk
Urethane,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Urethane.,increase,risk
Urethane,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Urethane.,increase,risk
Urethane,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Urethane.,increase,risk
Urethane,Quinupramine,The risk or severity of CNS depression can be increased when Urethane is combined with Quinupramine.,increase,risk
Urethane,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Urethane.,increase,risk
Urethane,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Urethane.,increase,risk
Urethane,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Urethane.,increase,risk
Urethane,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Urethane.,increase,risk
Urethane,Vilazodone,The risk or severity of CNS depression can be increased when Urethane is combined with Vilazodone.,increase,risk
Urethane,Viloxazine,The risk or severity of CNS depression can be increased when Urethane is combined with Viloxazine.,increase,risk
Urethane,Vortioxetine,The risk or severity of CNS depression can be increased when Urethane is combined with Vortioxetine.,increase,risk
Urethane,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Urethane.,increase,risk
Urethane,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Urethane.,increase,risk
Urethane,Ziconotide,The risk or severity of CNS depression can be increased when Urethane is combined with Ziconotide.,increase,risk
Urethane,Zimelidine,The risk or severity of adverse effects can be increased when Urethane is combined with Zimelidine.,increase,risk
Urethane,Ziprasidone,The risk or severity of adverse effects can be increased when Urethane is combined with Ziprasidone.,increase,risk
Urethane,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Urethane.,increase,risk
Urethane,Zolpidem,Urethane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Urethane,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Urethane.,increase,risk
Urethane,Zopiclone,The risk or severity of adverse effects can be increased when Urethane is combined with Zopiclone.,increase,risk
Urethane,Zotepine,The risk or severity of CNS depression can be increased when Urethane is combined with Zotepine.,increase,risk
Urethane,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Urethane.,increase,risk
Urethane,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Urethane.,increase,risk
Zomepirac,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Zomepirac.,increase,risk
Zomepirac,Betulinic Acid,The risk or severity of adverse effects can be increased when Zomepirac is combined with Betulinic Acid.,increase,risk
Zomepirac,Bicisate,Zomepirac may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Zomepirac,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Bismuth subgallate,Zomepirac may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Zomepirac,Bisoprolol,Zomepirac may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Zomepirac,Bisoxatin,Zomepirac may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Zomepirac,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Bivalirudin.,increase,risk
Zomepirac,Bleomycin,Zomepirac may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Zomepirac,Boceprevir,The metabolism of Zomepirac can be decreased when combined with Boceprevir.,decrease,no risk
Zomepirac,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Brexpiprazole,The risk or severity of hypertension can be increased when Zomepirac is combined with Brexpiprazole.,increase,risk
Zomepirac,Brivaracetam,Zomepirac may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Zomepirac,Bromazepam,Zomepirac may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Zomepirac,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Zomepirac.,increase,risk
Zomepirac,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Zomepirac.,increase,risk
Zomepirac,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Zomepirac.,increase,risk
Zomepirac,Bufexamac,The risk or severity of adverse effects can be increased when Zomepirac is combined with Bufexamac.,increase,risk
Zomepirac,Bumadizone,The risk or severity of adverse effects can be increased when Zomepirac is combined with Bumadizone.,increase,risk
Zomepirac,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Bupropion,Zomepirac may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Zomepirac,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Zomepirac.,increase,risk
Zomepirac,Butabarbital,Zomepirac may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Zomepirac,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Zomepirac.,increase,risk
Zomepirac,Gabapentin enacarbil,Zomepirac may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Zomepirac,Gadobenic acid,Zomepirac may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Zomepirac,Gadodiamide,Zomepirac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Zomepirac,Gadofosveset trisodium,Zomepirac may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Zomepirac,Gadopentetic acid,Zomepirac may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Zomepirac,Gadoteric acid,Zomepirac may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Zomepirac,Gadoteridol,Zomepirac may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Zomepirac,Ganciclovir,Zomepirac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Zomepirac,Gatifloxacin,Zomepirac may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Zomepirac,Gemcitabine,Zomepirac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Zomepirac,Gemfibrozil,Zomepirac may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Zomepirac,Gemifloxacin,Zomepirac may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Zomepirac,Gentamicin,Zomepirac may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Zomepirac,Gimeracil,Zomepirac may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Zomepirac,Givosiran,The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Givosiran.,increase,risk
Zomepirac,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Zomepirac.,decrease,no risk
Zomepirac,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Zomepirac.,decrease,no risk
Zomepirac,Glipizide,The protein binding of Glipizide can be decreased when combined with Zomepirac.,decrease,no risk
Zomepirac,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Zomepirac.,decrease,no risk
Zomepirac,Glofitamab,The serum concentration of Zomepirac can be increased when it is combined with Glofitamab.,increase,no risk
Zomepirac,Glyburide,The protein binding of Glyburide can be decreased when combined with Zomepirac.,decrease,no risk
Zomepirac,Glycerol phenylbutyrate,Zomepirac may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Zomepirac,Glycol salicylate,The risk or severity of adverse effects can be increased when Zomepirac is combined with Glycol salicylate.,increase,risk
Zomepirac,Golodirsen,Zomepirac may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Zomepirac,Goserelin,Zomepirac may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Zomepirac,Grepafloxacin,Zomepirac may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Zomepirac,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Zomepirac.,increase,no risk
Zomepirac,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Zomepirac.,increase,risk
Zomepirac,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Heparin.,increase,risk
Zomepirac,Hydralazine,Zomepirac may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Zomepirac,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Zomepirac.,increase,risk
Zomepirac,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Zomepirac.,increase,risk
Zomepirac,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Zomepirac.,increase,risk
Zomepirac,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Zomepirac.,increase,risk
Zomepirac,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Zomepirac.,increase,risk
Zomepirac,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Hydromorphone,Zomepirac may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Zomepirac,Hydroxocobalamin,Zomepirac may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Zomepirac,Hydroxyethyl Starch,Zomepirac may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Zomepirac,Kanamycin,Zomepirac may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Zomepirac,Ketamine,Zomepirac may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Zomepirac,Ketazolam,Zomepirac may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Zomepirac,Ketoconazole,The metabolism of Zomepirac can be decreased when combined with Ketoconazole.,decrease,no risk
Zomepirac,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zomepirac.,increase,risk
Zomepirac,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Zomepirac.,increase,risk
Zomepirac,Octinoxate,Zomepirac may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Zomepirac,Ofloxacin,Zomepirac may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Zomepirac,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Zomepirac.",increase,risk
Zomepirac,Olodaterol,The risk or severity of hypertension can be increased when Zomepirac is combined with Olodaterol.,increase,risk
Zomepirac,Olsalazine,The risk or severity of nephrotoxicity can be increased when Zomepirac is combined with Olsalazine.,increase,risk
Zomepirac,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Zomepirac is combined with Omacetaxine mepesuccinate.,increase,risk
Zomepirac,Omaveloxolone,The serum concentration of Zomepirac can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zomepirac,Opium,Zomepirac may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Zomepirac,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Zomepirac.,increase,risk
Zomepirac,Oseltamivir,Zomepirac may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Zomepirac,Oxacillin,Zomepirac may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Zomepirac,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Zomepirac.,increase,risk
Zomepirac,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Zomepirac.,increase,risk
Zomepirac,Oxazepam,Zomepirac may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Zomepirac,Oxprenolol,Zomepirac may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Zomepirac,Oxybenzone,Zomepirac may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Zomepirac,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Zomepirac.,increase,risk
Zomepirac,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Zomepirac.,increase,risk
Zomepirac,Oxyquinoline,Zomepirac may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Zomepirac,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Zomepirac.,increase,risk
Zomepirac,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Zomepirac is combined with Quinapril.",increase,risk
Zomepirac,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Quinidine,Zomepirac may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Zomepirac,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Zomepirac.,increase,risk
Zomepirac,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Zomepirac.,decrease,no risk
Zomepirac,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Urokinase.,increase,risk
Zomepirac,Vaborbactam,Zomepirac may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Zomepirac,Vadadustat,The serum concentration of Zomepirac can be increased when it is combined with Vadadustat.,increase,no risk
Zomepirac,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Zomepirac.,increase,risk
Zomepirac,Valbenazine,Zomepirac may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Zomepirac,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Zomepirac.,increase,risk
Zomepirac,Valganciclovir,Zomepirac may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Zomepirac,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Zomepirac.,decrease,no risk
Zomepirac,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Zomepirac.",increase,risk
Zomepirac,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Zomepirac.,increase,risk
Zomepirac,Vancomycin,Zomepirac may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Zomepirac,Varenicline,Zomepirac may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Zomepirac,Venetoclax,The metabolism of Zomepirac can be decreased when combined with Venetoclax.,decrease,no risk
Zomepirac,Venlafaxine,Zomepirac may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Zomepirac,Verapamil,The metabolism of Zomepirac can be decreased when combined with Verapamil.,decrease,no risk
Zomepirac,Vilanterol,The risk or severity of hypertension can be increased when Zomepirac is combined with Vilanterol.,increase,risk
Zomepirac,Vilazodone,The risk or severity of hypertension can be increased when Zomepirac is combined with Vilazodone.,increase,risk
Zomepirac,Viloxazine,The metabolism of Zomepirac can be decreased when combined with Viloxazine.,decrease,no risk
Zomepirac,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Vorapaxar.,increase,risk
Zomepirac,Voriconazole,The serum concentration of Zomepirac can be increased when it is combined with Voriconazole.,increase,no risk
Zomepirac,Vortioxetine,The risk or severity of hypertension can be increased when Zomepirac is combined with Vortioxetine.,increase,risk
Zomepirac,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Warfarin.,increase,risk
Zomepirac,Xamoterol,The risk or severity of hypertension can be increased when Zomepirac is combined with Xamoterol.,increase,risk
Zomepirac,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Ximelagatran.,increase,risk
Zomepirac,Xylometazoline,The risk or severity of hypertension can be increased when Zomepirac is combined with Xylometazoline.,increase,risk
Zomepirac,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Zomepirac.,increase,risk
Zomepirac,Zaleplon,Zomepirac may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Zomepirac,Zanamivir,Zomepirac may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Zomepirac,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Zomepirac.,increase,risk
Zomepirac,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Zomepirac.,increase,risk
Zomepirac,Ziprasidone,The metabolism of Zomepirac can be decreased when combined with Ziprasidone.,decrease,no risk
Zomepirac,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Zomepirac is combined with Zofenopril.",increase,risk
Zomepirac,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Zomepirac is combined with Zoledronic acid.,increase,risk
Zomepirac,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Zomepirac.,increase,risk
Zomepirac,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Zomepirac.,increase,risk
Lysergic acid diethylamide,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Butaperazine,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Butaperazine.,increase,risk
Lysergic acid diethylamide,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Butriptyline,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Butriptyline.,increase,risk
Lysergic acid diethylamide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Gabapentin enacarbil.,increase,risk
Lysergic acid diethylamide,Galantamine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Galantamine.,decrease,no risk
Lysergic acid diethylamide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lysergic acid diethylamide is combined with Ganaxolone.",increase,risk
Lysergic acid diethylamide,Gefitinib,The metabolism of Lysergic acid diethylamide can be decreased when combined with Gefitinib.,decrease,no risk
Lysergic acid diethylamide,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Gilteritinib,The therapeutic efficacy of Lysergic acid diethylamide can be decreased when used in combination with Gilteritinib.,decrease,no risk
Lysergic acid diethylamide,Givosiran,The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Givosiran.,increase,no risk
Lysergic acid diethylamide,Glofitamab,The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Glofitamab.,increase,no risk
Lysergic acid diethylamide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Glycerol phenylbutyrate,The metabolism of Lysergic acid diethylamide can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Lysergic acid diethylamide,Golimumab,The metabolism of Lysergic acid diethylamide can be increased when combined with Golimumab.,increase,no risk
Lysergic acid diethylamide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Guanabenz,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Lysergic acid diethylamide,Guanadrel,Lysergic acid diethylamide may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Lysergic acid diethylamide,Guanethidine,Lysergic acid diethylamide may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Lysergic acid diethylamide,Guanfacine,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Lysergic acid diethylamide,Guanoxan,Lysergic acid diethylamide may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Lysergic acid diethylamide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Halofantrine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Halofantrine.,decrease,no risk
Lysergic acid diethylamide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Hydralazine,Lysergic acid diethylamide may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Lysergic acid diethylamide,Hydrochlorothiazide,Lysergic acid diethylamide may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Lysergic acid diethylamide,Hydrocodone,Lysergic acid diethylamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lysergic acid diethylamide,Hydroflumethiazide,Lysergic acid diethylamide may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Lysergic acid diethylamide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Hydroxychloroquine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Lysergic acid diethylamide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lysergic acid diethylamide.,increase,no risk
Lysergic acid diethylamide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Ketoconazole,The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Ketoconazole.,increase,no risk
Lysergic acid diethylamide,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lysergic acid diethylamide is combined with Oliceridine.",increase,risk
Lysergic acid diethylamide,Olmesartan,Lysergic acid diethylamide may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Lysergic acid diethylamide,Olodaterol,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Lysergic acid diethylamide,Omaveloxolone,The serum concentration of Lysergic acid diethylamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lysergic acid diethylamide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Opium,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Opium.,increase,risk
Lysergic acid diethylamide,Orciprenaline,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Lysergic acid diethylamide,Oritavancin,The metabolism of Lysergic acid diethylamide can be decreased when combined with Oritavancin.,decrease,no risk
Lysergic acid diethylamide,Orphenadrine,Lysergic acid diethylamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lysergic acid diethylamide,Osilodrostat,The metabolism of Lysergic acid diethylamide can be decreased when combined with Osilodrostat.,decrease,no risk
Lysergic acid diethylamide,Ospemifene,The metabolism of Lysergic acid diethylamide can be decreased when combined with Ospemifene.,decrease,no risk
Lysergic acid diethylamide,Oxamniquine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Oxamniquine.,decrease,no risk
Lysergic acid diethylamide,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxprenolol,Oxprenolol may increase the vasoconstricting activities of Lysergic acid diethylamide.,increase,no risk
Lysergic acid diethylamide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxybutynin,The metabolism of Lysergic acid diethylamide can be decreased when combined with Oxybutynin.,decrease,no risk
Lysergic acid diethylamide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxymetazoline,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Lysergic acid diethylamide,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Quinapril,Lysergic acid diethylamide may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Lysergic acid diethylamide,Quinidine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Quinidine.,decrease,no risk
Lysergic acid diethylamide,Quinine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Quinine.,decrease,no risk
Lysergic acid diethylamide,Quinupramine,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Quinupramine.,increase,risk
Lysergic acid diethylamide,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Lysergic acid diethylamide.,decrease,no risk
Lysergic acid diethylamide,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Vadadustat,The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Vadadustat.,increase,no risk
Lysergic acid diethylamide,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lysergic acid diethylamide.,decrease,no risk
Lysergic acid diethylamide,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Lysergic acid diethylamide is combined with Valproate bismuth.,increase,risk
Lysergic acid diethylamide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Valsartan,Lysergic acid diethylamide may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Lysergic acid diethylamide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Vemurafenib,The metabolism of Lysergic acid diethylamide can be decreased when combined with Vemurafenib.,decrease,no risk
Lysergic acid diethylamide,Venetoclax,The metabolism of Lysergic acid diethylamide can be decreased when combined with Venetoclax.,decrease,no risk
Lysergic acid diethylamide,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Lysergic acid diethylamide is combined with Venlafaxine.,increase,risk
Lysergic acid diethylamide,Verapamil,The metabolism of Lysergic acid diethylamide can be decreased when combined with Verapamil.,decrease,no risk
Lysergic acid diethylamide,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Lysergic acid diethylamide.,decrease,no risk
Lysergic acid diethylamide,Vibegron,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Lysergic acid diethylamide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Vilanterol,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Lysergic acid diethylamide,Vilazodone,The metabolism of Lysergic acid diethylamide can be decreased when combined with Vilazodone.,decrease,no risk
Lysergic acid diethylamide,Viloxazine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Viloxazine.,decrease,no risk
Lysergic acid diethylamide,Vinblastine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Vinblastine.,decrease,no risk
Lysergic acid diethylamide,Vinorelbine,The metabolism of Lysergic acid diethylamide can be decreased when combined with Vinorelbine.,decrease,no risk
Lysergic acid diethylamide,Voriconazole,The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Voriconazole.,increase,no risk
Lysergic acid diethylamide,Vortioxetine,Lysergic acid diethylamide may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Lysergic acid diethylamide,Warfarin,The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Warfarin.,increase,risk
Lysergic acid diethylamide,Xamoterol,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Lysergic acid diethylamide,Xylometazoline,Lysergic acid diethylamide may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Lysergic acid diethylamide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Ziconotide,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Ziconotide.,increase,risk
Lysergic acid diethylamide,Zimelidine,The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Zimelidine.,increase,risk
Lysergic acid diethylamide,Ziprasidone,The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Ziprasidone.,increase,risk
Lysergic acid diethylamide,Zofenopril,Lysergic acid diethylamide may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Lysergic acid diethylamide,Zolmitriptan,Lysergic acid diethylamide may increase the vasoconstricting activities of Zolmitriptan.,increase,no risk
Lysergic acid diethylamide,Zolpidem,Lysergic acid diethylamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Lysergic acid diethylamide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Zopiclone,The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Zopiclone.,increase,risk
Lysergic acid diethylamide,Zotepine,The risk or severity of CNS depression can be increased when Lysergic acid diethylamide is combined with Zotepine.,increase,risk
Lysergic acid diethylamide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Lysergic acid diethylamide.,increase,risk
Lysergic acid diethylamide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Lysergic acid diethylamide.,increase,risk
Buformin,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Buformin.,increase,risk
Buformin,Gatifloxacin,The therapeutic efficacy of Buformin can be increased when used in combination with Gatifloxacin.,increase,no risk
Buformin,Gefapixant,The therapeutic efficacy of Buformin can be increased when used in combination with Gefapixant.,increase,no risk
Buformin,Gemifloxacin,The therapeutic efficacy of Buformin can be increased when used in combination with Gemifloxacin.,increase,no risk
Buformin,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Buformin.,increase,risk
Buformin,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Buformin.,increase,risk
Buformin,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Buformin.,increase,risk
Buformin,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Buformin.,increase,risk
Buformin,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Buformin.,increase,risk
Buformin,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Buformin.,increase,risk
Buformin,Glymidine,The therapeutic efficacy of Buformin can be increased when used in combination with Glymidine.,increase,no risk
Buformin,Goserelin,The therapeutic efficacy of Buformin can be decreased when used in combination with Goserelin.,decrease,no risk
Buformin,Grepafloxacin,The therapeutic efficacy of Buformin can be increased when used in combination with Grepafloxacin.,increase,no risk
Buformin,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Buformin.,increase,risk
Buformin,Guanidine,The risk or severity of adverse effects can be increased when Guanidine is combined with Buformin.,increase,risk
Buformin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Buformin.,increase,risk
Buformin,Haloperidol,The therapeutic efficacy of Buformin can be decreased when used in combination with Haloperidol.,decrease,no risk
Buformin,Histrelin,The therapeutic efficacy of Buformin can be decreased when used in combination with Histrelin.,decrease,no risk
Buformin,Hydrochlorothiazide,The therapeutic efficacy of Buformin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Buformin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Buformin.,increase,risk
Buformin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Buformin.,increase,risk
Buformin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Buformin.,increase,risk
Buformin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Buformin.,increase,risk
Buformin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Buformin.,increase,risk
Buformin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Buformin.,increase,risk
Buformin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Buformin.,increase,risk
Buformin,Hydroflumethiazide,The therapeutic efficacy of Buformin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Buformin,Hydroxychloroquine,The therapeutic efficacy of Buformin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Buformin,Hydroxyprogesterone caproate,The therapeutic efficacy of Buformin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Buformin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Buformin is combined with Ketotifen.,increase,risk
Buformin,Octreotide,The therapeutic efficacy of Buformin can be decreased when used in combination with Octreotide.,decrease,no risk
Buformin,Ofloxacin,The therapeutic efficacy of Buformin can be increased when used in combination with Ofloxacin.,increase,no risk
Buformin,Olanzapine,The therapeutic efficacy of Buformin can be decreased when used in combination with Olanzapine.,decrease,no risk
Buformin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Buformin.,increase,no risk
Buformin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Buformin.,increase,no risk
Buformin,Oxprenolol,The therapeutic efficacy of Buformin can be increased when used in combination with Oxprenolol.,increase,no risk
Buformin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Buformin.,increase,no risk
Buformin,Quetiapine,The therapeutic efficacy of Buformin can be decreased when used in combination with Quetiapine.,decrease,no risk
Buformin,Quinethazone,The therapeutic efficacy of Buformin can be decreased when used in combination with Quinethazone.,decrease,no risk
Buformin,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Buformin.,increase,risk
Buformin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Buformin.,increase,risk
Buformin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Buformin.,decrease,no risk
Tienilic acid,Bleomycin,Tienilic acid may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Bosentan,The metabolism of Bosentan can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Bretylium,Bretylium may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Brimonidine,Brimonidine may increase the antihypertensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Brivaracetam,Tienilic acid may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Bromazepam,Tienilic acid may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Budesonide,Tienilic acid may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Bumadizone,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Bumadizone.,decrease,no risk
Tienilic acid,Bumetanide,Tienilic acid may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Bupivacaine,Bupivacaine may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Bupropion,Tienilic acid may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Buspirone,Tienilic acid may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Butabarbital,Tienilic acid may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Butorphanol,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Butorphanol.,decrease,no risk
Tienilic acid,Butriptyline,Butriptyline may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Gabapentin enacarbil,Tienilic acid may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gadobenic acid,Tienilic acid may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gadodiamide,Tienilic acid may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gadofosveset trisodium,Tienilic acid may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gadopentetic acid,Tienilic acid may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gadoteric acid,Tienilic acid may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gadoteridol,Tienilic acid may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Ganciclovir,Tienilic acid may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gemcitabine,Tienilic acid may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gemfibrozil,Tienilic acid may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gimeracil,Tienilic acid may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Glipizide,Tienilic acid may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Gluconic Acid,The risk or severity of dehydration can be increased when Tienilic acid is combined with Gluconic Acid.,increase,risk
Tienilic acid,Glyburide,The metabolism of Glyburide can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Glycerin,The risk or severity of dehydration can be increased when Tienilic acid is combined with Glycerin.,increase,risk
Tienilic acid,Glycerol phenylbutyrate,Tienilic acid may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Glycol salicylate,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Tienilic acid,Golodirsen,Tienilic acid may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Goserelin,Tienilic acid may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Guanabenz,Guanabenz may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Guanadrel,Guanadrel may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Guanethidine,Tienilic acid may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Guanfacine,Tienilic acid may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Guanoxan,Tienilic acid may increase the hypotensive activities of Guanoxan.,increase,no risk
Tienilic acid,Haloperidol,Tienilic acid may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Halothane,The metabolism of Halothane can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Hydralazine,Tienilic acid may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Hydrochlorothiazide,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Tienilic acid,Hydrocodone,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Hydrocodone.,decrease,no risk
Tienilic acid,Hydroflumethiazide,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Tienilic acid,Hydromorphone,Tienilic acid may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Hydroxocobalamin,Tienilic acid may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Hydroxyethyl Starch,Tienilic acid may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Ketamine,Tienilic acid may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Ketazolam,Tienilic acid may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Ketoprofen,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Ketoprofen.,decrease,no risk
Tienilic acid,Ketorolac,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Ketorolac.,decrease,no risk
Tienilic acid,Obinutuzumab,Tienilic acid may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Tienilic acid,Octinoxate,Tienilic acid may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Olanzapine,Olanzapine may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Oliceridine,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Oliceridine.,decrease,no risk
Tienilic acid,Olmesartan,Olmesartan may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Opicapone,Opicapone may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Opium,Tienilic acid may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Oseltamivir,Tienilic acid may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Oxacillin,Tienilic acid may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Oxaprozin,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Oxaprozin.,decrease,no risk
Tienilic acid,Oxazepam,Tienilic acid may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Oxprenolol,Oxprenolol may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Oxybenzone,Tienilic acid may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Oxycodone,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Oxycodone.,decrease,no risk
Tienilic acid,Oxymetazoline,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Tienilic acid,Oxymorphone,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Oxymorphone.,decrease,no risk
Tienilic acid,Oxyphenbutazone,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Tienilic acid,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Tienilic acid is combined with Oxyphenisatin acetate.,increase,risk
Tienilic acid,Oxyquinoline,Tienilic acid may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Quetiapine,Quetiapine may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Quinapril,Quinapril may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Quinidine,Tienilic acid may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Quinine,The metabolism of Quinine can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Quinupramine,Quinupramine may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Udenafil,Udenafil may increase the antihypertensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Unoprostone,Tienilic acid may increase the hypotensive activities of Unoprostone.,increase,no risk
Tienilic acid,Vaborbactam,Tienilic acid may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Valaciclovir,Tienilic acid may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Valbenazine,Tienilic acid may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Valdecoxib,The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Valdecoxib.,decrease,no risk
Tienilic acid,Valganciclovir,Tienilic acid may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Valsartan,The metabolism of Valsartan can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Vancomycin,Tienilic acid may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Varenicline,Tienilic acid may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Venlafaxine,Tienilic acid may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Verapamil,Tienilic acid may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Vericiguat,Vericiguat may increase the hypotensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Vilanterol,Tienilic acid may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Vilazodone,Vilazodone may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Viloxazine,Tienilic acid may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Vortioxetine,Tienilic acid may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Warfarin,The metabolism of Warfarin can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Xamoterol,Xamoterol may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Yohimbine,Yohimbine may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Zaleplon,Tienilic acid may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Zanamivir,Tienilic acid may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Ziconotide,The risk or severity of CNS depression can be increased when Tienilic acid is combined with Ziconotide.,increase,risk
Tienilic acid,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Zileuton,The metabolism of Zileuton can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Tienilic acid.,increase,no risk
Tienilic acid,Zofenopril,Tienilic acid may increase the hypotensive activities of Zofenopril.,increase,no risk
Tienilic acid,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Tienilic acid,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Zonisamide,Tienilic acid may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tienilic acid,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Tienilic acid.,decrease,no risk
Tienilic acid,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Tienilic acid.,decrease,no risk
Zimelidine,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Betrixaban,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Betrixaban.,increase,risk
Zimelidine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Bexagliflozin.,increase,risk
Zimelidine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Bivalirudin,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Bivalirudin.,increase,risk
Zimelidine,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bosentan,The metabolism of Bosentan can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Zimelidine.,increase,risk
Zimelidine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Zimelidine.,increase,risk
Zimelidine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Zimelidine.,increase,risk
Zimelidine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Zimelidine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Zimelidine.,increase,risk
Zimelidine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Zimelidine.,increase,risk
Zimelidine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Zimelidine.,increase,risk
Zimelidine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Zimelidine.,increase,risk
Zimelidine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Zimelidine.,increase,risk
Zimelidine,Budesonide,The metabolism of Budesonide can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Bumadizone.,increase,risk
Zimelidine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zimelidine.,increase,risk
Zimelidine,Buprenorphine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Zimelidine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Zimelidine.,increase,risk
Zimelidine,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Zimelidine.,increase,risk
Zimelidine,Busulfan,The metabolism of Busulfan can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Zimelidine.,increase,risk
Zimelidine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Zimelidine.,increase,risk
Zimelidine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Zimelidine.,increase,risk
Zimelidine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Zimelidine.,increase,risk
Zimelidine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Zimelidine.,increase,risk
Zimelidine,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Zimelidine.,increase,risk
Zimelidine,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Zimelidine.,increase,risk
Zimelidine,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Zimelidine.,increase,risk
Zimelidine,Galantamine,The metabolism of Galantamine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Zimelidine.,increase,risk
Zimelidine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zimelidine is combined with Ganaxolone.",increase,risk
Zimelidine,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Zimelidine.,increase,risk
Zimelidine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Gilteritinib,The therapeutic efficacy of Zimelidine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Zimelidine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Gliclazide,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Gliclazide.,increase,risk
Zimelidine,Glimepiride,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glimepiride.,increase,risk
Zimelidine,Glipizide,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glipizide.,increase,risk
Zimelidine,Gliquidone,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Gliquidone.,increase,risk
Zimelidine,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Zimelidine.,increase,risk
Zimelidine,Glyburide,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glyburide.,increase,risk
Zimelidine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Glycol salicylate.,increase,risk
Zimelidine,Glymidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Glymidine.,increase,risk
Zimelidine,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Zimelidine.,increase,risk
Zimelidine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Zimelidine.,increase,risk
Zimelidine,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Zimelidine.,increase,risk
Zimelidine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Zimelidine.,increase,risk
Zimelidine,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Zimelidine.,increase,risk
Zimelidine,Heparin,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Heparin.,increase,risk
Zimelidine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Zimelidine.,increase,risk
Zimelidine,Hydrochlorothiazide,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Hydrochlorothiazide.,increase,risk
Zimelidine,Hydrocodone,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zimelidine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Hydroflumethiazide.,increase,risk
Zimelidine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Zimelidine.,increase,risk
Zimelidine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Zimelidine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Zimelidine.,increase,risk
Zimelidine,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Zimelidine.,increase,risk
Zimelidine,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Ketoprofen.,increase,risk
Zimelidine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Ketorolac.,increase,risk
Zimelidine,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Zimelidine.,increase,risk
Zimelidine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Zimelidine.,increase,risk
Zimelidine,Olaparib,The metabolism of Olaparib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zimelidine is combined with Oliceridine.",increase,risk
Zimelidine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Zimelidine.,increase,risk
Zimelidine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Zimelidine.,increase,risk
Zimelidine,Orphenadrine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Zimelidine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Oxaprozin.,increase,risk
Zimelidine,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Zimelidine.,increase,risk
Zimelidine,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Zimelidine.,increase,risk
Zimelidine,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Zimelidine.,increase,risk
Zimelidine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Zimelidine.,increase,risk
Zimelidine,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zimelidine.,increase,risk
Zimelidine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Zimelidine.,increase,risk
Zimelidine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Zimelidine.,increase,risk
Zimelidine,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Oxyphenbutazone.,increase,risk
Zimelidine,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Zimelidine.,increase,risk
Zimelidine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Zimelidine.,increase,risk
Zimelidine,Quinethazone,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Quinethazone.,increase,risk
Zimelidine,Quinidine,The metabolism of Quinidine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Zimelidine.,increase,risk
Zimelidine,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Zimelidine.,increase,risk
Zimelidine,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Ubidecarenone.,increase,risk
Zimelidine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Udenafil,The metabolism of Udenafil can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Zimelidine.,increase,risk
Zimelidine,Urokinase,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Urokinase.,increase,risk
Zimelidine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Valdecoxib.,increase,risk
Zimelidine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Valproate bismuth.,increase,risk
Zimelidine,Valproic acid,The risk or severity of adverse effects can be increased when Valproic acid is combined with Zimelidine.,increase,risk
Zimelidine,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vasopressin,Zimelidine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Zimelidine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Zimelidine.,increase,risk
Zimelidine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Venlafaxine.,increase,risk
Zimelidine,Verapamil,The metabolism of Verapamil can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Zimelidine.,increase,risk
Zimelidine,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Zimelidine.,increase,risk
Zimelidine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Vildagliptin.,increase,risk
Zimelidine,Viloxazine,The risk or severity of adverse effects can be increased when Viloxazine is combined with Zimelidine.,increase,risk
Zimelidine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vincristine,The metabolism of Vincristine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vindesine,The metabolism of Vindesine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vorapaxar,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Vorapaxar.,increase,risk
Zimelidine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zimelidine.,increase,risk
Zimelidine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Zimelidine.,increase,no risk
Zimelidine,Ximelagatran,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ximelagatran.,increase,risk
Zimelidine,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Zimelidine.,increase,risk
Zimelidine,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Zimelidine.,increase,risk
Zimelidine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Ziconotide,The risk or severity of adverse effects can be increased when Ziconotide is combined with Zimelidine.,increase,risk
Zimelidine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Zileuton,The metabolism of Zileuton can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Ziprasidone,The risk or severity of adverse effects can be increased when Zimelidine is combined with Ziprasidone.,increase,risk
Zimelidine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Zolmitriptan.,increase,risk
Zimelidine,Zolpidem,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zimelidine,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Zimelidine.,increase,risk
Zimelidine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Zimelidine.,decrease,no risk
Zimelidine,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Zimelidine.,increase,risk
Zimelidine,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Zimelidine.,increase,risk
Zimelidine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Zimelidine.,increase,risk
Methaqualone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Methaqualone.,increase,risk
Methaqualone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Methaqualone is combined with Gabapentin enacarbil.,increase,risk
Methaqualone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Methaqualone.,increase,risk
Methaqualone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Methaqualone is combined with Ganaxolone.",increase,risk
Methaqualone,Gepirone,The risk or severity of CNS depression can be increased when Methaqualone is combined with Gepirone.,increase,risk
Methaqualone,Glofitamab,The serum concentration of Methaqualone can be increased when it is combined with Glofitamab.,increase,no risk
Methaqualone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Methaqualone.,increase,risk
Methaqualone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Methaqualone.,increase,risk
Methaqualone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Methaqualone.,increase,risk
Methaqualone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Methaqualone.,increase,risk
Methaqualone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Methaqualone.,increase,risk
Methaqualone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Methaqualone.,increase,risk
Methaqualone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Methaqualone.,increase,risk
Methaqualone,Hydrocodone,Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Methaqualone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Methaqualone.,increase,risk
Methaqualone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methaqualone.,increase,no risk
Methaqualone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Methaqualone.,increase,risk
Methaqualone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Methaqualone.,increase,risk
Methaqualone,Ketoconazole,The metabolism of Methaqualone can be decreased when combined with Ketoconazole.,decrease,no risk
Methaqualone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Methaqualone.,increase,risk
Methaqualone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Methaqualone is combined with Oliceridine.",increase,risk
Methaqualone,Omaveloxolone,The serum concentration of Methaqualone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Methaqualone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Methaqualone.,increase,risk
Methaqualone,Opium,The risk or severity of CNS depression can be increased when Methaqualone is combined with Opium.,increase,risk
Methaqualone,Orphenadrine,Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Methaqualone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Methaqualone.,increase,risk
Methaqualone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Methaqualone.,increase,risk
Methaqualone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Methaqualone.,increase,risk
Methaqualone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Methaqualone.,increase,risk
Methaqualone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Methaqualone.,increase,risk
Methaqualone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Methaqualone.,increase,risk
Methaqualone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Methaqualone.,increase,risk
Methaqualone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Methaqualone.,increase,risk
Methaqualone,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Methaqualone.,increase,risk
Methaqualone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Methaqualone.,increase,risk
Methaqualone,Quinupramine,The risk or severity of CNS depression can be increased when Methaqualone is combined with Quinupramine.,increase,risk
Rapacuronium,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Rapacuronium.,increase,risk
Rapacuronium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Gabapentin enacarbil.,increase,risk
Rapacuronium,Galantamine,The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Galantamine.,decrease,no risk
Rapacuronium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Rapacuronium.,increase,risk
Rapacuronium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Rapacuronium is combined with Ganaxolone.",increase,risk
Rapacuronium,Gentamicin,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Gentamicin.,increase,no risk
Rapacuronium,Gepirone,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Gepirone.,increase,risk
Rapacuronium,Ginkgo biloba,The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Rapacuronium,Glucagon,Rapacuronium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Rapacuronium,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Rapacuronium.,increase,risk
Rapacuronium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Rapacuronium.,decrease,no risk
Rapacuronium,Glycopyrronium,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Glycopyrronium.,increase,risk
Rapacuronium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Rapacuronium.,increase,risk
Rapacuronium,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Rapacuronium.,increase,risk
Rapacuronium,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Rapacuronium.,increase,risk
Rapacuronium,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Rapacuronium.,increase,risk
Rapacuronium,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Rapacuronium.,increase,risk
Rapacuronium,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Rapacuronium.,increase,risk
Rapacuronium,Hetacillin,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Hetacillin.,increase,no risk
Rapacuronium,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Rapacuronium.,increase,risk
Rapacuronium,Hexocyclium,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hexocyclium.,increase,risk
Rapacuronium,Homatropine,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Homatropine.,increase,risk
Rapacuronium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Rapacuronium.,increase,risk
Rapacuronium,Huperzine A,The therapeutic efficacy of Rapacuronium can be decreased when used in combination with Huperzine A.,decrease,no risk
Rapacuronium,Hydrochlorothiazide,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Rapacuronium,Hydrocodone,Rapacuronium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Rapacuronium,Hydrocortisone,The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone.,increase,risk
Rapacuronium,Hydrocortisone acetate,The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone acetate.,increase,risk
Rapacuronium,Hydrocortisone butyrate,The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone butyrate.,increase,risk
Rapacuronium,Hydrocortisone cypionate,The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone cypionate.,increase,risk
Rapacuronium,Hydrocortisone succinate,The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Hydrocortisone succinate.,increase,risk
Rapacuronium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Rapacuronium.,increase,no risk
Rapacuronium,Hydromorphone,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Hydromorphone.,increase,risk
Rapacuronium,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rapacuronium.,increase,no risk
Rapacuronium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Rapacuronium.,increase,risk
Rapacuronium,Kanamycin,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Kanamycin.,increase,no risk
Rapacuronium,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Rapacuronium.,increase,risk
Rapacuronium,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Rapacuronium.,increase,risk
Rapacuronium,Ketoconazole,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Ketoconazole.,increase,no risk
Rapacuronium,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Rapacuronium.,increase,risk
Rapacuronium,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Rapacuronium.,increase,risk
Rapacuronium,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Rapacuronium is combined with Oliceridine.",increase,risk
Rapacuronium,Olodaterol,The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Olodaterol.,increase,risk
Rapacuronium,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Rapacuronium.,increase,risk
Rapacuronium,Opium,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Opium.,increase,risk
Rapacuronium,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Rapacuronium.,increase,risk
Rapacuronium,Orphenadrine,Rapacuronium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Rapacuronium,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Rapacuronium is combined with Ouabain.,increase,risk
Rapacuronium,Oxacillin,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Oxacillin.,increase,no risk
Rapacuronium,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxycodone,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxycodone.,increase,risk
Rapacuronium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxymorphone,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Oxymorphone.,increase,risk
Rapacuronium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Rapacuronium.,decrease,no risk
Rapacuronium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Rapacuronium.,increase,risk
Rapacuronium,Oxytetracycline,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Oxytetracycline.,increase,no risk
Rapacuronium,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Rapacuronium.,increase,risk
Rapacuronium,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Rapacuronium.,increase,risk
Rapacuronium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Rapacuronium.,increase,no risk
Rapacuronium,Quinidine,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Quinidine.,increase,no risk
Rapacuronium,Quinine,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Quinine.,increase,no risk
Rapacuronium,Quinupramine,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Quinupramine.,increase,risk
Rapacuronium,Umeclidinium,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Umeclidinium.,increase,risk
Rapacuronium,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Rapacuronium.,increase,risk
Rapacuronium,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Rapacuronium.,increase,risk
Rapacuronium,Vamorolone,The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Vamorolone.,increase,risk
Rapacuronium,Vancomycin,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Vancomycin.,increase,no risk
Rapacuronium,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Rapacuronium.,increase,risk
Rapacuronium,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Rapacuronium.,increase,risk
Rapacuronium,Verapamil,Verapamil may increase the neuromuscular blocking activities of Rapacuronium.,increase,no risk
Rapacuronium,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Rapacuronium.,increase,risk
Rapacuronium,Vilanterol,The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Vilanterol.,increase,risk
Rapacuronium,Vilazodone,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Vilazodone.,increase,risk
Rapacuronium,Viloxazine,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Viloxazine.,increase,risk
Rapacuronium,Viomycin,The therapeutic efficacy of Rapacuronium can be increased when used in combination with Viomycin.,increase,no risk
Rapacuronium,Vortioxetine,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Vortioxetine.,increase,risk
Rapacuronium,Xamoterol,The risk or severity of Tachycardia can be increased when Rapacuronium is combined with Xamoterol.,increase,risk
Rapacuronium,Xylometazoline,Xylometazoline may increase the neuromuscular blocking activities of Rapacuronium.,increase,no risk
Rapacuronium,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Rapacuronium.,increase,risk
Rapacuronium,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Rapacuronium.,increase,risk
Rapacuronium,Ziconotide,Ziconotide may increase the neuromuscular blocking activities of Rapacuronium.,increase,no risk
Rapacuronium,Zimelidine,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Zimelidine.,increase,risk
Rapacuronium,Ziprasidone,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Ziprasidone.,increase,risk
Rapacuronium,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Rapacuronium.,increase,risk
Rapacuronium,Zolpidem,Rapacuronium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Rapacuronium,Zonisamide,Zonisamide may increase the neuromuscular blocking activities of Rapacuronium.,increase,no risk
Rapacuronium,Zopiclone,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Zopiclone.,increase,risk
Rapacuronium,Zotepine,The risk or severity of CNS depression can be increased when Rapacuronium is combined with Zotepine.,increase,risk
Rapacuronium,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Rapacuronium.,increase,risk
Maraviroc,Vadadustat,The serum concentration of Maraviroc can be increased when it is combined with Vadadustat.,increase,no risk
Maraviroc,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Maraviroc.,decrease,no risk
Maraviroc,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Maraviroc.,decrease,no risk
Maraviroc,Venetoclax,The metabolism of Maraviroc can be decreased when combined with Venetoclax.,decrease,no risk
Maraviroc,Verapamil,The metabolism of Maraviroc can be decreased when combined with Verapamil.,decrease,no risk
Maraviroc,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Maraviroc.,decrease,no risk
Maraviroc,Viloxazine,The metabolism of Maraviroc can be decreased when combined with Viloxazine.,decrease,no risk
Maraviroc,Voriconazole,The metabolism of Maraviroc can be decreased when combined with Voriconazole.,decrease,no risk
Maraviroc,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Maraviroc.,decrease,no risk
Maraviroc,Zimelidine,The metabolism of Maraviroc can be decreased when combined with Zimelidine.,decrease,no risk
Maraviroc,Ziprasidone,The metabolism of Maraviroc can be decreased when combined with Ziprasidone.,decrease,no risk
Amineptine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Amineptine.,increase,risk
Amineptine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Amineptine.,increase,risk
Amineptine,Butriptyline,The risk or severity of CNS depression can be increased when Amineptine is combined with Butriptyline.,increase,risk
Amineptine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Amineptine.,increase,risk
Clofedanol,Benzphetamine,Benzphetamine may decrease the sedative activities of Clofedanol.,decrease,no risk
Clofedanol,Benzylpenicilloyl polylysine,Clofedanol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Clofedanol,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Clofedanol.,decrease,no risk
Clofedanol,Hyoscyamine,Clofedanol may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Cyclandelate,Galantamine,Galantamine may increase the bradycardic activities of Cyclandelate.,increase,no risk
Cyclandelate,Gallamine triethiodide,Cyclandelate may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Cyclandelate,Gliclazide,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Gliclazide.,increase,risk
Cyclandelate,Glimepiride,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Glimepiride.,increase,risk
Cyclandelate,Glipizide,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Glipizide.,increase,risk
Cyclandelate,Gliquidone,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Gliquidone.,increase,risk
Cyclandelate,Glofitamab,The serum concentration of Cyclandelate can be increased when it is combined with Glofitamab.,increase,no risk
Cyclandelate,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Cyclandelate.,decrease,no risk
Cyclandelate,Glyburide,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Glyburide.,increase,risk
Cyclandelate,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Cyclandelate.,decrease,no risk
Cyclandelate,Glymidine,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Glymidine.,increase,risk
Cyclandelate,Guanfacine,Guanfacine may increase the bradycardic activities of Cyclandelate.,increase,no risk
Cyclandelate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cyclandelate.,increase,no risk
Cyclandelate,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Cyclandelate.,increase,risk
Cyclandelate,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Cyclandelate.,increase,risk
Cyclandelate,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Cyclandelate.,increase,no risk
Cyclandelate,Ketoconazole,The metabolism of Cyclandelate can be decreased when combined with Ketoconazole.,decrease,no risk
Cyclandelate,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Cyclandelate.,increase,risk
Cyclandelate,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Cyclandelate.,increase,risk
Cyclandelate,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Cyclandelate.,increase,no risk
Cyclandelate,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Cyclandelate.,increase,risk
Cyclandelate,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Cyclandelate.,increase,risk
Cyclandelate,Omaveloxolone,The serum concentration of Cyclandelate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cyclandelate,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Cyclandelate.,increase,no risk
Cyclandelate,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Cyclandelate.,increase,no risk
Cyclandelate,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Cyclandelate.,increase,risk
Cyclandelate,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Cyclandelate.,increase,no risk
Cyclandelate,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Cyclandelate.,increase,risk
Cyclandelate,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Cyclandelate.,decrease,no risk
Debrisoquine,Galantamine,The metabolism of Debrisoquine can be decreased when combined with Galantamine.,decrease,no risk
Debrisoquine,Gefitinib,The metabolism of Debrisoquine can be decreased when combined with Gefitinib.,decrease,no risk
Debrisoquine,Givosiran,The serum concentration of Debrisoquine can be increased when it is combined with Givosiran.,increase,no risk
Debrisoquine,Glycerol phenylbutyrate,The metabolism of Debrisoquine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Debrisoquine,Glycol salicylate,The therapeutic efficacy of Debrisoquine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Debrisoquine,Golimumab,The metabolism of Debrisoquine can be increased when combined with Golimumab.,increase,no risk
Debrisoquine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Debrisoquine.,decrease,no risk
Debrisoquine,Guanadrel,Guanadrel may increase the hypotensive activities of Debrisoquine.,increase,no risk
Debrisoquine,Guanethidine,Guanethidine may increase the hypotensive activities of Debrisoquine.,increase,no risk
Debrisoquine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Debrisoquine.,decrease,no risk
Debrisoquine,Guanoxan,Debrisoquine may increase the hypotensive activities of Guanoxan.,increase,no risk
Debrisoquine,Halofantrine,The metabolism of Debrisoquine can be decreased when combined with Halofantrine.,decrease,no risk
Debrisoquine,Haloperidol,The serum concentration of Debrisoquine can be increased when it is combined with Haloperidol.,increase,no risk
Debrisoquine,Halothane,Halothane may decrease the antihypertensive activities of Debrisoquine.,decrease,no risk
Debrisoquine,Hydralazine,Hydralazine may increase the hypotensive activities of Debrisoquine.,increase,no risk
Debrisoquine,Hydrochlorothiazide,The therapeutic efficacy of Debrisoquine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Debrisoquine,Hydroflumethiazide,The therapeutic efficacy of Debrisoquine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Debrisoquine,Hydroxychloroquine,The metabolism of Debrisoquine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Debrisoquine,Hydroxyzine,The metabolism of Debrisoquine can be decreased when combined with Hydroxyzine.,decrease,no risk
Debrisoquine,Ketoconazole,The metabolism of Debrisoquine can be decreased when combined with Ketoconazole.,decrease,no risk
Debrisoquine,Ketoprofen,The therapeutic efficacy of Debrisoquine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Debrisoquine,Ketorolac,The therapeutic efficacy of Debrisoquine can be decreased when used in combination with Ketorolac.,decrease,no risk
Flunarizine,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Benoxaprofen is combined with Flunarizine.,increase,risk
Flunarizine,Benperidol,The risk or severity of CNS depression can be increased when Flunarizine is combined with Benperidol.,increase,risk
Flunarizine,Benzatropine,The metabolism of Flunarizine can be decreased when combined with Benzatropine.,decrease,no risk
Flunarizine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Benzocaine.,increase,risk
Flunarizine,Benzphetamine,Benzphetamine may decrease the sedative activities of Flunarizine.,decrease,no risk
Flunarizine,Benzydamine,The risk or severity of hyperkalemia can be increased when Flunarizine is combined with Benzydamine.,increase,risk
Flunarizine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Benzyl alcohol.,increase,risk
Flunarizine,Benzylpenicilloyl polylysine,Flunarizine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Flunarizine,Bepridil,Bepridil may increase the arrhythmogenic activities of Flunarizine.,increase,no risk
Flunarizine,Beractant,Flunarizine may increase the bradycardic activities of Beractant.,increase,no risk
Flunarizine,Berotralstat,The metabolism of Flunarizine can be decreased when combined with Berotralstat.,decrease,no risk
Flunarizine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Flunarizine.,decrease,no risk
Flunarizine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Flunarizine.,increase,no risk
Flunarizine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Bexagliflozin.,increase,risk
Flunarizine,Bexarotene,The metabolism of Flunarizine can be decreased when combined with Bexarotene.,decrease,no risk
Flunarizine,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Flunarizine.,increase,no risk
Flunarizine,Bimekizumab,The metabolism of Flunarizine can be increased when combined with Bimekizumab.,increase,no risk
Flunarizine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Flunarizine.,decrease,no risk
Flunarizine,Bioallethrin,Flunarizine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Flunarizine,Biperiden,The metabolism of Flunarizine can be decreased when combined with Biperiden.,decrease,no risk
Flunarizine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Flunarizine.,decrease,no risk
Flunarizine,Bisoprolol,The therapeutic efficacy of Flunarizine can be increased when used in combination with Bisoprolol.,increase,no risk
Flunarizine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Flunarizine.,decrease,no risk
Flunarizine,Boceprevir,The serum concentration of Flunarizine can be increased when it is combined with Boceprevir.,increase,no risk
Flunarizine,Borage oil,The therapeutic efficacy of Flunarizine can be decreased when used in combination with Borage oil.,decrease,no risk
Flunarizine,Bortezomib,The metabolism of Flunarizine can be decreased when combined with Bortezomib.,decrease,no risk
Flunarizine,Bosentan,The metabolism of Flunarizine can be increased when combined with Bosentan.,increase,no risk
Flunarizine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Flunarizine.,increase,risk
Flunarizine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Flunarizine.,increase,risk
Flunarizine,Bretylium,Bretylium may increase the arrhythmogenic activities of Flunarizine.,increase,no risk
Flunarizine,Brexanolone,The risk or severity of CNS depression can be increased when Flunarizine is combined with Brexanolone.,increase,risk
Flunarizine,Brexpiprazole,The risk or severity of CNS depression can be increased when Flunarizine is combined with Brexpiprazole.,increase,risk
Flunarizine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.,increase,no risk
Flunarizine,Brivaracetam,The risk or severity of CNS depression can be increased when Flunarizine is combined with Brivaracetam.,increase,risk
Flunarizine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Flunarizine.,increase,risk
Flunarizine,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Flunarizine.,increase,risk
Flunarizine,Bromotheophylline,Flunarizine may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flunarizine,Bromperidol,The risk or severity of CNS depression can be increased when Flunarizine is combined with Bromperidol.,increase,risk
Flunarizine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Flunarizine.,increase,risk
Flunarizine,Bumadizone,The risk or severity of hyperkalemia can be increased when Flunarizine is combined with Bumadizone.,increase,risk
Flunarizine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Bupivacaine.,increase,risk
Flunarizine,Buprenorphine,Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Flunarizine,Bupropion,The metabolism of Flunarizine can be decreased when combined with Bupropion.,decrease,no risk
Flunarizine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Flunarizine.,increase,risk
Flunarizine,Butabarbital,The metabolism of Flunarizine can be increased when combined with Butabarbital.,increase,no risk
Flunarizine,Butacaine,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Butacaine.,increase,risk
Flunarizine,Butalbital,The metabolism of Flunarizine can be increased when combined with Butalbital.,increase,no risk
Flunarizine,Butamben,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Butamben.,increase,risk
Flunarizine,Butaperazine,The risk or severity of CNS depression can be increased when Flunarizine is combined with Butaperazine.,increase,risk
Flunarizine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Flunarizine.,increase,risk
Flunarizine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Flunarizine.,increase,risk
Flunarizine,Butriptyline,The risk or severity of CNS depression can be increased when Flunarizine is combined with Butriptyline.,increase,risk
Flunarizine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Flunarizine.,increase,risk
Flunarizine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Flunarizine is combined with Gabapentin enacarbil.,increase,risk
Flunarizine,Galantamine,Galantamine may increase the bradycardic activities of Flunarizine.,increase,no risk
Flunarizine,Gallamine triethiodide,Flunarizine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Flunarizine,Gamolenic acid,The therapeutic efficacy of Flunarizine can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Flunarizine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Flunarizine is combined with Ganaxolone.",increase,risk
Flunarizine,Ganciclovir,The therapeutic efficacy of Flunarizine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Flunarizine,Gatifloxacin,The metabolism of Flunarizine can be decreased when combined with Gatifloxacin.,decrease,no risk
Flunarizine,Gefitinib,The metabolism of Flunarizine can be decreased when combined with Gefitinib.,decrease,no risk
Flunarizine,Gemfibrozil,The metabolism of Flunarizine can be decreased when combined with Gemfibrozil.,decrease,no risk
Flunarizine,Gemifloxacin,The metabolism of Flunarizine can be decreased when combined with Gemifloxacin.,decrease,no risk
Flunarizine,Gepirone,The risk or severity of CNS depression can be increased when Flunarizine is combined with Gepirone.,increase,risk
Flunarizine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Flunarizine.,increase,no risk
Flunarizine,Ginkgo biloba,The metabolism of Flunarizine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Flunarizine,Givosiran,The serum concentration of Flunarizine can be increased when it is combined with Givosiran.,increase,no risk
Flunarizine,Gliclazide,The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Gliclazide.,increase,risk
Flunarizine,Glimepiride,The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Glimepiride.,increase,risk
Flunarizine,Glipizide,The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Glipizide.,increase,risk
Flunarizine,Gliquidone,The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Gliquidone.,increase,risk
Flunarizine,Glofitamab,The serum concentration of Flunarizine can be increased when it is combined with Glofitamab.,increase,no risk
Flunarizine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Flunarizine.,decrease,no risk
Flunarizine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Flunarizine.,increase,risk
Flunarizine,Glyburide,The metabolism of Flunarizine can be decreased when combined with Glyburide.,decrease,no risk
Flunarizine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Flunarizine.,decrease,no risk
Flunarizine,Glycerol phenylbutyrate,The metabolism of Flunarizine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Flunarizine,Glymidine,The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Glymidine.,increase,risk
Flunarizine,Golimumab,The metabolism of Flunarizine can be increased when combined with Golimumab.,increase,no risk
Flunarizine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Flunarizine.,increase,risk
Flunarizine,Grepafloxacin,The metabolism of Flunarizine can be decreased when combined with Grepafloxacin.,decrease,no risk
Flunarizine,Guanabenz,The metabolism of Flunarizine can be decreased when combined with Guanabenz.,decrease,no risk
Flunarizine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Flunarizine.,increase,risk
Flunarizine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Flunarizine.,increase,risk
Flunarizine,Halofantrine,The metabolism of Flunarizine can be decreased when combined with Halofantrine.,decrease,no risk
Flunarizine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Flunarizine.,increase,risk
Flunarizine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Flunarizine.,increase,risk
Flunarizine,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Flunarizine.,increase,risk
Flunarizine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Flunarizine.,increase,risk
Flunarizine,Hydrocodone,Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Flunarizine,Hydrocortisone,The metabolism of Flunarizine can be increased when combined with Hydrocortisone.,increase,no risk
Flunarizine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Flunarizine.,increase,risk
Flunarizine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Flunarizine.,increase,risk
Flunarizine,Hydroxychloroquine,The therapeutic efficacy of Flunarizine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Flunarizine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Flunarizine.,increase,no risk
Flunarizine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flunarizine.,increase,no risk
Flunarizine,Hyoscyamine,Flunarizine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Flunarizine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Flunarizine.,increase,risk
Flunarizine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Flunarizine.,increase,risk
Flunarizine,Ketoconazole,The metabolism of Flunarizine can be decreased when combined with Ketoconazole.,decrease,no risk
Flunarizine,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Flunarizine.,increase,risk
Flunarizine,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Flunarizine.,increase,risk
Flunarizine,Obeticholic acid,The metabolism of Flunarizine can be decreased when combined with Obeticholic acid.,decrease,no risk
Flunarizine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Flunarizine.,increase,no risk
Flunarizine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Flunarizine.,increase,risk
Flunarizine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Flunarizine is combined with Oliceridine.",increase,risk
Flunarizine,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Flunarizine.,increase,risk
Flunarizine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Flunarizine.,decrease,no risk
Flunarizine,Omaveloxolone,The serum concentration of Flunarizine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Flunarizine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Flunarizine.,increase,risk
Flunarizine,Opium,The risk or severity of CNS depression can be increased when Flunarizine is combined with Opium.,increase,risk
Flunarizine,Oritavancin,The metabolism of Flunarizine can be decreased when combined with Oritavancin.,decrease,no risk
Flunarizine,Orlistat,Orlistat can cause a decrease in the absorption of Flunarizine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Flunarizine,Orphenadrine,Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Flunarizine,Osilodrostat,The metabolism of Flunarizine can be decreased when combined with Osilodrostat.,decrease,no risk
Flunarizine,Osimertinib,The serum concentration of Flunarizine can be decreased when it is combined with Osimertinib.,decrease,no risk
Flunarizine,Ospemifene,The metabolism of Flunarizine can be decreased when combined with Ospemifene.,decrease,no risk
Flunarizine,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Flunarizine.,increase,no risk
Flunarizine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Flunarizine.,increase,no risk
Flunarizine,Oxamniquine,The metabolism of Flunarizine can be decreased when combined with Oxamniquine.,decrease,no risk
Flunarizine,Oxandrolone,The metabolism of Flunarizine can be decreased when combined with Oxandrolone.,decrease,no risk
Flunarizine,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Flunarizine.,increase,risk
Flunarizine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Flunarizine.,increase,risk
Flunarizine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Flunarizine.,increase,risk
Flunarizine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Oxetacaine.,increase,risk
Flunarizine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Flunarizine.,increase,risk
Flunarizine,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Flunarizine.,increase,no risk
Flunarizine,Oxtriphylline,Flunarizine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flunarizine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Oxybuprocaine.,increase,risk
Flunarizine,Oxybutynin,The metabolism of Flunarizine can be decreased when combined with Oxybutynin.,decrease,no risk
Flunarizine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Flunarizine.,increase,risk
Flunarizine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Flunarizine.,increase,risk
Flunarizine,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Flunarizine.,increase,risk
Flunarizine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Flunarizine.,decrease,no risk
Flunarizine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Flunarizine.,increase,risk
Flunarizine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Flunarizine.,increase,risk
Flunarizine,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Flunarizine.,increase,risk
Flunarizine,Quinidine,Quinidine may increase the arrhythmogenic activities of Flunarizine.,increase,no risk
Flunarizine,Quinine,The metabolism of Flunarizine can be decreased when combined with Quinine.,decrease,no risk
Flunarizine,Quinupramine,The risk or severity of CNS depression can be increased when Flunarizine is combined with Quinupramine.,increase,risk
Fluspirilene,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Fluspirilene.,decrease,no risk
Fluspirilene,Boceprevir,The metabolism of Fluspirilene can be decreased when combined with Boceprevir.,decrease,no risk
Fluspirilene,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Fluspirilene.,increase,risk
Fluspirilene,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Fluspirilene.,increase,risk
Fluspirilene,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Fluspirilene.,increase,risk
Fluspirilene,Bretylium,Bretylium may increase the arrhythmogenic activities of Fluspirilene.,increase,no risk
Fluspirilene,Brexanolone,The risk or severity of CNS depression can be increased when Fluspirilene is combined with Brexanolone.,increase,risk
Fluspirilene,Brexpiprazole,The risk or severity of CNS depression can be increased when Fluspirilene is combined with Brexpiprazole.,increase,risk
Fluspirilene,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fluspirilene.,increase,no risk
Fluspirilene,Brivaracetam,The risk or severity of CNS depression can be increased when Fluspirilene is combined with Brivaracetam.,increase,risk
Fluspirilene,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Fluspirilene.,increase,risk
Fluspirilene,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Fluspirilene.,increase,risk
Fluspirilene,Bromperidol,The risk or severity of CNS depression can be increased when Fluspirilene is combined with Bromperidol.,increase,risk
Fluspirilene,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Fluspirilene.,increase,risk
Fluspirilene,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Fluspirilene.,increase,risk
Fluspirilene,Bumadizone,The risk or severity of hyperkalemia can be increased when Fluspirilene is combined with Bumadizone.,increase,risk
Fluspirilene,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Fluspirilene.,increase,risk
Fluspirilene,Buprenorphine,Fluspirilene may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Fluspirilene,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Fluspirilene.,increase,risk
Fluspirilene,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Fluspirilene.,increase,risk
Fluspirilene,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Fluspirilene.,increase,risk
Fluspirilene,Butabarbital,The metabolism of Fluspirilene can be increased when combined with Butabarbital.,increase,no risk
Fluspirilene,Butalbital,The metabolism of Fluspirilene can be increased when combined with Butalbital.,increase,no risk
Fluspirilene,Butaperazine,The risk or severity of CNS depression can be increased when Fluspirilene is combined with Butaperazine.,increase,risk
Fluspirilene,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Fluspirilene.,increase,risk
Fluspirilene,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Fluspirilene.,increase,risk
Fluspirilene,Butriptyline,The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Butriptyline.,increase,risk
Mepenzolate,Galantamine,The therapeutic efficacy of Mepenzolate can be decreased when used in combination with Galantamine.,decrease,no risk
Mepenzolate,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Mepenzolate.,increase,risk
Mepenzolate,Ginkgo biloba,The therapeutic efficacy of Mepenzolate can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Mepenzolate,Glucagon,Mepenzolate may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Mepenzolate,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Mepenzolate.,decrease,no risk
Mepenzolate,Glycopyrronium,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Glycopyrronium.,increase,risk
Mepenzolate,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Mepenzolate.,increase,risk
Mepenzolate,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Mepenzolate.,increase,risk
Mepenzolate,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Mepenzolate.,increase,risk
Mepenzolate,Hexocyclium,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Hexocyclium.,increase,risk
Mepenzolate,Homatropine,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Homatropine.,increase,risk
Mepenzolate,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Mepenzolate.,increase,risk
Mepenzolate,Huperzine A,The therapeutic efficacy of Mepenzolate can be decreased when used in combination with Huperzine A.,decrease,no risk
Mepenzolate,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Mepenzolate.,increase,no risk
Mepenzolate,Hydrocodone,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Hydrocodone.,increase,risk
Mepenzolate,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Mepenzolate.,increase,no risk
Mepenzolate,Hydromorphone,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Hydromorphone.,increase,risk
Mepenzolate,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Mepenzolate.,increase,risk
Mepenzolate,Ketamine,The therapeutic efficacy of Mepenzolate can be decreased when used in combination with Ketamine.,decrease,no risk
Mepenzolate,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Mepenzolate.,increase,risk
Mepenzolate,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Mepenzolate is combined with Oliceridine.",increase,risk
Mepenzolate,Olodaterol,The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Olodaterol.,increase,risk
Mepenzolate,Opium,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Opium.,increase,risk
Mepenzolate,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Mepenzolate.,increase,risk
Mepenzolate,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Mepenzolate.,increase,risk
Mepenzolate,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Mepenzolate.,increase,risk
Mepenzolate,Oxycodone,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Oxycodone.,increase,risk
Mepenzolate,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Mepenzolate.,increase,risk
Mepenzolate,Oxymorphone,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Oxymorphone.,increase,risk
Mepenzolate,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Mepenzolate.,increase,risk
Mepenzolate,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Mepenzolate.,decrease,no risk
Mepenzolate,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Mepenzolate.,increase,risk
Mepenzolate,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Mepenzolate.,increase,risk
Mepenzolate,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Mepenzolate.,increase,no risk
Mepenzolate,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Mepenzolate.,increase,risk
Mepenzolate,Quinupramine,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Quinupramine.,increase,risk
Mepenzolate,Umeclidinium,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Umeclidinium.,increase,risk
Mepenzolate,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Mepenzolate.,increase,risk
Mepenzolate,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Mepenzolate.,increase,risk
Mepenzolate,Vilanterol,The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Vilanterol.,increase,risk
Mepenzolate,Xamoterol,The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Xamoterol.,increase,risk
Mepenzolate,Xylometazoline,The risk or severity of Tachycardia can be increased when Mepenzolate is combined with Xylometazoline.,increase,risk
Mepenzolate,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Mepenzolate.,increase,risk
Tetrabenazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Gefitinib,The metabolism of Tetrabenazine can be decreased when combined with Gefitinib.,decrease,no risk
Tetrabenazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Givosiran,The serum concentration of Tetrabenazine can be increased when it is combined with Givosiran.,increase,no risk
Tetrabenazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Glasdegib.,increase,risk
Tetrabenazine,Glutethimide,The risk or severity of sedation and somnolence can be increased when Glutethimide is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Glycerol phenylbutyrate,The metabolism of Tetrabenazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Tetrabenazine,Golimumab,The metabolism of Tetrabenazine can be increased when combined with Golimumab.,increase,no risk
Tetrabenazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Halofantrine,The metabolism of Tetrabenazine can be decreased when combined with Halofantrine.,decrease,no risk
Tetrabenazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Haloperidol.,increase,risk
Tetrabenazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Hydroxyzine.,increase,risk
Tetrabenazine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Ketoconazole,The metabolism of Tetrabenazine can be decreased when combined with Ketoconazole.,decrease,no risk
Tetrabenazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Tetrabenazine.,decrease,no risk
Tetrabenazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Opium,The metabolism of Opium can be decreased when combined with Tetrabenazine.,decrease,no risk
Tetrabenazine,Oritavancin,The metabolism of Tetrabenazine can be decreased when combined with Oritavancin.,decrease,no risk
Tetrabenazine,Orphenadrine,The metabolism of Tetrabenazine can be decreased when combined with Orphenadrine.,decrease,no risk
Tetrabenazine,Osilodrostat,The metabolism of Tetrabenazine can be decreased when combined with Osilodrostat.,decrease,no risk
Tetrabenazine,Ospemifene,The metabolism of Tetrabenazine can be decreased when combined with Ospemifene.,decrease,no risk
Tetrabenazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Oxamniquine,The metabolism of Tetrabenazine can be decreased when combined with Oxamniquine.,decrease,no risk
Tetrabenazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Oxazepam,The risk or severity of sedation and somnolence can be increased when Oxazepam is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Oxprenolol,The metabolism of Tetrabenazine can be decreased when combined with Oxprenolol.,decrease,no risk
Tetrabenazine,Oxybutynin,The metabolism of Tetrabenazine can be decreased when combined with Oxybutynin.,decrease,no risk
Tetrabenazine,Oxycodone,The metabolism of Tetrabenazine can be decreased when combined with Oxycodone.,decrease,no risk
Tetrabenazine,Oxymorphone,The metabolism of Tetrabenazine can be decreased when combined with Oxymorphone.,decrease,no risk
Tetrabenazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Quazepam,The risk or severity of sedation and somnolence can be increased when Quazepam is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Quinidine,The metabolism of Tetrabenazine can be decreased when combined with Quinidine.,decrease,no risk
Tetrabenazine,Quinine,The metabolism of Tetrabenazine can be decreased when combined with Quinine.,decrease,no risk
Tetrabenazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Quizartinib.,increase,risk
Tetrabenazine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Tetrabenazine.,decrease,no risk
Tetrabenazine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Tetrabenazine.,decrease,no risk
Tetrabenazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Vandetanib.,increase,risk
Tetrabenazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Vemurafenib.,increase,risk
Tetrabenazine,Venlafaxine,The metabolism of Tetrabenazine can be decreased when combined with Venlafaxine.,decrease,no risk
Tetrabenazine,Verapamil,The metabolism of Tetrabenazine can be decreased when combined with Verapamil.,decrease,no risk
Tetrabenazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Vilazodone,The metabolism of Tetrabenazine can be decreased when combined with Vilazodone.,decrease,no risk
Tetrabenazine,Viloxazine,The metabolism of Tetrabenazine can be decreased when combined with Viloxazine.,decrease,no risk
Tetrabenazine,Vinblastine,The metabolism of Tetrabenazine can be decreased when combined with Vinblastine.,decrease,no risk
Tetrabenazine,Vinorelbine,The metabolism of Tetrabenazine can be decreased when combined with Vinorelbine.,decrease,no risk
Tetrabenazine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Tetrabenazine.,decrease,no risk
Tetrabenazine,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Zaleplon,The risk or severity of sedation and somnolence can be increased when Zaleplon is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Tetrabenazine is combined with Ziprasidone.,increase,risk
Tetrabenazine,Zolpidem,The risk or severity of sedation and somnolence can be increased when Zolpidem is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Zopiclone,The risk or severity of sedation and somnolence can be increased when Zopiclone is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Tetrabenazine.,increase,risk
Tetrabenazine,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Tetrabenazine.,increase,risk
Ixabepilone,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Bosentan,The metabolism of Ixabepilone can be increased when combined with Bosentan.,increase,no risk
Ixabepilone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Brodalumab,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Brodalumab.,increase,risk
Ixabepilone,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Ixabepilone.,decrease,no risk
Ixabepilone,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Bupivacaine.,increase,risk
Ixabepilone,Buprenorphine,The metabolism of Ixabepilone can be decreased when combined with Buprenorphine.,decrease,no risk
Ixabepilone,Buspirone,The metabolism of Buspirone can be decreased when combined with Ixabepilone.,decrease,no risk
Ixabepilone,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Ixabepilone.,increase,risk
Ixabepilone,Butacaine,The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Butacaine.,increase,risk
Ixabepilone,Butalbital,The metabolism of Ixabepilone can be increased when combined with Butalbital.,increase,no risk
Ixabepilone,Butamben,The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Butamben.,increase,risk
Ixabepilone,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ixabepilone.,increase,risk
Ixabepilone,Gilteritinib,The metabolism of Ixabepilone can be decreased when combined with Gilteritinib.,decrease,no risk
Ixabepilone,Ginkgo biloba,The metabolism of Ixabepilone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ixabepilone,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Glatiramer,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Glatiramer.,increase,risk
Ixabepilone,Glecaprevir,The metabolism of Ixabepilone can be decreased when combined with Glecaprevir.,decrease,no risk
Ixabepilone,Glofitamab,The serum concentration of Ixabepilone can be increased when it is combined with Glofitamab.,increase,no risk
Ixabepilone,Glyburide,The metabolism of Ixabepilone can be decreased when combined with Glyburide.,decrease,no risk
Ixabepilone,Glycerol phenylbutyrate,The metabolism of Ixabepilone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ixabepilone,Golimumab,The metabolism of Ixabepilone can be increased when combined with Golimumab.,increase,no risk
Ixabepilone,Grapefruit,The serum concentration of Ixabepilone can be increased when it is combined with Grapefruit.,increase,no risk
Ixabepilone,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Griseofulvin,The metabolism of Ixabepilone can be increased when combined with Griseofulvin.,increase,no risk
Ixabepilone,Guselkumab,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Guselkumab.,increase,risk
Ixabepilone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ixabepilone.,increase,risk
Ixabepilone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ixabepilone.,increase,risk
Ixabepilone,Hydralazine,The serum concentration of Ixabepilone can be increased when it is combined with Hydralazine.,increase,no risk
Ixabepilone,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Ixabepilone.,increase,risk
Ixabepilone,Hydrocortamate,The metabolism of Ixabepilone can be increased when combined with Hydrocortamate.,increase,no risk
Ixabepilone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Hydrocortisone acetate,The metabolism of Ixabepilone can be increased when combined with Hydrocortisone acetate.,increase,no risk
Ixabepilone,Hydrocortisone butyrate,The metabolism of Ixabepilone can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Ixabepilone,Hydrocortisone succinate,The metabolism of Ixabepilone can be increased when combined with Hydrocortisone succinate.,increase,no risk
Ixabepilone,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Ixabepilone.,increase,risk
Ixabepilone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ixabepilone.,increase,risk
Ixabepilone,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ixabepilone.,increase,risk
Ixabepilone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Ketazolam,The serum concentration of Ixabepilone can be increased when it is combined with Ketazolam.,increase,no risk
Ixabepilone,Ketoconazole,The metabolism of Ixabepilone can be decreased when combined with Ketoconazole.,decrease,no risk
Ixabepilone,Obinutuzumab,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Obinutuzumab.,increase,risk
Ixabepilone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Ixabepilone.,increase,no risk
Ixabepilone,Octreotide,The serum concentration of Ixabepilone can be increased when it is combined with Octreotide.,increase,no risk
Ixabepilone,Ofatumumab,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Ofatumumab.,increase,risk
Ixabepilone,Olaparib,The metabolism of Ixabepilone can be decreased when combined with Olaparib.,decrease,no risk
Ixabepilone,Olutasidenib,The metabolism of Ixabepilone can be increased when combined with Olutasidenib.,increase,no risk
Ixabepilone,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Omaveloxolone,The serum concentration of Ixabepilone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ixabepilone,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Oritavancin,The metabolism of Ixabepilone can be increased when combined with Oritavancin.,increase,no risk
Ixabepilone,Orphenadrine,The metabolism of Ixabepilone can be decreased when combined with Orphenadrine.,decrease,no risk
Ixabepilone,Osilodrostat,The metabolism of Ixabepilone can be decreased when combined with Osilodrostat.,decrease,no risk
Ixabepilone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ixabepilone.,increase,risk
Ixabepilone,Oxcarbazepine,The metabolism of Ixabepilone can be increased when combined with Oxcarbazepine.,increase,no risk
Ixabepilone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Oxetacaine.,increase,risk
Ixabepilone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ixabepilone.,decrease,no risk
Ixabepilone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Oxybuprocaine.,increase,risk
Ixabepilone,Oxybutynin,The serum concentration of Ixabepilone can be increased when it is combined with Oxybutynin.,increase,no risk
Ixabepilone,Ozanimod,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Ozanimod.,increase,risk
Ixabepilone,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Quinine,The serum concentration of Quinine can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Quinupristin,The metabolism of Ixabepilone can be decreased when combined with Quinupristin.,decrease,no risk
Ixabepilone,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ixabepilone.,increase,risk
Ixabepilone,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Upadacitinib,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Upadacitinib.,increase,risk
Ixabepilone,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Ixabepilone.,increase,risk
Ixabepilone,Vadadustat,The serum concentration of Ixabepilone can be increased when it is combined with Vadadustat.,increase,no risk
Ixabepilone,Valproic acid,The serum concentration of Ixabepilone can be increased when it is combined with Valproic acid.,increase,no risk
Ixabepilone,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ixabepilone.,increase,risk
Ixabepilone,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Vedolizumab,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Vedolizumab.,increase,risk
Ixabepilone,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Verapamil,The metabolism of Ixabepilone can be decreased when combined with Verapamil.,decrease,no risk
Ixabepilone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ixabepilone.,decrease,no risk
Ixabepilone,Vilanterol,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Vilanterol.,increase,risk
Ixabepilone,Viloxazine,The metabolism of Ixabepilone can be decreased when combined with Viloxazine.,decrease,no risk
Ixabepilone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Vincristine,The excretion of Vincristine can be decreased when combined with Ixabepilone.,decrease,no risk
Ixabepilone,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Ixabepilone.,increase,risk
Ixabepilone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ixabepilone.,increase,risk
Ixabepilone,Vitamin E,The metabolism of Ixabepilone can be increased when combined with Vitamin E.,increase,no risk
Ixabepilone,Voclosporin,The risk or severity of adverse effects can be increased when Ixabepilone is combined with Voclosporin.,increase,risk
Ixabepilone,Vorapaxar,The metabolism of Ixabepilone can be decreased when combined with Vorapaxar.,decrease,no risk
Ixabepilone,Voriconazole,The metabolism of Ixabepilone can be decreased when combined with Voriconazole.,decrease,no risk
Ixabepilone,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Ixabepilone.,increase,risk
Ixabepilone,Voxelotor,The serum concentration of Ixabepilone can be increased when it is combined with Voxelotor.,increase,no risk
Ixabepilone,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Ixabepilone.,increase,no risk
Ixabepilone,Warfarin,The metabolism of Ixabepilone can be increased when combined with Warfarin.,increase,no risk
Ixabepilone,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ixabepilone.,increase,risk
Ixabepilone,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ixabepilone.,increase,risk
Ixabepilone,Zafirlukast,The serum concentration of Ixabepilone can be increased when it is combined with Zafirlukast.,increase,no risk
Ixabepilone,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Ixabepilone.,increase,risk
Ixabepilone,Zimelidine,The metabolism of Ixabepilone can be decreased when combined with Zimelidine.,decrease,no risk
Ixabepilone,Ziprasidone,The metabolism of Ixabepilone can be decreased when combined with Ziprasidone.,decrease,no risk
Ixabepilone,Zuclopenthixol,The metabolism of Ixabepilone can be decreased when combined with Zuclopenthixol.,decrease,no risk
Celiprolol,Betahistine,The therapeutic efficacy of Celiprolol can be decreased when used in combination with Betahistine.,decrease,no risk
Celiprolol,Betaine,Betaine may increase the bradycardic activities of Celiprolol.,increase,no risk
Celiprolol,Betamethasone,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Celiprolol.,increase,risk
Celiprolol,Betamethasone phosphate,The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Celiprolol.,increase,risk
Celiprolol,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Celiprolol.,increase,no risk
Celiprolol,Bethanechol,The risk or severity of adverse effects can be increased when Celiprolol is combined with Bethanechol.,increase,risk
Celiprolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Celiprolol.,decrease,no risk
Celiprolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Celiprolol.,increase,no risk
Celiprolol,Bilastine,The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Bilastine.,increase,risk
Celiprolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Celiprolol.,increase,no risk
Celiprolol,Bimekizumab,The metabolism of Celiprolol can be increased when combined with Bimekizumab.,increase,no risk
Celiprolol,Bioallethrin,Celiprolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Celiprolol,Biperiden,The metabolism of Celiprolol can be decreased when combined with Biperiden.,decrease,no risk
Celiprolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Celiprolol.,increase,risk
Celiprolol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Celiprolol.,increase,risk
Celiprolol,Bosentan,Bosentan may increase the hypotensive activities of Celiprolol.,increase,no risk
Celiprolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Celiprolol.,increase,risk
Celiprolol,Bretylium,Bretylium may increase the arrhythmogenic activities of Celiprolol.,increase,no risk
Celiprolol,Brexpiprazole,The therapeutic efficacy of Celiprolol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Celiprolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Celiprolol.,increase,no risk
Celiprolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Celiprolol.,increase,no risk
Celiprolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Celiprolol is combined with Bromotheophylline.,increase,risk
Celiprolol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Celiprolol.,increase,risk
Celiprolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Celiprolol.,increase,risk
Celiprolol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Celiprolol.,increase,risk
Celiprolol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Celiprolol.,increase,risk
Celiprolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Celiprolol.,decrease,no risk
Celiprolol,Bumetanide,The risk or severity of hypokalemia can be increased when Celiprolol is combined with Bumetanide.,increase,risk
Celiprolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Celiprolol.,increase,no risk
Celiprolol,Buprenorphine,The metabolism of Celiprolol can be decreased when combined with Buprenorphine.,decrease,no risk
Celiprolol,Bupropion,The metabolism of Celiprolol can be decreased when combined with Bupropion.,decrease,no risk
Celiprolol,Buserelin,The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Buserelin.,increase,risk
Celiprolol,Buspirone,Buspirone may decrease the antihypertensive activities of Celiprolol.,decrease,no risk
Celiprolol,Butabarbital,The serum concentration of Celiprolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Celiprolol,Butalbital,The serum concentration of Celiprolol can be decreased when it is combined with Butalbital.,decrease,no risk
Celiprolol,Butaperazine,The serum concentration of Celiprolol can be increased when it is combined with Butaperazine.,increase,no risk
Celiprolol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Celiprolol.,increase,risk
Roxadustat,Gadoxetic acid,The serum concentration of Gadoxetic acid can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Gemfibrozil,The metabolism of Roxadustat can be decreased when combined with Gemfibrozil.,decrease,no risk
Roxadustat,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Golimumab,The metabolism of Roxadustat can be increased when combined with Golimumab.,increase,no risk
Roxadustat,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Halofantrine,The metabolism of Roxadustat can be decreased when combined with Halofantrine.,decrease,no risk
Roxadustat,Hydrocortisone,The metabolism of Roxadustat can be increased when combined with Hydrocortisone.,increase,no risk
Roxadustat,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Hydroxychloroquine,The metabolism of Roxadustat can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Roxadustat,Kaolin,Kaolin can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Ketamine,The metabolism of Roxadustat can be decreased when combined with Ketamine.,decrease,no risk
Roxadustat,Ketoconazole,The metabolism of Roxadustat can be decreased when combined with Ketoconazole.,decrease,no risk
Roxadustat,Ketoprofen,The metabolism of Roxadustat can be decreased when combined with Ketoprofen.,decrease,no risk
Roxadustat,Ketorolac,The metabolism of Roxadustat can be decreased when combined with Ketorolac.,decrease,no risk
Roxadustat,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Roxadustat.,decrease,no risk
Roxadustat,Omaveloxolone,The serum concentration of Roxadustat can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Roxadustat,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Oxybutynin,The metabolism of Roxadustat can be decreased when combined with Oxybutynin.,decrease,no risk
Roxadustat,Ozanimod,Roxadustat may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Roxadustat,Quinidine,The metabolism of Roxadustat can be decreased when combined with Quinidine.,decrease,no risk
Roxadustat,Quinine,The metabolism of Roxadustat can be decreased when combined with Quinine.,decrease,no risk
Roxadustat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Vadadustat,The serum concentration of Roxadustat can be increased when it is combined with Vadadustat.,increase,no risk
Roxadustat,Valsartan,The serum concentration of Valsartan can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Roxadustat.,decrease,no risk
Roxadustat,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Roxadustat.,increase,no risk
Roxadustat,Zinc,Zinc can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc dibutyldithiocarbamate,Zinc dibutyldithiocarbamate can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxadustat,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Roxadustat resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Roxadustat,Zopiclone,The metabolism of Roxadustat can be decreased when combined with Zopiclone.,decrease,no risk
Cediranib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Benzocaine.,increase,risk
Cediranib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Benzyl alcohol.,increase,risk
Cediranib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Bupivacaine.,increase,risk
Cediranib,Butacaine,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Butacaine.,increase,risk
Cediranib,Butamben,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Butamben.,increase,risk
Cediranib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Oxetacaine.,increase,risk
Cediranib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cediranib is combined with Oxybuprocaine.,increase,risk
Cediranib,Voriconazole,The serum concentration of Cediranib can be increased when it is combined with Voriconazole.,increase,no risk
Posizolid,Belantamab mafodotin,The excretion of Belantamab mafodotin can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Bosentan,The excretion of Bosentan can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Posizolid.,increase,no risk
Posizolid,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Ouabain,The excretion of Ouabain can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Valsartan,The excretion of Valsartan can be decreased when combined with Posizolid.,decrease,no risk
Posizolid,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Posizolid.,decrease,no risk
Biricodar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Vincristine,The excretion of Vincristine can be decreased when combined with Biricodar.,decrease,no risk
Biricodar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Biricodar.,increase,no risk
Biricodar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Biricodar.,increase,no risk
Dronedarone,Belzutifan,The serum concentration of Dronedarone can be decreased when it is combined with Belzutifan.,decrease,no risk
Dronedarone,Bempedoic acid,The excretion of Bempedoic acid can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Benazepril,Dronedarone may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Dronedarone,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Bendroflumethiazide,Dronedarone may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Dronedarone,Benorilate,The risk or severity of hypertension can be increased when Dronedarone is combined with Benorilate.,increase,risk
Dronedarone,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Dronedarone.,increase,risk
Dronedarone,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Benzphetamine,The therapeutic efficacy of Dronedarone can be decreased when used in combination with Benzphetamine.,decrease,no risk
Dronedarone,Benzydamine,The risk or severity of hypertension can be increased when Dronedarone is combined with Benzydamine.,increase,risk
Dronedarone,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Bepridil,Bepridil may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Beractant,Dronedarone may increase the bradycardic activities of Beractant.,increase,no risk
Dronedarone,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Betamethasone,The metabolism of Dronedarone can be increased when combined with Betamethasone.,increase,no risk
Dronedarone,Betamethasone phosphate,The metabolism of Dronedarone can be increased when combined with Betamethasone phosphate.,increase,no risk
Dronedarone,Betaxolol,Dronedarone may increase the bradycardic activities of Betaxolol.,increase,no risk
Dronedarone,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Bexarotene,The metabolism of Dronedarone can be increased when combined with Bexarotene.,increase,no risk
Dronedarone,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Bifonazole,The metabolism of Dronedarone can be decreased when combined with Bifonazole.,decrease,no risk
Dronedarone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Dronedarone.,increase,risk
Dronedarone,Bimekizumab,The metabolism of Dronedarone can be increased when combined with Bimekizumab.,increase,no risk
Dronedarone,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Bioallethrin,Dronedarone may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Dronedarone,Bisoprolol,Dronedarone may increase the bradycardic activities of Bisoprolol.,increase,no risk
Dronedarone,Boceprevir,The metabolism of Dronedarone can be decreased when combined with Boceprevir.,decrease,no risk
Dronedarone,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Bosentan,The metabolism of Dronedarone can be increased when combined with Bosentan.,increase,no risk
Dronedarone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Bretylium,Bretylium may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Bromocriptine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Dronedarone.",increase,no risk
Dronedarone,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Dronedarone.,increase,risk
Dronedarone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Dronedarone.,increase,risk
Dronedarone,Budesonide,The metabolism of Dronedarone can be increased when combined with Budesonide.,increase,no risk
Dronedarone,Bumadizone,The risk or severity of hypertension can be increased when Dronedarone is combined with Bumadizone.,increase,risk
Dronedarone,Bumetanide,The excretion of Bumetanide can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Dronedarone.,increase,risk
Dronedarone,Buspirone,The metabolism of Buspirone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Butalbital,The metabolism of Dronedarone can be increased when combined with Butalbital.,increase,no risk
Dronedarone,Butriptyline,Dronedarone may increase the QTc-prolonging activities of Butriptyline.,increase,no risk
Dronedarone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Dronedarone.,increase,risk
Dronedarone,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Galantamine,The metabolism of Galantamine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Ganciclovir,The risk or severity of adverse effects can be increased when Dronedarone is combined with Ganciclovir.,increase,risk
Dronedarone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Dronedarone.,increase,risk
Dronedarone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Dronedarone.,increase,risk
Dronedarone,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Dronedarone.,increase,risk
Dronedarone,Ginkgo biloba,The metabolism of Dronedarone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dronedarone,Glasdegib,Glasdegib may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Glecaprevir,The metabolism of Dronedarone can be decreased when combined with Glecaprevir.,decrease,no risk
Dronedarone,Glofitamab,The serum concentration of Dronedarone can be increased when it is combined with Glofitamab.,increase,no risk
Dronedarone,Glyburide,The metabolism of Dronedarone can be decreased when combined with Glyburide.,decrease,no risk
Dronedarone,Glycerol phenylbutyrate,The metabolism of Dronedarone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Dronedarone,Golimumab,The metabolism of Dronedarone can be increased when combined with Golimumab.,increase,no risk
Dronedarone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dronedarone.,increase,risk
Dronedarone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Dronedarone.,increase,risk
Dronedarone,Grapefruit,The serum concentration of Dronedarone can be increased when it is combined with Grapefruit.,increase,no risk
Dronedarone,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Grepafloxacin,Grepafloxacin may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Griseofulvin,The metabolism of Dronedarone can be increased when combined with Griseofulvin.,increase,no risk
Dronedarone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Guanadrel,Dronedarone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Dronedarone,Guanethidine,Dronedarone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Dronedarone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Guanoxan,Dronedarone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Dronedarone,Halofantrine,Halofantrine may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Haloperidol,The risk or severity of QTc prolongation can be increased when Dronedarone is combined with Haloperidol.,increase,risk
Dronedarone,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Dronedarone.,increase,risk
Dronedarone,Histamine,The serum concentration of Histamine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Dronedarone.,increase,risk
Dronedarone,Hydralazine,The serum concentration of Dronedarone can be increased when it is combined with Hydralazine.,increase,no risk
Dronedarone,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Hydrocortamate,The metabolism of Dronedarone can be increased when combined with Hydrocortamate.,increase,no risk
Dronedarone,Hydrocortisone,The metabolism of Dronedarone can be increased when combined with Hydrocortisone.,increase,no risk
Dronedarone,Hydrocortisone acetate,The metabolism of Dronedarone can be increased when combined with Hydrocortisone acetate.,increase,no risk
Dronedarone,Hydrocortisone butyrate,The metabolism of Dronedarone can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Dronedarone,Hydrocortisone cypionate,The metabolism of Dronedarone can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Dronedarone,Hydrocortisone phosphate,The metabolism of Dronedarone can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Dronedarone,Hydrocortisone succinate,The metabolism of Dronedarone can be increased when combined with Hydrocortisone succinate.,increase,no risk
Dronedarone,Hydroflumethiazide,Dronedarone may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Dronedarone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Hydroxyprogesterone caproate,The metabolism of Dronedarone can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Dronedarone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Dronedarone is combined with Hydroxyzine.,increase,risk
Dronedarone,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Dronedarone.,increase,no risk
Dronedarone,Ketamine,The metabolism of Ketamine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Ketazolam,The serum concentration of Dronedarone can be increased when it is combined with Ketazolam.,increase,no risk
Dronedarone,Ketoconazole,The metabolism of Dronedarone can be decreased when combined with Ketoconazole.,decrease,no risk
Dronedarone,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Dronedarone.,increase,risk
Dronedarone,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Dronedarone.,increase,risk
Dronedarone,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Dronedarone.,increase,no risk
Dronedarone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Dronedarone.,increase,risk
Dronedarone,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Olaparib,The metabolism of Olaparib can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Olmesartan,Dronedarone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Dronedarone,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Olutasidenib,The therapeutic efficacy of Dronedarone can be decreased when used in combination with Olutasidenib.,decrease,no risk
Dronedarone,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Opium,The metabolism of Opium can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Oritavancin,The metabolism of Dronedarone can be increased when combined with Oritavancin.,increase,no risk
Dronedarone,Orphenadrine,The metabolism of Dronedarone can be decreased when combined with Orphenadrine.,decrease,no risk
Dronedarone,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Osilodrostat,The metabolism of Dronedarone can be decreased when combined with Osilodrostat.,decrease,no risk
Dronedarone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Ouabain,The excretion of Ouabain can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Dronedarone.,increase,risk
Dronedarone,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Dronedarone.,increase,risk
Dronedarone,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Dronedarone.,increase,risk
Dronedarone,Oxcarbazepine,The metabolism of Dronedarone can be increased when combined with Oxcarbazepine.,increase,no risk
Dronedarone,Oxprenolol,Dronedarone may increase the bradycardic activities of Oxprenolol.,increase,no risk
Dronedarone,Oxybutynin,The serum concentration of Dronedarone can be increased when it is combined with Oxybutynin.,increase,no risk
Dronedarone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Dronedarone.,increase,risk
Dronedarone,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dronedarone.,increase,risk
Dronedarone,Quazepam,The metabolism of Quazepam can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Quinapril,The excretion of Quinapril can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Quinidine,Quinidine may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Quinine,Quinine may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Quinupramine,The risk or severity of hypertension can be increased when Dronedarone is combined with Quinupramine.,increase,risk
Dronedarone,Quinupristin,The metabolism of Dronedarone can be decreased when combined with Quinupristin.,decrease,no risk
Dronedarone,Quizartinib,The risk or severity of QTc prolongation can be increased when Dronedarone is combined with Quizartinib.,increase,risk
Dronedarone,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Udenafil,The metabolism of Dronedarone can be decreased when combined with Udenafil.,decrease,no risk
Dronedarone,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Valproic acid,Valproic acid may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Valsartan,Dronedarone may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Dronedarone,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vandetanib,Vandetanib may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Varenicline,The excretion of Varenicline can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vemurafenib,Vemurafenib may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Vernakalant,Vernakalant may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Dronedarone.,increase,risk
Dronedarone,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Viloxazine,The metabolism of Dronedarone can be decreased when combined with Viloxazine.,decrease,no risk
Dronedarone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Vincristine,The excretion of Vincristine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vindesine,The metabolism of Vindesine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vitamin E,The metabolism of Dronedarone can be increased when combined with Vitamin E.,increase,no risk
Dronedarone,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Vonoprazan,The metabolism of Dronedarone can be decreased when combined with Vonoprazan.,decrease,no risk
Dronedarone,Vorapaxar,The metabolism of Dronedarone can be decreased when combined with Vorapaxar.,decrease,no risk
Dronedarone,Voriconazole,The metabolism of Dronedarone can be decreased when combined with Voriconazole.,decrease,no risk
Dronedarone,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dronedarone.,increase,risk
Dronedarone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Voxelotor,The serum concentration of Dronedarone can be increased when it is combined with Voxelotor.,increase,no risk
Dronedarone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Dronedarone.,decrease,no risk
Dronedarone,Xylometazoline,Dronedarone may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Dronedarone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Zafirlukast,The serum concentration of Dronedarone can be increased when it is combined with Zafirlukast.,increase,no risk
Dronedarone,Zaleplon,The metabolism of Dronedarone can be decreased when combined with Zaleplon.,decrease,no risk
Dronedarone,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Dronedarone.,increase,no risk
Dronedarone,Ziconotide,Dronedarone may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Dronedarone,Zidovudine,The excretion of Zidovudine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Zileuton,The metabolism of Zileuton can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Zimelidine,The metabolism of Dronedarone can be decreased when combined with Zimelidine.,decrease,no risk
Dronedarone,Ziprasidone,Ziprasidone may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Zofenopril,Dronedarone may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Dronedarone,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Dronedarone.,increase,risk
Dronedarone,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Dronedarone.,increase,no risk
Dronedarone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Zotepine,The metabolism of Zotepine can be decreased when combined with Dronedarone.,decrease,no risk
Dronedarone,Zuclopenthixol,Zuclopenthixol may increase the QTc-prolonging activities of Dronedarone.,increase,no risk
Dronedarone,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Dronedarone.,decrease,no risk
Dexloxiglumide,Gefitinib,The metabolism of Dexloxiglumide can be decreased when combined with Gefitinib.,decrease,no risk
Dexloxiglumide,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Glipizide,The metabolism of Glipizide can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Glofitamab,The serum concentration of Dexloxiglumide can be increased when it is combined with Glofitamab.,increase,no risk
Dexloxiglumide,Glyburide,The metabolism of Glyburide can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Golimumab,The metabolism of Dexloxiglumide can be increased when combined with Golimumab.,increase,no risk
Dexloxiglumide,Halofantrine,The metabolism of Dexloxiglumide can be decreased when combined with Halofantrine.,decrease,no risk
Dexloxiglumide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dexloxiglumide.,increase,no risk
Dexloxiglumide,Halothane,The metabolism of Halothane can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydrocortisone,The metabolism of Dexloxiglumide can be decreased when combined with Hydrocortisone.,decrease,no risk
Dexloxiglumide,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Hydroxyzine,The metabolism of Dexloxiglumide can be decreased when combined with Hydroxyzine.,decrease,no risk
Dexloxiglumide,Ketamine,The metabolism of Ketamine can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Ketoconazole,The metabolism of Dexloxiglumide can be decreased when combined with Ketoconazole.,decrease,no risk
Dexloxiglumide,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Olaparib,The metabolism of Olaparib can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Omaveloxolone,The serum concentration of Dexloxiglumide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dexloxiglumide,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Osilodrostat,The metabolism of Dexloxiglumide can be decreased when combined with Osilodrostat.,decrease,no risk
Dexloxiglumide,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Oxcarbazepine,The metabolism of Dexloxiglumide can be increased when combined with Oxcarbazepine.,increase,no risk
Dexloxiglumide,Oxybutynin,The metabolism of Dexloxiglumide can be decreased when combined with Oxybutynin.,decrease,no risk
Dexloxiglumide,Oxycodone,The metabolism of Dexloxiglumide can be decreased when combined with Oxycodone.,decrease,no risk
Dexloxiglumide,Quetiapine,The metabolism of Dexloxiglumide can be decreased when combined with Quetiapine.,decrease,no risk
Dexloxiglumide,Quinine,The metabolism of Quinine can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Udenafil,The metabolism of Udenafil can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Vadadustat,The serum concentration of Dexloxiglumide can be increased when it is combined with Vadadustat.,increase,no risk
Dexloxiglumide,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Valsartan,The metabolism of Valsartan can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Venetoclax,The metabolism of Dexloxiglumide can be decreased when combined with Venetoclax.,decrease,no risk
Dexloxiglumide,Verapamil,The metabolism of Dexloxiglumide can be decreased when combined with Verapamil.,decrease,no risk
Dexloxiglumide,Viloxazine,The metabolism of Dexloxiglumide can be decreased when combined with Viloxazine.,decrease,no risk
Dexloxiglumide,Vincristine,The metabolism of Vincristine can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Voriconazole,The metabolism of Dexloxiglumide can be decreased when combined with Voriconazole.,decrease,no risk
Dexloxiglumide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Warfarin,The metabolism of Warfarin can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Zaleplon,The metabolism of Dexloxiglumide can be decreased when combined with Zaleplon.,decrease,no risk
Dexloxiglumide,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Zileuton,The metabolism of Zileuton can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Zimelidine,The metabolism of Dexloxiglumide can be decreased when combined with Zimelidine.,decrease,no risk
Dexloxiglumide,Ziprasidone,The metabolism of Dexloxiglumide can be decreased when combined with Ziprasidone.,decrease,no risk
Dexloxiglumide,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dexloxiglumide.,decrease,no risk
Dexloxiglumide,Zonisamide,The metabolism of Dexloxiglumide can be decreased when combined with Zonisamide.,decrease,no risk
Dexloxiglumide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dexloxiglumide.,decrease,no risk
Tirapazamine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Benzocaine.,increase,risk
Tirapazamine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Benzyl alcohol.,increase,risk
Tirapazamine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Bupivacaine.,increase,risk
Tirapazamine,Butacaine,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Butacaine.,increase,risk
Tirapazamine,Butamben,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Butamben.,increase,risk
Tirapazamine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Oxetacaine.,increase,risk
Tirapazamine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tirapazamine is combined with Oxybuprocaine.,increase,risk
Nebivolol,Betaine,Betaine may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Nebivolol,Bethanechol,The risk or severity of adverse effects can be increased when Nebivolol is combined with Bethanechol.,increase,risk
Nebivolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Bimekizumab,The metabolism of Nebivolol can be increased when combined with Bimekizumab.,increase,no risk
Nebivolol,Bioallethrin,Nebivolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Nebivolol,Biperiden,The metabolism of Nebivolol can be decreased when combined with Biperiden.,decrease,no risk
Nebivolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Nebivolol.,increase,risk
Nebivolol,Boceprevir,The metabolism of Nebivolol can be decreased when combined with Boceprevir.,decrease,no risk
Nebivolol,Bortezomib,The metabolism of Nebivolol can be decreased when combined with Bortezomib.,decrease,no risk
Nebivolol,Bosentan,Bosentan may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Nebivolol.,increase,risk
Nebivolol,Bretylium,Bretylium may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Nebivolol,Brexpiprazole,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Nebivolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Nebivolol.,increase,no risk
Nebivolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Nebivolol is combined with Bromotheophylline.,increase,risk
Nebivolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Nebivolol.,increase,risk
Nebivolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Nebivolol.,increase,risk
Nebivolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Nebivolol.,increase,no risk
Nebivolol,Buprenorphine,The metabolism of Nebivolol can be decreased when combined with Buprenorphine.,decrease,no risk
Nebivolol,Bupropion,The metabolism of Nebivolol can be decreased when combined with Bupropion.,decrease,no risk
Nebivolol,Buspirone,Buspirone may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Butabarbital,Butabarbital may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Butalbital,Butalbital may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Butaperazine,The serum concentration of Nebivolol can be increased when it is combined with Butaperazine.,increase,no risk
Nebivolol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Nebivolol.,increase,risk
Nebivolol,Galantamine,Galantamine may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Gefitinib,The metabolism of Nebivolol can be decreased when combined with Gefitinib.,decrease,no risk
Nebivolol,Gemfibrozil,The metabolism of Nebivolol can be decreased when combined with Gemfibrozil.,decrease,no risk
Nebivolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Givosiran,The serum concentration of Nebivolol can be increased when it is combined with Givosiran.,increase,no risk
Nebivolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Glofitamab,The serum concentration of Nebivolol can be increased when it is combined with Glofitamab.,increase,no risk
Nebivolol,Glucagon,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Glucagon.,decrease,no risk
Nebivolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Glycerol phenylbutyrate,The metabolism of Nebivolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Nebivolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Golimumab,The metabolism of Nebivolol can be increased when combined with Golimumab.,increase,no risk
Nebivolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Guanadrel,Guanadrel may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Guanethidine,Guanethidine may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Guanoxan,Nebivolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Nebivolol,Halofantrine,The metabolism of Nebivolol can be decreased when combined with Halofantrine.,decrease,no risk
Nebivolol,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nebivolol.,increase,no risk
Nebivolol,Halothane,Halothane may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Nebivolol.,increase,risk
Nebivolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Nebivolol.,increase,risk
Nebivolol,Huperzine A,Huperzine A may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Hydralazine,Hydralazine may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Hydroflumethiazide,The therapeutic efficacy of Nebivolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Nebivolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Nebivolol.,decrease,risk
Nebivolol,Hydroxyzine,The metabolism of Nebivolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Nebivolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Nebivolol,Ketamine,Ketamine may increase the bradycardic activities of Nebivolol.,increase,no risk
Nebivolol,Ketoconazole,The metabolism of Nebivolol can be decreased when combined with Ketoconazole.,decrease,no risk
Nebivolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Nebivolol.,increase,risk
Nebivolol,Obinutuzumab,Nebivolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Nebivolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Nebivolol.,increase,no risk
Nebivolol,Olanzapine,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Olanzapine.,decrease,no risk
Nebivolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Nebivolol.,decrease,no risk
Nebivolol,Olmesartan,Olmesartan may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Omaveloxolone,The serum concentration of Nebivolol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nebivolol,Omeprazole,The metabolism of Nebivolol can be decreased when combined with Omeprazole.,decrease,no risk
Nebivolol,Ondansetron,The metabolism of Nebivolol can be decreased when combined with Ondansetron.,decrease,no risk
Nebivolol,Opicapone,The risk or severity of adverse effects can be increased when Nebivolol is combined with Opicapone.,increase,risk
Nebivolol,Opium,The metabolism of Opium can be decreased when combined with Nebivolol.,decrease,no risk
Nebivolol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Oritavancin,The metabolism of Nebivolol can be decreased when combined with Oritavancin.,decrease,no risk
Nebivolol,Orphenadrine,The metabolism of Nebivolol can be decreased when combined with Orphenadrine.,decrease,no risk
Nebivolol,Osilodrostat,The metabolism of Nebivolol can be decreased when combined with Osilodrostat.,decrease,no risk
Nebivolol,Ospemifene,The metabolism of Nebivolol can be decreased when combined with Ospemifene.,decrease,no risk
Nebivolol,Ouabain,Nebivolol may increase the bradycardic activities of Ouabain.,increase,no risk
Nebivolol,Oxamniquine,The metabolism of Nebivolol can be decreased when combined with Oxamniquine.,decrease,no risk
Nebivolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Oxcarbazepine,The metabolism of Nebivolol can be decreased when combined with Oxcarbazepine.,decrease,no risk
Nebivolol,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Nebivolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Nebivolol is combined with Oxtriphylline.,increase,risk
Nebivolol,Oxybutynin,The metabolism of Nebivolol can be decreased when combined with Oxybutynin.,decrease,no risk
Nebivolol,Oxycodone,The metabolism of Nebivolol can be decreased when combined with Oxycodone.,decrease,no risk
Nebivolol,Oxymetazoline,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Nebivolol,Oxymorphone,The metabolism of Nebivolol can be decreased when combined with Oxymorphone.,decrease,no risk
Nebivolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Quetiapine,Quetiapine may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Quinapril,Quinapril may increase the hypotensive activities of Nebivolol.,increase,no risk
Nebivolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Nebivolol,Quinine,The metabolism of Nebivolol can be decreased when combined with Quinine.,decrease,no risk
Nebivolol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Nebivolol.,increase,risk
Nebivolol,Udenafil,Udenafil may increase the antihypertensive activities of Nebivolol.,increase,no risk
Nebivolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Nebivolol.,decrease,no risk
Nebivolol,Unoprostone,Nebivolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Nebivolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Nebivolol.,increase,risk
Nebivolol,Vadadustat,The serum concentration of Nebivolol can be increased when it is combined with Vadadustat.,increase,no risk
Nebivolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Nebivolol.,decrease,no risk
Nebivolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Valproic acid,The metabolism of Nebivolol can be decreased when combined with Valproic acid.,decrease,no risk
Nebivolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Nebivolol.,increase,no risk
Nebivolol,Varenicline,The risk or severity of adverse effects can be increased when Nebivolol is combined with Varenicline.,increase,risk
Nebivolol,Vemurafenib,The metabolism of Nebivolol can be decreased when combined with Vemurafenib.,decrease,no risk
Nebivolol,Venetoclax,The metabolism of Nebivolol can be decreased when combined with Venetoclax.,decrease,no risk
Nebivolol,Venlafaxine,The metabolism of Nebivolol can be decreased when combined with Venlafaxine.,decrease,no risk
Nebivolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Nebivolol.,increase,risk
Nebivolol,Vericiguat,The risk or severity of adverse effects can be increased when Nebivolol is combined with Vericiguat.,increase,risk
Nebivolol,Vernakalant,Nebivolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Nebivolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Vilazodone,The metabolism of Nebivolol can be decreased when combined with Vilazodone.,decrease,no risk
Nebivolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Nebivolol.,increase,no risk
Nebivolol,Viloxazine,The metabolism of Nebivolol can be decreased when combined with Viloxazine.,decrease,no risk
Nebivolol,Vinblastine,The metabolism of Nebivolol can be decreased when combined with Vinblastine.,decrease,no risk
Nebivolol,Vinorelbine,The metabolism of Nebivolol can be decreased when combined with Vinorelbine.,decrease,no risk
Nebivolol,Vonoprazan,The metabolism of Nebivolol can be decreased when combined with Vonoprazan.,decrease,no risk
Nebivolol,Voriconazole,The metabolism of Nebivolol can be decreased when combined with Voriconazole.,decrease,no risk
Nebivolol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Nebivolol.,decrease,no risk
Nebivolol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Nebivolol.,decrease,no risk
Nebivolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Nebivolol.,decrease,no risk
Nebivolol,Xylometazoline,Nebivolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Nebivolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Zafirlukast,The metabolism of Nebivolol can be decreased when combined with Zafirlukast.,decrease,no risk
Nebivolol,Ziconotide,Nebivolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Nebivolol,Zimelidine,The serum concentration of Nebivolol can be increased when it is combined with Zimelidine.,increase,no risk
Nebivolol,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Nebivolol.,increase,no risk
Nebivolol,Zofenopril,Nebivolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Nebivolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Nebivolol.,decrease,no risk
Nebivolol,Zolpidem,The metabolism of Nebivolol can be decreased when combined with Zolpidem.,decrease,no risk
Nebivolol,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Nebivolol.,increase,no risk
Nebivolol,Zuclopenthixol,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Omacetaxine mepesuccinate,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Omacetaxine mepesuccinate.,increase,risk
Omacetaxine mepesuccinate,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Omacetaxine mepesuccinate.,increase,risk
Omacetaxine mepesuccinate,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Omacetaxine mepesuccinate.,increase,risk
Omacetaxine mepesuccinate,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Omacetaxine mepesuccinate.,increase,risk
Omacetaxine mepesuccinate,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Omacetaxine mepesuccinate.,increase,risk
Omacetaxine mepesuccinate,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Omacetaxine mepesuccinate.,increase,risk
Halofuginone,Benzocaine,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Benzocaine.,increase,risk
Halofuginone,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Benzyl alcohol.,increase,risk
Halofuginone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Bupivacaine.,increase,risk
Halofuginone,Butacaine,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Butacaine.,increase,risk
Halofuginone,Butamben,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Butamben.,increase,risk
Halofuginone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Oxetacaine.,increase,risk
Halofuginone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Halofuginone is combined with Oxybuprocaine.,increase,risk
Halofuginone,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Halofuginone is combined with Zoledronic acid.,increase,risk
Nilotinib,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Nilotinib.,increase,risk
Nilotinib,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Nilotinib.,increase,risk
Nilotinib,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Nilotinib.,increase,risk
Nilotinib,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Nilotinib.,increase,risk
Nilotinib,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Belatacept,The risk or severity of adverse effects can be increased when Nilotinib is combined with Belatacept.,increase,risk
Nilotinib,Belimumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Belimumab.,increase,risk
Nilotinib,Belinostat,The metabolism of Belinostat can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Belzutifan,The serum concentration of Nilotinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Nilotinib,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Nilotinib.,increase,risk
Nilotinib,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Nilotinib.,increase,risk
Nilotinib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Nilotinib.,increase,risk
Nilotinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Benzocaine.,increase,risk
Nilotinib,Benzphetamine,The metabolism of Benzphetamine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Nilotinib.,increase,risk
Nilotinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Benzyl alcohol.,increase,risk
Nilotinib,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bepridil,The metabolism of Bepridil can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bifonazole,The metabolism of Nilotinib can be decreased when combined with Bifonazole.,decrease,no risk
Nilotinib,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Nilotinib.,increase,risk
Nilotinib,Bimekizumab,The metabolism of Nilotinib can be increased when combined with Bimekizumab.,increase,no risk
Nilotinib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Bisoprolol,The metabolism of Bisoprolol can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Nilotinib.,increase,risk
Nilotinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Nilotinib.,increase,risk
Nilotinib,Blinatumomab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Blinatumomab.,increase,risk
Nilotinib,Boceprevir,The metabolism of Nilotinib can be decreased when combined with Boceprevir.,decrease,no risk
Nilotinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Nilotinib.",decrease,no risk
Nilotinib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bosentan,The metabolism of Bosentan can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Nilotinib.,increase,risk
Nilotinib,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Brodalumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Brodalumab.,increase,risk
Nilotinib,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Nilotinib.,increase,risk
Nilotinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Nilotinib.,increase,risk
Nilotinib,Budesonide,The metabolism of Budesonide can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Nilotinib.,increase,risk
Nilotinib,Buspirone,The metabolism of Buspirone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Butacaine.,increase,risk
Nilotinib,Butalbital,The metabolism of Nilotinib can be increased when combined with Butalbital.,increase,no risk
Nilotinib,Butamben,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Butamben.,increase,risk
Nilotinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Nilotinib.,increase,risk
Nilotinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Nilotinib.,increase,risk
Nilotinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Galantamine,The metabolism of Galantamine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Nilotinib.,increase,risk
Nilotinib,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Nilotinib.,increase,risk
Nilotinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Nilotinib.,increase,risk
Nilotinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Ginkgo biloba,The metabolism of Nilotinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Nilotinib,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Glatiramer,The risk or severity of adverse effects can be increased when Nilotinib is combined with Glatiramer.,increase,risk
Nilotinib,Glecaprevir,The metabolism of Nilotinib can be decreased when combined with Glecaprevir.,decrease,no risk
Nilotinib,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Glofitamab,The serum concentration of Nilotinib can be increased when it is combined with Glofitamab.,increase,no risk
Nilotinib,Glyburide,The metabolism of Glyburide can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Glycerol phenylbutyrate,The metabolism of Nilotinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Nilotinib,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Golimumab,The metabolism of Nilotinib can be increased when combined with Golimumab.,increase,no risk
Nilotinib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nilotinib.,increase,risk
Nilotinib,Granisetron,The metabolism of Granisetron can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Grapefruit,The serum concentration of Nilotinib can be increased when it is combined with Grapefruit.,increase,no risk
Nilotinib,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Griseofulvin,The metabolism of Nilotinib can be increased when combined with Griseofulvin.,increase,no risk
Nilotinib,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Guselkumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Guselkumab.,increase,risk
Nilotinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Haloperidol.,increase,risk
Nilotinib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Nilotinib.,increase,risk
Nilotinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Nilotinib.,increase,risk
Nilotinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Nilotinib.,increase,risk
Nilotinib,Hydralazine,The serum concentration of Nilotinib can be increased when it is combined with Hydralazine.,increase,no risk
Nilotinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Nilotinib.,increase,risk
Nilotinib,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydrocortamate,The metabolism of Nilotinib can be increased when combined with Hydrocortamate.,increase,no risk
Nilotinib,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Nilotinib.,increase,risk
Nilotinib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Nilotinib.,increase,risk
Nilotinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Hydroxyzine.,increase,risk
Nilotinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Nilotinib.,increase,risk
Nilotinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Ketamine,The metabolism of Ketamine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Ketoconazole,The metabolism of Nilotinib can be decreased when combined with Ketoconazole.,decrease,no risk
Nilotinib,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Obinutuzumab.,increase,risk
Nilotinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Ocrelizumab.,increase,risk
Nilotinib,Octreotide,The serum concentration of Nilotinib can be increased when it is combined with Octreotide.,increase,no risk
Nilotinib,Ofatumumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Ofatumumab.,increase,risk
Nilotinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Nilotinib.,increase,risk
Nilotinib,Olanzapine,Olanzapine can cause a decrease in the absorption of Nilotinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nilotinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Nilotinib.,increase,risk
Nilotinib,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Ombitasvir,Nilotinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Nilotinib,Omeprazole,The serum concentration of Nilotinib can be decreased when it is combined with Omeprazole.,decrease,no risk
Nilotinib,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Opium,The metabolism of Opium can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oritavancin,The metabolism of Nilotinib can be increased when combined with Oritavancin.,increase,no risk
Nilotinib,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oteseconazole,The serum concentration of Nilotinib can be increased when it is combined with Oteseconazole.,increase,no risk
Nilotinib,Ouabain,The excretion of Ouabain can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Nilotinib.,increase,risk
Nilotinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Nilotinib.,increase,risk
Nilotinib,Oxcarbazepine,The metabolism of Nilotinib can be increased when combined with Oxcarbazepine.,increase,no risk
Nilotinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Oxetacaine.,increase,risk
Nilotinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Oxybuprocaine.,increase,risk
Nilotinib,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Nilotinib.,increase,risk
Nilotinib,Ozanimod,Nilotinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Nilotinib,Quazepam,The metabolism of Quazepam can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Quinidine,The metabolism of Quinidine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Quinine,The metabolism of Quinine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Quinupristin,The metabolism of Nilotinib can be decreased when combined with Quinupristin.,decrease,no risk
Nilotinib,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Nilotinib.,increase,risk
Nilotinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Udenafil,The metabolism of Udenafil can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Nilotinib.,increase,risk
Nilotinib,Vadadustat,The serum concentration of Nilotinib can be increased when it is combined with Vadadustat.,increase,no risk
Nilotinib,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Valproic acid,The serum concentration of Nilotinib can be increased when it is combined with Valproic acid.,increase,no risk
Nilotinib,Valsartan,The excretion of Valsartan can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Nilotinib.,increase,risk
Nilotinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Vedolizumab,The risk or severity of adverse effects can be increased when Nilotinib is combined with Vedolizumab.,increase,risk
Nilotinib,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Verapamil,The metabolism of Verapamil can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Nilotinib.,increase,risk
Nilotinib,Verteporfin,Nilotinib may increase the photosensitizing activities of Verteporfin.,increase,no risk
Nilotinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Nilotinib.,increase,no risk
Nilotinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Nilotinib.,decrease,no risk
Nilotinib,Viloxazine,The metabolism of Nilotinib can be decreased when combined with Viloxazine.,decrease,no risk
Nilotinib,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vincristine,The excretion of Vincristine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vismodegib,Vismodegib may decrease the excretion rate of Nilotinib which could result in a higher serum level.,decrease,no risk
Nilotinib,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Voriconazole,The metabolism of Nilotinib can be decreased when combined with Voriconazole.,decrease,no risk
Nilotinib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Nilotinib.,increase,risk
Nilotinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Voxelotor,The serum concentration of Nilotinib can be increased when it is combined with Voxelotor.,increase,no risk
Nilotinib,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Warfarin,The metabolism of Warfarin can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Nilotinib.,increase,risk
Nilotinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Nilotinib.,increase,risk
Nilotinib,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Zafirlukast,The serum concentration of Nilotinib can be increased when it is combined with Zafirlukast.,increase,no risk
Nilotinib,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Zileuton,The metabolism of Zileuton can be decreased when combined with Nilotinib.,decrease,no risk
Nilotinib,Zimelidine,The metabolism of Nilotinib can be decreased when combined with Zimelidine.,decrease,no risk
Nilotinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Nilotinib is combined with Ziprasidone.,increase,risk
Lorcaserin,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Benznidazole,Lorcaserin may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Lorcaserin,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Lorcaserin.,increase,risk
Lorcaserin,Benzthiazide,Benzthiazide may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorcaserin,Benzydamine,Benzydamine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Bepotastine,Lorcaserin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bepridil,The metabolism of Bepridil can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Berotralstat,The metabolism of Lorcaserin can be decreased when combined with Berotralstat.,decrease,no risk
Lorcaserin,Betamethasone,The metabolism of Lorcaserin can be increased when combined with Betamethasone.,increase,no risk
Lorcaserin,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Bicisate,Lorcaserin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bimekizumab,The metabolism of Lorcaserin can be increased when combined with Bimekizumab.,increase,no risk
Lorcaserin,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Biperiden,The metabolism of Lorcaserin can be decreased when combined with Biperiden.,decrease,no risk
Lorcaserin,Bismuth subgallate,Lorcaserin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bisoprolol,Bisoprolol may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bisoxatin,Lorcaserin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bleomycin,Bleomycin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Boceprevir,The metabolism of Lorcaserin can be decreased when combined with Boceprevir.,decrease,no risk
Lorcaserin,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Lorcaserin.,increase,risk
Lorcaserin,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Lorcaserin.,increase,risk
Lorcaserin,Brexanolone,The risk or severity of CNS depression can be increased when Lorcaserin is combined with Brexanolone.,increase,risk
Lorcaserin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Lorcaserin.,increase,no risk
Lorcaserin,Brivaracetam,The risk or severity of CNS depression can be increased when Lorcaserin is combined with Brivaracetam.,increase,risk
Lorcaserin,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Lorcaserin.,increase,risk
Lorcaserin,Bromocriptine,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Bromocriptine.,increase,risk
Lorcaserin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorcaserin,Bromperidol,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Bromperidol.,increase,risk
Lorcaserin,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Lorcaserin.,increase,risk
Lorcaserin,Budesonide,Budesonide may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bumadizone,Bumadizone may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Bumetanide,Bumetanide may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorcaserin,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Buprenorphine,Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Lorcaserin,Bupropion,The metabolism of Lorcaserin can be decreased when combined with Bupropion.,decrease,no risk
Lorcaserin,Buspirone,The metabolism of Buspirone can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Lorcaserin.,increase,risk
Lorcaserin,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Lorcaserin.,increase,risk
Lorcaserin,Butaperazine,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Butaperazine.,increase,risk
Lorcaserin,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Lorcaserin.,increase,risk
Lorcaserin,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Lorcaserin.,increase,risk
Lorcaserin,Butriptyline,The risk or severity of CNS depression can be increased when Lorcaserin is combined with Butriptyline.,increase,risk
Lorcaserin,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Lorcaserin.,increase,risk
Lorcaserin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lorcaserin is combined with Gabapentin enacarbil.,increase,risk
Lorcaserin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gadodiamide,Gadodiamide may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gadofosveset trisodium,Lorcaserin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gadoteric acid,Lorcaserin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gadoteridol,Gadoteridol may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Galantamine,The metabolism of Galantamine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Lorcaserin.,increase,risk
Lorcaserin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lorcaserin is combined with Ganaxolone.",increase,risk
Lorcaserin,Ganciclovir,Ganciclovir may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gatifloxacin,The metabolism of Lorcaserin can be decreased when combined with Gatifloxacin.,decrease,no risk
Lorcaserin,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Gemcitabine,Gemcitabine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gemfibrozil,The metabolism of Lorcaserin can be decreased when combined with Gemfibrozil.,decrease,no risk
Lorcaserin,Gemifloxacin,The metabolism of Lorcaserin can be decreased when combined with Gemifloxacin.,decrease,no risk
Lorcaserin,Gentamicin,Lorcaserin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Lorcaserin.,increase,risk
Lorcaserin,Gilteritinib,The therapeutic efficacy of Lorcaserin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Lorcaserin,Gimeracil,Lorcaserin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lorcaserin,Givosiran,The serum concentration of Lorcaserin can be increased when it is combined with Givosiran.,increase,no risk
Lorcaserin,Glipizide,Glipizide may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Glofitamab,The serum concentration of Lorcaserin can be increased when it is combined with Glofitamab.,increase,no risk
Lorcaserin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Lorcaserin.,increase,risk
Lorcaserin,Glycerol phenylbutyrate,The metabolism of Lorcaserin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Lorcaserin,Golimumab,The metabolism of Lorcaserin can be increased when combined with Golimumab.,increase,no risk
Lorcaserin,Golodirsen,Lorcaserin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Lorcaserin,Goserelin,Goserelin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Lorcaserin.,increase,risk
Lorcaserin,Grepafloxacin,The metabolism of Lorcaserin can be decreased when combined with Grepafloxacin.,decrease,no risk
Lorcaserin,Guanabenz,The metabolism of Lorcaserin can be decreased when combined with Guanabenz.,decrease,no risk
Lorcaserin,Guanethidine,Guanethidine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Lorcaserin.,increase,risk
Lorcaserin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Lorcaserin.,increase,risk
Lorcaserin,Halofantrine,The metabolism of Lorcaserin can be decreased when combined with Halofantrine.,decrease,no risk
Lorcaserin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Lorcaserin.,increase,risk
Lorcaserin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Lorcaserin.,increase,risk
Lorcaserin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Lorcaserin.,increase,risk
Lorcaserin,Hydralazine,Hydralazine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorcaserin,Hydrocodone,Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lorcaserin,Hydrocortisone,The metabolism of Lorcaserin can be increased when combined with Hydrocortisone.,increase,no risk
Lorcaserin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorcaserin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Lorcaserin.,increase,risk
Lorcaserin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Hydroxyethyl Starch,Lorcaserin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Lorcaserin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lorcaserin.,increase,no risk
Lorcaserin,Kanamycin,Lorcaserin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Lorcaserin.,increase,risk
Lorcaserin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Lorcaserin.,increase,risk
Lorcaserin,Ketoconazole,The metabolism of Lorcaserin can be decreased when combined with Ketoconazole.,decrease,no risk
Lorcaserin,Ketoprofen,Ketoprofen may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Ketorolac,Ketorolac may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
